P01  Reproductive Genetics/Prenatal Genetics Material and methods: The data from Medical Genetic Center Register was analyzing by the MedCalc 15.8 E-
P01 .07 program. Epidemiological monitoring of congenital malforma- Results: The incidence rate of congenital malformations tions in Yakutia from 2007 to 2018 over a 12-year period averaged 29.4 cases per 1000 newborns with a standard deviation of 2.9. It’s high A.I.Fedorov1,A.L.Sukhomyasova1,2,A.N.Sleptsov2,1,N. indicator In Russia (>20 ‰). At this period, the average R. Maksimova1 annual number of births was 15725.7 (SD 1174.3). The high frequencies of malformations in 2012, 2017 and 2018 1Research Laboratory “Molecular Medicine and Human was observing (Table 1). The observed differences are Genetics”, Medical Institute, M. K. Ammosov North- statistically signiﬁcantly (p < 0.05). Eastern Federal University, Yakutsk, Russian Federation, 2Medical Genetic Center, Republican Hospital №1 – Table 1. Congenital malformations prevalence “NationalMedicalCenter”,Yakutsk,RussianFederation Years Incidenceswith95%CI Introduction: Congenital malformations represent an 2007 0.0296(0.02694-0.03246) urgent problem that affects the structure of infant and child 2008 0.02734(0.02479-0.03008) mortality. In Yakutia, the prevalence of congenital mal- 2009 0.02743(0.02492-0.03012) formations is recording in Register of Medical Genetic 2010 0.02893(0.02636-0.03168) Center, Republican Hospital №1 - “National Medical 2011 0.02981(0.02723-0.03258) Center”. The purpose of epidemiological monitoring is to 2012 0.03336(0.03067-0.03622)Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 799 and rs560654095. The frequency of the rs34957925 minor Years Incidenceswith95%CI variant in the endometriosis group corresponded its rate in European populations. The frequency of the minor 2013 0.0273(0.02485-0.02992) rs560654095 variant was 0.061 (G-0.00001, 1000 2014 0.02704(0.02463-0.02963) Genomes). 2015 0.02527(0.02289-0.02783) Conclusions: We did not found statistically signiﬁcant 2016 0.02977(0.0271-0.03263) differences in allele frequencies ofEM patients and control 2017 0.03265(0.02973-0.03579) groups for the polymorphic variants the WNT7A, TWIST1 2018 0.03464(0.03154-0.03797) and WNT4 genes. In endometriosis patients a high representation (6%) of the rs560654095 minor allele was Conclusion: Thus, Yakutia is region with a high found. The HOXA10 gene product binds to the β-actin frequency of congenital malformations, and in recent years promoter and regulates its expression in the endometrium. an increase the frequency of their registration. The Furtherstudiesareinprogresstocheckthisunusualﬁnding. prevalence of congenital malformations is vary at approx- ThisworkwasﬁnanciallysupportedbytheRussianScience imate intervals of 4-5 years and increase tendency may Foundation (No. 19-15-00108) persist for several years because improved diagnostic N.S. Osinovskaya: None. N.Y. Shved: None. O.V. methods. Malysheva: None. M.I. Yarmolinskaya: None. V.S. Research is part of the project FSRG-2020-0014 “Arctic Baranov: None. Genomics: epidemiology, heredity and pathology”. A.I. Fedorov: None. A.L. Sukhomyasova: None. A.N. E-
P01 .12 Sleptsov: None. N.R. Maksimova: None. NF
E2 L2
 and JUN transcription study in fetal and maternal tissues of women with pregnancy loss in the E- P01
.09 ﬁrst trimester Analysis of the minor allele frequency of WNT7A (rs2639607), WNT4 (rs7521902), TWIST1 (rs4721745) E. Mashkina, K. Kovalenko and HOXA10 gene (exon2) in women with presumably hereditary forms of endometriosis. Southern Federal University, Rostov-on-Don, Russian Federation N.S.Osinovskaya1,2,N.Y.Shved1,O.V.Malysheva1,M.I. Yarmolinskaya1, V. S. Baranov1 Background: The cells constantly interact with many sig- naling molecules. This leads to dynamic changes in the 1Ott’s Scientiﬁc Research Institute of Obstetrics, Gynecol- spectrum of expressed genes. Nrf2 and JUN are transcrip- ogy and Reproductology, St. Petersburg, Russian Federa- tion factors that are involved in maintaining intracellular tion, 2North-Western State Medical University named after redoxhomeostasis,whichisnecessaryforcellsproliferation I.I. Mechnikov, Saint-Petersburg, Russian Federation and differentiation. These transcription factors activate the antioxidantdefenseofcellsfromoxidativestress.Incurrent Introduction: According to GWAS, over 100 genes are work, we investigated the expression of NF E2
L2 , JUN, associated with development of endometriosis (EM) - SOD1 genes in chorionic and decidual tissues after spon- common gynecologic disorder. The present work was taneous abortion compared to normal ﬁrst trimester devoted to the study of exon 2 polymorphism in HOXA10 pregnancies. geneaswellasthefrequencyofminorallelicvariantsofthe Materialsandmethods:Samplesofchorionictissueand WNT7A, WNT4, TWIST1 genes. decidua were taken after surgical termination of normally Materials and methods: DNA samples extracted from progressing pregnancies and spontaneous abortion in 5-9 peripheralbloodof41patientswithlaparoscopicallyproved week of gestation. RNA expression was analyzed using endometriosis and 43 ones from the control cohort were quantitative real-time PCR method. Data were analyzed used.Real-timePCRwasappliedtoanalyzeallelicvariants using the 2-ΔΔCT method. of the WNT7A, WNT4, TWIST1 genes. Sanger sequencing Results: The transcription level of the NF
E2 L2
, JUN, of the 2nd exon of the HOXA10 gene was performed in 41 SOD1 genes is signiﬁcantly higher in decidual tissue cells patients with proved endometriosis. compared to chorion cells during normal pregnancy Results: The frequencies of the minor variants: (p<0.0001). Thus, the tissue-speciﬁc transcription level of rs12639607 (WNT7A), rs4721745 (TWIST1), rs7521902 the NF E2
L2 , JUN, SOD1 genes has been revealed for (WNT4) corresponded its rate in European populations. In physiological pregnancy. The correlation in the mRNA the HOXA10 gene, we identiﬁed two variants: rs34957925 levels of the JUN, NF
E2 L2
 and SOD1 genes was detected800 J.delPicchia indecidua.Inchorionictissueduringnormalpregnancy,the This report stresses the importance of molecular diagnosis levelofmRNAoftheSOD1geneisdirectlyproportionalto in IP for genetic counseling of the entire family. the mRNA of the NF E2
L2  gene (r=0.81 p=0.0002). With S. Koka: None. O. Lobel: None. E. Zivi: None. Z. Ben- miscarriage the level of mRNA of the JUN gene in the Neriah: None. A. Frumkin: None. O. Weiss: None. S. chorionic tissue is signiﬁcantly higher compared to the Zeligson: None. R. Segel: None. control. Conclusion: The results demonstrated that high JUN E-
P01 .18 transcription level in chorionic tissue could be associated Reciprocal 7p deletion-7q duplication in a malformed with miscarriage in ﬁrst trimester of pregnancy. fetus due to maternal inversion of chromosome 7 - E. Mashkina: None. K. Kovalenko: None. cytogenetic and microarray analysis E-
P01 .14 M. Hristova-Savova1, R. Bozhilova2, V. Peycheva2, PrenataldiagnosisofXq28microdeletionincludingexon E. Dimova3, K. Belemezova1, S. Yovinska1, M. Rizov1, 10 of IKBKG gene in male fetus with increased nuchal P. Chaveeva1, A. Shterev1, R. Kaneva2, I. Dimova1,2 translucency and hydrops and a family history of Incontinentia Pigmenti 1SAGBAL "Dr Shterev", Soﬁa, Bulgaria, 2Molecular MedicineCenter,MedicalUniversitySoﬁa,Soﬁa,Bulgaria, S.Koka1,O.Lobel1,E.Zivi1,Z.Ben-Neriah1,A.Frumkin2, 3RWTH, Aachen, Germany O. Weiss1, S. Zeligson1, R. Segel1 Pericentricinversionsoccurinhumanwithafrequencyof 1Shaare Zedek Medical Center, Jerusalem, Israel, 1-2%ofgeneralpopulation.Thesebalancedchromosomal 2Cytogenetics Lab, Department of Genetics, Hadassah rearrangements do not cause any problem for the carrier, Medical Center, Jerusalem, Israel but during meiosis there is a risk of inversion loop for- mation in the offspring leading to de novo duplication, Introduction: Incontinentia Pigmenti (IP), is an X-linked deletionoracombinationofboth[duplicationq/deletionp dominant Male-lethal disorder, caused by devastating (dup q/del p) or del q/dup p]. Signiﬁcant numbers of mutations in IKBKG gene. A recurrent exon 4_10 deletion recombinants are produced when the inverted segment in the IKBKG gene accounts for 60 to 80% of IP-causing size is >50% of the total length of the affected chromo- mutations,butotherpointmutationsalong thegeneaswell some. We report here a case of prenatal diagnostics of a as exon 10 (which include the zinc-ﬁnger domain) trun- fetus with multiple anomalies: severe growth retardation, cating mutation were described previously. enlarged third ventricle, agenesis of ductus venosus, and Materials and methods: Chromosomal Microarray cystofthebloodcord.Cytogeneicanalysiswasperformed Analysis (CMA) was performed in chorionic villi sample after amniocentesis and pathologic duplication of chro- of aborted pregnancy of fetus with increased nuchal mosome 7q was revealed. To clarify the aberration we translucency and hydrops, and his 31 years old healthy made array CGH analysis; the results showed combined mother. aberrations: 3.96 Mbp deletion of 7p (arr[hg19] Results: CMA of the fetus found a 34kbp deletion on 7p22.3p22.2(54,185-4,017,864)x1) and 47 Mbp duplica- Xq28 chromosome including at least exon 10 of IKBKG tion of 7q (7q31.1q36.3(111,668,521-159,118,566)x3). gene - arr[hg19]Xq28(153,792,620-153,826,362)x0. Preli- We tested the parents by cytogenetic analysis in a minary results show that the healthy mother carries the meantime. The mother was revealed to be a carrier of deletion in a mosaic state. Family history includes another pericentric inversion in chromosome 7 - 46,XX,inv(7) termination of pregnancy of a male fetus with increased (p22;q31). Thus, we clarify the genetic diagnosis in the nuchaltranslucency,twospontaneousearlyabortions,agirl fetus - the recombinant chromosome 7 [rec(7)dup(7q)inv with suspected clinical diagnosis of IP and one health boy. (7)(p22q31)mat] must have arisen through meiotic Therecurrentexon4_10deletioninIKBKGwaspreviously crossing-over between the inverted chromosome and the excluded in the symptomatic girl. normal chromosome 7 in the maternal germline. Conclu- Conclusions: Here we describe a 34kbp deletion on sion: Array CGH is the most powerful technique in Xq28 chromosome including exon 10 of IKBKG gene determining the exact size and boundaries of the unba- inherited from a healthy mother as a cause for increased lanced segments in case of rearranged chromosomes and, nuchal translucency and hydrops in male fetus with family in combination with parental cytogenetic analysis, for history suspicious for familial IP. The deletion segregation providing the adequate genetic counselling. in the family is now in progress and we believe it will M. Hristova-Savova: None. R. Bozhilova: None. V. explain the girl phenotype as well as the obstetric history. Peycheva: None. E. Dimova: None. K. Belemezova: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 801 S. Yovinska: None. M. Rizov: None. P. Chaveeva: None. K. Kartvelishvili: None. N. Pirtskhelani: None. N. A. Shterev: None. R. Kaneva: None. I. Dimova: None. Kochiashvili: None. L. Makhaldiani: None. E-
P01 .19 E-
P01 .20 The impact of maternal inherited thrombophilia on Panels of genetic tests in infertile men with severe intra uterine growth restriction spermatogenic failure K. Kartvelishvili1,2, N. Pirtskhelani2,3, N. Kochiashvili2, S. Yovinska1, M. Hristova-Savova1, K. Belemezova1, L. Makhaldiani4 M. Rizov1, T. Milachich1, T. Timeva1, P. Andreeva1, D. Savova1, M. Yunakova1, A. Shterev1, I. Dimova2 1Tbilisi State Medical University, Tbilisi, Georgia, 2National Forensics Bureau/Forensic Biology (DNA) 1SAGBAL “D Shterev”, Soﬁa, Bulgaria, 2SAGBAL Department, Tbilisi, Georgia, 3Tbilisi Open University, “D Shterev”; Department of Medical genetics, Medical Tbilisi, Georgia, 4K. Eristavi National Center of Experi- University Soﬁa, Bulgaria, Soﬁa, Bulgaria mental and Clinical Surgery, Tbilisi, Georgia Weofferedinourclinicsdifferentkindsofgeneticanalyses Introduction: Intrauterine growth restriction (IUGR) is with the aim to clarify diagnosis in men with severe sper- deﬁned as estimated fetal weight below gestational age. matogenicfailure.Wehaveperformedcytogeneticanalysis Inherited thrombophilia is a blood coagulation disorder, in 770 men attending reproductive clinics (group I), 88 which predisposes to thrombosis. Since the placenta is rich withconﬁrmed diagnosisof oligoastenozoospermia (group inbloodvessels,itisreasonabletoinferthatclotformation II) and 43 with conﬁrmed azoospermia (group III). within the placental vasculature may result in placental Numerical sex chromosomal aberrations (incl. mosaicism) insufﬁciency, intrauterine growth restriction and other were found in 3.3% of group I, 3.4% of group II (mainly complications. polysomy Y) and 9.3% of group III (mainly Klinefelter Aim:Theaimofthisstudywastodeterminetheintensity syndrome); female karyotype was diagnosed in 0.6% of of connection between inherited thrombophilia (Factor V men. Structural chromosomal aberrations (mainly translo- Leiden, Prothrombin G20210A and MTHFR 
C677 T gene cations)weredetectedin1.2%ofgroupI,3.4%ofgroupII mutations) and IUGR. and none of group III. Chromosomal heteromorphism was Materials and methods: 48 Georgian women with revealed, respectively, in 13%, 13.6% and 11.5%. DNA pregnancy complication (IUGR of unknown origin) and analysis for 10 pathogens (CT, MG, MH, UP, UU, TV, 100 controls (women with three or more uncomplicated NG, TP, H
S1  and 2) was performed in ejaculate of men pregnancies) were investigated for detection of inherited witholigoastenozoospermiaandazoospermia.Thetestwas thrombophilia by PCR analyses. positive in 61.5% of azoospermic men and in 21% of oli- Results: Relationships between IUGR and FVL (12.5% goastenozoospermic (p<0.01) as double infection was in patients and 0% in control; χ2(1,N=148)=13.028, revealed in 38% and 12%, respectively (p<0.05). The sta- p=0.001) and Prothrombin (8.33% in patients and 1% in tistically higher frequency was established for Ureaplasma control; χ2(1,N=148)=5.343, p=0.038) mutations were parvum (54% vs 15%) and Herpes simplex (23% vs 3%). signiﬁcant. Relationship between IUGR and MTHFR Genotyping for 24 mutations and IVS 8 intron poly- mutation (6.25% in patients and 1% in control; χ2(1, morphism in CFTR gene was performed in 52 men with N=148)=3.399, p=0.1) was weak. The combined double severe male factor. Both delf508 mutation and IVS 8 5T and triple mutations were seen in 4 cases, which was not was found in 5.8% of the analyzed men. In conclusion, by seen in control group. It is important to note that 46 applying all of the above mentioned analyses in 52 men (95.83%) patients had a history of other pregnancy withseveremalefactor,wewereabletomakediagnosisin complications and thrombosis, 19(39.53%) patients had a 60% of them. history of stillbirth. S. Yovinska: None. M. Hristova-Savova: None. K. Conclusion: There are few studies concerning the Belemezova: None. M. Rizov: None. T. Milachich: None. association between IUGR and thrombophilia. Our study T.Timeva:None.P.Andreeva:None.D.Savova:None.M. reconﬁrms impact of studied mutations (totally 23%) on Yunakova: None. A. Shterev: None. I. Dimova: None. IUGR. Further research will help to clarify who should receive thromboprophylaxis to prevent adverse pregnancy E-
P01 .21 outcomes in women with inherited thrombophilia. Recurrent congenital microcephaly: a case report802 J.delPicchia M. N. Komnenić Radovanović1, I. Novaković2, M. Rizov1, K. Belemezova1, M. Hristova-Savova1, G.Čuturilo3,2,J.RumlStojanović3,B.Petrović1,O.Kontić- S. Yovinska1, T. Milachich2, G. Ganeva3, T. Timeva3,4, Vučinić1,2 A. Shterev3, I. Dimova1 1Clinic for gynecology and obstretrics, Clinical centre of 1Genetics laboratory, SAGBAL “Dr Shterev”, Soﬁa, Serbia, Belgrade, Serbia, 2Faculty of Medicine, University Bulgaria, Soﬁa, Bulgaria, 2IVF laboratory, SAGBAL “Dr of Belgrade, Serbia, Belgrade, Serbia, 3University Chil- Shterev”, Soﬁa, Bulgaria, Soﬁa, Bulgaria, 3SAGBAL “Dr dren’s Hospital, Belgrade, Serbia, Belgrade, Serbia Shterev”, Soﬁa, Bulgaria, Soﬁa, Bulgaria, 4“Angel Kan- chev” University of Ruse, Ruse, Bulgaria Introduction:Wereportthecaseofacouplewiththreelost pregnancies,twowithprimarycongenitalmicrocephaly(the Structural chromosomal abnormalities are responsible for ﬁrst and the third pregnancy, both with male fetuses). The different reproductive issues such as infertility and secondpregnancyendedasamissedabortion.Karyotyping recurrent pregnancy loss. Polymorphic variations are was perfomed to the couple and results were normal kar- known to occur in the general population. They include yotypes. Couple negated the family burden, but X-linked varyingsizesofheterochromatinblocks,satelliteorrepeat and primary autosomal recessive microcephaly was sequence regions and inversions. However, previous stu- suspected. dies have reported that heterochromatin polymorphisms Materials and methods: After fetal ultrasonogram aremorefrequentininfertilemen.Thismaybeassociated showing recurrent primary microcephaly in the third with infertility and unsuccessful pregnancy. Pre- pregnancy, fetal blood sample obtained by cordocentesis. implantation genetic testing for aneuploidy (PGT-A) is a The sample was used for standard cytogenetic analysis, common method in the assisted reproduction techniques aCGH and clinical exome next generation sequencing. (ART) to determine the genetic status of human embryos. Results: The fetal karyotyping showed a normal male In the presented case we report an infertile couple with karyotype (46,XY), conﬁrmed by aCGH analysis. Clinical recurrent implantation failures (RIF). Karyotyping by G- exome testing and bioinformatic analysis of the genes banding of cultured peripheral blood lymphocytes was known to be associated with microcephaly and similar performedonbothpatients.Aftertheanalysis,inthemale pathological conditions detected pathogenic and likely partner was detected heterochromatin polymorphism, pathogenic variant in the ASPM (abnormal spindle-like karyotype- 46, XY, 9qh+. After genetic counseling, microcephaly-associated) gene. Pathogenic variant was PGD-A was used. For detection of chromosomal imbal- ASPM c.7324C> T, known stop gained mutation with ancesalaser-assistedbiopsywasperformedonblastocyst conﬁrmed maternal origin. Likely pathogenic variant was stage embryos followed by whole genome ampliﬁcation newely described fremeshift deletion ASPM c.10148 delC, (WGA) and next generation sequencing (NGS) was with conﬁrmed paternal origin. performed according to manufacturer’s instructions. 6 Conclusions: Comprehensive genetic testing of affected embryos were biopsied and analyzed. None of the fetus showed compound heterozygous mutations in ASPM embryoswaseuploid.Variousaberrations-fromsingleto gene, designed as MCPH5 (microcephaly primary heredi- complex monosomies and trisomies, were detected. Due tary)locus.Anautosomalrecessivepatternofinheritanceof to the lack of an euploid embryo, transfer was not per- the detected mutations is most likely involved in the formed. This case report is a good example for the formation of primary congenital microcephaly. reproductive failures at carriers of chromosomal hetero- Patients are genetically informed about the mode of chromatin polymorphisms. NGS allows screening of all inheritance of these mutations, possibility of prenatal 24 chromosomes. It’s effective, ensuring a high level of testing, as well as of the possibility of in vitro fertilization conﬁdence in the results and subsequent selection of for the purpose of preimplantation genetic diagnosis of euploid embryos for transfer. detected mutations. M. Rizov: None. K. Belemezova: None. M. Hristova- M.N. Komnenić Radovanović: None. I. Novaković: Savova: None. S. Yovinska: None. T. Milachich: None. G. None. G. Čuturilo: None. J. Ruml Stojanović: None. B. Ganeva: None. T. Timeva: None. A. Shterev: None. I. Petrović: None. O. Kontić-Vučinić: None. Dimova: None. E-
P01 .24 E-
P01 .25 PGT-Abecauseofmale9qhchromosomalheteromorph- Chromosomal centromeric polymorphisms and couple ism revealed only unbalanced embryos infertilityAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 803 P.Gkika1,D.Athanasiou1,P.Symeonidis2,F.Gkaitatzi2,E. We report on a non-consanguineous couple who presented Kontomanolis2, N. Koutlaki2, T. S. Lialiaris1 in the 25th week of their second pregnancy. The fetus showed mild cerebral ventriculomegaly, hypoplasia of 1DemokritusUniversityofThrace,MedicalSchool,Deptof the cerebellum and a peculiar posture of the ﬁngers Genetics,Alexandroupolis,Greece,2DemokritusUniversity without further abnormalities. Family history revealed that of Thrace, Medical School, Dept of Obstetrics & Gynecol- his1.5yearoldsisterpostnatallyshowedaﬁxedpostureof ogy, University Hospital of Alexandroupolis,, Alexandrou- the ﬁngers and a general developmental delay but no polis, Greece diagnostics had been done so far. In order to exclude tris- omy 18, the couple decided for amniocentesis. Array-ana- Introduction: A possible association between the appear- lysis showed a gain of 14.7Mb inthe chromosomalregion ance of pericentric chromosomal polymorphisms in cyto- 3p25.1-p26.3 and a loss of 5.3 Mb in 6q27 not visible in genetic examinations and idiopathic reproductive failure in conventional karyotype (GTG-banding, 400 bands). The northeastern Greek population was examined. sister clinically exhibits a striking similarity with features Material and methods: Lymphocyte cultures of periph- already described in partial trisomy 3p like hypertelorism, eral blood from 150 individuals, mainly couples, were round face, short neck, down slanting palpebral ﬁssures, harvested and processed according to standard laboratory psychomotordelayandbehavioralproblems.Chromosomal protocols. The samples were visualized using C-banding analysis and array-analysis were performed and technique. At least 15 metaphases were analyzed visually revealed the same abnormalities as in the fetus. We there- per case, and 5 of them were karyotyped using MetaSys- foresuspectedabalancedtranslocationinoneoftheparents tems Ikaros software and a Zeiss Axio Imager. Z.2 and indeed the mother carries a balanced reciprocal trans- microscope. location (46,XX,t(3;6)(p25.1;q27)). Despite the clinical Results:Chromosomalvariationsincentromereareaof1,9 variability, the parents felt reassured because they did not and16chromosomeswereidentiﬁedin115of150individuals experiencetheirdaughterasahandicappedchild.Therefore, with failed reproductive clinical histories. After dividing the they decided to continue pregnancy. Our case illustrates, results by gender, a higher frequency of the chromosome 9 that minor ﬁndings in prenatal ultrasound and detailed polymorphism was observed in women. The frequency of family history may be crucial in prenatal diagnosis. More- chromosomal polymorphismsin chromosome 1 and 16were over, it stresses the importance of array-analysis in the broadly similar for both genders. As for the couples, we prenatal setting. We postulate that genetic counselling observed that appearance of chromosomal centromeric should be offered early in pregnancy to all families with polymorphisms in both partners was signiﬁcantly higher, retarded children. reaching a considerable number of 74%. U.Siebers-Renelt:None.I.vanDeest:None.J.Steinhard: Conclusions: Increasing evidence from our research has None. C. Müller-Hofstede: None. Y. Stratis: None. A. conﬁrmed that infertility and subfertility are closely related Bohring: None. A. Röpke: None. to chromosomal polymorphisms as 80 % of the patients were identiﬁed with a centromeric chromosomal variation. E-
P01 .29 Nevertheless, their mechanism and reason of appearance is Expression Proﬁle of Complement Activation at yet unclear and to explain the potential reasoning and the Decidual Tissue in Patients with Recurrent meaningofthisphenomenonfurtherstudieswillbeneeded. Pregnancy Loss P. Gkika: None. D. Athanasiou: None. P. Symeonidis: None. F. Gkaitatzi: None. E. Kontomanolis: None. N. I. Yilmaz1, P. Ata1, N. Karakas2, E. Buyukbayrak2 Koutlaki: None. T.S. Lialiaris: None. 1MarmaraUniversitySchoolofMedicineMedicalGenetics, E-
P01 .26 Istanbul, Turkey, 2Marmara University School of Medicine Prenatal detection of a 3p-duplication / 6q-deletion by Dept of Obstetrics and Gynecology, Istanbul, Turkey array-Analysis not visible in GTG-banding Recurrent pregnancy losses (RPL) are seen in approxi- U. Siebers-Renelt1, I. van Deest2, J. Steinhard2, C. Müller- mately 1% of fertile women. RPL are deﬁned as sponta- Hofstede1, Y. Stratis1, A. Bohring1, A. Röpke1 neous and terminating at least two or more consecutive pregnancies, seen in 0.5-3% of all pregnancies. Damage in 1Institut für Humangenetik, University Hospital, Muenster, decidual tissue occuring with the effect of maternal anti- Germany, 2Zentrum für Pränatalmedizin, Muenster, bodies, has a contribution of complement activation. Germany Seventeen percent of women with at least 2 recurrent804 J.delPicchia abortionsandthirtysevenpercentofthosewithmorethan3 patients’ sera. Patient group had higher progesterone level abortions were detected in idiopathic RPL patients having and lower TSH level compared to controls. We evaluated no autoimmune background. The complement system, is a theexpressionlevelofProgesteroneReceptorGene(PGR), ﬁrst defense mechanism towards unwanted pathogens and and downstream genes; Inositol 1,4,5-Trisphosphate host elements. Decay accelerating factor (DAF,CD55), Receptor Type 3 (ITPR3), Extracellular Signal-Regulated MAC inhibitory protein (MAC-IP,CD59) and membrane Kinase 1 (MAPK1) and Proline Rich Transmembrane co-factor protein (MCP,CD46) are major complement Protein 2 (PRRT2) of the decidual tissue. The expression inhibitory proteins which are highly expressed in normal analysis using CFX real-time PCR platform were done placenta. Herein, we had nine women with spontaneous throughQiagenGeneGlobeassaytool.Internalcontrolgene abortion as our control group and seventeen women with was GAPDH for analysis. As a preliminary ﬁnding, PGR RPL as our study group. TSH, T3, T4, and progesterone, gene expression level was diminished in our case group also 
C3 , 
C4  serum levels were determined. Since CD55, comparedtothatofcontrols.Conversely,ITPR3expression CD46 and CD59 of fetal trophoblast and maternal tissues was elevated and there was a slight increase in MAPK1 are crucial to provide tissue homeostasis, we analyzed the gene expression in patients compared to controls (p>0.05). expressionofthesegenesusingCFXreal-timePCRsetting. As protective effect of progesterone on decidual tissue is ThestatisticalanalysisaccordingtoaverageCTvalueswere strongly associated with expression of PGR and its down- done through Qiagen GeneGlobe assay tool. As a pre- stream genes, possible future treatment targets could be liminary ﬁnding of this research, CD55 expression level identiﬁed for RPL. was reasonably elevated at decidual tissues of our cases P. Ata: None. I. Yilmaz: None. N. Karakas: None. compared to that of controls. Although, CD46 expression A. Eren: None. E. Buyukbayrak: None. levels weredifferentamong twogroups,thedifference was not remarkable as CD55 expression (p>0.05). To support E-
P01 .32 pregnancy in RPL, regulation of complement activation MaternalpathogenicKCNQ1variantandpredisposition might be crucial. to recurrent fetal loss I. Yilmaz: None. P. Ata: None. N. Karakas: None. E. Buyukbayrak: None. L. Kasak1, K. Rull1,2, T. Yang3, D. Roden3, M. Laan1 E-
P01 .31 1Institute of Biomedicine and Translational Medicine, Progesterone Receptivity and Expression of Progester- UniversityofTartu,Tartu,Estonia,2Women’sClinic,Tartu one Triggered Genes at the Decidual Tissue in Patients University Hospital, Tartu, Estonia, 3Departments of with Recurrent Pregnancy Loss. Medicine, Pharmacology and Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, P.Ata1,I.Yilmaz1,N.Karakas2,A.Eren3,E.Buyukbayrak2 United States 1MarmaraUniversitySchoolofMedicineMedicalGenetics, Introduction: Recurrent pregnancy loss (RPL) concerns Istanbul, Turkey, 2Marmara University School of Medicine up to 5% of women of childbearing age. Up to 25% of Dept of Obstetrics and Gynecology, Istanbul, Turkey, 3Koc RPL cases remain idiopathic, suggesting a possible mono- University College of Sciences Molecular Biology and genic origin. The study aimed to identify the genetic cause Genetics, Istanbul, Turkey of idiopathic late RPL in a family with multiple mis- carriages without fetal malformations or chromosomal Recurrent pregnancy losses (RPL) are deﬁned as sponta- abnormalities. neous termination of at least two or more consecutive Materialsandmethods:Exomesequencingwasapplied pregnancies. It accounts 0.5-3% of all pregnancies. Its to three miscarried fetuses and the mother, who had etiology is still unknown in about half of the cases. Since experienced ﬁve live births, intersected by three early progesterone stabilizes endometrial tissue, it affects decid- pregnancy losses, and six fetal deaths. Interestingly, 4/5 ual tissue during differentiation by changing the expres- karyotyped fetal losses had a normal female karyotype, sivity of different genes. Progesterone unresponsiveness whereas all but one live-born children are male. duetodecreasedexpressionofitsreceptoranddownstream Results: The miscarried conceptuses do not share any genes,ratherthanhormonedeﬁciencymayeffectthefateof rare single nucleotide variants not detected in live-born pregnancy itself. Herein, nine women with spontaneous children. However, the mother carries a KCNQ1 p. abortionascontrolgroups,andseventeenwomenwithRPL Val173Aspsubstitution(rs199472695),previouslyreported as our case group were analyzed; and TSH, T3,T4, pro- in a patient with long QT syndrome (LQTS; gesterone, and 
C3 ,
C4  levels were determined in the PMID:16414944). KCNQ1 protein forms potassiumAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 805 channelsandregulatesthecardiacactionpotentialduration. Postmortem radiographical and histopathological ﬁndings Consistent with a recent epidemiological study were consistent with Diastrophic Dysplasia. (PMID:31520628), mothers carrying pathogenic heterozy- Discussion: Targeted FGFR3 mutation testing, based on gous variants in LQTS genes have an elevated risk of fetal themother’sphenotype,wouldhavemissedtheDiastrophic deathregardlessofthecarrierstatusofthefetus.Functional Dysplasia diagnosis in the fetus, preventing informed assay conﬁrmed pathogenicity of the p.Val173Asp variant. decision for this pregnancy and proper genetic counselling The mutant channel signiﬁcantly reduced total activating for the family. Therefore, this case highlights the utility of anddeactivatingcurrents,withdramaticallypositiveshiftof exome sequencing for complex overlapping prenatal voltage dependence of activation by ~10 mV. phenotypes such as skeletal dysplasia, and underscores the Conclusions: Dysfunction of KCNQ1 contributes not contributionofpostmortempathologicalexaminationtothe only to the risk of sudden death from LQTS, but also as a phenotype- genotypecorrelation, which isessential for the maternal risk factor to RPL. The exact molecular mechan- correct interpretation of exome sequencing results. ism behind this effect is still to be clariﬁed. G. Christopoulou: None. A. Oikonomaki: None. S. Funding: Estonian Research Council grant IUT34-12 Samara: None. A. Xefteris: None. A. Κonstantinidou: L. Kasak: None. K. Rull: None. T. Yang: None. None. P. Constantoulakis: None. D. Roden: None. M. Laan: None. E-
P01 .34 E-
P01 .33 Homozygous hypomorphic SOX9 mutation in two 46, Prenatal diagnosis of a complex skeletal dysplasia case XY sisters without skeletal malformations deciphered by exome sequencing and postmortem pathological examination S. Ledig1, A. Tewes1, T. Özdemir2, A. Bohring1, P. Wieacker1 G. Christopoulou1, A. Oikonomaki1, S. Samara1, A. Xefteris2, A. Κonstantinidou3, P. Constantoulakis1 1Institute for Human Genetics, Münster, Germany, 2Department of Medical Genetics, Izmir, Turkey 1Genotypos Science Labs MSA, Athens, Greece, 2Euroge- netica S.A., Thessaloniki, Greece, 3Department of Pathol- Haploinsufﬁciency of the SOX9 gene in humans causes the ogy,Unit ofPerinatal Pathology,National &Kapodistrian skeletal malformation syndrome campomelic dysplasia University of Athens (NKUA), Athens, Greece (CD), which is a semilethal disorder characterised by con- genital bowing of the long bones, cleft palate, absence of Introduction: We present a prenatal and postmortem olfactory bulbs and tracts, heart and renal malformations, diagnosisofdiastrophicdysplasia(DD)inafetusconceived hypoplastic lungs, narrow thoracic cage, and delayed bone by a mother with hypochondroplasia. age. CD patients generally die from respiratory distress. Materials and methods: Prenatal testing at 13 weeks Together with the bone disease 75% of CD-patients show gestationwasrequestedduetoamaternalhypochondropla- testicular dysgenesis leading to sex reversal. Here, we sia phenotype of unknown genetic background. Clinical describe two sisters with the suspicion of non-syndromic exome sequencing was performed on DNA extracted from XY DSD (disorder of sexual development) and no signs of chorionic villi and maternal blood, using Sophia Genetics’ skeletalmalformations.CausativemutationsinSRY,NR5A1 Clinical Exome Solution v2. Following preparations andDHHhavebeenexcludedbySanger-sequencingbefore according to the manufacturer’s protocol, DNA libraries whole-exome-sequencing was performed and surprisingly were sequenced on an Illumina NextSeq-500 genetic revealed in both sisters homozygosity for undescribed var- analyser.Dataprocessing,variantcallingandpre-classiﬁca- iant c.1518C>G p.(Leu506Val) in SOX9. The consanguine tion were conducted by SOPHiA DDM® bioinformatics parents are heterozygous for c.1518C>G p.(Leu506Val) in pipelines. SOX9. Functional characterization of SOX9 c.1518C>G p. Results: A FGFR3 pathogenic variant was identiﬁed in (Leu506Val) by luciferase assay showed no decrease of the mother, conﬁrming her phenotype; this variant was not transactivating function on Col2a1 promotor in contrast to detected in the fetus. However, one maternally inherited two SOX9 mutations (c.347C>T p.(Ala116Val) and pathogenic and one of unknown signiﬁcance SL
C26 A2 c.358C>Tp.(Arg120Cys))knowntobeassociatedwithCD, variants were identiﬁed, related, according to the literature, explaining the non-skeletal phenotype of our patients. to four distinct genetic skeletal dysplasias of various Therefore, we suggest that SOX9 variant c.1518C>G p. severity and prognosis. On 2nd trimester ultrasound the (Leu506Val) is a hypomorphic mutation that causes XY fetus presented short long bones and, following clinical DSD without raising any SOX9 related skeletal phenotype. genetic counselling, the pregnancy was terminated.806 J.delPicchia S. Ledig: None. A. Tewes: None. T. Özdemir: None. A. Introduction: Wlaker-Warburg syndrome (WWS) is Bohring: None. P. Wieacker: None. clinically deﬁned as congenital muscular dystrophy acom- panied by a variety of brain and eye malformations. E-
P01 .35 Its represents the most severe clinical phenotype in a Vascular endothelial growth factor serum level during spectrumofalpha-dystroglycanposttranslationalproccesing pregnancy and VEGF rs2010963 polymorphism among abnormalities, wich share adefect inlaminin bindin glycan women with congenital heart defects in the fetus synthesis. Homozygotics or compound heterozygotics mutations in several genes had been described as causative Y. Sharhorodska1,2,3, I. Haiboniuk1, A. Malahova1, for WWS, but very low cases with complete homozygotics U. Dorofeyeva3, O. Shkolnyk1, H. Makukh1 delections. Here we described two cases of prenatal diag- nosis in a couple with complete CRPPA gene delection. In 1Institute of Heredetary Pathology NAMS, Lviv, Ukraine, the ﬁrst pregnancy, amniocentesis was done for genetics 2Danylo Halytsky Lviv National Medical University, Lviv, prenatal diagnosis, when by eco at 16 gestation week, was Ukraine, 3Medical Center Intersono Medicover Group, detected absence of cerebellar vermis, megacisterna magna Lviv, Ukraine with occipital bone defects and. At a second pregnancy chorionic villis sampling was performed at 12 The aim of the study to determine serum level of vascular gestation week. endothelial growth factor (VEGF) during pregnancy as a Materials and methods: Karyotype was performed with possible diagnostic marker of congenital heart defects in the standar methods. Comparative genomic hybridation offspring.Materialsandmethods.Theserumconcentrationof (CGH-Array) was performed with the Agilent platform, VEGF by ELISA was measured among 24 pregnant women suplied by PerkinElmer. (term 20-30 weeks of gestation) with prenatally diagnosed Results: In the ﬁrst fetus, the fetal Karyotype was congenital heart defects (CHDs) in fеtus. For control group normal (46,XX), but the CGH-Array detected an homo- we studied the serum of 45 pregnant women without com- zygotic 354,58 Kb delecttion at 7p21.2. CGH-Array of plicated genetic and obstetric history. For the analysis of both parents presented the same chromosomal microdelec- rs2010963VEGFthePCR-RFLPmethodwasused.Results. tion in heterozygosis and was recomended genetic MaternalVEGF405GGgenotypewassigniﬁcantlycorrelated prenatal diagnosis for another pregnancies. In the next with congenital heart defects of the fеtus (p=0.017, OR = pregnancy, chorionic villis sample was analided with de 3.45 (95% CI: 1.22 - 9.72)). In the CHD group, compared same reults; normal karyotype (46,XY) and homozygotic with controls, VEGF serum levels were signiﬁcantly higher 354,58 Kb delection at 7p21,2. In both cases the gestation (285.6±4.5 vs. 268,0±5,2 pg/mL, p=0.029). The VEGF was ﬁnised. serumlevelinpregnantwomenwithgenotypeVEGF405GG Conclusions: The use of CGH-Array in prenatal was higher compare with another genotypes group 405GC diagnosis when ecograﬁcs anomalies are detected is the and405CC.Conclusions.Ourstudysuggests thatevaluation election method for detection of chromosomal microdelec- of VEGF serum level during pregnancy may provide prog- tions and microduplications. nostic data, andhelp identify patients who would have CHD M. Perez Sanchez: None. M. Bellido díaz: None. T. De offetus.Mothersrs2010963VEGFgenotypemayplayarole Haro Romero.: None. A. González Ramírez: None. in the susceptibility of conhenital heart defects in offspring. Y. Sharhorodska: None. I. Haiboniuk: None. A. Mala- E-
P01 .37 hova: None. U. Dorofeyeva: None. O. Shkolnyk: None. H. Fetal mosaicism in dichorionic twin pregnancies: Makukh: None. challenges for accurate diagnosis and results interpretation E-
P01 .36 Detection of complete delection of CRRPA gene in E. Margarit1,2, M. Vallecillos1, M. Rubio1, I. Madrigal1,2, prenatal CGH-Array performer by eco anomalies. A C. Badenas1,2, A. Soler1,2 case report. 1HOSPITAL CLÍNIC, BARCELONA, Spain, 2IDIBAPS, M.PerezSanchez1,M.Bellidodíaz1,T.DeHaroRomero.1, Barcelona, Spain A. González Ramírez2 The risk of fetal structural abnormalities and chromosomal 1Servicio Andaluz de Salud (SAS)., Granada, Spain, aneuploidy is increased in twin pregnancies compared with 2FIBAO., Granada, Spain singleton gestations. In many cases, the chromosomeAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 807 constitution of twin fetuses is discordant, so an accurate E-
P02  Sensory Disorders (Eye, Ear, Pain) prenatal diagnosis is needed. We report two dichorionic/dia- mniotic twin pregnancies presenting with ultrasound anoma- lies affecting only one of the fetuses (fetus B). A chorionic E-
P02 .04 villussample(CVS)wasobtained separately foreachone of Congenital bilateral iris coloboma in a patient with thefetuses,allowingindividualanalysestodeterminepossible 16q23.1q23.2 deletion chromosomalabnormalities.Inbothcases,sampleswereﬁrst analyzed by QF-PCR to detect possible common aneu- B. Aleksiūnienė1, B. Tumienė1, R. Strupaitė–Šileikienė2, A. ploidies.Inthreeofthefetuses,anXchromosomeaneuploidy Utkus1 in mosaic form was detected. Additional analyses by con- ventionalcytogenetics,QF-PCRand/orarraywereperformed 1DepartmentofHumanandMedicalGeneticsofInstituteof ﬁrstinCVSandlaterinamnioticﬂuid(AF)samplesinorder Biomedical Sciences, Faculty of Medicine, Vilnius Uni- to interpretate the results, detecting possible conﬁned pla- versity,Vilnius,Lithuania,2CentreofEyeDiseases,Vilnius centalmosaicismandallowingadeﬁnitivediagnosisforeach UniversityHospitalSantarosKlinikos, Vilnius, Lithuania fetus. Detailed results and possible embryological interpreta- tions are presented. Clinical and molecular characterization of rare chromoso- mal abnormalities helps to detect the candidate genes for congenitalanomalies.Congenitalocularcolobomaisabirth FetusA FetusB defect caused by abnormal development of the eye during CAS
E1  embryogenesis. We report on a 33-year-old man with Ultrasound1 normalfetal edema+increasednuchalfold bilateral congenital coloboma of the iris at 6 o‘clock. The structure +ductusagenesis patient has a high myopia and myopic astigmatism, BCVA QF-PCR mos90%X/ mos10%X/90%XX ofBE-0,7.Choroidal neviofbotheyeswerealsonoticed. (CVS) 10%XX He has no other speciﬁc complaints as photophobia or CVS-short 45,X - nictalopia, the color vision is full. There were no dys- culture morphic signs or developmental issues. Chromosomal CVS-long mos45,X[3]/46, - microarray analysis using the HumanCytoSNP-12v2.1 culture XX[27] BeadChip (Illumina Inc., San Diego, CA, USA) was per- Array(CVS) - mos10%X/90%XX QF-PCR(AF) ≈XX X formed and revealed a 2.96 Mb in size deletion in the 16q23.1q23.2 region, arr[GRCh37]16q23.1q23.2 AF-culture mos45,X[2]/46, 45,X[20] XX[78] (78473430_81434676)×1. The deleted region encompasses Control normalfetal subcutaneousedema+ascitis 12 protein-coding genes, including 5 disease-associated ultrasound structure genes WWOX, MAF, GCSH, BCO1 and GAN. Three genes CAS
E2  WWOX, GCSH and GAN are associated with autosomal Ultrasound1 normalfetal edema+increasedNT+reverse recessive disorders. MAF is associated with Ayme-Gripp structure ductusvenosus syndrome and various types of cataracts. BCO1 encodes QF-PCR mosX/ XX beta-carotene oxygenase 1, which is a key enzyme in the (CVS) XXorXXX production of vitamin A from carotenoids. Deﬁciency of CVS-long 45,X 46,XX,+11,der(11;22)(p10;q10) this enzyme results in hypercarotenemia and secondary culture vitamin A deﬁciency. We speculate that haploinsufﬁciency Array(CVS) mosX/ dup11p of BCO1 may be related to congenital bilateral iris colo- XXorXXX boma in our patient. QF-PCR(AF) XX - B. Aleksiūnienė:None. B. Tumienė:None. R. Strupaitė– Array(AF) XX - Šileikienė: None. A. Utkus: None. Control normalfetal nofetalactivity ultrasound structure E-
P02 .07 First reported case of Doyne Honeycomb Retinal E.Margarit:None.M.Vallecillos:None.M.Rubio:None. Dystrophy (Malattia Leventinese/Autosomal Dominant I. Madrigal: None. C. Badenas: None. A. Soler: None. Drusen) in Scandinavia808 J.delPicchia I. N. Sheyanth1,2,3, M. B. Petersen1,2,3, L. P. Kiruparajan4, as well as grants already received); Signiﬁcant; The Obel S. K. Abildgaard4 Family Foundation. L.P. Kiruparajan: None. S.K. Abildgaard: None. 1Research and Knowledge Center in Sensory Genetics, Aalborg, Denmark, 2Department of Clinical Medicine, E-
P02 .08 Aalborg University, Aalborg, Denmark, 3Department of LOX
L1  and CACNA1A SNPs associated with exfolia- Clinical Genetics, Aalborg University Hospital, Aalborg, tion syndrome susceptibility in a sample of Northern Denmark, 4Department of Ophthalmology, Aalborg Uni- Spanishpopulation,revealedbyhigh-resolutionmelting versity Hospital, Aalborg, Denmark analysis. Introduction: Doyne Honeycomb Retinal Dystrophy L.Escudero-Arrarás1,A.Lara1,M.Rodríguez-Hidalgo1,T. (DHRD)/ Malattia Leventinese (ML) is an autosomal Alberdi2, A. Basasoro2, I. Rodríguez-Agirretxe2,3,4, dominant, progressive eye disorder characterized by mas- J. Mendicute2, J. Ruiz Ederra1,4 sivecentralretinaldrusen often partly coalescent forming a characteristichoneycombpattern.Debutofvisionlossoften 1Biodonostia Health Research Institute, San Sebastián, occurs in mid-early adulthood and the degree varies. A Spain,2DepartmentofOphthalmology,DonostiaUniversity single mutation in EFEM
P1 c.1033C>T p.(Arg345Trp) has Hospital, San Sebastián, Spain, 3Instituto Clínico-Quirúr- been identiﬁed as the cause. gico de Oftalmología, Bilbao, Spain, 4RETICS OFTARED, Materials and methods: We report a 57-year-old NationalInstituteofHealthCarlosIII,MinistryofEconomy Scandinavian woman of non-consanguineous Danish Cau- and Competitiveness, Madrid, Spain casian parents presenting with vision loss and metamor- phopsia. Ophthalmological examination revealed massive Introduction: Exfoliation syndrome (XFS) is a systemic harddrusenonbotheyesinthemacularregionandnasalto disease associated with age and characterized by the for- the disc as well as macular hyperpigmentation. Optical mationanddepositionofawhitishﬁbrillarsubstanceinthe coherence tomography on the left eye showed partly anterior segment ofthe eye. XFS is a multifactorial disease affected foveal conﬁguration with slightly increased foveal with genetic and non-genetic factors associated. LOX
L1  thickness. The patient was clinically diagnosed with and CACNA1A are the main genes associated with an DHRD/ML and followed annually with stable conditions. increased risk. Ten years later reduced visual acuity primarily on the left Materialsandmethods:Highresolutionmelting(HRM) eye and increased atrophy with subretinal ﬂuid were is a simple and high-throughput assay, which has been observed. Anti-vascular endothelial growth factor (anti- widely applied in sequence polymorphism identiﬁcation. VEGF) was administrated, but without effect. Family OurmaingoalwastotestthesuitabilityofHRManalysisas history revealed no other cases of reduced vision. a genetic screening technique for XFS. We analyzed 26 Diagnostic next generation sequencing of seven genes XFS patients and 52 controls. We analyzed LOX
L1  (Amplexa FleckRet7 Panel) associated with ﬂecked retina (rs1048661, rs3825942, rs2165241, rs16958477, was performed at Amplexa Genetics using NovaSeq 6000. rs12914489, rs11638944, rs7173049) and CACNA1A The mutation was veriﬁed by bidirectional Sanger (rs4926244) genes. Detected variants were conﬁrmed by sequencing. Sanger sequencing. Results: Aknown pathogenic mutation NM_001039348 Results: The allelic and genotypic frequencies of the (EFEM
P1 ): c.1033C>T, p.(Arg345Trp) previously seen in SNPs are shown in the Table 1. Most XFS SNP were relation to DHRD/ML was identiﬁed in a heterozygote properly resolved by this technique, with the exception of state in the index. No other causative variants were rs1048661 and rs3825942. This is like due to the high identiﬁed. percentage of CG (~70%) surrounding these SNP. Conclusion: To our knowledge this case represents the Conclusion: Our method provides a genotyping strategy ﬁrst molecular genetically veriﬁed case of DHRD/ML in for identifying individuals with XFS-SNPs in a cost- Scandinavia. Grants: The Obel Family Foundation effective way for most variants analyzed. I.N. Sheyanth: B. Research Grant (principal investigator, LEA is supported by fellowships from Fundación Jesús collaborator or consultant and pending grants as well as deGangoitiBarreraandfromtheHealthDepartmentofthe grants already received); Signiﬁcant; The Obel Family Basque Government (2018111062 and MTVD19/BD/006). Foundation. M.B. Petersen: B. Research Grant (principal Supported by grants from the ISCIII and FEDER (PI18/ investigator, collaborator or consultant and pending grants 00507) and BEGISARE.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 809 Table 1. Allelic and genotypic frequencies for the most homozygotes for STRC gene deletion, B) eight were com- prevalent SNPs in LOX
L1  and CACNA1A. pound heterozygotes for STRC gene deletion and point inactivating mutation and C) three were compound hetero- SNP XFS Controls SNP XFS Controls SNP XFS Controls SNP XFS Controls (n=24) (n=52) (n=24) (n=52) (n=24) (n=52) (n=24) (n=52) zygotes for point inactivating mutations. Other biallelic rs2165241 rs1048661 rs16958477 rs11638944 pathogenic mutations were detected in genes MYO15A (six Allele Allele Allele Allele C 0.885 0.702 G 0.923 0.933 A 0.788 0.865 C 0.942 0.981 patients), LOXHD1 (ﬁve patients), TMPRS
S3  (ﬁve T 0.115 0.298 T 0.077 0.067 C 0.212 0.135 G 0.058 0.019 patients), CDH23 (four patients), OTOG (two patients). Genotype Genotype Genotype Genotype Other genes with biallelic pathogenic mutations were CC 0.808 0.673 GG 0.885 0.885 AA 0.731 0.577 CC 0.885 0.962 CT 0.154 0.058 GT 0.077 0.096 AC 0.269 0.423 CG 0.115 0.038 detected only once among patients. Supported by AZV 16- TT 0.038 0.269 TT 0.038 0.019 CC 0 0 GG 0 0 31173A. rs4926244 rs3825942 rs12914489 rs7173049 Allele Allele Allele Allele D. Šafka Brožková: None. S. Poisson Marková: None. J. T 0.971 0.981 G 1 0.981 G 0.808 0.827 A 0.981 0.942 Laštůvková: None. D. Rašková: None. A. Uhrová Mészár- C 0.029 0.019 A 0 0.019 A 0.192 0.173 G 0.019 0.058 Genotype Genotype Genotype Genotype osová: None. P. Seeman: None. TT 0.942 0.962 GG 1 0.962 GG 0.615 0.654 AA 0.962 0.885 TC 0.058 0.038 GA 0 0.038 GA 0.385 0.346 AG 0.038 0.115 CC 0 0 AA 0 0 AA 0 0 GG 0 0 E-
P02 .12 Possible digenic inheritance of mutations in OTOG and OTOGL as cause of prelingual mild hearing loss L. Escudero-Arrarás: None. A. Lara: None. M. Rodrí- guez-Hidalgo:None.T.Alberdi:None.A.Basasoro:None. M. Sinnema1, V. Vernimmen1, H. Yntema2 I. Rodríguez-Agirretxe: None. J. Mendicute: None. J. Ruiz Ederra: None. 1Department of Clinical Genetics, MUMC, Maastricht, Netherlands, 2Department of Human Genetics, Radboud E-
P02 .11 University Medical Centre, Nijmegen, Netherlands Overview of mutations causing early nonsyndromic hearing loss among Czech patients with excluded Normal 0 21 false false false NL X-NONE X-NONE /* pathogenic mutations in GJB2 gene. Style Deﬁnitions */ table.MsoNormalTable {mso-style- name:Standaardtabel; mso-tstyle-rowband-size:0; mso- D. Šafka Brožková1, S. Poisson Marková1, J. Laštůvková2, tstyle-colband-size:0; mso-style-noshow:yes; mso-style- D. Rašková3, A. Uhrová Mészárosová1, P. Seeman1 priority:99;mso-style-parent:"";mso-padding-alt:0cm5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin- 12nd Faculty of Medicine, Charles University and Uni- right:0cm; mso-para-margin-bottom:10.0pt; mso-para-mar- versity Hospital Motol, Prague, Czech Republic, 2Depart- gin-left:0cm; line-height:115%; mso-pagination:widow- ment of Medical Genetics, Masaryk Hospital in Usti nad orphan; font-size:11.0pt; font-family:“Calibri”,“sans-serif”; Labem, Regional Corporation, Usti nad Labem, Czech mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor- Republic, 3Centre for Medical Genetics and Reproductive latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font: Medicine, Gennet,, Prague, Czech Republic minor-latin; mso-fareast-language:EN-US;} Background: Autosomalrecessivenon-syndromichearingloss(DFNB)is Nonsyndromic autosomal recessive hearing loss is a het- a genetically heterogeneous disorder. OTOG and OTOGL erogeneous disease where over 80 genes has been reported were identiﬁed as autosomal recessive hearing loss genes. tobeassociatedwith.Weexaminedagroupofpatientswith Patient: We describe a 20-year old girl with moderate pre- early/prelingual nonsyndromic hearing loss (NSHL) in lingual hearing loss. Whole exome sequencing showed a whichweexcludedpathogenicmutationsinGJB2gene.We pathogenic nonsense mutation in the OTOG gene examined421unrelatedpatientsfordeletionsofSTRCgene (c.2500C>T) and a partial gene deletion of the with quantitative comparative ﬂuorescent PCR (QCF PCR) OTOGL gene (deletion exon 9-41). Additional and201unrelatedpatientswith nextgenerationsequencing Sanger sequencing of both genes did not show a second by custom designed NSHL gene panel. We discovered the mutation in one of the genes. The father of the proband is disease cause in 54 patients, from which 43 we diagnosed the only family member with the same audiologic withNSHLpanelexamination(21.4%).Themostfrequent proﬁle. Co-segregation between the hearing loss type of nonsyndromic hearing loss is DFNB16, caused by phenotype and the potential causative mutations was ver- biallelic mutations in the STRC gene and detected to be a iﬁed in all family members by Sanger sequencing. cause of hearing loss in 23 patients, almost half of the Father and daughter are the only family members with the clariﬁed patients (43%). The spectrum of STRC gene combination of the OTOG and OTOGL mutation. Conclu- mutations was as follows; A) twelve patients were sions: We identiﬁed heterozygous mutations in OTOG810 J.delPicchia and OTOGL in a girl and her father with prelingual Gene Variant Protein Zygosity Relateddisease hearing loss. OTOG and OTOGL show striking similarities in terms of structure, expression as well as clinical pheno- p. type.Tothebestofourknowledge,thisistheﬁrstreportof (Val4980Ala) LR
P5  c.442C>T p.(Gln148*) Heterozygosity Osteopetrosis possible biallellic inheritance of mutations in OTOG and Dominant1 OTOGL. TNC c.5317G>A p. Heterozygosity DFNA56 (Val1773Met) M. Sinnema: None. V. Vernimmen: None. H. Yntema: HK1 c.60+2T>A p.? Homozygosity Neuropathy None. hereditary sensorimotor (RusseType) E-
P02 .13 USH1G c.742C>T p.(Gln248*) Homozygosity UsherSyndrome Whole exome sequencing in hearing loss Mexican type1G family cases M. Arenas-Sordo1, P. Linares Mendoza1, J. Doll2, P. M. Arenas-Sordo: None. P. Linares Mendoza: None. J. Bahena2, M. Hofrichter2, B. Vona2, K. Peñuelas-Romero1, Doll: None. P. Bahena: None. M. Hofrichter: None. B. T. Haaf2 Vona: None. K. Peñuelas-Romero: None. T. Haaf: None. 1Instituto Nacional de Rehablitacion, Mexico City, Mexico, E-
P02 .14 2Institute of Human Genetics, Julius Maximilians Univer- Mutational spectrum of the SL
C26 A4 gene and its sity, Würzburg, Germany contribution to the etiology of hearing loss in the indigenous peoples of Southern Siberia (Russia) Introduction: Congenital hearing loss is one of the most frequent and genetically heterogeneous sensory diseases in V.Y.Danilchenko1,M.V.Zytsar1,M.S.Bady-Khoo2,E.A. humans. Its prevalence is 1-2 per 1000 live newborns. Maslova1,3, A. A. Bondar4, I. V. Morozov3,4, N. A. Globally, the GJB2 gene is responsible for almost 20% of Barashkov5,6, O. L. Posukh1,3 congenitalhearinglossbutinMexicoitislower.Mutations in about 200 other genes have been associated. Current 1Institute of Cytology and Genetics, Siberian Branch of studies of new generation sequencing (NGS) has a diag- Russian Academy of Sciences, Novosibirsk, Russian Fed- nostic rate of about 40%. eration, 2Perinatal Center of the Republic of Tyva, Kyzyl, Material and method: Ten familial cases of bilateral Russian Federation, 3Novosibirsk State University, Novosi- sensorineural hearing loss, severe to profound, non- birsk, Russian Federation, 4Institute of Chemical Biology syndromic, with complete audiological studies and tomo- andFundamentalMedicine,SiberianBranchoftheRussian graphic image of the ear, were studied. Sanger sequencing Academy of Sciences, Novosibirsk, Russian Federation, of GJB2 was done and when no pathogenic variants were 5Yakut Scientiﬁc Centre of Complex Medical Problems, found in this gene, WES was performed. Yakutsk, Russian Federation, 6M.K. Ammosov North-East- Results:1patientpresentedpathogenic variants ofGJB2 ern Federal University, Yakutsk, Russian Federation (c.139G> T and c.551G> C), the rest of the results are shown in the table. In 4 patients, the origin of the hearing Introduction: Mutations in the SL
C26 A4 gene (7q22-q31) loss could not be determined. The results found, for the leadtorecessivelyinheriteddeafness(DFNB4)andPendred most part, are those expected according to what is reported syndrome.Morethan500pathogenicSL
C26 A4-variantsare inother populations, especially variants in genes that cause currently revealed in deaf patients in different populations Usher syndrome. worldwide. This study aimed to investigate the SL
C26 A4 Conclusion: The aetiological diagnosis of hearing loss pathogeniccontributionindeafnesswithunknownetiology requires theclinical study ofpatients andtheirfamiliesand in patients belonging to indigenous peoples of Southern molecular studies, starting with the one with the highest Siberia: Tuvinians (the Tyva Republic) and Altaians (the prevalence to subsequently move to the different possibi- Altai Republic). lities.Itisnotpossibletodatetoknowtheetiologyin100% Materialsandmethods:Thestudyincluded232patients of cases. (171Tuvinians, 61Altaians) with hearing loss ofunknown etiology. Analysis of the SL
C26 A4 complete sequence including all 21 exons and ﬂanking regions was performed Gene Variant Protein Zygosity Relateddisease by Sanger sequencing. GPR98 c.5167C>G/ p. Compound Ushersyndrome Results: High contribution of the SL
C26 A4 mutations in c.14939T>C (Pro1723Ala)/ Heterozygosity type2C deafnesswasfoundinTuvinianpatients(28.2%)incontrastAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 811 to Altaian patients (4.3%). Both known (c.170C>A, c.919- Results: Affymetrix CytoScan Xon array: A mean of 56 2A>G, c.2027T>A, c.2034+1G>A, c.2168A>G) and CNVs/patient, both positive control and 10 potentially several novel pathogenic variants as well as a wide range disease-causing CNVs were detected. Agilent Custom ofbenignvariantswerefoundintheSL
C26 A4sequencesof array:Ameanof8CNVs/patient,onlyonepositivecontrol patients. High frequency of mutation c.919-2A>G in and 6 potentially disease-causing CNVs were found. Tuvinians (69.9% of all mutant alleles detected in patients Conclusions: ACA are easier to analyze, since their and carrier frequency reaching to 5.1% in controls) is results derive from only 123 IRD genes. Moreover, they probably due to the founder effect. include information from both exonic and intronic regions. Conclusion: This is the ﬁrst study to address the In contrast, ACX delivers information of CNV throughout SL
C26 A4 mutations contribution in deafness in Siberian the whole genome, with most probes enriched on exonic populations. Contrast differences in the proportion of regions.Thereforeinformationfromexonsismorerobustin deafness caused by SL
C26 A4 mutations were revealed in ACXarrays.Asageneralconclusion,AffymetrixCytoScan TuviniansandAltaiansdespiteoftheirrelatedethnicityand Xon arrays have more sensitivity but less speciﬁcity than close residence of these indigenous peoples of Southern our customized Agilent CGH array. Siberia. Obtained data signiﬁcantly contribute to the MRHissupportedbyafellowshipfromGobiernoVasco, SL
C26 A4 allelic diversity worldwide. Spain (Pre-2019-1-0325). Work supported by grants from StudywassupportedbyProjects#0259-2019-0010-C-01, the ISCIII and fondos FEDER (PI17/01413), from Depar- #0324-2019-0041-C-01 and RFBR grants #17-29- tamento de Salud of Gobierno Vasco (2018111062 and 06016_oﬁ-m, #20-015-00328_a. MTVD19/BD/006) and from BEGISARE. V.Y.Danilchenko:None.M.V.Zytsar:None.M.S.Bady- M. Rodríguez-Hidalgo: None. M. Ezquerra-Inchausti: Khoo:None.E.A.Maslova:None.A.A.Bondar:None.I.V. None. A. Lara-López: None. L. Escudero-Arrarás: None. Morozov: None. N.A. Barashkov: None. O.L. M.Galdós:None.G.Garay-Aramburu:None.C.Cruchaga: Posukh: None. None. C. Irigoyen: None. J. Ruiz-Ederra: None. E-
P02 .16 E-
P02 .17 Copynumbervariationanalysisinagroupofpreviously How prepare a corneal epithelium for cone-related unsolved patients with inherited retinal dystrophies: a transcriptomic proﬁle assessment in keratoconus? comparative study K. Jaskiewicz1, M. Maleszka-Kurpiel2,3, M. Rydzanicz4, M. Rodríguez-Hidalgo1, M. Ezquerra-Inchausti1, R. Ploski4, M. Gajecka1,5 A. Lara-López1, L. Escudero-Arrarás1, M. Galdós2, G.Garay-Aramburu3,C.Cruchaga4,C.Irigoyen1,5,J.Ruiz- 1Institute of Human Genetics, Poznan, Poland, 2Optegra Ederra1,6 Eye Health Care Clinic, Poznan, Poland, 3Chair of Ophthalmology and Optometry, Poznan University of 1IIS Biodonostia, San Sebastián, Spain, 2Cruces University MedicalSciences,Poznan,Poland,4DepartmentofMedical Hospital, Bilbao, Spain, 3Araba University Hospital, Genetics, Medical University of Warsaw, Warsaw, Poland, Vitoria-Gasteiz, Spain, 4Washington University School of 5Department of Genetics and Pharmaceutical Microbiol- Medicine, St. Louis, MO, United States, 5Donostia Uni- ogy, Poznan University of Medical Sciences, Poznan, versity Hospital, San Sebastián, Spain, 6RETICS Poland OFTARED, Madrid, Spain Introduction: Keratoconus is a multifactorial eye ectasia Introduction: Inherited retinal dystrophies (IRD) are an affecting 1 per 2000 individuals worldwide, characterized heterogeneousgroupofdiseaseswith>250genesinvolved. by pathological cone formation decentered from pupil axis. Despitesubstantialprogressinmasssequencingtechniques, Because all corneal layers are involved in disease progres- the genetic cause of 35-45% of the cases of IRD is still sion we aimed to establish a protocol for transcriptomic unknown.SincetheparticipationofCNVsisinvolvedinat proﬁle based on three distinct corneal epithelium regions. least 1 in 13 patients, here we present the results of ana- Materialsandmethods:The 10corneal epitheliabefore lyzingCNVinacohortofBasquepatientsusing2different the corneal cross-linking procedure were stampted to approaches. maintain correct orientation for cutting on microscope Materials and methods: 48 IRD patients and 2 positive slides with light microscope’s control. As non-keratoconus controls were analyzed. We compared 2 hybridization control 5 myopia patients undergoing refractive error arrays: Affymetrix CytoScan Xon arrays (ACX) and correction were included. From each corneal epithelium AgilentCustomarrays(ACA),with123IRDrelatedgenes. the central, middle, and periphery corneal region samples812 J.delPicchia were proceeded based on epithelial thickness mapping and mutationinTUBB4Bgene,whichcausesArgtoCyschange corneal tomography maps. The RNA samples were at391amino acidposition. Themutationwas absentinthe extracted using Norgen Biotek kits (Single Cell RNA sample of the unaffected family member. The clinical PuriﬁcationKit,RNA/DNA/ProteinPuriﬁcationPlusMicro evaluation of the ﬁndings reveals that the mutation fulﬁlls Kit),andRNAquality/quantitywerecompered(RNA6000 the criteria of pathogenic mutation and the clinical Pico Kit, Agilent). symptoms of the affected family members matches to Results: Study design included evaluation of unaffected Leber congenital amaurosis syndrome, which has been curvature of cornea and different physiological/functional previously correlated to this TUBB4B mutation. states of epithelial cells from keratoconus cone and non- Conclusion: Our unique ﬁndings with three affected cone corneal regions. After protocol establishment we family members carrying the TUBB4B mutation highlights obtained high quality RNA for RNA-seq libraries the importance of next generation sequencing in the preparation. discovery of new pathogenic variants and in diagnosis of Conclusions: The corneal material proceeded in accor- rare disorders; additionally, it will be important knowledge dance with the presented protocol will allow for detailed in gene therapy even in ophthalmology and otology. This keratoconus epithelium study involving the phenotypical work was supported by the grant NSRP K119540 and andtranscriptionalassessmentsofkeratoconusprogression. GINOP-2.3.2-15-2016-00039. Support: The National Science Centre grant no. 2018/31/ A.Maasz:None.R.Ripszam:None.A.Zsigmond:None. B/NZ5/03280. Co-ﬁnanced by the European Social Fund J. Bene: None. A. Gyenesei: None. B. Melegh: None. K. within the framework of the Operational Programme Hadzsiev: None. Knowledge Education Development, a non-competition project ‘International scholarship exchange of doctoral E-
P02 .20 students and academic staff’, implemented within the Mutational analysis of the most frequent genes in framework of the Action speciﬁed in the application No. Romanian patients with congenital non-syndromic POWR.03.03.03.00-00-00-PN13/18. hearing loss K. Jaskiewicz: None. M. Maleszka-Kurpiel: None. M. Rydzanicz: None. R. Ploski: None. M. Gajecka: None. I. Resmerita1, S. Cozma2, M. Panzaru1, E. Gorduza1, R. Popescu1, L. Radulescu2, L. Butnariu1, C. Rusu1 E-
P02 .18 Beta tubulin gene mutation in association with con- 1University of Medicine and Pharmacy “Grigore T. Popa” genital Leber herediter amaurosis syndrome Iasi - Medical Genetics Department, Iasi, Romania, 2Uni- versityofMedicineandPharmacy“GrigoreT.Popa”Iasi- A. Maasz1,2, R. Ripszam1,2, A. Zsigmond1,2, J. Bene1,2, ENT Department, Iasi, Romania A. Gyenesei2, B. Melegh1,2, K. Hadzsiev1,2 Introduction:Hearinglossisthemostcommoncongenital 1UniversityofPecs,DepartmentofMedicalGenetics,Pecs, sensory impairment worldwide, with a genetic etiology in Hungary,2SzentagothaiResearchCentre,Pecs,Hungary more than 60% of the cases. It is estimated that more than 70locimaycontributetonon-syndromicdeafness,themost Introduction: Beta-tubulin 4B isotype is one of the sub- commonly involved genes being GJB2, GJB3, GJA1, units of microtubules, which is responsible for the main- MYO6, SL
C26 A4, POU3F4. The knowledge on the pre- tenance of microtubules stability. The beta-tubulin 4B valence of mutations in a certain population allows the protein is encoded by TUBB4B gene located on chromo- development of adjusted screening programs. some 9. Genetic defects of microtubules have been asso- Materials and methods: We included in this study 144 ciated with several disorders like tubulinopathies, which unrelatedRomanianswithnon-syndromiccongenitalsevere show huge heterogeneity. In TUBB4B gene, only a few to profound hearing loss (NSHL). All of the individuals mutations have been identiﬁed to have implications in dis- were screened by Multiplex ligation-dependent probe orders, so far. ampliﬁcation (MLPA) for mutations in GJB2, GJB3, Patients and methods: The authors report a Hungarian GJB6, WF
S1  and POU3F4 genes, and Sanger sequencing familywithundiagnosedraredisorder.Thefamilymembers for variants in GJB2 gene. suffer from also ophthalmologic and otologic impairments. Results: We found 54 homozygotes or compound Theauthorsanalyzedtheprobandandheraffectedchildren heterozygotesindividuals(38%)and14carriersofdifferent and the unaffected mother of the proband using whole mutations on GJB2 gene. In the study group we found a genome sequencing (WGS). The authors found that all of total of 10 different mutations in GJB2 gene. The 35delG theaffectedfamilymemberscarrythec.1171C>Tmissense wasthemostcommonformofmutationthatwaspresentinAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 813 23outof54(43%)mutatedalleles.Thenextfrequenttypes pathogenicity of genetic alterations identify the variant as of mutation were WT313del14, IV
S1  and c.71G>A. We potentially pathogenic. also found 2 patients with mutations in WF
S1  gene. Funding: NSP “Young Scientists and Postdoctoral Conclusions: The etiology of deafness is an additional Fellows” argument, besides audiological tests, for early treatment D.R. Pencheva: None. K. Kamenarova: None. (best choice being cochlear implant) and an essential K. Mihova: None. V. Petkova: None. I. Dimova: None. element for the correct management of the individuals. M. Nacheva: None. V. Mitev: None. R. Kaneva: None. Moreover,identiﬁcationofthegeneticbasisofhearingloss in a child facilitates correct genetic counselling with E-
P02 .27 adequate molecular testing of the parents and subsequent The utility of whole-exome sequencing in establishing prenatal diagnosis. speciﬁc diagnosis in three cases with syndromic I. Resmerita: None. S. Cozma: None. M. Panzaru: None. cataracts E.Gorduza:None.R.Popescu:None.L.Radulescu:None. L. Butnariu: None. C. Rusu: None. P. Liskova, L. Dudakova, J. Moravikova, M. Magner, T. Honzik E-
P02 .24 Next-generation sequencing for germline mutation First Faculty of Medicine, Prague, Czech Republic analysis in patients with retinoblastoma Introduction: Congenital and juvenile cataracts can be D.R.Pencheva,K.Kamenarova,K.Mihova,V.Petkova,I. associatedwitharangeofsystemicsigns.Hereinweaimto Dimova, M. Nacheva, V. Mitev, R. Kaneva report results of molecular genetic investigation in six probands with syndromic cataracts without a deﬁnitive Genome Diagnostics Laboratory, Molecular Medicine clinical diagnosis. Center, Department of Medical Chemistry and Biochem- Materials and methods: Whole exome sequencing istry, Medical Faculty, Medical University of Soﬁa, Soﬁa, (WES) was performed in all index cases. Variants with Bulgaria minorallelefrequencylessthan0.005aspergnomADv.2 were ﬁltered and those located in genes listed in database Introduction: Retinoblastoma is the most common pedia- Cat-Map were given a priority for further evaluation. tric ocular tumor affecting the retina, initiated mainly by Conventional sequencing was used to conﬁrm the mutations in the tumor suppressor gene RB1. Both heredi- presence of the variants and for segregation analysis tary and sporadic forms of the disease are known. within the families. Variant-classiﬁcation was based on Materialsandmethods:Inthecurrentstudyweincluded the American College of Medical Genetics and Genomics two Bulgarian patients diagnosed with retinoblastoma. DNA guidelines. was isolated from blood. Next-generation sequencing was Results: One proband carried a heterozygous variant performedonMiSeq/IlluminaplatformwithTruSightCancer c.3491delinCO
L2 A1predictedtointerferewithpre-mRNA panel including 94 cancer related genes. splicing. Subsequent re-evaluation of his clinical data Results:Wefoundtwoheterozygousprobablypathogenic conﬁrmed the diagnosis of Stickler syndrome, which was variants both in RB1, encoding RB transcription corepres- also present in the mother. One proband had a de novo sor 1: c.2606C>T (p.Pro869Leu; rs775273085) in exon 25 arising heterozygous variant c.512T>G; p.(Leu171Trp) in and c.1960+1G>C in intron 19 of the RB1 gene. MYH9 allowing to make a diagnosis of MYH9-related Conclusions:The missense variant c.2606C> T (p. disease. The third case had a known heterozygous change Pro869Leu)inexon25isoflowfrequencyinthepopulation c.284G>C; p.(Gly95Ala) in RIT1 causing Noonan syn- (oneheterozygoteC/TisdetectedingnomAD,1/251337). drome. His mother was subsequently found to be also Thismutationwasalsodetectedinaheterozygouscondition mildly affected. No possibly pathogenic variant was in the mother of the patient, who was diagnosed with renal identiﬁed in three other probands. angiomyolipoma with focal hemorrhages and micro necro- Conclusions: WES allowed for providing deﬁnitive sis.Theothervariantc.1960+1G>Cfoundinintron19is diagnosis in three probands with syndromic cataracts. Our new for data bases. Single-point replacements of G>A and study shows that there is a need for raising awareness G>Tinthesamepositionhavebeenshowntobepathogenic among healthcare professionals regarding variable associa- in patients with retinoblastoma. According to the program tion of many syndromes with congenital or juvenile usedtoevaluatetheeffectofintronvariants,replacementof cataracts. Supported by AZV 17-30500A. c.1960 + 1G> C would affect mRNA splicing (ADA score P. Liskova: None. L. Dudakova: None. J. Moravikova: 0.99).All ofthesix commonly used programsto assessthe None. M. Magner: None. T. Honzik: None.814 J.delPicchia E-
P02 .29 E-
P02 .30 Clinical exome sequencing reveals Usher syndrome Usher syndrome type 3 in Russian population: 6 ﬁrst pathogenic PCDH15 and ADGRV1 variants in two reported cases. pedigrees with hearing and vision loss M. E. Ivanova1,2, E. R. Lozier3, V. S. Kaimonov2, I. V. K. Kamenarova1, S. Cherninkova2, K. Mihova1, Mironova2, E. A. Pomerantseva2, F. A. Konovalov3, A. A. F. Shakola1, V. Mitev1, R. Kaneva1 Isaev2 1Molecular Medicine Center, Medical University – Soﬁa, 1Oftalmic, Moscow, Russian Federation, 2Genetico, Mos- Soﬁa, Bulgaria, 2Department of Neurology, University cow, Russian Federation, 3Clinical bioinformatics labora- Hospital Alexandrovska, Medical University – Soﬁa, tory, Moscow, Russian Federation Bulgaria, Soﬁa, Bulgaria Introduction: Usher syndrome is one of the most frequent Introduction: Usher syndrome (USH) is a rare disorder reasons of combined blindness and deafness. There are causingretinitispigmentosa(RP),andsensorineuralhearing three types of Usher syndrome, type 3 is mild and can be loss. Due to the phenotypic and genetic heterogeneity of clinically evaluated quite accurately. There is no known this disease, the best method to screen the causative muta- effective treatment of Usher syndrome type 3. tionsisbyhigh-throughputsequencing.Bynext-generation Materials and methods: 120 patients with isolated and sequencing of clinical exome including known USH-cau- syndromic retinitis pigmentosa participated in the study sative genes, we aimed to identify the disease-causing under NCT03901391 clinical trial protocol. Out of 120 mutation in two USH-pedigrees. cases six were CLRN1 conﬁrmed. Complete ophthalmolo- Materials and methods: Using Illumina® platform, we gic,ENT,andvestibularmedicaltestsweredoneforclinical identiﬁed two pathogenic variants in two USH genes characterization. WES, Sanger sequencing were provided (PCDH15 and ADGRV1) segregating with vision and for genetic analysis and diagnosis conﬁrmation. hearing loss in two unrelated Bulgarian families. Results: 6 patients (4 male, 2 female) aged 30.2±6.9 Results: In a USH-family, an affected woman was yrs were diagnosed with CLRN1 associated retinopathy homozygous for a splice-site mutation in PCDH15 whichshowedclassicalretinitispigmentosabonespiculesin (c.3983+1G>T,p.?), predicted to cause splice error - a the peripheral retina combined with hearing loss starting known mutation for USH type-1F. Ophthalmological from early childhood. Four patients were having mild examination of the patient conﬁrmed typical RP and myopia and two were having emmetropia. Four of these prompted a corrected USH type diagnosis. Patient’s patients were unrelated to each other and two were sibs unaffected parents and brother were heterozygous for (brother and sister). All of the patients had c.567T>G p. the mutation. In an unrelated clinical case, two siblings Tyr189*mutationinhomozygousstate,whichprobablycan withRPwerehomozygousforanovelnonsensemutation denote the founder effect on the territory of Russia. inADGRV1(c.5709G>A,p.Trp1903*),predictedtocreate Conclusions: There were no previouslydescribed and a very premature stop codon and shortened protein. published Usher syndrome type 3 clinical cases in Russia Clinical follow-up subsequently conﬁrmed pre-existing conﬁrmed with CLRN1 gene mutations. There might be hearing loss since early childhood in the two patients, attractive perspectives for the treatment strategies for such resultinginareassigneddiagnosisofUSH.Asymptomatic groupofpatientsnotonlybecauseCLRN1genehasonly6 parents and brother were heterozygous carriers of the exonsand mRNA is relatively short (2,39 kb), but also mutation. because mutation is homogenous and includes only Conclusions:WehaverecruitedtwopedigreeswithUSH c.567T>G p.Tyr189* mutation in homozygous state. and found homozygous mutations in PCDH15 and Funding: Charity fund Con-nection. ADGRV1.Theproteinsencodedbythesegenesarethought M.E.Ivanova:None.E.R.Lozier:None.V.S.Kaimonov: tointeractwithoneanothertoformanetworkinthesensory None. I.V. Mironova: None. E.A. Pomerantseva: None. F. cells of the retina and inner ear. Grant references: D01- A. Konovalov: None. A.A. Isaev: None. 285/17.12.2019/D-230/17.12.2019/NSF/MES and КП-06- Н33/12/ NSF/MES. E-
P03 InternalOrgans&Endocrinology(Lung,Kidney, K. Kamenarova: None. S. Cherninkova: None. K. Liver, Gastrointestinal) Mihova: None. F. Shakola: None. V. Mitev: None. R. Kaneva: None. E-
P03 .01 Hyperaldosteronism in a patient with AT
P1 A1 deﬁciencyAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 815 S.Gisladottir,H.Gisladottir,J.J.Jonsson,H.T.Bjornsson Introduction: Familial neurohypophyseal diabetes insipi- dus is a rare disease producedby a deﬁciency in the secre- University Hospital of Iceland, Reykjavik, Iceland tion of antidiuretic hormone and is caused by mutations inthe AVP-NPII gene. Wereportapatientwithepisodesofhypertensivecrisisand Materials and methods: Clinical, biochemical and lactic acidosis from infancy. These episodes were found to genetic characterization of a group ofpatients clinically be related to hyperaldosteronism and ill treatable with diagnosed with Familial neurohypophyseal diabetes insipi- conventional blood pressure medication. At four months dus. TheAVP-NPII gene was screened for mutations by old, she was diagnosed with pulmonary hypertension and polymerase chain reaction followed bydirect Sanger refractory seizures. She also has developmental delay sequencing in 15 different unrelated families from Spain. compounded by multiple brain infarcts. She is treated with Results: The 15 probands presented with polyuria and alpha-agonists and ACE-inhibitors and responds well. She polydipsia as the most importantsymptom at the time of is also receiving anticonvulsants and PDE inhibitors. WGS diagnosis. In these patients, the disease was diagnosed at was performed for her in 2017 which identiﬁed a hetero- amedian of 6 years of age (range: 0.75 - 48 years). We zygous missense variant, p.Asp897Asn, in the AT
P1 A1 observed 11 presumed pathogenicvariants in 15 families: 8 gene (in the extracellular domain) that encodes for the missense,1nonsenseand2smalldeletionsof3nucleotides. Alpha-1 isoform of the Na(+)/K(+)-ATPase, which helps FouroftheAVP-NPIIvariantswerenovel(p.(Tyr21Cys),p. establish electrochemical gradient over plasma membranes. (Gly45Ser), p.(Cys75Tyr),p.(Gly88Cys)). In2018similarvariantsweredescribedintheAT
P1 A1gene Conclusions:WefoundautosomaldominantFNDIinthe inthreechildren(allintheintramembranousdomain).Their 15 probands studied due tolikely pathogenic variants in the phenotype has been described as a new disease called AVP-NPII gene conﬁrming the clinical diagnosis. Fourof hypomagnesemia, seizures and mental retardation 2 the AVP-NPII variants were novel. (MIM#618314) but none of these patients have hyper- A. Garcia: None. L. Madariaga: None. G. Pérez de aldosteronism. Our patient has demonstrated mild hypo- Nanclares: None. A. Vela: None. I. Rica: None. magnesemia as well as seizures and developmental delay. S. Gaztambide: None. R. Martinez: None. I. Martinez de Interestingly, somatic AT
P1 A1 disease causing variants, LaPiscina: None. I. Urrutia: None. A. Aguayo: None. have been found in aldosterone-producing adenomas. O. Velasco: None. L. Castaño: None. Additionallyin2018,variantsinthegenewerefoundtobe a novel cause of Charcot-Marie-Tooth syndrome (all in the E-
P03 .05 intracellular domain), so this gene can lead to multiple The intriguing role of bitter taste receptor TA
S2 R38 in phenotypes,whichcoulddifferdependingonthelocationof primary ciliary dyskinesia “PCD” the variants in the domains of the protein. We propose that her episodes of hypertensive crisis and hyperaldosteronism A. Robino1, G. Girotto2, U. Ambrosetti3, G. Piatti4 maybeanexpansionofthephenotypeoranoveladditional phenotype related to this gene. 1IRCCS-Burlo Garofolo Children Hospital, Trieste, Italy, S. Gisladottir: None. H. Gisladottir: None. J.J. Jonsson: 2IRCCS-Burlo Garofolo Children Hospital-University of None. H.T. Bjornsson: None. Trieste,Trieste,Italy,3IRCCSCa’Granda,AudiologyUnit- University of Milan, Milano, Italy, 4IRCCS Ca’ Granda, E-
P03 .04 Bronchopneumology Unit-University of Milan, Milano, Novel variants in the AVP-NPII gene associated with Italy neurohypophyseal diabetes insipidus PCD is arare genetic disease dueto malfunctioningand/or A. Garcia1, L. Madariaga1,2,3, G. Pérez de Nanclares1, altered ultrastructure of motile cilia leading to recurrent A. Vela1,3,2, I. Rica1,2, S. Gaztambide1,2,3, R. Martinez1, respiratory infections of upper and lower airways. Chronic I. Martinez de LaPiscina1, I. Urrutia1, A. Aguayo1, rhinosinusitis and bronchiectasis are very common in PCD O. Velasco4, L. Castaño1,2,3 patients. Recently, it has been shown the presence of taste receptors in the respiratory tract and the possible involve- 1IISBiocrucesBizkaia,CIBERDEM,CIBERER,Barakaldo, mentofbittertastereceptorTA
S2 R38gene,insusceptibility Spain, 2Hospital Universitario Cruces, Barakaldo, Spain, torespiratory infections and rhinosinusitis. The aim of this 3UPV/EHU, Leioa, Spain, 4IIS Biocruces Bizkaia, Bara- study is to evaluate the frequency of TA
S2 R38 poly- kaldo, Spain morphisms in PCD patients and their possible correlations with clinical outcomes of the disease. Genetic and816 J.delPicchia phenotypic data of 35 PCD patients were collected. Clin- with R1158X mutation, deletion of exons 18-20 in three ical evaluation includes: number of respiratory infections patients with F508del mutation and in one with R334W, per year and pathogens; Lund McKay score; number of deletionofexons2and3intwopatientswithF508del,two lung lobes involved; modiﬁed Bhalla score. As regards deletions of exons 2 and 13 in one patient. The last ﬁnding genetic data, 3 polymorphisms (rs1726866,rs713598, is novel and not described in databases. The clinical rs10246939) within TA
S2 R38 gene were analyzed and presentation of CF in all of them was with early onset (in patients classiﬁed as PAV/PAV, PAV/AVI and AVI/AVI. the ﬁrst year of life), meconium ileus, failure to thrive, A signiﬁcant difference in the distribution of TA
S2 R38 pancreatic insufﬁciency, chronic obstructive lung disease haplotype between patients with and without neonatal and abnormal sweat test levels. respiratorydistressemerged(p-value=0.01).Inparticular,a Conclusion:Weestablishedthatoverallfrequencyofthe lower percentage of PAV/PAV individuals showed a high large deletions in our patients is about 1% from all number of pulmonary exacerbations (≥ 2/year) (p- mutations that we found in CFTR gene. It must be kept in value=0.04) compared to those with AVI/AVI and AVI/ mind that >99% of all known point mutations have allele PAV haplotypes. Moreover, no patients homozygous for frequencies that are below 0.1%. Therefore we believe that PAV/PAV haplotype presented with any chronic coloniza- it is suitable to use MLPA of CFTR gene for routine tion by Pseudomonas aeruginosa thus supporting the pos- molecular diagnostics of CF. sible role of TA
S2 R38 in susceptibility to respiratory N. Yaneva: None. M. Libik: None. G. Petrova: None. infections. In conclusion, here we report, for the ﬁrst time, I. Bradinova: None. M. Nikolova: None. M. Macek: None. a possible association of TA
S2 R38 polymorphisms with A. Savov: None. PCD phenotype. A larger collection of patients is in pro- gress and updated results will be presented and discussed. E-
P03 .07 A. Robino: None. G. Girotto: None. U. Ambrosetti: Differential molecular diagnosis of Cystic ﬁbrosis and None. G. Piatti: None. Shwachman-Diamond syndrom E-
P03 .06 M. Kazaryan1,2, T. Adyan2,1, A. Polyakov2 Clinics and genetics in CF patients with large deletions 1RNRMU, Moscow, Russian Federation, 2Research Centre N. Yaneva1, M. Libik2, G. Petrova3, I. Bradinova1, M. for Medical Genetics, Moscow, Russian Federation Nikolova4, M. Macek2, A. Savov1 Cystic ﬁbrosis (CF) and Shwachman-Diamond syndrome 1National Genetic Laboratory, University Hospital of (SDS) are autosomal recessive disorders, associated with Obstetrics and Gynecology “Maichin Dom”, Soﬁa, Bul- mutations in CFTR and SBDS genes respectively. CF and garia, 2Department of Biology and Medical Genetics, SDS have general symptom - exocrine pancreatic insufﬁ- Charles University-2nd Faculty of Medicine and Motol ciency. This study aims to describe the possibility of mis- University Hospital, Prague, Czech Republic, 3Pediatric diagnosis in case of conditions with common symptoms, cilinic, UMHAT "Alexandrovska", Soﬁa; Pediatric depart- such as CF and SDS. The ﬁrst cohort of 94 patients aged ment, Medical University of Soﬁa, Soﬁa, Bulgaria, 4Pedia- from 0 to 40 years with primary SDS diagnosis were tric clinic, UMHAT“Sveta Marina“, Varna; Medical investigated for the presence of 30 CFTR gene mutations Univcersity Varna, Varna, Bulgaria that are most frequent in Russian Federation. The second cohort of 361 patients with primary CF diagnosis was Introduction:Cysticﬁbrosis(CF)isthemostcommonlife- analyzed for the presence of 2 common SBDS gene muta- shortening condition with autosomal recessive inheritance. tions (this sample was divided into 2groups:246 probands It is associated with at least one mutation on each allele on agedfrom0to5yearsand115probandsagedfrom6to10 CF transmembrane conductance regulator (CFTR). After years). MLPA-method was used to determine point muta- screeningforpointmutationsandsmallindel,usingSanger tions; deletion/insertion mutations were tested by multiplex sequencing and NGS, in some patients the second disease AFLP-method and automated sequencing as well. We causing mutation remains unidentiﬁed. identiﬁed one heterozygous carrier of F508del mutation in Materials and methods: We performed MLPA analysis the CFTR gene in SDS sample (sequencing of the entire for detection of large deletions and duplications in CFTR coding region of this gene and MLPA-analysis did not gene,using 
P091 MLPA MRCHollandkit inagroup of44 reveal a second pathogenic variant in this patient). In a CF patients with only one mutation. group of 0-5 years CF patients 4 probands were found to Results:TheMLPAscreeningdetectedlargedeletionsin have both mutations in the SBDS gene and one proband eight patients (18%): deletion of exons 4-11 in one patient have1heterozygousmutation.Inagroupof6-10yearsCFAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 817 patients only 1 proband had both mutations. Our results treatmentwiththyroidhormoneandthatfuturepregnancies demonstratethatpatientswithsuspectedCFandundetected should be carefully monitored for the presence of prenatal mutations in the CFTR gene are necessary to differential goiter. diagnosis with a SDS. N.Zdraveska:None.V.Anastasovska:None.N.Schoen- M. Kazaryan: None. T. Adyan: None. A. Polyakov: makers: None. A. Nicholas: None. M. Kocova: None. None. E-
P03 .10 E-
P03 .08 Molecular investigation of Cystic Fibrosis: CFTR Thyroid peroxidase (TPO) mutations in Macedonian mutation spectrum among Greek population patients with congenital hypothyroidism M. Argyraki, M. Chatziapostolou, S. Vittas N. Zdraveska1, V. Anastasovska1, N. Schoenmakers2, A. Nicholas2, M. Kocova1 DNA - Diagnosis N Analysis Laboratory, Thessaloniki, Greece 1UniversityChildren’sHospitalSkopje,Skopje,Macedonia, The Former Yugoslav Republic of, 2University of Cam- Introduction: Cystic Fibrosis (CF) represents the second bridge Metabolic Research Laboratories, Wellcome Trust- mostcommoncongenitaldisorderamongGreekpopulation. Medical Research Council Institute of Metabolic Science, Approximately 4-5% of Greek population represents Addenbrooke’s Hospital, Cambridge, United Kingdom asymptomatic CF mutation carriers. This in conjunction with the limited knowledge about this disease necessitates Introduction: Congenital hypothyroidism (CH) due to the implementation of carrier screening programs. thyroiddyshormonogenesisisaheterogenicdisordercaused Materials and methods: The study population consisted by impairment in any stage of the thyroid hormone bio- of 485 Greek individuals screened for CF mutations. We synthesis pathway. Mutations in seven genes may be used a targeted NGS to sequence all CFTR gene coding associatedwiththyroiddyshormonogenesis:SL
C5 A5(NIS), regions, intron/exon splice sites and UTRs, combined with SC
L26 A4 (PDS), TG, TPO, DUOX2, DUOXA2, and IYD MLPA analysis. (DHEA
L1 ). Defects in thyroid peroxidase (TPO) gene are Results: Molecular analysis showed that 96 indivi- reported as the most frequent cause of dyshormonogenesis duals (19.8%) represent CF mutation carriers, consisting with permanent CH characterized with permanent total of 24 individuals (4.75%) carrying typical CF-causing iodide organiﬁcation defect. mutations, 38 individuals (7.52%) carrying CFTR-RD Methods:Acomprehensive,phenotype-driven,approach (CFTR-related disorders) mutations and 38 individuals was used to identify underlying mutations in Macedonian (7.52%)carryingvariantsofuncertainsigniﬁcance(VOUS). cohort of CH patients, by sequentially screening known Seven cases of complex alleles that carry two mutations dyshormonogenesis-associated genes. Genomic DNA was were also observed, a factor that can complicate CFTR extracted from peripheral blood leukocytes, and Sanger diagnosisandclinicalevaluation.Themostcommontypical sequencing was used to screen for TPO gene mutations in mutation identiﬁed in 15 carriers was ΔF508, followed by all coding exons and exon/intron boundaries ampliﬁed by 621+1G>T mutation occurring in 3 carriers. Likewise, PCR speciﬁc primers. R75Q mutation represents the most common CFTR-RD Results:AnalysisoftheTPOgenerevealed variantsin3 mutation identiﬁed (8 carriers), followed by 
L997 F and cases including 2 siblings who each harboured a hetero- R1162L (found in 6 and 4 carriers respectively). Lastly, zygous frameshift variant, p.A397Pfs*77, inherited from a c.2620-15C>G mutation was identiﬁed in 11 carriers, euthyroid father. An unrelated case was compound hetero- representing the most common VOUS mutation in the zygous for a maternally inherited missense mutation, p. population studied. R438H, and a paternally inherited frameshift variant, p. Discussion: Aim ofthecurrentstudy was toestimatethe 
E17 Dfs*77. All 3 cases exhibited severe CH at diagnosis, CFTR mutation spectrum and the prevalence of CF with signiﬁcantly elevated serum TSH values (mean: mutation carriers among Greek population. Accurate 103mU/L, range >75-159mU/L) and low fT4 values knowledge of CF mutation spectrum provides information (mean<4ug/dl). Goitre was diagnosed on the neonatal for CF prevention programs and may prove particularly thyroidultrasoundandduringfoetalultrasoundexamination important for providing more sufﬁcient genetic counselling in the third case. to the Greek population. Conclusion: Finding TPO gene mutations in a neonate M. Argyraki: None. M. Chatziapostolou: None. with CH indicates that the subject will require life-long S. Vittas: None.818 J.delPicchia E-
P03 .13 E-
P03 .14 Correlationof10SNPpolymorphismsinmodiﬁergenes The c.7G>A variant in EHHADH associated with (TNF, GST, HFE) with phenotype of Slovak cystic Fanconi renotubular syndrome is also responsible for ﬁbrosis (CF) patients hepatic failure E. Tóthová Tarová1, A. Soltysova2, A. Ficek3,P. Celec4,5,3, P. Rollier1,2, M. Barth1, V. Milon1, N. Gueguen1, C. Bris1, H. Kayserova6, L. Kádasi3,2 L. Damaj2, A. Ryckewaert3, S. Odent2, V. Procaccio1, A. Ziegler1, D. Bonneau1 1Department of Biology, Faculty of Education, J. Selye University, Komárno, Slovakia, 2Institute of Molecular 1Department of Biochemistry and Genetics, Angers Uni- Physiology and Genetics, Slovak Academy of Sciences, versity Hospital, Angers, France, 2Department of Clinical Bratislava, Slovakia, 3Department of Molecular Biology, Genetics, Rennes University Hospital, Rennes, France, Comenius University, Bratislava, Slovakia, 4Institute of 3Department of Pediatrics, Rennes University Hospital, Pathological Physiology, Faculty of Medicine, Comenius Rennes, France University, Bratislava, Slovakia, 5Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Introduction: EHHADH was ﬁrst associated to a human Bratislava, Slovakia, 6Center of Cystic Fibrosis, Depart- disease by Klootwijk et al. in 2014 who reported that the ment of Pediatric Pneumology, University Hospital, pathogenic variant c.7G>A;p.
E3 K was responsible for an Bratislava, Slovakia isolated Fanconi renotubularsyndrome. Thisvariantcauses an addressing defect of this peroxisomal protein leading to Cystic ﬁbrosis (CF) is still the most serious autosomal its abnormal localization to mitochondria. We report a recessive disease in the white population despite second case harbouring the same mutation in EHHADH as improved treatment of CF patients. More than 2000 that previously reported who was affected with a broader identiﬁed mutations have been previously described in phenotype including recurrent hypoglycemia and hepatic theCFTRgene.EveninCFpatientswithidenticalCFTR cytolysis associated to Fanconi syndrome. genotypes, there are a large number of serious lung Materials and methods: Recruitment of the patient, diseases and other symptoms. Environment and poly- exomesequencingandfunctionalanalyseswerecarriedout morphisms in other genes play a particularly important at the Angers University Hospital. role in the phenotypic modiﬁcation of disease. The main Results: At 4 months of age, the individual presented aim of our study was the correlation analysis of 10 SNP with hypoglycemia, ketonuria, lactic acidosis and hepatic polymorphisms/variants in selected modiﬁer genes cytolysis. Subsequently, he presented recurrent episodes of (TNFα, GSTM, GSTP, GSTT and HFE) and subsequent vomiting and/or diarrhea with hypoglycemia after long correlation analysis with clinical symptoms of patients, fasting requiring glucose infusions. Additional features mainly spirometry measurements of lung function. To included severe Fanconi tubulopathy with glucosuria, identify these polymorphisms, we used methods such as tubular proteinuria, hypouricemia, and nephrocalcinosis. PCR and direct sequencing. Our results show a sig- Mitochondrial respiratory chain analyses performed on niﬁcant association of the TNFα gene polymorphism hepatocytes showed a decreased activity of complex I and (rs1800629) with cardiomyopathy, another polymorph- IV, including a 70% decrease in complex IV/citrate ism (rs361525) with hypoalbuminemia and distal synthase ratio which was conﬁrmed by the decrease of the obstructive syndrome, and two other polymorphisms same complexes using Western blot analyses. Exome (rs1800630, rs1799724) with bacterial infections of analysis evidenced the missense mutation c.7G>A;p.
E3 K Pseudomonas aeruginosa. The GSTT1 gene show sig- in EHHADH. This mutation was inherited from the father niﬁcant association with the nasal polyps, GST
P1  gene who was asymptomatic at age 54. (rs1695) with a worse pulmonary function by vital Conclusions:Weexpandthephenotypicspectrumofthe capacity of lung (FEV ), also HFE gene polymorphism c.7G>A mutation in EHHADH with the description of 1 (rs1799945)withworsepulmonaryfunction(FEV ).Our hepatic failure, including cytolysis and hypoglycemic 1 results can be used as a prognostic marker in the treat- episodes,associatedwithFanconitubulopathy.Thisdisease ment of CF patients. isanautosomaldominantdisorderwithagreatvariabilityin E.Tóthová Tarová:None.A.Soltysova:None.A.Ficek: expression. None. P. Celec: None. H. Kayserova: None. L. P. Rollier: None. M. Barth: None. V. Milon: None. Kádasi: None. N. Gueguen: None. C. Bris: None. L. Damaj: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 819 A.Ryckewaert:None.S.Odent:None.V.Procaccio:None. E. Lausch: None. D. Matheisl: None. R. Hentschel: None. A. Ziegler: None. D. Bonneau: None. M. Pohl: None. M. Schmidts: None. E-
P03 .15 E-
P03 .18 Renal phenotype expansion in known syndromes using Juvenile nephronophthisis due to NPH
P1  homozygous whole exome sequencing deletion revealed by whole exome sequencing I. Schüle1, K. Häffner1,2, J. Kracht1, G. Ruzaike1, G. Christopoulou1, A. Oikonomaki1, S. Samara1, S. E. Lausch1, D. Matheisl1, R. Hentschel1, M. Pohl1, Bournazos1, C. Melexopoulou2, J. Boletis2, P. M. Schmidts1 Constantoulakis1 1Clinic for General Pediatrics, Adolescent Medicine and 1Genotypos Science Labs MSA, Athens, Greece, 2Depart- Neonatology, University of Freiburg, Freiburg im Breis- ment of Nephrology and Renal Transplantation, Laiko gau,Germany,2ClinicforInternalMedicineIVNephrology Hospital, Athens, Greece and General Medicine, University of Freiburg, Freiburg, Germany Introduction: Renal failure is a major cause of morbidity and mortality worldwide and revealing a potential genetic Background: Patients with rare syndromes often background is essential for the patients’ management and have mutations in genes that are not covered by organ families’ counselling. speciﬁc NGS Panels. Whole exome sequencing (WES) Materials and methods: A 17-year-old female with helps ﬁnding the underlying genetic cause of end-stage tubulointerstitial nephritis was referred for whole exome renal disease (ESRD) especially in patients with extrarenal sequencing(WES).WESwasperformedonDNAextracted features. from peripheral blood, using the Twist Human Exome Methodsandresults:WereporttwocaseswithESRDin Core-v2 kit (Twist Bioscience). Following preparations patients with extrarenal organ involvement. A 14 year old according to the manufacturer’s protocol, libraries were boy with a history of perinatal asphyxia presented with a sequenced on an Illumina NextSeq-500 genetic analyser. ﬁrst seizure and ESRD. In addition he showed a Data processing, variant calling and pre-classiﬁcation were psychomotor developmental retardation, muscular hypoto- conducted by SOPHiA DDM® bioinformatics pipelines. nia and facial dysmorphism. The second patient was a MultiplexLigation-dependentProbeAmpliﬁcation(MLPA) newborn with congenital kidney failure, cleft palate, was performed (
P387 -
C1 , Coffalyser net, MRC-HOL- microcephaly, hypothyroidism and also facial dysmorph- LAND) to further conﬁrm results. ism. WES revealed a heterozygous variant in the KANS
L1  Results: No pathogenic/likely pathogenic SNVs/Indels gene (c.1284delA:p.V428fs) in the 14 year old patient not were detected, related to the phenotype. Gene coverage detected in the mother (father unavailable) and a hetero- analysis revealed a homozygous NPH
P1  whole gene zygous de novo variant in the KMT2D gene (c.
C8434 T:p. deletion, subsequently conﬁrmed by MLPA. Deletions Q2812X) in the newborn. Both variants have not been including at least NPH
P1  are associated with Juveline previously described in literature. nephronophthisis, which is in concordance with the Discussion: KANS
L1  and KMT2D mutations cause phenotype. Parental DNA MLPA analyses revealed Koolen-de Vries and Kabuki Syndrome. While clinical NPH
P1  heterozygous deletions in both, whereas the features observed in our patients ﬁt well with those proband’ssisterwascompletelynormalthus,substantiating conditions, renal disease is extraordinarily severe in our inheritance and further guiding the selection of the cases:noESRDhasbeenpreviouslyreportedforKoolen-de appropriate family member for possible kidney Vries Syndrome and likewise, congenital ESRD has not transplantation. beendescribedintheliteratureforKabukisyndromesofar. Discussion: Optimization in WES protocols allows Our ﬁndings extend the kidney phenotype in these greater conﬁdence in calling copy number variations. syndromes and show the utility of WES to unravel the By applying this approach, deﬁnite diagnosis of cause of ESRD in children that would be missed by gene the nephropathy was achieved, otherwise challenging panel based NGS. with traditional methods. Whole exome sequencing I.Schüle:None.K.Häffner:B.ResearchGrant(principal permits a large number of genes investigated, for different investigator, collaborator or consultant and pending grants types of variants, establishing diagnosis and leading to as well as grants already received); Signiﬁcant; Green- accurateandtimelydecisionsforthepatient’sandfamilies’ ovationBiotechGmbh.J.Kracht:None.G.Ruzaike:None. healthcare.820 J.delPicchia G.Christopoulou:None.A.Oikonomaki:None.S.Samara: M.M. Litvinova: None. T.V. Filippova: None. D.V. None. S. Bournazos: None. C. Melexopoulou: None. J. Svetlichnaya: None. S.Z. Nuralieva: None. A.D. Matsvay: Boletis: None. P. Constantoulakis: None. None. K. Khaﬁzov: None. E-
P03 .19 E-
P03 .20 Polymorphisms of calcium metabolism genes associated A rare presentation of NPH
P3  nephronophthisis with kidney stone disease in Russian population L. Ramos1,2, S. Fernandes1, C. S. Rosas1, M.M.Litvinova1,2,T.V.Filippova1,D.V.Svetlichnaya1,S. A. C. Marinhas3,4, T. Luís5,4, S. Ferreira6, C. Gomes4 Z. Nuralieva1, A. D. Matsvay3, K. Khaﬁzov3 1Medical Genetics Unit, Hospital Pediátrico, Centro 1I.M. Sechenov First Moscow State Medical University HospitalareUniversitáriodeCoimbra,Coimbra,Portugal, (Sechenov University), Moscow, Russian Federation, 2The 2Faculty of Health Sciences, Universidade da Beira Loginov Moscow Clinical Scientiﬁc Center of Moscow Interior, Covilhã, Portugal, 3Pediatric Unit, Hospital HealthDepartment,Moscow,RussianFederation,3“Center Pediátrico, Centro Hospitalar e Universitário de Coimbra, of Strategic Planning” of the Ministry of Health of the Coimbra, Portugal, 4Pediatric Nephrology Unit, Hospital Russian Federation, Moscow, Russian Federation Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, 5Pediatric Unit, Centro Hospitalar do Introduction: Kidney stone disease (KSD) is an urgent Baixo Vouga, Aveiro, Portugal, 6Pediatric Hepatology problem of modern medicine due to high prevalence and Unit, Hospital Pediátrico, Centro Hospitalar e Universi- recurrence rate of the pathology. The particular scientiﬁc tário de Coimbra, Coimbra, Portugal interest is currently focused on the genetic mechanisms of urolithiasis. The aim of this study was to investigate an Introduction: Nephronophthisis (NPHP) is an autosomal association between polymorphic loci of the calcium recessive cystic kidney disease that usually progresses to metabolism genes and the risk of KSD development in end-stagerenaldisease(ESRD).Itiscausedbymutationsin Russian population. genes that encode proteins involved in the function of pri- Materials and methods: Based on the analysis of mary cilia, basal bodies and centrosomes, resulting in renal scientiﬁcliteratureandgenomicdatabases,thelist ofgenes and extrarenal manifestations. Prenatal history of oligohy- and polymorphisms associated with KSD in different dramnios and kidney cysts can be present. Infantile type of countries was formed. The information was obtained from NPHP develops ESRD in the ﬁrst three years of age and is case-control studies and GWAS. Finally, we formed a the most severe form. It is usually caused by mutations in genetic panel which included SNPs of VDR, CASR, NPH
P2  and NPH
P3  genes. CALCR, SL
C34 A1, CLDN14, TRPV5, TRPV6, KLOTHO, Objective: We intend to demonstrate how difﬁcult the ORAI1, ALPL, RG
S14 , OPN, MGP, PLAU, AQ
P1 , DGKH genotype/phenotype correlation in NPHP is, and reinforce genes. The study group consisted of 77 patients with KSD. the use of gene panel or exome in this disease. The control group included76personswithout urolithiasis. Materials and methods: Report of clinical manifesta- Genetic analysis was carried out by next generation tions, laboratory examination and imaging data in family sequencing using the Ion 
S5  platform. We also studied related foetus and child with different features of NPHP. A the presence of familial cases of KSD in the NGS panel for cholestasis was performed. observed group. Results: Previously healthy child presents pruritus and Results: Among patients with KSD 54% had family laboratory examination with renal/liver dysfunction at the history of urolithiasis, 44% had recurrent course of the ageof21months.Ultrasoundshowednormal-sizedkidneys disease. 9 SNPs in 4 genes showed statistically signiﬁcant with cysts and absent hepatobiliar, pancreatic or cardiac association with KSD: rs219781, rs219780, rs219779, changes.Theﬁrstpregnancyoftheparentswascomplicated rs219778, rs219777, rs1544410, rs731236, rs11746443, due to nephromegaly with microcysts and anamnios - the rs6486795.Theoddsratiorangedfrom1.2to2.5depending diagnosisofNPHPwasevoked.TheNGSpanelidentiﬁeda on polymorphism. homozygous NPH
P3  variant, c.3601G>T p.(Glu1201*), Conclusions: Targeted genetic panel for detecting the and molecular testing to her consanguineous parents is genetic predisposition to urolithiasis was designed and being performed. validated. Polymorphic loci of genes CLDN14, VDR, Conclusion: NPHP is characterized by a signiﬁcant SL
C34 A1, and ORAI1 are associated with KSD in Russian genetic and clinical heterogeneity. Gene panel or exome is population. the most appropriate approach when NPHP is suspected.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 821 The etiologic diagnosis is important for management and havebeen previously reportedfor PHOX2B,andhighlights genetic counselling. the variability in clinical expression and disease severity of L. Ramos: None.S. Fernandes: None. C.S. Rosas: None. non-PARM mutations. A.C. Marinhas: None. T. Luís: None. S. Ferreira: None. C. I. Borg: None. M. Pace Bardon: None. N. Pace: None. Gomes: None. E-
P03 .22 E-
P03 .21 GeNepher:buildingadata-andbiobankfor(suspected) A novel pathological variant in the PHOX2B gene hereditary renal disease associated with a respiratory/ Hirschsprung phenotype in a three-generation family L. R. Claus1, F. Boulogne2, M. R. Lilien1, M.B.Rookmaaker1,A.vanderZwaag1,T.Q.Nguyen1,M. I. Borg1,2, M. Pace Bardon3, N. Pace4,5 C.Verhaar1,N.V.A.M.Knoers2,P.Deelen1,2,L.Franke2, M. H. de Borst2, A. M. van Eerde1 1Department of Pathology, University of Malta, Msida, Malta, 2Medical Genetics Unit, Department of Pathology, 1University Medical Center Utrecht, Utrecht, Netherlands, Mater Dei Hospital, Msida, Malta, 3Department of 2UniversityMedicalCenterGroningen,Groningen,Nether- Medicine, Mater Dei Hospital, Msida, Malta, 4Department lands ofAnatomy,UniversityofMalta,Msida,Malta,5Centrefor Molecular Medicine and Biobanking, University of Malta, Introduction: A substantial part of patients with renal Msida, Malta disease has an undiscovered monogenic cause. The timely awareness of a potential genetic etiology in kidney disease Introduction: Mutations in the PHOX2B gene cause con- patients has profound implications for diagnosis and sub- genital central hypoventilation syndrome (CCHS), a rare sequent care pathways, for family members (e.g. in pre- autonomic nervous system dysfunction disorder char- symptomatic testing and family donation) and for options acterised by a decreased ventilatory response to hypercap- regarding establishing a family. nia. Affected subjects require lifelong ventilatory support, Methods: We will set-up the GeNepher Data- and and develop hypoventilation during the non-REM phase of Biobank. Dutch patients with known and suspected heredi- sleep where autonomic control of breathing predominates. taryrenaldiseaseareeligibleforinclusion.Informedconsent CCHS may be isolated or associated with disorders char- will cover use of available medical data, use of available acterised by defective migration/differentiation of neural DNA/sequencing data and in selected cases consent for crest derivatives, including aganglionic megacolon or additional blood sampling, skin biopsy or urine collection. milder gastrointestinal phenotypes, such as constipation. The GeNepher Data- and Biobank will be used to: MostcasesofCCHSarede-novo,causedbyheterozygosity for polyalanine repeat expansion mutations (PARMs) in 1. Answer questions regarding etiology. In unsolved exon 3. The remaining 10% of cases are due to hetero- caseswewillperformadd-onanalysestoidentifynew zygous non-PARM missense, nonsense or frameshift candidate genes for renal disease. In order to mutations. optimally identify new candidates, and to gain new Methodology: We describe a three-generation Maltese- insights, we are developing a kidney speciﬁc gene Caucasian family with a variable CCHS/Hirschsprung network using kidney derived RNA-sequencing data. phenotype, characterised by chronic constipation, three Ultimately we will perform functional studies to siblings with Hirschsprung disease necessitating surgery validateplausiblecandidates.InGeNepherthereisan and chronic hypoxia requiring non-invasive ventilation. infrastructure for return of relevant ﬁndings. Results:BidirectionalsequencingofPHOX2Brevealeda 2. Study modiﬁers of progressive renal disease like novel heterozygous c.241+2delT splice variant that segre- NPH
P1 -nephronophtisis. gateswiththeCCHS/Hirschsprungphenotypeinthefamily. 3. Contact patients for opportunities in treatment devel- The deletion lies in the donor splice site of exon 1 and has opment or when diagnose speciﬁc trials are started or not been reported in literature or genomic databases. treatment is approved. Bioinformatic analysispredicts thatthemutationwill result inskippingofexon1andtheformationofanon-functional Results: Inclusions will start in Q2 of 2020. protein product. The mutation is pathogenic according to Conclusions: The GeNepher Data- and Biobank will ACMG, PV
S1 , PM2 and P
P1  criteria. improve diagnosis of renal disease by identifying genetic Conclusion:Thisreportexpandsthemutationalspectrum causes,provideinsightintopathophysiologyandcontribute of PHOX2B. It is signiﬁcant as no splice-site mutations to development of new therapies.822 J.delPicchia Grant references: Dutch Kidney Foundation, Kolff conﬁrmedthatp.(T125M)isafoundermutation.Thisstudy Postdoc Senior Grant was supported grant PI17/00153 co-ﬁnanced by the ISCIII- L.R. Claus: None. F. Boulogne: None. M.R. Lilien: Subdirección General de Evaluación y Fomento de la None. M.B. Rookmaaker: None. A. van der Zwaag: None. InvestigaciónandtheERDF“AnotherwaytobuildEurope”. T.Q. Nguyen: None. M.C. Verhaar: None. N.V.A.M. E.Córdoba-Lanús:None.A.Perdomo-Ramírez:None.G. Knoers: None. P. Deelen: None. L. Franke: None. M.H. Mura-Escorche: None. S. Carinelli: None. E. Ramos- de Borst: None. A.M. van Eerde: None. Trujillo: None. F. Claverie-Martín: None. E-
P03 .23 E-
P03 .25 Founder effect of SL
C2 A9 mutation p.(T125M) in Molecular study of Wilson disease in a Spanish cohort Spanish families with hereditary renal hipouricemia type 2 M. Antolin1, I. Paramanov1, P. Fernandez1, L. Iranzo1, D. Martinez1, E. García-Arumí1,2, E. Tizzano1 E. Córdoba-Lanús1,2, A. Perdomo-Ramírez1, G. Mura-Escorche1,3, S. Carinelli1, E. Ramos-Trujillo1, 1Department of Clinical and Molecular Genetics and F. Claverie-Martín1 Medicine Genetics Group, VHIR, University Hospital Vall d’Hebron, Barcelona, Spain, 2CIBERER, Centro de Inves- 1Unidad de Investigación, Hospital Universitario Nuestra tigaciónBiomédicaenReddeEnfermedadesRaras,ISCIII, Señora de Candelaria, Santa Cruz de Tenerife, Spain, Madrid, Spain 2IUETSPC, Universidad de La Laguna, Santa Cruz de Tenerife,Spain,3UniversidaddeLaLaguna,SantaCruzde Introduction:Wilsondisease(WD)isadisordercausedby Tenerife, Spain biallelic pathogenic variants in AT
P7 B gene, resulting in abnormal copper metabolism and deposition, leading to a Introduction: Renal hypouricemia (RHUC) is a rare combination of hepatic, neurologic, and psychiatric fea- inherited disorder characterized by impaired urate reab- tures. Diagnosis is conﬁrmed by molecular analysis of sorption in the proximal tubule. Some patients may present AT
P7 B gene. severe complications such as exercise-induced acute renal Materials and methods: 34 patients with WD were failureandnephrolithiasis.RHUCiscausedbyinactivating studied using two long range PCR (exon 2-9; exon 10-21 mutations in the SL
C22 A12 (RHUC type 1) or SL
C2 A9 AT
P7 B gene). Fragmentation, indexing, library preparation (RHUC type 2) genes, which encode urate transporters (NEBNextUltraDNAlibraryprepkit)andsequencingina URAT1andGLUT9,respectively.Recently,we found that MiSeq platform (Illumina) were performed. Exon 1 was mutation c.374C>T, p.(T125M) is recurrent in Spanish analysed by Sanger sequencing. familieswithRHU
C2 .Therefore,wehypothesizedthatthis Results: Genetic diagnosis was achieved in 18 WD might be due to a founder effect. patients whereas only one pathogenic variant was found in Methods: Thirteen new patients with RHUC were 5.Familiarstudieshaveallowedtheidentiﬁcationof2WD analyzed by sequencing the SL
C22 A12 and SL
C2 A9 patients before clinical manifestations. 86% of the variants coding exons. To determine whether patients with the p. were described as pathogenic whereas 14% were not (T125M) mutation had a common p.(T125M)-linked described previously. A prevalent AT
P7 B allelic variant, haplotype a SNPs-haplotype analysis was performed. A p.(Met645Arg),wasfoundin5patients(28%),intranswith total of nine patients from apparently unrelated families other allelic variants. The splicing mutation c.1708-1G>A were included in this analysis. Six informative SNPs were was found in 3 patients (17%) whereas the c.1708-1G>C analyzed by PCR ampliﬁcation from genomic DNA and was found in one (6%), all in homozygous state. The most direct sequencing. prevalentpathogenicvariantinEuropep.(His1069Gln)was Results: Seven patients carried SL
C22 A12 mutation p. found in heterozygosis in 2 patients, representing only the (T467M),andsixpresentedtherecurrentSL
C2 A9mutation 4,4 % of pathogenic alleles in our cohort. p.(T125M).Allelescarryingthep.(T125M)mutationshared Conclusions: The most common allelic variant among a common SNP haplotype. Every patient harboring this our WD patients was p.(Met645Arg) followed by the mutation in homozygous state had a common haplotype splicing variant c.1708-1G>A. Familiar genetic study of (0.7 frequency), G-A-C-T-G-T-C-T (mutant allelein bold). WD by NGS allows the molecular diagnosis of asympto- WhilethehaplotypeG-G-C-C-G-T-Cwasthemostfrequent matic patients and prevent disease. between controls (0.42). M. Antolin: None. I. Paramanov: None. P. Fernandez: Conclusions: Mutation p.(T125M) is the most common None. L. Iranzo: None. D. Martinez: None. E. García- variantinSpanishpatientswithRHU
C2 .Haplotypeanalysis Arumí: None. E. Tizzano: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 823 E-
P04  Skeletal, Connetive Tissue, Ectodermal and Skin G. Wurpts15, S. Moebus16, P. M. Krawitz3, J. Stingl17, B. Disorders Sachs*15,18, M. M. Nöthen*1, * equally shared E-
P04 .02 1InstituteofHumanGenetics,UniversityofBonn,Schoolof The ﬁrst missense mutation in CSTA gene causes Acral Medicine & University Hospital Bonn, Bonn, Germany, Peeling Skin Syndrome in a Turkish family, Review of 2Center for Human Genetics, University of Marburg, the literature Marburg, Germany, 3Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany, A. C. Ceylan1, S. Emre2, G. G. Ceylan1 4Department of Otorhinolaryngology - Head and Neck Surgery and Audiology, University Hospital of Copenha- 1Yildirim BeyazitUniversity MedicalSchool Department of gen, Rigshospitalet F-2071, Copenhagen, Denmark, Medical Genetics, Ankara, Turkey, 2Yildirim Beyazit 5Department of Clinical Genetics, Odense University University Medical School Department of Dermatology, Hospital, Odense, Denmark, 6Research Unit of Dermato- Ankara, Turkey Venerology, Clinical Institute, University of Southern Denmark, Odense, Denmark, 7Department of Medical Introduction: Acral Peeling Skin Syndrome (APSS) is a Sciences, Clinical Pharmacology and Science for Life rare, autosomal recessive genodermatosis. The disease is Laboratory, Uppsala University, Uppsala, Sweden, characterized by superﬁcial peeling of the corniﬁed epi- 8Department of Medical Sciences, Clinical Chemistry, dermallayer.Skinfragilityoftenaffectshandsandfeet.Itis Uppsala University, Uppsala, Sweden, 9Uppsala Clinical most commonly caused by mutations in the TGM5 Research Center, Uppsala, Sweden, 10Department of (*603805).CSTA(*184600)rarelycausesAPSS.Weintend Dermatology and Allergy, Comprehensive Allergy Center, to invest if there is a new mutation in genes related Hannover Medical School, Hannover, Germany, 11Depart- with APSS. ment of Dermatology, SLK Hospital Heilbronn, Heilbronn, Materialsandmethods:Twosiblingswerepresentedus Germany, 12Department of Dermatology and Venerology, because of chronic and superﬁcial itchy skin lesions. After Medical University of Graz, Graz, Austria, 13Clinic and the dermatological examinations, clinical exome solution- Polyclinic for Dermatology and Allergology, University was performed for the molecular diagnosis of one of the Hospital Bonn, Bonn, Germany, 14Department of Otorhi- patients. Sanger sequencing was performed for the other nolaryngology, Head and Neck Surgery, Ulm University patient to ﬁnd if there is the same mutation. Medical Center, Ulm, Germany, 15Department of Derma- Results: A novel homozygote missense mutation was tology and Allergology, Aachen Comprehensive Allergy found in CSTA gene in both of the siblings. This variant Center, University Hospital of RWTH Aachen, Aachen, fulﬁlls PM1, PM2, P
P3  and P
P4 , and should therefore be Germany, 16Centre of Urban Epidemiology, Institute of regarded as a likely pathogenic according to the joint Medical Informatics, Biometry, and Epidemiology, Uni- consensus recommendation of the ACMG and AMP. versity of Essen, Essen, Germany, 17Institute for Clinical Conclusion: Peeling skin syndromes appears to be Pharmacology, University Hospital of RWTH Aachen, heterogeneous clinically and genetically. Inhere, we report Aachen, Germany, 18Federal Institute for Drugs and sixth family with a novel homozygote missense CSTA Medical Devices, Research Division, Bonn, Germany mutationandclinicalﬁndings.Itisshownthatdifferenttype of CSTA mutations can also cause APSS unlike previously Angioedema are known adverse drug reactions of ACE reported cases, and will contribute to better illumination of inhibitors (ACEi) that can become a potentially life-threa- the phenotype regarding with the literature review. tening event. Results of previous research suggest that A.C. Ceylan: None. S. Emre: None. G.G. Ceylan: None. susceptibility to ACEi induced angioedema (ACEi AE) is dependentonageneticpredispositionandnon-geneticrisk E-
P04 .03 factors. However, as the biological mechanisms contribut- Molecular genetic investigation of ACE inhibitor ing to these angioedema are still largely unknown, further induced angioedema research is needed. The aim of the present study was to investigatecommonandraregeneticvariationinACEiAE C. Mathey1, A. F. Forstner1,2, C. Maj3, O. Borisov3, patients. In a targeted sequencing approach, we investi- E. R. Rassmussen4, A. Bygum5,6, C. von Buchwald4, gated the occurrence rate of known pathogenic mutations M. Wadelius7, P. Hallberg7, M. Karawajczyk8, associated with monogenic forms of angioedema in 69 N. Eriksson7,9, B. Wedi10, D. Wieczorek10, P. M. Amann11, German and 68 Danish patients with ACEi AE. All sam- H.Löfﬂer11,L.Koch12,C.Schöfﬂ12,N.Evertz13,J.Greve14, ples were sequenced on an Illumina NextSeq platform using single molecule molecular inversion probes. In824 J.delPicchia addition, all samples were genotyped on the Illumina Chelyabinsk, Russian Federation, 10Department of sports Inﬁnium Global Screening Array to identify common medicine and physical rehabilitation, Ural state university genetic variants contributing to angioedema risk under of physical culture, Chelyabinsk, Russian Federation, ACEi. Analysis of the sequencing data revealed no known 11Department of Physical Education, Gdansk University pathogenic mutations in genes associated with the mono- of Physical Education and Sport, Gdansk, Poland genic forms of angioedema. However, we identiﬁed 19 other rare (MAF≤0.05), non-synonymous variants for ACL rupture is one of severe multifactorial injuries. The which a contribution to ACEi AE risk cannot be excluded. ACTN3rs1815739polymorphismaffectmusclestructureand Qualitycontrolandimputationofthearraydataiscurrently metabolism and it has been associated with muscle injuries. ongoing.Furthermore,wearecurrentlyapplyingtheabove Resistancetofatigueandmusclestiffnessareconsideredrisk investigation strategies to an independent Swedish sample factorsforACLinjury.Theaimofourstudywastodetermine (n=77). Follow-up of the variants identiﬁed by targeted theinﬂuenceofACTN3rs1815739onACLruptureinItalian, sequencing in larger patient samples as well as subsequent Japanese, Polish and Russian population samples. A total of biostatistics/-informatics analyses of the GWAS data will 1706subjects(n=596ACLrupturepatients(cases);n=1113 help to gain further insights into the underlying molecular controls) from Italy (n=52 cases; n=81 controls), Japan mechanisms of ACEi AE. (n=74cases;n=395controls),Poland(n=237cases;n=230 C.Mathey:None.A.F.Forstner:None.C.Maj:None.O. controls) and Russia (n=233 cases; n=407 controls) partici- Borisov: None. E.R. Rassmussen: None. A. Bygum: None. pated in the study. DNA samples were genotyped by Taq- C. von Buchwald: None. M. Wadelius: None. P. Hallberg: Man. R packages were used for statistical analysis. The None.M.Karawajczyk:None.N.Eriksson:None.B.Wedi: genotype distributions of all control groups were in HWE. None.D.Wieczorek:None.P.M.Amann:None.H.Löfﬂer: Since the Italian, Polish and Russian samples had similar None.L.Koch:None.C.Schöfﬂ:None.N.Evertz:None.J. genotypedistributions(allp>0.05)theywerepooledtogether Greve: None. G. Wurpts: None. S. Moebus: None. P.M. (European cases and controls). Krawitz: None. J. Stingl: None. B. Sachs*: None. M.M. Genotypesdistribution(%andcounts)inEuropeanandJapanesecase Nöthen*: None. andcontrolsgroups RR RX XX E-
P04 .04 ACTN3 rs1815739 polymorphism is associated with Europeancases(n=522) 0,370(193) 0,500(261) 0,130(68) anterior cruciate ligament (ACL) rupture in physically Europeancontrols(n=718) 0,372(267) 0,450(323) 0,178(128) activepeoplefromItalian,Japanese,PolishandRussian Japanesecases(n=74) 0,270(20) 0,527(39) 0,203(15) cohorts Japanesecontrols(n=395) 0,220(87) 0,463(183) 0,316(125) V. Pushkarev1,2,3, N. Kikuchi4, H. Kumagai5, N. Kamiya6, E. Miyamoto-Mikami7, N. Fuku7, C. Calò8, M. Massidda8, Signiﬁcant differences in ACTN3 rs1815739 genotype D. Dyatlov9, E. Bykov10, P. Cieszczyk11 frequencies were found between cases and controls in the European sample (Fisher’s Exact Test, p=0,048). The XX 1Medical Genetic Centre “Progen”, Moscow, Russian genotype was underrepresented in the cases (odds ratio Federation, 2Moscow Center of Advanced Sport Technol- (OR)=0.69; 95% conﬁdence interval (CI), 0.50-0.95, ogies, Moscow, Russian Federation, 3Genetic laboratory, P=0.021) in comparison with controls. The same trend Ural State University of Physical Culture, Chelyabinsk, hasbeenshowedbetweencasesandcontrolsintheJapanese Russian Federation, 4Department of Training Science, population (OR = 0.55; 95% CI, 0.30-1.006, P = 0.05). Nippon Sport Science University, Tokyo, Japan, 5Graduate The XX ACTN3 rs1815739 seems to protect against ACL School of Health and Sports Science, Juntendo University, rupture in three European and Japanese cohorts. Chiba, Japan and Reseach fellow of Japanese Society for V. Pushkarev: None. N. Kikuchi: None. H. Kumagai: the Promotion of Science, Tokyo, Japan, 6Faculty of Budo None. N. Kamiya: None. E. Miyamoto-Mikami: None. N. and Sport Studies, Tenri University, Nara, Japan, 7Grad- Fuku: None. C. Calò: None. M. Massidda: None. D. uate School of Health and Sports Science, Juntendo Dyatlov: None. E. Bykov: None. P. Cieszczyk: None. University, Chiba, Japan, 8Department of Environmental and Life Science, University of Cagliary, Calgary, Italy, E-
P04 .05 9Department of the Theory of Physical Culture and Congenital contractural arachnodactyly syndrome in Biomechanics, Ural State University of Physical Culture, Polish family with c.4216T/c variant in FBN2 gene.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 825 M.A.Malarska,H.Moczulska,K.Antosik,P.Jakiel,P.M. Medical University, Yerevan, Armenia, 11Kurume Univer- Pachniak, M. Borowiec sity School of Medicine, Kurume, Japan, 12Wakayama Medical University, Wakayama, Japan, 13ViennaLab Diag- Department of Clinical Genetics, Lodz, Poland nostics, Vienna, Austria, 14Fondazione IRCCS Policlinico SanMatteo,Pavia,Italy,15KazusaDNAResearchInstitute, The congenital contractural arachnodactyly (CCA, Beals Kisarazu, Japan, 16Hacettepe University, Ankara, Turkey, syndrome, OMIM: 121050) is an autosomal dominant 17Center of Medical Genetics and Primary health Care, condition including contractures, crumpled ears, arachno- Yerevan State Medical University, Yerevan, Armenia, dactyly, dolichostenomelia, scoliosis and pectus defor- 18European Molecular Quality Network (EMQN), Manche- mities. The congenital contractural arachnodactyly has ster Centre for Genomic Medicine, St Mary’s Hospital, overlapping features with the Marfan syndrome. Both Manchester, United Kingdom, 19University of Groningen, syndromes result from mutations in genes from the ﬁbrillin University Medical Center Groningen, Groningen, Nether- family, FBN1 and FBN2 respectively. We identiﬁed the lands, 20INSERM, Montpellier, France c.4216T>CvariantintheFBN2geneinaPolishfamilywith thecongenitalcontracturalarachnodactyly.Thevariationin Introduction: A growing number of monogenic autoin- phenotypic expression was high in the family. In some ﬂammatorydiseases(AIDs)hasbeenidentiﬁedsince1997. subjects there was only an arachnodactyly, but in others Their clinical diagnosis remains a challenge in face of there were many features like severe kyphoscoliosis with overlapping inﬂammatory symptoms. The previous guide- dolichostenomelia, arachnodactyly, camptodactyly, talipes lines for genetic testing of AIDs were limited to Sanger equinovarus and ureteropelvic junction obstruction. We based diagnosis of four prototypic recurrent fevers (MEFV, found for the ﬁrst time a hydronephrosis in the congenital MVK, TNFRSF1A, and NLR
P3  genes). Revised guidelines contractural arachnodactyly syndrome. There were no cru- employingnextgenerationsequencing(NGS)areneededto pledearintheanalysedfamily.Thec.4216T>Cvarianthad improve diagnosis and precision of AIDs treatment. been previously found in a Chinese family with modest Methods: Based on a survey regarding gene scope and family variation in phenotypic expression. Our observation available methodology in AIDs laboratories (Rowczenio et al, conﬁrmstherelationshipbetweenc.4216T>Cvariantinthe 2019), and on annotation of AIDs gene variants by experts’ FBN2 gene and the congenital contractural arachnodactyly. consensus(vanGijnetal,2018;Infeversdatabase),adraftof M.A. Malarska: None. H. Moczulska: None. K. Antosik: recommendationswaswrittenbyEuropeanMolecularGenetics None. P. Jakiel: None. P.M. Pachniak: None. M. Quality Network members. The recommendations were Borowiec: None. discussed by a panel of experts of the International Society for Systemic AIDs (ISSAID) during a consensus meeting. E-
P04 .06 Results: Four additional disease genes are recommended ISSAID and EMQN best practice guidelines for gene for the core screen of auto-inﬂammatory diseases (ADA2, panel based diagnosis of autoinﬂammatory diseases NOD2,PSTPI
P1 ,andTNFAI
P3 ).Theinitialscreen,eithera single gene or panel screen is oriented by the clinical Y.Shinar1,I.Ceccherini2,D.Rowczenio3,I.Aksentijevich4, autoinﬂammatory suspicion. In overt cases complementary J.Arostegui5,6,E.Ben-Chétrit7,G.Boursier8,M.Gattorno9, methods to identify large deletions or insertions (i.e. copy H. Hayrapetyan10, H. Ida11, N. Kanazawa12, H. J. number variation) or search for somatic mosaicism are Lachmann3, A. Mensa-Vilaro5, R. Nishikomori11, C. recommended. A genotype table based on the 5-category Oberkanins13, L. Obici14, O. Ohara15, S. Ozen16, T. variantpathogenicityclassiﬁcationwithdistinctionbetween Sarkisian17, K. Sheils18, N. Wolstenholme18, E. Zonneveld- rare/novel or common variants of unknown signiﬁcance, Huijssoon19, I. Touitou20, M. E. van Gijn19 and consideration of dose effect, provides the clinical signiﬁcance of prototypic genotypes per gene and disease. 1ShebaMedicalCenter,RamatGan,Israel,2IRCCSIstituto Conclusions: These guidelines will improve the practice Giannina Gaslini, Genova, Italy, 3UCL Medical School, of AIDs diagnosis provided by the medical community. E- London, United Kingdom, 4National Human Genome Rare-3 grant 9003037603. Research Institute, Bethesda, MD, United States, 5Hospital Y. Shinar: None. I. Ceccherini: None. D. Rowczenio: Clínic, Barcelona, Spain, 6Institut d’Investigacions Biomè- None. I. Aksentijevich: None. J. Arostegui: None. E. Ben- diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, Chétrit: None. G. Boursier: None. M. Gattorno: None. 7Hadassah-Hebrew University Medical Center, Jerusalem, H. Hayrapetyan: None. H. Ida: None. N. Kanazawa: None. Israel, 8CHU Montpellier, Univ Montpellier, Montpellier, H.J. Lachmann: None. A. Mensa-Vilaro: None. R. Nishi- France, 9IRCCS G. Gaslini, Genova, Italy, 10Center of komori: None. C. Oberkanins: None. L. Obici: None. Medical Genetics and Primary Health Care, Yerevan State O. Ohara: None. S. Ozen: None. T. Sarkisian: None.826 J.delPicchia K. Sheils: None. N. Wolstenholme: None. E. Zonneveld- M. C. Martínez-Romero1,2,3, M. Barreda-Sánchez1,3, Huijssoon: None. I. Touitou: None. M.E. van Gijn: None. M.E.Pérez-Tomás1,M.J.Ballesta-Martínez1,2,3,V.López- González1,4,2, M. J. Sánchez-Soler1,2,3, A. T. Serrano- E-
P04 .08 TGDS pathogenic variants cause Catel-Man- Antón1,2,4, L. Rodríguez-Peña1, M. E. Hernández1, T. zke syndrome without Manzke dysostosis Martínez-Menchón1,4, P. Sánchez-Pedreño1,4, G. Glover1,2, P. Carbonell1,2, V. Cabello-Chaves5, Grupo de F. Boschann1, K. Stuurman2, C. de Bruin3, M. van Investigación Español de Displasias Ectodérmicas, E. Slegtenhorst2, H. van Duyvenvoorde4, S. Kant2,4, N. Ehmke1 Guillén-Navarro1,2,4 1Charité-Universitaetsmedizin Berlin, Berlin, Germany, 1Sección de Genética Molecular (Centro de Bioquímica y 2Department ofClinicalGenetics,ErasmusMC,University GenéticaClínica),SeccióndeGenéticaMédica(Serviciode Medical Center Rotterdam, Rotterdam, Netherlands, Pediatría), Servicio de Medicina Interna y Servicio de 3Department of Pediatric Endocrinology, Leiden Uni, Dermatología. Hospital Clínico Universitario Virgen de la Rotterdam, Netherlands, 4Department of Clinical Genetics, Arrixaca. Instituto Murcia, Murcia, Spain, 2CIBERER, Leiden University Medical Center, Leiden, Netherlands Centro de Investigación Biomédica en Red de Enferme- dades Raras, Instituto de Salud Carlos III, Madrid, Spain, Introduction: Catel-Manzke syndrome, also known as 3Cátedra de Genética Médica. UCAM- Universidad micrognathia-digital-syndrome, is characterized by the com- Católica de Murcia, Murcia, Spain, 4Departamentos de bination of the two cardinal features Pierre-Robin sequence Pediatría y Dermatología. Facultad de Medicina. UMU- (with or without cleft palate) and bilateral hyperphalangism. Universidad de Murcia, Murcia, Spain, 5Servicio de Hyperphalangism is caused by an accessory ossiﬁcation Nefrología. Hospital Universitario Virgen del Rocío, center in the second metacarpo-phalangeal joint leading to Sevilla, Spain radial deviation and ulnar clinodactyly of the index ﬁngers. Individuals without one of the two major hallmarks or with Introduction: HELIX syndrome (OMIM#617671) is an additional hand malformations have been described as aty- autosomal recessive genetic disorder, described in 2017, pical or Catel-Manzke-like syndrome. Biallelic pathogenic characterized by hypohidrosis, electrolyte imbalance, lacri- variants in TGDS have been described in nine individuals mal glands dysfunction, ichthyosis, and xerostomia; and including one fetus with Catel-Manzke syndrome. associated with pathogenic variants in CLDN10 gene that Material and methods: We performed trio exome encodes a member of claudins proteins (integral membrane sequencing in two individuals who presented with dis- components of tight junction). So far, only 4 families have proportionate short stature, micrognathia as well as mild been reported. bilateralradialdeviationandulnarclinodactylyoftheindex Materials and methods: Subjects. Two Spanish adult ﬁngers, but without radiological signs of hyperphalangism. brothers (41/38 years old) born to consanguineous parents Results: We found known pathogenic variants in TGDS presenting with a long history of hypohidrosis, dry skin, in both individuals. The two individuals described here are alacrimia and xerostomia, diagnosed as ectodermal dyspla- the ﬁrst with conﬁrmed TGDS pathogenic variants who sia(ED).ComplementaryexamsshowedrenallossofNaCl present with almost normal hand radiographs and therefore with secondary hyperaldosteronism, hypercalcemia, hyper- do not show one of the clinical hallmarks of Catel-Manzke magnesemia and hypokalemia. Genetic analysis. CLDN10 syndrome.Inaddition,disproportionateshortstaturehasnot gene was designed with Primer3 software for all coding been described as a feature of Catel-Manzke syndrome. exons. Sanger sequencing was performed using BigDye Conclusion:Ourﬁndingsextendthephenotypicspectrum terminator (Life-Technologies), analysed in ABI3130 ofCatel-Manzkesyndrome.TGDS-associatedCatel-Manzke Genetic Analyser (Applied-Biosystems) and aligned with syndrome should be considered in individuals with mild human reference genome GRCh37/hg19; the identiﬁed ulnar clinodactyly and radial deviation of the index ﬁngers variant was segregated in progenitors. even without radiological evidence of hyperphalangism. Results: The sequence analysis revealed a frameshift F. Boschann: None. K. Stuurman: None. C. de Bruin: genetic variant in CLDN10 (NM_006984.4): None. M. van Slegtenhorst: None. H. van Duyvenvoorde: c.322_329del8/p.Gly108fs, in exon 2, in homozygosity in None. S. Kant: None. N. Ehmke: None. bothaffectedbrothersandinheterozygosityinparents.This variant, not previously described, was found in a highly E-
P04 .09 conserved region by in silico prediction software, being A novel pathogenic variant in the CLDN10 gene categorized as pathogenic. associated with HELIX syndrome Conclusions: 1. A new CLDN10A pathogenic variant associatedtoHELIXsyndromeintheﬁrstSpanishaffectedAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 827 family is described, supporting the implication of this gene 36m respectively. whole- exome sequencing test was done in this rare disorder.2. Clinical manifestations such as for the patient. The results showed a novel homozygous lacrimal dysfunction, xerostomia and electrolyte imbalance mutation(c.533-1G>A)inexon6oftheLTB
P4 gene.After in suspected ED without speciﬁc molecular diagnosis are this observation we perform the Sanger sequencing for his the clue for HELIX syndrome. parents. As a result, his parents have a heterozygous This project has been funded by ISCIII-Madrid-Spain- mutation in the same gene and same location. This ﬁnding FEDER (PI/14/01259 and PI/17/00796) and AADE. can be useful in genetic counseling of cutis laxa in this M.C. Martínez-Romero: None. M. Barreda-Sánchez: family. None. M.E. Pérez-Tomás: None. M.J. Ballesta-Martínez: M.Mazaheri:None.M.yavari:None.R.Mirjalili:None. None. V. López-González: None. M.J. Sánchez-Soler: A. Razavi: None. None. A.T. Serrano-Antón: None. L. Rodríguez-Peña: None. M.E. Hernández: None. T. Martínez-Menchón: E-
P04 .11 None. P. Sánchez-Pedreño: None. G. Glover: None. P. Analysis of xenobiotics biotransformation and DNA Carbonell: None. V. Cabello-Chaves: None. E. Guillén- repair genes as factors of etiology and pathogenesisin Navarro: None. children with congenital spine deformities E-
P04 .10 S.Khalchitsky1,M.Sogoyan1,S.Vissarionov1,A.Dmitriev2 Identiﬁcation a novel mutation of LTB
P4  gene in a patient with congenital cutis laxa: a case report 1The Turner Scientiﬁc Research Institute for Children`s Orthopedics, Saint-Petersburg, Russian Federation, 2Insti- M. Mazaheri1,2, M. yavari3, R. Mirjalili2, A. Razavi3 tute of Experimental Medicine, Saint-Petersburg, Russian Federation 1Shahid Sadoughi University of Medical Sciences, Yazd, Iran, Islamic Republic of, 2Mother and Newborn Health Introduction: Spine congenital curvatures formed as a Research Center Shahid Sadoughi University of Medical result of anomalies in the development of vertebral bodies Sciences,Yazd,IRAN.,Yazd,Iran,IslamicRepublicof,3Dr. leadstosevereandrigiddeformitiesofthespinalcolumnin Mazaheri’s Medical Genetics lab Yazd, IRAN., Yazd, Iran, the adolescent age and are often accompanied by irrever- Islamic Republic of sible neurologic disorders. There for genetic markers study of the congenital malformations is an important and Normal 0 false false false EN-US X-NONE FA /* Style urgent task. Deﬁnitions */ table.MsoNormalTable {mso-style-name:"- Materials and methods: The study of 200 children with Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-col- congenitalspinedeformities(CSD)and96healthychildren band-size:0; mso-style-noshow:yes; mso-style-priority:99; without pathology of the spine was carried out. Molecular mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; diagnostics was carried out by analysis of multiple mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; polymorphic regions in the genes of detoxiﬁcation and mso-pagination:widow-orphan; font-size:10.0pt; font- DNA repair. Genotyping of the gene polymorphism was family:"Times New Roman","serif";} Cutis laxa is a rare performed using polymerase chain reaction. disorder characterized by degenerative changes in elastic Results: The polymorphisms of the genes CY
P1 A2, ﬁbres.Congenitalcutislaxaismorecommonthanacquired GSTM1, GSTT1, GST
P1 , NAT2, XRC
C1 , XRC
C3  and their cutis laxa. The recessively inherited form is severe and frequency distribution among patients with CSD and morefrequent.Cutislaxaaffectsallracesandboththesexes control group were investigated. Signiﬁcant differences in equally. LTB
P4 , an extracellular protein that is closely the distribution of genotypes compared with the control relatedtoﬁbrillins,consistsofepidermalgrowthfactor-like group were found in the polymorphic regions of the genes domains interspersed with four 8-cys domains (including a CY
P1 A2, GSTM1,GSTT1,NAT2, XRC
C3 .However,inthe hybrid domain). The third 8-cys domain covalently binds GST
P1  and XRC
C1  genes, no signiﬁcant differences the small latent TGFβ1 complex. A proline -rich hinge between the CSD patients and the control group was region provides ⋯exibility to the protein. The N-terminus observed. of LTB
P4  binds to the microibrillar structures. A 4-month- Conclusions: All patients with congenital spine defor- old full term normally delivered neonate was referred with mities had signiﬁcant changes in some candidate genes complaints of respiratory distress from his birth. Physical alleles. Itwas foundthat thenumberofminor alleles inthe examination revealed laxity of the skin and heart problem genes under investigation correlate with the severity of and swelling around the eyes. Length, weight, and head congenital deformity and the variability of vertebral circumference percentiles at birth were 55cm, 4100 gr and anomalies. It was determined that in children with828 J.delPicchia combined defects in the spine development, there is a variants in MYH3. The American Journal of Human greater number of mutations compared to children with Genetics, 102, 1115-1125. isolated vertebral anomalies. A.P. Vasconcelos: None. F. Ayala: None. I. Alonso: S. Khalchitsky: None. M. Sogoyan: None. S. Vissario- None. M. Leão: None. nov: None. A. Dmitriev: None. E-
P04 .13 E-
P04 .12 Case report: cellular interference highlights an unusual Another family with compound heterozygosity for X-linked mode of inheritance and seemingly genetic variants in MYH3 paradox in craniofrontonasal dysplasia A. P. Vasconcelos1, F. Ayala2, I. Alonso3,4, M. Leão1 J. Ronez, S. Morlot, B. Schlegelberger, H. Wallaschek 1Department of Medical Genetics, Centro Hospitalar Uni- DepartmentofHumanGenetics,HannoverMedicalSchool, versitárioSãoJoão,Porto,Portugal,2DepartmentofMedical Hannover, Germany Genetics, Universidade Estadual de Campinas, Campinas, Brazil,3IBMC-InstituteforMolecularandCellBiology,i3S- Introduction: craniofrontonasal dysplasia is a rare form of Instituto deInvestigaçãoeInovação emSaúde,Universidade frontonasaldysplasiacausedbymutationsintheEFNB1gene do Porto, Porto, Portugal, 4Genetyca-ICM, Instituto de on the X chromosome. EFNB1 encodes for ephrin-B1, a Estudos Celulares e Moleculares, Porto, Portugal transmembraneligandoftheEphBreceptorwithcrucialroles in cell migration and pattern formation during skeletal devel- Contractures, pterygia, and variable skeletal fusions syn- opment. The phenotype is more pronounced in females, who drome 1B (CPSKF1B) (OMIM #618469) is an autosomal characteristically present with frontonasal dysplasia and cor- recessive disorder, characterized by contractures of prox- onar craniosynostosis, while the manifestation in males is imalanddistaljoints,multiplepterygiainvolvingtheneck, usually milder, often only characterized by hypertelorism. elbows,ﬁngers,and/orknees,andvariablevertebral,carpal Case report: We, here, present an 11-week-old girl who and tarsal fusions, ﬁrstly described by Cameron-Christie presented with dysmorphic facies. Leading characteristics et al. All those patients, displaying remarkable phenotypic were plagiocephaly, hypertelorism, a cleft palate, slanted variability,werecompoundheterozygousforvariantsinthe eyes, dysplastic ears and a broad nasal bridge. Molecular MYH3 gene (Cameron-Christie et al., 2018). We describe genetic analyses of the girl revealed a pathogenic de novo an 11 years-old male patient, born from non-con- nonsense variant in the EFNB1 gene, which triggers sanguineous parents, with no relevant family history, nonsense mediated decay. whosephenotypewasconsistentwithCPSKF1B,including Background:Femaleswithaheterozygousmutationinthe arthrogryposis of the hips, knees and elbows, multiple EFNB1 gene usually display a more severe phenotype than pterygia, severe scoliosis and vertebral fusions at cervical, hemizygous males. The embryonal X-inactivation leads to a dorsal,lumbarandlumbosacrallevels.Attheageof9there heterogenicpopulationofcellseitherexpressing themutated was no radiological evidence of carpal synostosis. Addi- or the wildtype allele, disrupting the correct formation of tionally, he has triangular shaped face, low-set ears, bilat- boundaries within the frontal bone precursors during eral down slanted palpebral ﬁssures, ptosis, and embryogenesis. Hemizygous males display a homogenous micrognatia.Geneticanalysisidentiﬁedthreeheterozygous cell population, since no functional ephrin-B1 can be variants in MYH3 [NM_002470.3: c.5072del,p.(Ala1691- producedatall,inwhichcaseotherephrin-Bfamilymembers Valfs*52) in exon 35; c.749G>A,p.(Arg250Gln) and are likely to compensate by assuming ephrin-B1 function. c.787G>T,p.(Asp263Tyr) in the same allele in exon 9]. Conclusion:Due tocellularinterference,craniofrontona- Genetic testing of his parents identiﬁed the ﬁrst of these sal dysplasia does not follow a classic Mendelian mode of variants in the mother and the others in the father, sug- inheritance. Our case report is a good example for this gesting an autosomal recessive pattern of inheritance. Our mechanism and highlights the need to be aware of such patientpresentsseveraldysmorphicfeaturesnotpreviously unusual modes of inheritance in genetic counselling. reported by Cameron-Christie et al. References: J. Ronez: None. S. Morlot: None. B. Schlegelberger: CAMERON-CHRISTIE, S. R., WELLS, C. F., SIMON, None. H. Wallaschek: None. M., WESSELS, M., TANG, C. Z., WEI, W., TAKEI, R., AARTS-TESSELAAR, C., SANDARADURA, S. & SIL- E-
P04 .15 LENCE, D. O. 2018. Recessive Spondylocarpotarsal Heterozygous 7q32.3-q35 deletion causes syndromic synostosis syndrome due to compound heterozygosity for craniosynostosisAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 829 E. Bukowska-Olech1, D. Simon2, D. Larysz3, Norway, 3Helse Vest, Bergen, Norway, 4Department of A. Jamsheer1,2 Pediatrics, Helse Førde, Førde, Norway, 5Department of Clinical Science, Universtity of Bergen, Bergen, Norway, 1Department of Medical Genetics, Poznan University of 6DepartmentofOrthopedicSurgery,HelseBergen,Bergen, Medical Sciences, Poznan, Poland, 2Centers for Medical Norway, 7Department of Clinical Medicine, University of Genetics GENESIS, Poznan, Poland, 3Department of Bergen,Bergen,Norway,8MassachusettsGeneralHospital, Radiotherapy, The Maria Skłodowska Curie Memorial Boston, MA, United States, 9Stanley Center for Psychiatric Cancer Centre and Institute of Oncology, Gliwice Branch, Research, Harvard/MIT, Boston, MA, United States, Gliwice, Poland, Gliwice, Poland 10Department of Radiology, University Hospital of North Norway, Tromsø, Norway, 11Department of Clinical Background: The most commonly recognisable syndromes Medicine, University of Tromsø, Tromsø, Norway with craniosynostosis (CS) are regarded as monogenic dis- ordersandresultfromdifferentpathogenicvariantsaffecting Introduction:Developmentaldysplasiaofthehip(DDH) genes, that encode ﬁbroblast growth factor receptors is a congenital condition affecting 2-3% of all infants (1). (FGFRs)suchasFGFR1, FGFR2, and FGFR3. However,a DDHincreasestheriskofosteoarthritisandisthecauseof couple of studies have also pointed to copy number varia- 30% of all total hip arthroplasties in adults < 40 years of tions (CNVs) as molecular causes of syndromic CS. age (2). We aim to explore the genetic background of Materials and methods: The female patient with DDH in order to improve diagnosis and personaliz psychomotor delay, intellectual disability and multiple CS treatment. and her healthy parents were subjected to standard Materials and method: We conducted a structured karyotyping analysis. Next, we have implemented array PubMed-search and added selected studies from our comparative genomic hybridisation (array CGH) for the archives. A total of 66 papers were included for detailed proband (SurePrint G3 Human CGH Microarray 4×180; review. In addition, we are conducting a heritability AgilentTechnologies),followedbymicroarray-basedgenes analysis in the Norwegian Twin Registry using Falconer’s expression proﬁling (one-color SurePrint G3 Unrestricted method. GE 8x60K microarray; Agilent Technologies). Results: The results of the heritability analyses will be Results: Karyotyping analysis revealed a heterozygous presented at the conference. Similar studies have found a deletiononchromosome7(der7).Furthermore,withtheuseof heritability of ~80%. The literature review revealed that array CGH, we have shown, that the aberration was 12.782 the majority of published papers on the genetics of DDH Mb in size and mapped to locus 7q32.3-q35 (HG19 – were mostly underpowered for detection of any associa- chr7:131521826-144304164). The CNV encompassed 143 tion. One large genome wide association study has been genesincludingtheBRAF,thatencodesB-Raf.B-rafbelongs published, establishing GDF5 as a plausible risk factor. to one of the molecules involved in RAS/MAPK pathway. Thisstudyfoundasinglenucleotidepolymorphism-based Conclusion:OurﬁndingsupportsthecontributionofCNVs heritability of 55%, however GDF5 only explains tosyndromicCSdevelopment.Wealsopointedtotheexisting ~1.5% (3). interaction between RAS and FGFs signaling cascades and Conclusion: DDH is known to be congenital and conclude that dysregulation of those intracellular pathways heritable, with family occurrence of DDH already included maygiverisetoCS.Finally,westronglysuggestscreeningof as a risk factor in most screening programs. Despite this, RAS-associatedgenesinpatientswithNoonan-likesyndrome high quality genetic research is scarce, and no genetic risk andskullabnormalities.Thisworkwassupportedbythegrant factors have been soundly established, prompting the need fromthePolishNationalScienceCentre,PolandUMO-2016/ for more research. 23/N/NZ5/02577 to Ewelina Bukowska-Olech. (1) Rosendahl et al, 1996, Pediatric Radiology (2) E. Bukowska-Olech: None. D. Simon: None. D. Larysz: Engesæteretal,2011,ActaOrthopaedica(3)Hatzikotoulas None. A. Jamsheer: None. et al, 2018, Communications Biology Grants: Helse Vest (F-12550-D11544) E-
P04 .16 K.K.Jacobsen:None.L.B.Laborie:None.H.Kristensen: Genetic risk factors for hip dysplasia None. A. Schäfer: None. T. Gundersen: None. T. Zayats: None. K. Rosendahl: None. K. K. Jacobsen1, L. B. Laborie2,3, H. Kristensen4,5, A. Schäfer4, T. Gundersen6,7, T. Zayats8,9, K. Rosendahl10,11 E-
P04 .17 Ectodermal Dysplasia Type 4: Phenotype-Genotype 1Department of Orthopedic Surgery, Helse Førde, Førde, Correlation Norway,2Department ofRadiology,Helse Bergen,Bergen,830 J.delPicchia A.Ozaydin1,G.Gencebay2,A.KalayciYigin1,M.T.Alay1, Ehlers-Danlos syndrome (EDS) is a generic term for a M. Seven1 clinically and genetically heterogeneous group of con- nective tissue disorders. According to the clinical picture 1Department of Medical Genetics, Cerrahpasa Medical and underlying genetic mutation 13 subtypes are dis- Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, tinguished.Wesawourprobandasaﬁveyearoldgirlwith 2Department of Skin and Venereal Diseases, Cerrahpasa severe periodontitis and premature loss of several teeth. MedicalFaculty,IstanbulUniversity-Cerrahpasa,Istanbul, Moreovershedisplayedashortstature,jointhypermobility, Turkey chronicpain,recurrentluxationofkneecaps,ﬂatfeet,asoft and hyperelastic skin with multiple subcutaneous papules, Introduction: Ectodermal dysplasia is a rare hereditary easy bruising, and pretibial hyperpigmentation. Due to diseasethatischaracterizedbyellipticalnoduleslocatedon those signs and symptoms EDS was suspected and genetic the hair shaft. Fragile hair ﬁbers are found in the temporal testing brought about. NGS analysis of 44 connective tis- and occipital region, resulting in alopecia. Patients are sue-relatedgenesrevealedapathogenicframeshiftmutation usually normal at birth, but the hair becomes fragile in the in CO
L5 A1, conﬁrming the diagnosis Classical EDS. This ﬁrst few months of life. In severe cases, eyebrows, eye- diagnosis was consistent with the proband’s joint and skin lashes, and other body hairs may also be affected. The related phenotype, yet did not explain her severe dental disease can be isolated to the scalp, and may be accom- phenotype. As the dental status was highly suggestive of panied by tooth and nail disorders. Ectodermal dysplasia is periodontalEDS,analysisoftheunderlyinggenes
C1 Rand generally caused by mutations in KRT81, KRT83, KRT85 
C1 Swasperformed.Thedetectionofapathogenicmissense and KRT86 genes. mutation in 
C1 R conﬁrmed the additional diagnosis peri- Clinical Findings and Method: In the physical exam- odontal EDS. Analysis of the parents showed the CO
L5 A1 ination of mother and her three children; localized mutation being maternally inherited whereas the 
C1 R alopecia, brittle hair-body hair and nail dystrophy were mutation occured de novo. Our patient’s mother experi- detected and ectodermal dysplasia was considered. DNA enced many signs of Classical EDS already in her child- was isolated from peripheral blood samples of mother and hood,yetthisdiagnosiswasneversuspectedinherbeforeit her children. Due to the pre-diagnosis of ectodermal was conﬁrmed in her daughter. To our knowledge, this is dysplasia clinical exom analysis was performed in the the ﬁrst reported case of Classical and Periodontal Ehlers- KRT gene family. Danlos Syndrome in one single person. Result: As a result of the analysis, the change of c. F. Stock: None. M.R. Hanisch: None. S. Lechner: None. G565A(p.D189N)inexon2ofKRT85geneinmotherand S. Biskup: None. A. Bohring: None. herchildrenwasdetectedasheterozygousandconﬁrmedby Sangersequencing.Thischangewasevaluatedaccordingto E-
P04 .19 the American College of Medical Genetics criteria and Role of TANGO1 gene in hypermobile type of Ehlers- compared with genetic databases. Danlos syndrome Conclusion:Asaresultoftheevaluation,itisconsidered asavariantofunknownclinicalsigniﬁcance(VUS)andasa A. Junkiert-Czarnecka, M. Pilarska-Deltow, A. Bak, pathological variant in silico databases. M. Heise, O. Haus A. Ozaydin: None. G. Gencebay: None. A. Kalayci Yigin: None. M.T. Alay: None. M. Seven: None. Department of Clinical Genetics Nicolaus Copernicus University, Bydgoszcz, Poland E-
P04 .18 AcaseofClassicalandconcomitantPeriodontalEhlers- Introduction: Hypermobile Ehlers-Danlos syndrome Danlos syndrome (hEDS)isanon-inﬂammatory,autosomalconnectivetissue disorder. It is perhaps the most common hereditary con- F. Stock1, M. R. Hanisch2, S. Lechner3, S. Biskup3, nective tissue disorder with a prevalence estimate at about A. Bohring1 1/5000. hEDS unlike other types of EDS, has no known genetic etiology. One of disfunctions in hEDS patients’ 1Institut für Humangenetik, Universitätsklinikum Münster, cells is impaired transport of extracellular matrix proteins Münster, Germany, 2Klinik für Mund-, Kiefer- und from cells to intercellular space. Protein taking part in this Gesichtschirurgie, Universitätsklinikum Münster, Münster, process is TANGO1 encoded by TANGO1 gene. The aim Germany, 3Praxis für Humangenetik Tübingen, Tübingen, ofstudyisasequencinganalysisofTANGO1geneandalso Germany the evaluation of the potential role of detected variants inAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 831 these gene on their role in the etiology of the hypermobile withOtopalatodigitalSpectrumDisorder,Dyggve-Melchior- type of Ehlers-Danlos syndrome. Clausensyndrome,Immuno-osseusdysplasiaSchimketype, Methods: The study was carried out in a group of 100 Acromesomelic dysplasia, Spondyloepimetaphyseal displa- patientswithhypermobiletypeofEhlers-Danlossyndrome. sia with joint laxity type 2, Osteogenesis imperfecta, Control group consisted of 100 persons from general Osteopetrosis autosomal recessive type 1, Hypochondropla- population. Sequencing analysis of gene TANGO1 was sia, Mucolypidosis type IV, Mucopolisaccharidosis type performed using Sanger sequencing technique. Results IIIA, Craniofrontonasal dysplasia, Oculo-dento-digital dys- Among 100 hEDS patients in two c.1099A>T (p. plasia, Crouzon syndrome, Craniosynostosis type 3, Short Thr367Ser) variant and in next three patients c.2637C>A sature - brachydactyly - intellectual developmental disabil- (p.Asp879Glu) variant were detected. All patients were not ities - seizures syndrome, 3MC syndrome, Trichorhinopha- mutation carriers of other connective tissue protein coding langealsyndromeandotherrareskeletaldisorders.Inseven genes (previous study). According to ACMG guideline cases we performed prenatal diagnosis. variants were evaluated as VUS. Conclusion: To what extent early genomic diagnosis Conclusion: This study is the next small step in the prevents additional unnecessary diagnostics and the oppor- recognition and understanding of the complex picture of tunity for anticipatory guidance-related management in hEDS. Analysis of genes encoding of ECM protein carrier patients with skeletal dysplasia? We tried to answer this may be a new approach to evaluate genetic background of questionbasedontheﬁrstexperiencesinoursinglegenetic hypermobile type of Ehlers-Danlos syndrome. This inves- outpatient clinic. This study represent the pilot study with tigation was ﬁnanced by grant of National Science Centre an aim to establish the multidisciplinary skeletal dysplasia Poland (2018/29/N/NZ5/00345). Center. A.Junkiert-Czarnecka:None.M.Pilarska-Deltow:None. M.Mijovic:None.J.RumlStojanovic:None.A.Miletic: A. Bak: None. M. Heise: None. O. Haus: None. None. B. Bosankic: None. H. Janeski: None. B. Peterlin: None. A. Maver: None. G. Cuturilo: None. E-
P04 .20 Skeletal dysplasia in the era of genomic testing: ﬁrst E-
P04 .21 experience of a single genetic outpatient clinic Identiﬁcation of rare mutation in ext2 gene among from Serbia patients with multiple hereditary exostoses M.Mijovic1,J.RumlStojanovic1,A.Miletic1,B.Bosankic1, A. Yakovleva, A. Danilova, M. Savvina, D. Petukhova, H. Janeski1, B. Peterlin2, A. Maver2, G. Cuturilo1,3 A. Sukhomyasova, N. Maksimova 1University Children’s Hospital, Department of Clinical North-Eastern Federal University, Yakutsk, Russian Fed- Genetics, Belgrade, Serbia, 2Clinical Institute of Medical eration Genetics, University Medical Centre Ljubljana, Ljubljana, Slovenia, 3Faculty of Medicine, University of Belgrade, Multiple hereditary exostoses (MHE) is an autosomal domi- Belgrade, Serbia nant hereditary disorder and the prevalence in various populations ranges is estimated from 1-2 per 100 Introduction: Skeletal dysplasia are very heterogeneous thousand people or 1 in 7000 orthopedic patients. According groupofgeneticdisorders,forwhichinmostcasesgenomic todataobtainedfromthe“registerofhereditaryandcongenital testing (NGS technology) is the ﬁrst-choice method in pathologyoftherepublicofSakha(Yakutia)”80patientsand genetic testing. We want to present our diagnostic rate, their relatives from different ethnic groups were registered. distribution of frequencies between subgroups from classi- Geneticanalysiswasconductedfor65patientswithMHEand ﬁcation of skeletal dysplasia and we try to give an answer their relatives from 30 unrelated families. Next-generation about impact of diagnosis. sequencing(NGS)andSangersequencingmethodswereused. Materials and methods: We present our results for The EXT2 gene from a patient with MHE was sequenced pediatricpatientswithdifferentskeletaldysplasiawhowere usingNGSmethod.Theanalysisrevealednonsense mutation ﬁrst assessed in genetic outpatient clinic at Department of c.751>T(p.Gln251*)inexon5ofEXT2geneinheterozygous Clinical Genetics, University Children’s Hospital in Bel- conditionanditalsowereconﬁrmedintherest79patientsand grade and referred for diagnostic whole exome sequencing their relatives by the Sanger’s sequencing method. This (WES), from 2015 to 2019. WES was performed for all 51 mutation was found and conﬁrmed in 16 patients from four patients. familieswithMHE.Thus,fortheﬁrsttimeintheRepublicof Results: Causative gene variants were identiﬁed in 38 Sakha(Yakutia),amoleculargeneticstudyoftheEXT2gene patients (74.5%, n=38/51). We have diagnosed patient(s) wasperformedinpatientswithMHEandtheirrelatives.Arare832 J.delPicchia nonsensemutationc.751C>T(NM_001178083)wasdetected sensibility and reliability, as well as it enables discarding inexon5oftheEXT2gene,whichleadstothereplacementof aneuploidy, for example a possible Klinefelter karyotype. thecodingcodonwithastopcodonatthe251positionofthe J. Fortuño: None. M. Oliva: None. I. Royo: None. M. protein (p.Gln251 *, NP_001171554). In the future, the Flores: None. A. Torrents: None. F. Martínez: None. N. diagnosticofthismutationcanbeincludedintheprogramof Pérez: None. C. Camprubí: None. genetic testing for medical and genetic counseling. The research is supported by the project FSRG-2020-0014 E-
P04 .23 “GenomicofArctic:epidemiology,hereditaryandpathology” Agenesis of corpus callosum - a new phenotypic aspect A. Yakovleva: None. A. Danilova: None. M. Savvina: in ﬁbrodysplasia ossiﬁcans progressiva? None. D. Petukhova: None. A. Sukhomyasova: None. N. Maksimova: None. N. Meier, N. Knoll, S. Kleiner, M. Ritthaler, E. Wohlleber, J. Kohlhase E-
P04 .22 Mosaicism in the PHEX gene. Is it more common than SYNLAB MVZ Humangenetik Freiburg GmbH, Freiburg, we thought? Germany J. Fortuño1, M. Oliva1, I. Royo1, M. Flores1, A. Torrents1, Introduction: Mutations in ACVR1 cause ﬁbrodysplasia F. Martínez2, N. Pérez2, C. Camprubí1 ossiﬁcans progressiva (FOP). The classical clinical feature of FOP is progressive heterotopic ossiﬁcation, but affected 1Reference Laboratory, L’Hospitalet de Llobregat, Spain, individualsoftendisplayﬁrsttoeandthumbmalformations. 2Hospital Universitario Nuestra Señora de Candelaria, Wereportonaoneyearoldpatientwithmotordevelopment Santa Cruz de Tenerife, Spain delay,corpuscallosumagenesis,bilateralhanddeformities, hypospadias and bilateral agenesis of the ﬁrst toes. Smith- Introduction: Familial X-linked hypophosphatemic rickets Lemli-Opitz syndrome had been suspected as the cause for (XLHR)isdeﬁnedasagroup ofdisorderscharacterizedby limb malformations and hypospadias, and the child was rickets with bone deformities, short stature, dental anoma- referred to genetics in order to rule out or to conﬁrm this lies, hypophosphatemia and increased activity of serum diagnosis. alkaline phosphatases. According to the bibliography, Material and Methods: normal results for 7-dehydro- pathogenicvariantsinthePHEXgenearethemostcommon cholesterol levels made Smith-Lemli-Opitz syndrome cause of XLHR and only a few cases of mosaicism have unlikely, and we suspected a submicroscopic chromosomal been described worldwide. We present two unrelated Can- anomalyoranunknownsyndromeastheunderlyingcause. ary Islands (Spain) family cases referred with XLHR clin- We performed karyotyping and CGH, which revealed ical suspicion in whom mosaic variants have been normal results, followed by whole exome identiﬁed. sequencing (WES). Materials and methods: Genomic DNA was isolated Results:WESdetectedaheterozygousdenovovariantin from EDTA blood using a standard protocol. Next ACVR1: c.1067G>A, p.G356D. A literature search showed Generation Sequencing (NGS) was used to analyse PHEX that patients with absent ﬁrst toes and mild brain gene in the probands. Sanger sequencing was used to abnormalities were previously reported in FOP, but perform the study in the mother’s proband. agenesisofthecorpuscallosumhadnotyetbeenobserved. Results:Inonefamily,anonsensepathogenicvariant(p. Furthermore, hypospadias was reported once in an atypical Gln394Ter) was found in mosaicism in the proband. In the case of FOP. other family, the proband was hemizygous for a missense Conclusions: The combination of ﬁrst toe anomalies, variantofuncertainsigniﬁcance(VUS)(p.Ala267Glu).The especially agenesis of ﬁrst toes, in combination with family analysis reveals that his unaffected mother was hypospadias and brain malformations may be the clinical mosaic. presentation of FOP before the characteristic heterotopic Conclusions: To our knowledge, the identiﬁed cases are ossiﬁcations appear. Agenesis of corpus callosum may be the ﬁrst families with mosaic variants in PHEX gene part of the phenotypic spectrum of FOP. The diagnosis of reported in Spain. In the genetic counselling context, the FOPpriortotheﬁrstheterotopicossiﬁcationcanleadtoan “recurrence” of mosaicism in PHEX gene, emphasize to improved clinical management to prevent early heterotopic consider unaffected males as possible mosaic carriers. The ossiﬁcations in the child. advantage of performing PHEX gene analysis by NGS is N. Meier: None. N. Knoll: None. S. Kleiner: None. M. noteworthy:itallowsdetectionofmosaicvariantswithhigh Ritthaler: None. E. Wohlleber: None. J. Kohlhase: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 833 E-
P04 .24 canaidininterpretingnewvariantsandpromoteappropriate GDF5 clinical and molecular spectrum: expanding genetic counselling. current knowledge on genotype-phenotype correlations D. Guadagnolo: None. M. Genovesi: None. E. March- ionni: None. S. Bernardo: None. A. Giovannetti: None. N. D. Guadagnolo1, M. Genovesi1, E. Marchionni1, Panzironi:None.A.Traversa:None.F.DiPalma:None.G. S. Bernardo1, A. Giovannetti2, N. Panzironi1, A.Traversa2, Mastromoro: None. P. Palumbo: None. M. Carella: None. F. Di Palma1, G. Mastromoro1, P. Palumbo3, M. Carella3, T. Mazza: None. V. Caputo: None. A. Pizzuti: None. T. Mazza4, V. Caputo1, A. Pizzuti1 E-
P04 .25 1Department of Experimental Medicine, Sapienza Univer- IdentiﬁcationandcharacterizationofaGLMNsplicesite sity of Rome, Italy, Rome, Italy, 2Laboratory of Clinical variant in a three-generation-family with glomuvenous Genomics, Fondazione IRCCS Casa Sollievo della Soffer- malformations enza,SanGiovanniRotondo,Italy,3LaboratoryofMedical Genetics, Fondazione IRCCS Casa Sollievo della Soffer- D. Skowronek1, M. Hebebrand2, R. Erber3, A. Agaimy3, enza, Rome, Italy, 4Laboratory of Bioinformatics, Fonda- C. Zweier2, U. Felbor1, M. Rath1 zione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy 1Department of Human Genetics, University Medicine Greifswald, and Interfaculty Institute of Genetics and Introduction: Brachydactyly is a bone development Functional Genomics, University of Greifswald, Greifs- abnormality presenting with variable phenotype and dif- wald, Germany, 2Institute of Human Genetics, Friedrich- ferent transmission patterns. Mutations in GDF5 (growth/ Alexander-Universität Erlangen-Nürnberg, Erlangen, Ger- differentiation factor 5, MIM: 601146) gene account for a many, 3Institute of Pathology, University Hospital Erlan- signiﬁcantamountofcases.A3-generationfamilyshowing gen, Comprehensive Cancer Center Erlangen-EMN, isolated brachydactyly was studied. The proband and his Friedrich-Alexander University Erlangen-Nürnberg grandfather showed features of C and A1 brachydactyly (FAU), Erlangen, Germany types, his mother showed only subtle signs. Materials and methods: Whole Exome Sequencing Introduction: Glomuvenous malformations (GVMs) are (WES) was performed on the two affected individuals. An painful vascular lesions with distended venous lumina that in-depthanalysisofGDF5genotype-phenotypecorrelations are surrounded by multiple layers of smooth-muscle-like was performed through literature reviewing and retrieving glomus cells. Familial GVMs (OMIM: 138000) are inher- information from several databases to elucidate GDF5 ited in an autosomal dominant manner and associated with related molecular pathogenic mechanisms. loss-of-function germline variants in the GLMN gene. Results: WES analysis disclosed a known pathogenic Material and Methods: We here describe the natural variant in GDF5 (NM_000557.4:c.157dupC), segregating history of GVM disease in a three-generation family and with the phenotype. The frameshift variant was previously reportontheidentiﬁcationandcharacterization ofaGLMN associated with Brachydactyly type C in heterozygosis and splice site mutation by NGS gene panel sequencing and the severe Grebe chondrodysplasia in homozygosis. We transcript analysis. extended and updated the spectrum of GDF5 genotype- Results: At ﬁrst clinical examination, the 16-year-old phenotype correlations. In total, ﬁfty pathogenic mutations male index patient presented multiple, sharply deﬁned were associated with nine clinical phenotypes and auto- bluishpapulesonvariouslocations.His35-year-oldmother somal dominant and recessive transmissions even for the had approximately ten papules clustering on her back and samephenotype.Presentationsrangefromseveredefectsin his7-year-oldmaternalhalf-sisterpresentedwithtwobluish limb morphogenesis to conditions with redundant ossiﬁca- papulesonher neck. The index patient’s maternal aunt and tion.Weproposethatthisclinical gradientcanbelinkedto grandfather were also reported to have one or two bluish a continuum of GDF5-activity variation, with variable loss spots each. Using NGS gene panel sequencing, we ofGDF5-activityunderlyingbonedevelopmentdefects,and identiﬁed the heterozygous splice site variant c.1299 gain-of-functionmutationscausingdisorderswithexcessive +1G>A in the GLMN gene of the index case which had bone formation. notbeenreportedintheliteraturebefore.Heterozygosityfor Conclusions: Our in-depthanalysison GDF5 pathogeni- thesubstitutionatthedonorsplice siteofexon14wasalso city mechanisms furtherly supports that mutation and shown for the index patient’s mother and maternal half- zygosity backgrounds resulting in the same level of GDF5 sister. A GLMN transcript analysis ﬁnally veriﬁed that this activity may lead to similar phenotypes. This information variantcausesout-of-frameskippingofexon14.Following834 J.delPicchia thelatestACMGguidelinesforvariantinterpretation,itwas Conclusions: Considering the results of the study, we classiﬁed as pathogenic for autosomal dominant GVM. cannot exclude that the genes we identiﬁed may have a Conclusion:Thethree-generation-familyreportedhereis pathogenic effect, forming the hEDS phenotype. The a testimony for the variable expressivity of GVMs, best research was partly supported by project 558-2019-0012 explained by Knudson’s two-hit model. (№АААА-А19-119021290033-1) of FSBSI «D.O. Ott D. Skowronek: None. M. Hebebrand: None. R. Erber: Research Institute of Obstetrics, Gynaecology and None. A. Agaimy: None. C. Zweier: None. U. Felbor: Reproductology». None. M. Rath: None. T.I. Kadurina: None. L.R. Lonishin: None. E.A. Sereb- ryakova: None. L.N. Abbakumova: None. A.S. E-
P04 .26 Glotov: None. Identiﬁcationofnovelcandidategenesforthehypermo- bile type of Ehlers-Danlos Syndrome E-
P04 .27 Genotype-phenotype correlations in hereditary multiple T. I. Kadurina1, L. R. Lonishin2, E. A. Serebryakova1,3, exostoses L. N. Abbakumova4, A. S. Glotov3 I. Akalin1, K. Kurosawa2, B. Yeter3, E. Akbas4, 1North-Western State Medical University named after I.I. G. Nishimura5, W. Wuyts6, N. H. Elcioglu3 Mechnikov, St. Petersburg, Russian Federation, 2Peter the GreatSt.PetersburgPolytechnicUniversity,St.Petersburg, 1Istanbul Medeniyet University, Faculty of Medicine, Russian Federation, 3D.O. Ott Research Institute of Department of Medical Genetics, Istanbul, Turkey, 2Kana- Obstetrics, Gynecology and Reproductology, St. Peters- gawa Children’s Medical Center, Department of Medical burg, Russian Federation, 4Saint-Petersburg State Pedia- Genetics,Yokohoma,Japan,3Marmara University,Faculty tric Medical University, Russia, St. Petersburg, Russian of Medicine, Department of Pediatric Genetics, Istanbul, Federation Turkey, 4Istanbul Medeniyet University, Faculty of Medi- cine, Istanbul, Turkey, 5Center for Intractable Diseases, Introduction: There has been valuable progress in Saitama Medical University Hospital, Saitama, Japan, the use of different molecular diagnostic technologies to 6Department of Respiratory Diseases, University Hospitals clarify the classiﬁcation of the hypermobile type of Ehlers- Leuven, Leuven, Belgium Danlos Syndrome (hEDS). Diagnosis of hEDS is only based on clinical criteria, due to the absence of an Hereditary Multiple Exostoses (HME) is a complex heredi- identiﬁedgeneandaprotein,thusthemainobjectivewasto tarymusculoskeletaldisorderdiagnosedateitherpediatricor identify possible molecular genetic causes of hEDS adult age. HME is characterized by progressive exophytic development. osseous projections that form next to the growth plates of Materials and methods: For research, genomic DNA many skeletal elements, including long bones, ribs and samples of unrelated patients with hEDS were used (9 vertebrae. In addition to pain and functional problems par- females and 23 males). In all cases, the diagnosis was ticular forehand deformities are main complaints of the established by international recommendations for 2017 patients in the clinics that the treatment is restricted to sur- EDS. Whole-exome sequencing was performed on a gical excision of the lesions. The main complication is HiSeq2500. Assessment of the pathogenicity of the development of osteochondromas. Mutations in EXT1 or identiﬁed variants was based on the recommendations of EXT2genesthatencodeglycosyltransferasesareresponsible ACMG and Sherloc on the interpretation of data obtained for the disease and represented locus heterogeneity. None- by the next-generation sequencing method. theless,genotype-phenotypeinterventionsarestillimportant Results: As a result of the pathogenicity assessment, 7 wepresented20HMEcasesamong9familiesanddiscussed pathogenic and 5 probably pathogenic variants were genotype-phenotype correlations. This project has been identiﬁed in the encoding regions of the ABCA4, ABC
C9 , founded by The Scientiﬁc And Technological Research CBS, CCD
C8 , FIG4, GJB2, HGD, KRT14, LMNA, Council Of Turkey (TUBITAK; Project #217
S675 ) MEFV, PROM1, RYR1, SL
C26 A2 and USH2A genes in I. Akalin: None. K. Kurosawa: None. B. Yeter: None. E. the heterozygous state. Also, 15 genes were selected with Akbas:None. G. Nishimura: None. W. Wuyts: None. N.H. variants of unknown clinical signiﬁcance based on data on Elcioglu: None. protein expression and high speciﬁcity of physical interac- tions among themselves that may be involved in the E-
P04 .28 development of hEDS. Recurrent bone pain - more than tumors and inﬂammationAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 835 M. M. Khelifa1, S. V. Hardenberg1, B. Auber1, B. Introduction: Hereditary ichthyosis is common name for Schlegelberger1, S. Mukodzi2, J. Wiens2, A. K. Bergmann1 many dry and scaly skin disorders ranging in frequency fromcommontoveryrare.Clinicalgenealogicalanalysisof 1MedizinischeHochschule Hannover, Hannover,Germany, hereditary forms of ichthyosis (from 1989 to 2018) are 2Klinikum Wolfsburg, Wolfsburg, Germany conducted in the Republic of Sakha (Yakutia), Russia. Materials and methods: Data was collected from the Hyperostosis-hyperphosphatemia syndrome (HHS) and genetic history of patients of the “Republican Genetic hyperphosphatemic familial tumoral calcinosis (HFTC) Register of Hereditary and Congenital Pathology of the are the clinical manifestations of a rare autosomal reces- Republic of Sakha (Yakutia)” of the Medical Genetics sive disease caused by the inactivation of the ﬁbroblast Center of the Republican hospital №1 “National center of growth factor 23 (FGF23), Polypeptide N-Acet- medicine”. ylgalactosaminyltransferase3(GALNT3)orKlothogenes, Results: The number of patients with ichthyosis is 126 which in turn leads to an elevated blood phosphate level patients (104 families) according to the genetic register of resulting mainly from an excessive proximal renal tubular Yakutia according to date of 2018. The frequency of phosphatereabsorption.Wereportthecaseofa5-year-old ichthyosiswasabout1/7675,prevalenceis13,0to100000. female of healthy non-consanguineous parents of German Gender: 94 men (74.6%), 32 women (25.4%). Ethnicity: and Italian descent. She initially presented with recurrent Yakut-109(86.5%),Russian-17(13.5%).Infourfamilies lower leg pain. Bone biopsy was inconclusive, as well as affected patients of both genders and in ten cases only infectious work-up. Imaging identiﬁed a diaphyseal males.Allpatientshaddryness,peelingoftheskin.Insome sclerosisand hyperostosis oftheribs. Hyperphosphatemia cases, more severe symptoms were noted in the form of was observed. Thus, panel diagnostics of the genes pityriasis peeling, follicular keratosis. The manifestation FGF23, GALNT3 and KL was performed. Two hetero- varied from birth to adolescence. zygous variants in GALNT3 (NM_004482.3) were identi- Conclusions: It is difﬁcult to establish the type of ﬁed, one previously undescribed missense variant inheritance and further medical and genetic counseling c.782G>A p.(Arg261Gln), classiﬁed as a variant of because of genetic heterogeneity and the similarity of the uncertain signiﬁcance. Protein-modeling of this variant clinical features of ichthyosis. Thus, there is a strong need suggested the disruption of GALNT3 activity, leading to inahighlyspeciﬁcdiagnosticmethodandin-depthresearch an increased inactivation of the phosphaturic hormone study for precise diagnosis, treatment and prevention of FGF23 causing HHS/HFTC. The second variant these diseases. Project: FSRG-2020-0014 “Genomics of c.803dupC p.(Thr269Asnfs*3) was previously described Arctics: epidemiology, hereditary and pathology” inaHHS/HFTCpatientandclassiﬁedaslikelypathogenic V.M.Sofronova:None.A.L.Sukhomyasova:None.N.R. (ACMG guidelines). In HHS/HFTC, no genotype-pheno- Maksimova: None. type correlation was described so far, and suggested treatment regimes are heterogeneous. Thus, in addition to E-
P04 .31 the detailed case, we present an overview of genotype- Jeune Syndrome with a novel DYN
C2 H1 mutation phenotype correlation and a collection of follow-up descriptionsofdiseasecoursesonpatientsreportedbefore N.H.Elcioglu1,B.Yeter1,J.Y.Xue2,Z.Wang2,L.Guo2,G. 2015. In conclusion, we aim to raise awareness of HHS/ Nishimura3, S. Ikegawa2 HFTC as a syndrome presenting primary with bone pain and radiographic changes. 1Department of Pediatric Genetics, Marmara University M.M. Khelifa: None. S.V. Hardenberg: None. B. Auber: MedicalSchool,Istanbul,Turkey,2LaboratoryofBoneand None. B. Schlegelberger: None. S. Mukodzi: None. J. Joint Diseases, Center for Integrative Medical Sciences, Wiens: None. A.K. Bergmann: None. RIKEN, Tokyo, Japan, 3Center for Intractable Diseases, Saitama Medical University Hospital, Saitama, Japan EN-
P04 .29 Clinical and genealogical characteristics of hereditary Jeune Asphyxiating Thoracic Dystrophy(OMIM%208500, forms of ichthyosis in the Republic of Sakha (Yakutia) ATD, Short-rib thoracic dysplasia with or without poly- dactyly) is an autosomal recessive skeletal dysplasia char- V. M. Sofronova, A. L. Sukhomyasova, N. R. Maksimova acterized by short stature and pulmonary hypoplasia secondary to the small thoracic cage. Polydactyly, glo- North-Eastern Federal University, Yakutsk, Russian Fed- merular sclerosis, biliary dysgenesis, hirshprung disease, eration retinal dysplasia and cardiac defects are the other ﬁndings. Here, we will a male patient who was diagnosed as Jeune836 J.delPicchia syndrome at the age of 3 month-old. He was born to a 28 Bencodinggene(FLNB).FLNBisanessentialcytoskeletal years old G3
P3 L3
 mother by ceserean section with a birth protein which is thought to play a key role in bone mor- weight of2685 gat36 weeksofgestation. His birth length phogenesis. However, the skeletal phenotype of Larsen was 44.5 cm, head circumference was 35 cm. He was syndrome has not yet been characterized in details. hospitalized in a newborn intensive care unit for 3 months Materials and methods: A case-study. Two Caucasian due to respiratory distress. Except that the parents were far women (mother and daughter; age 63 and 33 years) with bloodrelatedtherewasnoparticularfamilialhistory.Inhis Larsen syndrome carrying a novel FLNB c.688G>T, p. last follow-up at the age of 4.5 years, his measurements (Val230Phe) variant were included. A bone morphologic were weight:14kg(-1.9 sds), height:97cm(-2.4 sds), evaluation was performed including DXA-scanning and HC:50cm(10-25p). The patient had a narrow thorax and high-resolution peripheral quantitative tomography (HR- pectus carinatum. On the radiographs, horizontal and short pQCT scan) evaluating their bone microstructure. Further- ribs, hypoplastic iliac wings and horizontal acetabulum more, an iliac crest bone biopsy from the mother was were detected. Mild sleep apnea was deﬁned in poly- evaluated by µCT. somnography. A novel homozygous missense mutation c. Results:Bothwomenshowedsignsof severe osteoporo- G6439T in the DYN C2
H1 gene was detected on exome sis. The HR-pQCT scan showed a low estimated bone sequencing for the etiologicall cause. Jeune syndrome is a strengthandvolumedensityaswellasdecreasedtrabecular genetically heterogeneous disease nearly forty genes have numbercomparedtodatafromapopulation-basedgroupof been identiﬁed and deﬁned as ciliopathy. There may be Danish women. The µCT analysis of the bone biopsy slight to moderate short stature although respiratory difﬁ- showed similar trabecular changes. The porosity of the culties eventuate in all survivors. Moreover, laboratory cortical bone was found to be normal or decreased in both evaluation of urine/blood, abdominal US, spirometry and the HR-pQCT and the µCT analysis. ophtalmological exam should be recommended for renal, Conclusions: Our ﬁndings include an early onset of hepatic and eye involvement severe osteoporosis, which is likely due to structural N.H.Elcioglu:None.B.Yeter:None.J.Y.Xue:None.Z. changes in the trabecular bone compartment. On the other Wang: None. L. Guo: None. G. Nishimura: None. S. hand,thecorticalbonecompartmentshowsnoosteoporotic Ikegawa: None. characteristics. This highlights that the investigated FLNB variant may have a very different effect on the trabecular E- P04
.33 and cortical compartments. Severe osteoporosis in Larsen syndrome: genetic and T.M. Juul: None. C. Ejersted: None. L. Folkestad: None. bone morphological investigations - a case report K. Brusgaard: None. S. Hansen: None. C.M. Andreasen: None. L.K. Thomsen: None. J.S. Thomsen: None. T.L. T.M.Juul1,2,C.Ejersted3,L.Folkestad2,3,K.Brusgaard1,2, Andersen: None. A.L. Frederiksen: None. S. Hansen4,5, C. M. Andreasen6, L. K. Thomsen6, J. S. Thomsen7, T. L. Andersen2,7,8, A. L. Frederiksen1,2,9 E- P04
.35 Maffucci syndrome-like manifestations deciphered as a 1Dept. of Clinical Genetics, Odense University Hospital, compound heterozygote of Gronblad-Strandberg syn- Odense, Denmark, 2Dept. of Clinical Research, Faculty of drome by exome sequencing. Health, University of Southern Denmark, Odense, Den- mark, 3Dept. of Endocrinology M, Odense University A. Ikonomidis1, E. Oikonomidou2, A. Malamidou2, Hospital, Odense, Denmark, 4Dept. of Medicine, Hospital A. Arampatzi2, N. Peroulis2, K. Krapis3, T. Konstantoula3, of South West, Esbjerg, Denmark, 5Dept. of Regional P. Katsiaﬁloudis3, A. Papadogoulas3, M. Hatzimichail3, HealthResearch,UniversityofSouthernDenmark,Odense, T. Zafeiridis3, E. Neou3, D. Papadopoulos3, Denmark, 6Clinical Cell Biology, Dept. of Pathology, P. Papamichalis3, S. Karagiannis3, A. Komnos3, Odense University Hospital, Odense, Denmark, 7Dept. of K. Karakousis3, A. Xefteris2 Biomedicine, Aarhus University, Aarhus, Denmark, 8Dept. of Forensic Medicine, Aarhus University Hospital, Aarhus, 1Eurogenetica Thessalias, Larissa, Greece, 2Eurogenetica, Denmark, 9Dept. of Clinical Genetics, Aalborg University Thessaloniki, Greece, 3Koutlimpanio General Hospital of Hospital, Aalborg, Denmark Larissa, Larissa, Greece Introduction: Larsen syndrome is a genetic condition Introduction: Exome sequencing is a state of the art characterized by facial dysmorphology and skeletal defor- technique that may clarify the genotype of complex over- mities. The syndrome has a dominant inheritance and is lapping phenotypes. We present a case of a female with a caused by heterozygous pathogenic variants in the Filamin typicalclinicalphenotypeofMaffuccisyndromewhichwasAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 837 ﬁnally deciphered as a compound heterozygote of Gron- connective tissue disorder characterized by a combination blad-Strandberg syndrome. of cardiovascular, musculoskeletal, ophthalmic and pul- Materialsandmethods:A20-year-oldfemalesuspected monary manifestations. The wide clinical variability of this of Maffucci syndrome presented multiple cartilage defor- disorder can make its recognition difﬁcult. Diagnosis is mities as well as hemangiomas and lymphangiomas usually established based on the deﬁned clinical criteria of disseminated along her body. Clinical exome sequencing the Ghent-2 nosology. Approximately 1800 pathogenic or was performed onthe DNA extracted from patient’sblood, likelypathogenicvariantshavebeenidentiﬁedinFBN1,the using Sophia Genetics’ Clinical Exome Solution v2. majority of which are speciﬁc to a single family, and 25% Following preparations according to the manufacturer’s occurring de novo. Somatic and/or germline mosaicism protocol, DNA libraries were sequenced on an Illumina have been reported in rare cases. NextSeq-500 genetic analyser. Data processing, variant Here we describe an asymptomatic 50-year-old female calling and pre-classiﬁcation were conducted by SOPHiA who presented for genetic counselling after her two DDM® bioinformatics pipelines. daughters, from different partners, were both diagnosed Results: The patient carried wild-type isocitrate dehy- with MS. A known pathogenic variant, c.1693C>T, p. drogenase1(IDH1)andisocitratedehydrogenase2(IDH2) Arg565* in FBN1 (NM_000138.4), was conﬁrmed in both alleles related to Maffucci syndrome. Instead, she was affectedhalf-siblings.However,targetedSangersequencing found to be a compound heterozygote for ATP-binding- for this variant was negative in the mother. Repeat testing cassette-subfamily-C-member-6 gene (ABC C6
) related to via Next-Generation-Sequencing (NGS) of FBN1 was pseudoxanthoma elasticum or Gronblad-Strandberg syn- offered to the patient. drome.In particular, shecarriedthe pathogenic c.1652T>C NGS analysis of FBN1 revealed the presence of the (Phe551Ser) mutation and the c.2836C>A (Leu946Ile) variant in 9% of the sequencing reads. This is well below mutation which is of debatable pathogenicity. the allele frequency expected for a heterozygous germline Conclusions: Exome sequencing revealed a compound variant (~50%). Based on the family history, this variant heterozygote with Gronblad-Strandberg syndrome initially was reported at a mosaic level of 9%. suspected to present a case of Maffucci syndrome. These results are consistent with somatic and germline Pseudoxanthoma elasticum leads to mineralization of skin, mosaicisminthispatient.Therecurrenceriskforanyfuture eye, cardiovascular and gastrointestinal systems and offspring isnowknownto be up to50%. Additionally, she commonly present with papules in the skin and/or with has been referred to Cardiology and Genetics to assess for angioid streaks of the retina. Thus, in a great extent, the any clinical manifestations of MS in herself. clinical manifestations are in discordance with the under- A. Schaffer: None. L. Huang: None. O. Jarinova: None. lying genotype which suggests a novel phenotypic S. Hewson: None. R. Aul: None. J. McGowan-Jordan: manifestation of Gronblad-Strandberg syndrome. None. A. Smith: None. L. Bronicki: None. A. Ikonomidis: None. E. Oikonomidou: None. A. Malamidou:None.A.Arampatzi:None.N.Peroulis:None. E- P04
.37 K. Krapis: None. T. Konstantoula: None. P. Katsiaﬁloudis: Next Generation Sequencing in Marfan syndrome: rare None. A. Papadogoulas: None. M. Hatzimichail: None. T. genetic variants improve genotype phenotype Zafeiridis: None. E. Neou: None. D. Papadopoulos: None. correlation P. Papamichalis: None. S. Karagiannis: None. A. Komnos: None. K. Karakousis: None. A. Xefteris: None. N. Marinakis, C. Sofocleous, E. Tsoutsou, D. Veltra, M. Sviggou, J. Traeger-Synodinos, E. Fryssira E- P04
.36 AcasereportofsomaticmosaicismforaFBN1nonsense National & Kapodistrian University of Athens, Athens, variant Greece A.Schaffer1,L.Huang1,O.Jarinova1,S.Hewson2,R.Aul2, Introduction: Marfan syndrome (MFS) is an autosomal J. McGowan-Jordan1, A. Smith1, L. Bronicki1 dominantdisorderofconnectivetissuewithaprevalenceof 1per5000individuals.MFSischaracterizedbyearlyaortic 1Department of Genetics, Children’s Hospital of Eastern thoracic dilatations/aneurysms, defects of the skeletal and Ontario, Ottawa, ON, Canada, 2Department of Genetics, ocular systems, tall stature, arachnodactyly, pectus exca- Hospital for Sick Children, Toronto, ON, Canada vatum, joint hypermobility and ectopia lentis. Mutations in the Fibrillin-1 gene (FBN1) are the most common cause of Marfan syndrome (MS) is an autosomal dominant disorder MFS.Nevertheless,mutationsinothergenes(e.g.TGFBR1, caused by mutations in the ﬁbrillin-1 gene (FBN1). It is a FLNA, CO L5
A1, SL C2
A10, ADAMTS L4
, CBS, SMAD3,838 J.delPicchia TGFB2, MED12, FBN2, PLOD1, BMPR2 etc.) have also small for gestational age with dysmorphic facial features, beenassociatedwithMFS.Newtechnologies,suchasNext skeletalabnormalities,arthrogryposis,andhypoplasticlabia Generation Sequencing, contribute to the identiﬁcation of majora, without typical webbing. known and novel mutations in these genes. Results: WES analysis was conducted after negative Materials and methods: Clinical information and ﬁndings in karyotype, MLPA screening for microdeletions, peripheral blood samples were collected from 25 patients subtelomeric deletions and duplications, urinary GAGs, with Marfan or Marfan-like phenotype and heart defects. NGS for congenital arthrogryposes. Two pathogenic DNA extraction and Whole Exome Sequencing (WES), variants were identiﬁed in the CHRNG gene, c.241C>T analysingapproximately19.000genesdispersedthroughout previously reported in homozygous state in patient with a the genome-were applied. similarclinicalpicture,andc.1143G>Awhichhasnotbeen Results: WES analysis revealed positive results in 17 previously described. patients, accomplishing a diagnostic yield of 68%. Causa- Conclusions: Polimalformative syndromes including tive alterations included 14 known and novel pathogenic skeletal defects, and joint contractures, even without the variants in the FBN1 gene, 1 in the FBN2 gene, 1 in the typical webbing, should be tested for Escobar variants of BMPR2 gene and 1 in the SL C2
A10 gene. MPS,becausestandardarthrogryposisgenepanelscanmiss Conclusion: WES can support deﬁnitive diagnosis in the diagnosis. patients with Marfan or Marfan-like phenotypes, contribut- H. Kathom: None. D. Avdjieva-Tzavella: None. ing to precise prognosis, systematic monitoring, and when T. Delchev: None. S. Atemin: None. T. Todorov: None. appropriate, identiﬁcation of other family members. NGS A. Maver: None. B. Peterlin: None. V. Mitev: None. supports marked improvement in diagnostic-yield for A. Todorova: None. numerous inherited disorders including Marfan Syndrome, especiallyinthecaseofnonFBN1variants.Thestudywas E- P04
.40 carried out as part of the Erasmus+ project:N-GeneS Compound heterozygous variant in NBAS as a case of N. Marinakis: None. C. Sofocleous: None. E. Tsoutsou: bone fragility by the type of osteogenesis imperfecta None. D. Veltra: None. M. Sviggou: None. J. Traeger- Synodinos: None. E. Fryssira: None. D. A. Petukhova1, E. Gurinova2, A. Sukhomyasova1,2, N. Maksimova1 E- P04
.39 AnovelpathogenicvariantintheCHRNGgenelinkedto 1Research Laboratory “Molecular Medicine and Human Escobar variant of multiple pterygium syndrome Genetics”, Medical Institute, M. K. Ammosov North- Eastern Federal University, Yakutsk, Russian Federation, H. Kathom1, D. Avdjieva-Tzavella1, T. Delchev1, 2Medical Genetic Center, Republican Hospital №1 – S. Atemin2,3, T. Todorov3, A. Maver4, B. Peterlin4, «NationalMedicalCenter»,Yakutsk,RussianFederation V. Mitev2, A. Todorova2,3 Introduction: Biallelic mutations in the NBAS gene have 1University paediatric hospital "prof. Ivan Mitev", Soﬁa, been reported to cause three different clinical signs: short Bulgaria,2DepartmentofMedicalChemistryandBiochem- stature with optic nerve atrophy and Pelger-Huët anomaly istry, Medical University Soﬁa, Soﬁa, Bulgaria, 3Genetic (SOPH) syndrome, infantile liver failure syndrome 2 Medico-Diagnostic Laboratory “Genica”, Soﬁa, Bulgaria, (ILF S2
) and a combined severe phenotype including both 4Clinical Institute of Medical Genetics, UMC Ljubljana, SOPH and ILF S2
 features. Ljubljana, Slovenia MaterialandMethods:Here,wedescribeacaseofa6- year-old Yakut girl who presented with clinical signs of Introduction: Multiple pterygium syndromes (MPS) com- SOPH syndrome, acute liver failure (ALF) and bone prise a group of multiple congenital anomaly disorders fragility by the type of osteogenesis imperfecta (OI). characterized by webbing (pterygia) of the neck, elbows, Targeted panel sequencing for 494 genes of connective and/or knees and joint contractures (arthrogryposis)a. The tissuediseaseswasperformedonourpatient.Topredictthe multiple pterygium syndromes are phenotypically and protein-damaging effects of the suspected pathogenic genetically heterogeneous but are traditionally divided into variationsinNBAS,threedifferentsoftwareprogramswere prenatally lethal and nonlethal (Escobar) types. In this used: Polyphen-2, SIFT, MutationTaster. report we present a case of Escobar type MPS with novel Results:Themoleculargeneticstudyrevealedtheknown pathogenic variant in CHRNG. heterozygous variant c.5741G>A (p.Arg1914His) in 45 Materialsandmethods:Wepresenta25monthsoldgirl exonofNBAS.Also,in23exonofNBASwasidentiﬁeda from ﬁfth pregnancy with complications. She was born previously unreported missense heterozygous variantAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 839 c.2535G>T (p.Trp845Cys). Mutation affect evolutionarily parenttriosusingXHMM,CoNIFERandEXCAVATOR2. conserved amino acid residues and predicted to be highly Deﬁning XHMM as primary algorithm we established a damaging. ﬁltering pipeline considering sample wide frequency, de Conclusion: Timely health care of patients with such a novo status, calling intersection (CoNIFER and/or EXCA- setofclinical spectrumofSOPHsyndrome, ALFandbone VATOR2), annotation to RefSeq-genes, overlap with fragility can contribute to establishment coordinated multi- regions of segmental duplications and population fre- specialty management of the patient focusing on the health quency. CNVs were validated using qPCR. Three interest- problems issues through childhood. ingdenovoCNVswereidentiﬁed:A86kbdeletiononChr8 Grant:ThestudyissupportedbytheMinistryEducation inannsCL/Ppatient,a16MbdeletiononChr1inannsCPO and Science of Russian Federation (Project No. FSRG- patient, and an 877kb duplication on Chr2 in an nsCPO 2020-0014 “Genomics of Arctic: epidemiology, hereditary patient. Interesting candidate genes at these loci are LHX8, and pathology”). DLX1andDLX2,allsuggestedtocontributetocraniofacial D.A. Petukhova: None. E. Gurinova: None. A. Sukho- development:TargetedmutationsofLhx8inmiceleadtoan myasova: None. N. Maksimova: None. isolated cleft palate. In embryonic mice Dlx1 and Dlx2 are expressed in both the maxillary and the mandibular com- E- P04
.43 ponent of the ﬁrst pharyngeal arches, and Dlx1/2-/- mutant Nonsyndromic orofacial clefts - Identifying putative mice exhibit a cleft palate. Our results indicate that rare causative genes by CNV analysis of whole exome highly penetrant CNVs can contribute nsCL/P and nsCPO sequencing data risk.Toachievemoreevidenceforourﬁndings,replication studies in larger patient/control cohorts are essential. S. Hölzel1, N. Ishorst1, C. Greve1, F. Degenhardt1, D. S. Hölzel: None. N. Ishorst: None. C. Greve: None. F. Drichel2, C. Maj3, M. Nothnagel2, J. Y. Hehir-Kwa4, J. A. Degenhardt: None. D. Drichel: None. C. Maj: None. M. Veltman4,5, T. Kruse6, H. Reutter1,7, S. Nowak1, C. Nothnagel: None. J.Y. Hehir-Kwa: None. J.A. Veltman: Carels8,9, I. van Rooij10, K. U. Ludwig1, E. Mangold1 None.T. Kruse:None.H.Reutter:None.S.Nowak:None. C. Carels: None. I. van Rooij: None. K.U. Ludwig: None. 1InstituteofHumanGenetics,UniversityofBonn,Schoolof E. Mangold: None. Medicine and University Hospital Bonn, Bonn, Germany, 2Cologne Center for Genomics, University of Cologne, E- P04
.44 Cologne, Germany, 3Institute for Genomic Statistics and Glis3expressioninworkingmodelmurineosteoarthritis Bioinformatics,UniversityofBonn,SchoolofMedicineand University Hospital Bonn, Bonn, Germany, 4Departmentof E. Rothzerg Human Genetics, Donders Institute, Radboud University Medical Center, Nijmegen, Netherlands, 5Institute of University of Western Australia, Perth, Australia Genetic Medicine, Newcastle University, Newcastle-upon- Tyne, United Kingdom, 6Department of Orthodontics, Osteoarthritis (OA) is characterised by cartilage degrada- University of Cologne, Cologne, Germany, 7Department tion, hypertrophy and inﬂammation. Chondrocytes are the of Neonatology, Children’s Hospital, University of Bonn, only cells normally found in cartilage, producing and Bonn, Germany, 8Department of Human Genetics, KU maintaining the cartilaginous matrix. Chondrocyte hyper- Leuven,Leuven,Belgium,9Orthodontics,UniversityHospi- trophy is an essential process required for endochondral talsKULeuven,Leuven,Belgium,10DepartmentforHealth ossiﬁcation in mammals and it is also plays a role in the Evidence, Radboud Institute for Health Sciences, Radboud developmentofOA.Furthermore,geneticfactorshavebeen university medical center, Nijmegen, Netherlands found to be strong determinants of OA and are likely to operate via chondrocyte function. I previously identiﬁed Nonsyndromic cleft lip with/without palate (nsCL/P) and some novel candidate murine genes with a potential role in cleft palate only (nsCPO) are frequent congenital mal- OApathophysiology.However,oneofthecandidategenes, formations with high heritability estimates. Common risk Glis3, has showed a potential by expressed in hypertrophic loci explain only some of their heritability. Rare, highly chondrocytes in OA knee joints obtained from the colla- penetrant copy number variations (CNVs) encompassing borative cross mouse model, using immunohistochemistry. possiblecleftingsusceptibilitygenesmightpartiallyexplain In conclusion, this study has implicated several molecular the missing heritability. Aim of this study was to identify mechanism in the pathogenesis of cartilage degeneration, such genes by detecting de novo CNVs from whole-exome thus improving our understanding of OA and offering sequencing (WES) trio data. CNVs were called from WES potential molecular targets for novel therapeutic dataof50nsCL/Pand43nsCPOCentralEuropeanpatient/ approaches.840 J.delPicchia E. Rothzerg: None. E- P04
.49 E- P04
.47 Molecular genetic diagnostic in skeletal disorders - a AnovelhomozygousSLUR P1
variantinaboywithMal Western Romanian delineation de Meleda born to non-consanguineous parents I. E. Jurca- Simina1,2, A. Chirita-Emandi1,2, S. B. Gram1,2, J. Blechingberg3, K. Brusgaard1,2, N. Andreescu1,2, C. L. Șerban1,3, C. Zimbru1, M. Puiu1,2 A. Bygum4,2, L. B. Ousager1,2 1CenterofGenomicMedicineinVictorBabesUniversityof 1Department of Clinical Genetics, Odense University Medicine and Pharmacy, Timisoara, Romania, 2Depart- Hospital, Odense, Denmark, 2Department of Clinical ment of Medical Genetics, Louis Turcanu Emergency Research, University of Southern Denmark, Odense, Den- Hospital for Children, Timișoara, Romania, 3Functional mark, 3Department of Clinical Genetics, Aarhus University Sciences Department, University of Medicine and Phar- Hospital, Aarhus, Denmark, 4Department of Dermatology macy Victor Babes, Timișoara, Romania and Allergy Centre, Odense University Hospital, Odense, Denmark Introduction: Genetic skeletal disorders(GSD) represent a heterogeneous and large group, widening the more the Introduction: Mal de Meleda (MDM) is an autosomal sequencing technology thrives. We aim to contribute by recessive disorder characterized by transgredient hyperker- describing the regional Romanian cohort of patients with atosis and erythema of palms and soles with well-demar- GSD and their molecular features. cated borders. There might also be symptoms as Methods: The clinical workup was performed for each hyperhidrosis, macerations and malodour due to secondary affectedindividual.NGSwas performed using theIllumina bacterial infections. Associated perioral erythema, brachy- TruSight One (4813 genes) and TruSight Cardio (174 dactyly, scaly plaques on elbows and knees as well as nail genes) Sequencing Panels on MiSeq Illumina platform, as dystrophy has also been described. The disease presents by amplicon-based approach, but also PCR and Sanger early in childhood and has a progressive cause. MDM is were used. associated with variants in SLUR P1
. The HGMD database Results and discussions: 110 patients with GSD includes 23 different variants in SLUR P1
 related to MDM phenotypic component addressed the Genetics department or palmoplantar keratoderma. (July 2015–December 2019). 54.55% had conﬁrmed Material & methods: A 4-year-old boy presented with diagnosis, while 30.9% were tested negative for the anapproximatelytwo-yearhistoryoferythema,scalingand suspected disorder and 14.55% were not tested. 10% were diffuse, yellowish, transgredient keratoderma of palms and found with variants of uncertain signiﬁcance, needing soles.Hehadassociatedinterdigitalmacerations,dystrophia further testing. According to the Mortier’s et al. 2019 ofseveralnailsandrecurrentfungalandbacterialinfections. revision of nosology and classiﬁcation of GSD, we have He was born as the second child of non-consanguineous foundthefollowingcategoriesofdisorders:25%ofpatients parents and there was no family history of similar skin with overgrowth syndromes with skeletal involvement disease. The parents were from families living in different (Marfan, Loeys-Dietz, Congenital contractural arachnodac- regionsofDenmark.Genetictestingwasperformedusinga tyly), 10% with lysosomal storage diseases with skeletal next-generation sequencing-based gene panel targeting 28 involvement (Mucopolysaccharidosis), 5% with Limb genes related to palmoplantar keratoderma. hypoplasia–reduction defects group (Fanconi anemia and Results: A homozygous nonsense variant was identiﬁed Cornelia de Lange), 4% with Osteogenesis imperfecta and in SLUR P1
 (c.259del, p.(Ala87Profs*4)). The variant, decreased bone density, 2% with Brachydactylies with predicted to result in a premature stop codon, has not extraskeletal manifestations (Cofﬁn Siris) and unique previously been reported. A more distal frameshift variant patients in other several disorders like Spondyloperipheral has, however, been reported as disease-causing supporting dysplasia, Atelosteogenesis type 3, Chondroectodermal interpretation of the variant as likely pathogenic. The dysplasia, Asphyxiating thoracic dysplasia, etc. parents were heterozygous for the variant. Conclusion: Skeletal disorders are rare entities needing Conclusion: We identiﬁed a novel homozygous variant proﬁcient clinical and imagistic workup to reach diagnosis. in SLUR P1
 in a Caucasian boy with MDM, who was born We provide our Center’s diagnostic yields in GSD together to non-consanguineous parents. withparticularitiesanddiscussionsonourcohortofpatients. S.B. Gram: None. J. Blechingberg: None. K. Brusgaard: I.E.Jurca-Simina:D.SpeakersBureau/Honoraria(speak- None. A. Bygum: None. L.B. Ousager: None. ers bureau, symposia, and expert witness); Modest; Sanoﬁ. Other; Modest; Sanoﬁ, Takeda. A. Chirita-Emandi: Other;Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 841 Modest; Sanoﬁ, Takeda. N. Andreescu: Other; Modest; E- P04
.51 Sanoﬁ, Takeda. C.L. Șerban: None. C. Zimbru: None. M. Further clinical and molecular delineation of spondylo- Puiu: Other; Modest; Sanoﬁ, Takeda. costal dysostosis type 3 E- P04
.50 S. L. Schuhmann1, H. Koller2, H. Sticht3, C. Kraus1, M. A case report of a patient diagnosed with two skeletal Krumbiegel1, S. Uebe1, A. Ekici1, A. Reis1, C. T. Thiel1 dysplasias: osteogenesis imperfecta and pseudoachondroplasia 1Institute of Human Genetics, Friedrich-Alexander-Univer- sität Erlangen-Nürnberg FAU, Erlangen, Germany, 2Klini- L. Kievisiene1, M. Sukys1, R. Traberg1, R. Simonaityte2, kum rechts der Isar, Technische Universität München, V. Asmoniene1 Munich, Germany, 3Institute of Biochemistry, Friedrich- Alexander-Universität Erlangen-Nürnberg FAU, Erlangen, 1Department of Genetics and Molecular Medicine, Lithua- Germany nian University of Health Sciences, Kaunas, Lithuania, 2DepartmentofPediatricSurgery,LithuanianUniversityof Spondylocostal dysostosis (SCDO) is a heterogeneous Health Sciences, Kaunas, Lithuania group of rare spine disorders deﬁned by multiple vertebral segmentation defects and rib anomalies. Patients present Wepresentacasereportofa7yearsoldboy,theonlychild with shortenedtrunk inproportion toheightand signiﬁcant born to a man with osteogenesis imperfecta (OI) and a scoliosis. Seven subtypes of SCDO have been identiﬁed woman suspected to have pseudoachondroplasia, later on based on deleterious variants in one affected gene each conﬁrmed to have COMP gene pathogenic heterozygous (DL L3
, MES P2
, LFNG, HE S7
, TBX6, RIPPLY2, DMRT2), variant(c.1393G>C,p.Gly465Arg).Sincebirth,patienthad of mostly autosomal recessive inheritance. Most subtypes seven spontaneous fractures, predominantly in the lower include only few cases, like SCDO3 (LFNG) where only limbs. At the age of seven the patient exhibited dis- two affected individuals are reported to date with a total of proportionately short-limb short stature with height mea- three variants. sured96cm;<3rdpercentile.Thepatienthadbrachydactyly Inalargestudyongeneticcausesofskeletaldysplasiawe and ligamentous laxity with deformity of the lower limbs. recognized a 17-year-old individual from healthy consan- He also had characteristic radiological changes of pseu- guineous parents with severe vertebral segmentation doachondroplasia: short tubular bones with widened and defects, rib and further non skeletal anomalies including deformedmetaphysesandvertebralanomalies.Dualenergy solitary pelvic kidney, uterine dysgenesis, absence epilepsy x-rayabsorptiometrydetectedosteoporosis.Nextgeneration and inner ear deafness. Performing WES we identiﬁed a sequencing was performed for the patient, OI genes and homozygous missense variant c.59C>T, p.(Thr20Ile) in COMP gene known familial variant were analysed. It con- LFNG,neitherpreviouslydescribedinSCDO3patients,nor ﬁrmed the same pathogenic variant of COMP gene and in listedingeneticdatabases.Bothparentswereheterozygous. CO L1
A2 gene two heterozygous variants were found The variant is predicted to destabilize a hydrogen bond (c.2317C>T, p.Pro773Ser and c.2329_2331delCGT, p. leading to an impairment of protein function, likewise Arg777del). The former was considered to be variant of previously described variants inactivating the protein with uncertain signiﬁcance because in silico predictors assessed altered Notch signaling. it as benign, while the latter was assigned to be likely While the two previously reported cases had isolated pathogenic because computational predictors assessed it as skeletal anomalies the here reported individual presented pathogenic. None of these variants were described in with various additional symptoms. As no other variants populationdatabases.BothofCO L1
A2variantswerefound were identiﬁed neither in the exome nor in CMA we in father’s CO L1
A2 gene, meaning that they locate in the hypothesize that the phenotypic spectrum of this syndrome same allele.It remains unclearif these variants are disease- canbemuchbroader,perhapsdependingonthelocalization causing since neither of fathers’ family members were and nature of the affected variant, although we cannot affected with OI. Therefore, further sequencing of father’s exclude a blended phenotype due to an undetected ﬁrst-degreefamilymemberswillbeperformedtoconﬁrmif additional variant. these variants are truly de novo. S.L. Schuhmann: None. H. Koller: None. H. Sticht: L.Kievisiene:None.M.Sukys:None.R.Traberg:None. None. C. Kraus: None. M. Krumbiegel: None. S. Uebe: R. Simonaityte: None. V. Asmoniene: None. None. A. Ekici: None. A. Reis: None. C.T. Thiel: None.842 J.delPicchia E- P04
.52 M. van den Born1, M. Joosten1, P. Schut1, J. Cornette1, First reported case of Steel syndrome in the European A. van der Hout2, G. Mortier3 population: a novel homozygous mutation in CO L27
A1 1Erasmus MC, Rotterdam, Netherlands, 2University Medi- E. Kritioti1,2,3, A. Theodosiou1, N. Nicolaou2, A. calCentreGroningen,Groningen,Netherlands,3University Alexandrou1, I. Papaevripidou1, E. Efstathiou4, V. of Antwerp, Antwerp, Belgium Christophidou-Anastasiadou5, C. Sismani1,3, G. A. Tanteles2 Todiagnoseaspeciﬁclethalskeletaldysplasiapurelybased on ultrasound data can be quite challenging in a prenatal 1Cytogenetics and Genomics Department, The Cyprus setting. However, molecular testing of fetal DNA in com- Institute of Neurology and Genetics, Nicosia, Cyprus, bination with radiographic evaluation and autopsy post- 2Clinical Genetics Department, The Cyprus Institute of delivery usually allows the clinician to come up with a Neurology and Genetics, Nicosia, Cyprus, 3The Cyprus speciﬁcdiagnosis.Wereportacaseofplatyspondyliclethal School of Molecular Medicine, The Cyprus Institute of skeletal dysplasia, Torrance type (PLSD-T) that was initi- Neurology and Genetics, Nicosia, Cyprus, 4Pediatric ally diagnosed as achondrogenesis type 1A. Advanced Department, Larnaca General Hospital, Larnaca, Cyprus, ultrasound at 20 weeks of gestation showed, in addition to 5Clinical Genetics Department, Archbishop Makarios III generalizededema,shortenedandcurvedlongboneswitha Medical Centre, Nicosia, Cyprus thoracic–ACratioof0.68.At29weeksofgestation amale neonate was born who died directly after birth. Achon- Steel syndrome is an autosomal recessive disorder that drogenesis type 1A was initially suggested based on the primarily affects the skeletal system causing a variety of ultrasound abnormalities and clinical examination post- manifestations. Sixteen individuals with Steel syndrome, natally. Radiographs showed skeletal abnormalities remi- mainly Puerto Ricans (11/16), were previously reported to niscentofachondrogenesistype1A:severemicromeliawith carry bi-allelic mutations in the CO L27
A1 gene. Here, we ﬂared and cupped metaphyses, relatively large head, short present the ﬁrst patient with Steel syndrome in Europe and ilia and delayed vertebrae ossiﬁcation. All genes (TRI P11
, the sixth non-Puerto Rican carrying a novel homozygous SL C26
A2 and CO L2
A1) causing the different forms of mutationinCO L27
A1.Thepatientisa4-year-oldboyborn achondrogenesis (IA;IB;II) were sequenced. In TRI P11
, to non-consanguineous healthy parents, with dysmorphic only heterozygosity for a class 3 variant was identiﬁed and facial features, absent hip ossiﬁcation centres, external no variant could be identiﬁed on the other allele. However, rotation of both feet, relatively short stature, mild skin aclass4variantp.(lle1389dup),inCO L2
A1wasidentiﬁed syndactyly, short mid phalanges and bilateral sensorineural in the portion coding for the C-propeptide of type II col- hearing loss. Whole exome sequencing (WES) revealed a lagen. This ﬁnding led to the diagnosis of PLSD-Torrance novel homozygous missense variant [chr9.hg:19: type. This case demonstrates the phenotypical overlap g.116982108G>A; c.2409G>A; p.(Gly802Glu)] in between achondrogenesis type 1A and Torrance dysplasia. CO L27
A1(NM_032888.4).Thehomozygousmutationwas M. van den Born: None. M. Joosten: None. P. Schut: conﬁrmed by Sanger sequencinginthe proband and carrier None. J. Cornette: None. A. van der Hout: None. G. status was conﬁrmed in both parents and his unaffected Mortier: None. sibling. According to online and in-house minor allele fre- quency (MAF) databases, this is the ﬁrst CO L27
A1 muta- E- P04
.55 tion reported in the European population. Additional Novel variant in the EZH2 gene causing Weaver screening of healthy Greek-Cypriot individuals was thus syndrome performed, which did not reveal any additional carriers in the population for the variant in question. E. M. Vaiteniene1, L. Cimbalistiene1,2, G. Zukauskaite1, E. Kritioti: None. A. Theodosiou: None. N. Nicolaou: A. Utkus1 None. A. Alexandrou: None. I. Papaevripidou: None. E. Efstathiou:None.V.Christophidou-Anastasiadou:None.C. 1Department of Human and Medical Genetics, Institute of Sismani: None. G.A. Tanteles: None. Biomedical Sciences, Faculty of Medicine, Vilnius Uni- E- P04
.53 versity, Vilnius, Lithuania, 2Centre for Medical Genetics, Platyspondylic dysplasia, Torrance type resembling Vilnius University Hospital Santaros Klinikos, Vilnius, achondrogenesis type 1A LithuaniaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 843 Background: Overgrowth syndromes frequently share Obstetrics and Gynaecology, Erasmus MC, University overlapping manifestations and are difﬁcult to diagnose Medical Center Rotterdam, Rotterdam, Netherlands based on clinical features. Accurate diagnosis is important for prognosis and correct tumour surveillance program and Introduction: X-linked dominant chondrodysplasia punc- can be achieved with next-generation sequencing. tata (CDPX2) is an inherited condition present almost Results: A 4-year-old girl presenting with excessive exclusively in females, characterized by skeletal dysplasia, growthofprenatalonset,advancedboneage,macrocephaly, skin defects and congenital cataracts and caused byheter- development delay, intellectual disability, generalized sei- ozygous pathogenic variants in the EBP gene. Prenatal zuresandpeculiarfacewasreferredtoourclinic.Shewasa ultrasound diagnosis has been reported in some cases after third child in a healthy non-consanguineous family, born detection of asymmetric shortening of the long bones with prematurely at36weeksgestationwith birthweight3100 g cartilagestippling,representingfociofcalciﬁcation,usually and height 58 cm. Her karyotype revealed interstitial in the second trimester of pregnancy. inversion46,XX,inv(X)(p22;q28)whichwasinheritedfrom Materials and methods: A female fetus was diagnosed herhealthymother.Nopathogenicvariantswereobservedin with asymmetric bilateral short long bones and stippling of theNSD1gene.Attheageof22years,herheightis195cm, theproximalepiphysesofthehumerusbyprenatalultrasound weight140kg;limitedshoulder,elbowandwristmovement, examinationat21weeksofgestation.Absenceofnasalbones kyphosis, hypertrophic soft tissue around knees were wasalsoobservedpreviouslyat13weeks.Amniocentesiswas observed besides previously mentioned features. Her IQ performed for molecular analysis through array CGH and a score is 40. Next-generation sequencing for known over- 531 genes NGS panel for skeletal dysplasia. The pregnancy growth conditions revealed a novel missense heterozygous was terminated at 23weeks of gestation. Fetal gross EZH2 mutation c.373G>A (NM_004456.4:c.[373G>A]; examination, postnatal X-rays and steroid chromatography [373=], NP_004447.2:p.(Glu125Lys) within exon 5. Based in amniotic liquid were performed to assist in the diagnosis. on 11 in silico tools of pathogenicity prediction detected Results:TheNGSskeletaldysplasiapanelidentiﬁedade variant was characterized as pathogenic. In addition to the novo heterozygous missense variant c.388G>A p. typical ﬁndings of Weaver syndrome, our patient has (Gly130Arg), in the EBP gene. This variant was not polythelia, atrial septal defect and lumbar spinal stenosis. reportedintheliteraturenoringnomADorotherdatabases Conclusion: An increasing number of diagnoses with and in silico analysis predicts it as likely pathogenic. next-generation sequencing helps to gather more phenoty- Conclusions: To our knowledge this is a novel EBP pic information, improve management and surveillance of pathogenic variant, albeit missense variants changing the overgrowth syndromes. This example also highlights the same Gly130 have been previously associated to CDPX2. importance of periodic case reviews for patients not CDPX2 should be a diagnosis to bear in mind when short diagnosed on initial testing as more information becomes fetal long bones and stippling are present in second available in the medical literature. trimester of pregnancy. E.M. Vaiteniene: None. L. Cimbalistiene: None. G. M.N. Laço: None. M. Branco: None. M. Joosten: None. Zukauskaite: None. A. Utkus: None. P. DeKoninck: None. E. Galhano: None. F. Ramos: None. E- P04
.56 E- P05
 Cardiovascular Disorders Novel pathogenic variant inEBPgene is associated to X-linked dominant chondrodysplasia punctata in a E- P05
.01 female fetus. A new missense variant in ABCA1 gene, p.Ala2058Gly, in a myocardial infarction patient. M. N. Laço1,2,3, M. Branco4, M. Joosten5, P. DeKoninck6, E. Galhano4, F. Ramos1,4 R. Pan-Lizcano1, L. Nunez1, P. Pinon2, X. Flores2, G. Aldama2, R. Calvino2, N. Blanco-Menendez1, 1Medical Genetics Unit, Hospital Pediátrico, Centro N. Vazquez-Gonzalez3, J. M. Vazquez-Rodriguez3, HospitalareUniversitáriodeCoimbra,Coimbra,Portugal, M. Hermida-Prieto1 2Faculty of Medicine, University of Coimbra, Coimbra, Portugal, 3Faculty of Health Sciences, University of Beira 1Cardiology Research Group. Instituto de Investigación Interior, Covilhã, Portugal, 4Prenatal Diagnosis Center, Biomédica de A Coruña (INIBIC)-CHUAC-UDC, A Maternidade Bissaya Barreto, Centro Hospitalar e Uni- Coruña, Spain, 2Department of Cardiology, Complexo versitário de Coimbra, Coimbra, Portugal, 5Department of Hospitalario Universitario A Coruna (CHUAC)-INIBIC, A ClinicalGenetics,ErasmusMC,UniversityMedicalCenter Coruña, Spain, A Coruña, Spain, 3Department of Cardiol- Rotterdam, Rotterdam, Netherlands, 6Department of ogy, Complexo Hospitalario Universitario de A Coruña844 J.delPicchia (CHUAC)-CIBERCV, Instituto de Investigación Biomédica deACoruña(INIBIC),UniversidaddeACoruña(UDC),A Many ACTA2 missense variants are associated with Coruña, Spain aortic dissection but their role is still controversial. We describe a 53 year old male proband with a history of Background: Acute myocardial infarction (AMI) is a sudden death (maternal grandmother) and thoracic aortic complex multifactorial and polygenic disorder that leads aneurysminthefather.Theprobandbicycled regularlyand the causes of death in Western societies. However, experiencedabortedcardiacarrestattheageof52duringa the understanding of the genetic contribution to ischemic normal daylight activity. ECG showed transient ischemic heart diseases is very limited. It has been suggested that patterns with increased troponin-T values. A CT scan variants in genes related to pathways involved in athero- demonstratedatypeAaorticdissection(AD)notinvolving thrombosis could increase the risk of development cardiac coronary arteries, surgically corrected without complica- events. tions. During the follow up, occasional seizures were Methods: Genetic variants in 24 genes which encoded observed,successfullytreatedwithLevetiracetam.Ajmaline proteins related to pathways involved in atherothrombosis challengetestresultednegative,noarterialtortuosityneither wereanalyzedbynextgenerationsequencingin24patients signs of intracranial vessel involvement have been demon- with AMI. Mutation found was conﬁrmed by Sanger strated byAngio MRI.Theproband wasstudiedwith NGS sequencing.Visualizationofthemutationusingpdbviewer including panels for Brugada syndrome, LQTS and AD and in silico prediction of the effects produced by the genes. Only the c.1004C>T (p.Pro335Leu) heterozygous mutation(MutationTester,SNA P2
,SIFT2,Polyphen,PhD- missense variant in the ACTA2 gene was found. Proband’s SNP) were performed. only daughter is asymptomatic, negative at clinical eva- Results: In one patient, p.Ala2058Gly was identiﬁed in luation and does not carry the paternal variant. No other ABCA1 gene that encodes the ATP-binding cassette relatives are available to date. The c.1004C>T (p.Pro335- transporter 1, which is crucial in the initial step of high- Leu)intheACTA2geneispredictedtobe“pathogenic”by density lipoprotein (HDL) formation and in reverse several bioinformatics tools, but to date its clinical sig- cholesterol transport. All the in silico tools used suggested niﬁcance is still uncertain. This case suggests the impor- a pathological role of this variant. tance to consider clinical history in VUS evaluation for Conclusion: Our results are in concordance with speciﬁc conditions. Further studies are required to clarify previously reports that associated different variants in the role of ACTA2 missense variants in type A aortic ABCA1 gene with an increased risk of coronary artery dissections. disease and ischemic heart disease. Thus, mutations E.Micaglio:None.S.Benedetti:None.S.Marelli:None. in ABCA1 gene could have a role in the development of A.G.Pini:None.R.Cotugno:None.M.M.Monasky:None. AMI. Funding Acknowledgements: This work was G. Ciconte: None. P. Carrera: None. C. Pappone: None. supported by a grant from Instituto de Salud Carlos III (PI18/01737) and a non-conditional grant from Abbott E- P05
.03 Vascular. Molecular diagnosis of primary hypoalphalipoproteine- R. Pan-Lizcano: None. L. Nunez: None. P. Pinon: None. mia disease by Next Generation Sequencing X. Flores: None. G. Aldama: None. R. Calvino: None. N. Blanco-Menendez: None. N. Vazquez-Gonzalez: None. J. E. Sevilla, C. Rodríguez Jiménez, J. Sanguino, A. Carazo, M. Vazquez-Rodriguez: None. M. Hermida-Prieto: None. V. Fernández-Montaño, I. Rueda-Arenas, F. Arrieta, S. Rodríguez-Nóvoa E- P05
.02 VUS or non VUS in ACTA2? INGEMM, Madrid, Spain E. Micaglio1, S. Benedetti2, S. Marelli3, A. G. Pini3, Introduction: Hypoalphalipoproteinemia primary 2 (# R.Cotugno1,M.M.Monasky1,G.Ciconte1,P.Carrera2,C. 618463), is generally an autosomal recessive disorder Pappone1 associatedwithextremelylowlevelsofapoA-IandHDL-C in serum and, in most of the patients, premature athero- 1Arrhythmology and Clinical Electrophysiology, IRCCS sclerotic cardiovascular disease, xanthomas and corneal Policlinico San Donato, San Donato Milanese, Italy, opacities1.Currently,30familieshavebeendescribed.This 2Laboratory of Clinical Molecular Biology and Cytoge- disease is caused by pathogenic variants in APOA1 gene netics, IRCCS Ospedale San Raffaele, Milan, Italy, 3Car- (MIM107680)thatcodefortheApolipoproteinA-I(apoA- diovascular Genetics, IRCCS Policlinico San Donato, San I), the major structural component of HDL. Herein we Donato Milanese, ItalyAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 845 report a case of a male with suspicious of METABOL-v2 of 411 genes. LDL isolated from patient hypoalphalipoproteinemia. and the control were incubated with HepG2 cells. Uptake Materials and methods: A 58-year-old woman with and binding were measured by ﬂow cytometry in order to xanthomas, corneal clouding and familial history of determine the impact of APOB variant. isquemic cardiopathy, was remitted to our service for Results: A variant of unknown signiﬁcance (VUS) was genetic testing. The patient had extremely low levels of found in APOB_exon26_ NM_000384.2:c.11401T>A;p. apoA-I (<16.0 mg/dL) and HDL-C (6 mg/dL) in serum. (Ser3801Thr) in silico study showed damaging and Genesinvolvedincholesterolmetabolismwereanalyzedby conservation. However the LDL isolated of patient had NextGenerationSequence(NGS)usingacustomizedpanel thesame impact inuptake andbinding inLDLR ofHepG2 of 411 genes related with metabolic diseases. cells that the LDL isolated of control. Results: The frameshift mutation APOA1_NM_ Conclusions: This variant had conﬂict in the interpreta- 000039.2:c.85dupC;p.(Gln29Profs*29)wasfoundinhomo- tion of results in ClinVar has been classiﬁed as benign and zygosis in the patient resulting a truncated apoA-I. In as VUS. It is well known that exon 26 is critical in folding silico analysis showed damaging and conservation for this of APOB protein also, in silico analysis reﬂected impact in variant. Sanger sequencing conﬁrmed the variant found the variant. The functional characterization of variant in in APOA1. APOB has allowed us to classify it as benign avoiding the Conclusions: This variant c.85dupC;p.(Gln29Profs*29) “uncertain signiﬁcance”. has been previously described as a cause of ApoA1 References deﬁciency2. ApoA-I deﬁciency is generally associated with 1-Miserez,A.R.andKeller,U.(1995)Differencesinthe markedly increased risk of atherosclerotic cardiovascular phenotypic characteristics of subjects with familial defec- disease.However,inthisstudyweidentiﬁedahomozygous tive apolipoprotein B-100 and familial-hypercholesterole- frameshift mutation of the APOA1 gene as the molecular mia. Arterioscler. Thromb. Vasc. Biol, basis of apoA-I deﬁciency ina 58-year-old womanwithout C. Rodriguez Jimenez: None. D. Gómez-Coronado: isquemic cardiopathy. A familiar study would be required None. J. Sanguino: None. E. Sevilla: None. A. Carazo: for a better understanding of this rare disease-causing None. N. Gallego-Onís: None. V. Gómez del Pozo: None. mutation. F. Arrieta: None. S. Rodríguez-Nóvoa: None. E. Sevilla: None. C. Rodríguez Jiménez: None. J. Sanguino: None. A. Carazo: None. V. Fernández- E- P05
.05 Montaño: None. I. Rueda-Arenas: None. F. Arrieta: None. Phenotype-genotypecorrelationinRussianpatientswith S. Rodríguez-Nóvoa: None. arrhythmogenic right ventricular cardiomyopathy E- P05
.04 A. Shestak1, A. Bukaeva1, O. Blagova2, Y. Lutokhina2, Study functional in APOB in HepG2 from patient with M. Polyak1, S. Dzemeshkevich1, E. Zaklyazminskaya1 Familial Hypercholesterolemia. 1Petrovsky National Research Center of Surgery, Moscow, C. Rodriguez Jimenez1, D. Gómez-Coronado2, Russian Federation, 2The Department of Cardiology of the J. Sanguino1, E. Sevilla1, A. Carazo1, N. Gallego-Onís1, V.N. Vinogradov Faculty therapeutic clinic, I.M. Sechenov V. Gómez del Pozo1, F. Arrieta1, S. Rodríguez-Nóvoa1 First Moscow State Medical University, Moscow, Russian Federation 1INGEMM, Madrid, Spain, 2Hospital Ramón y Cajal, Madrid, Spain Arrhythmogenic right ventricular cardiomyopathy (ARVС) is an inherited disease leading to ﬁbro-fatty Introduction: Familial defective apoB100 (FCH L2
, # replacement of right ventricle and sudden cardiac death. 144010) is a genetic disorder of LDL metabolism char- Identiﬁcation of mutation(s) in causative genes is one of acterized by hypercholesterolemia and premature athero- themajordiagnosticcriteriaofARVC.Methods:Clinical, sclerosis. FCHL is caused by heterozygous mutation in the instrumental examination, medical and genetic counseling APOB gene. APOB is the ligand for the LDLreceptor and wereperformedfor70ARVCprobands(meanage41,9y. there are some essential residues that are decisive for the o.). Screening of 16 genes was performed by high- APOB-LDL receptor afﬁnity1. throughput semiconductor sequencing combined with Materials and methods: A 56-year-old man with raised Sanger sequencing. Potential role of genetic variants was levels of LDL-c in serum, with family history and evaluated according to ACMG criteria. Mutational spec- premature coronary artery disease. The DNA sample from trumofdesmosomalandnon-desmosomalgenesinARVC patient was analysed by NGS using a customized panel probandswasstudiedincomparisonwithcontrolgroupof846 J.delPicchia 46 DCM probands. Results: Deﬁnite, borderline or pos- respectively.TheACEIDandMTHFR C677
Tpolymorph- sibleARVCdiagnosisbasedontheTaskForceCriteriaof isms were genotyped using PCR based methods. Statistical 2010 was established for 70 probands. Some patients in tests were conducted with StatsDirect. The signiﬁcance of our cohort had signs of dilated/restrictive cardiomyopathy the differences in observed frequencies of polymorphisms (N=17), LVNC (N=10), BrS patterns (N=4). Likely was assessed by chi-squared test (p<0.05). The distribution pathogenic genetic variants and VUCSes were identiﬁed of the genotypes in all lots respects Hardy Weinberg in46%ofARVCprobandsindesmosomal(PK P2
,DSG2, equilibrium condition. DSP, DS C2
, JUP) and non-desmosomal (LMNA, SCN5A, Results: Signiﬁcant associations were detected between MYH7, MYBP C3
, TTN, FLNC, LDB3) genes. Mutational HA and the ACE DD (OR=1.44, p=0.0007) and MTHFR spectrum of genes in ARVC probands with a pre- TT (OR=1.46, p=0.0009). The ACE D allele was dominance of variants in desmosomal genes (64%) was associated with earlier onset of AH in patients with AH different from one in the DCM control group. (p=0.00005). ACE DD (OR=1.88, p=0.0006), ACE D Genetic variants in non-desmosomal genes prevailed in (OR=1.92, p<0.0001), and MTHFR TT (OR=2.28, patients with ARVC overlapping phenotypes. Conclu- p<0.0001) were signiﬁcantly associated with AH among sion: Likely pathogenic genetic variants and VUCSes subjects whose parents also have AH. Smoking subjects were identiﬁed in 46% of ARVC probands. Identiﬁcation with MTHFR TT genotype (OR=1.68, p=0.0004) and of mutations in desmosomal and non-desmosomal genes those heterozygous (OR=1.46, p=0.0002) or homozygous in addition to the deep phenotyping results allowed us to (OR=1.62,p=0.0005)forACEDpresentedhigherriskfor study the genetic heterogeneity of ARVC. This work was AH. ACE DD and alcohol consumption predispose to AH supported by Russian Science Foundation grant №16-15- (OR=5.6, p=0.0004). 10421. Conclusions:ThisstudysuggeststhatACEandMTHFR A.Shestak:None.A.Bukaeva:None.O.Blagova:None. genes are associated with AH in the studied population. Y. Lutokhina: None. M. Polyak: None. S. Dzemeshkevich: C. Barbarosie: None. R. Nica: None. O. Aparcioaie: None. E. Zaklyazminskaya: None. None. A. Duca: None. P. Apostol: None. O. Alexiu-Toma: None.I.Radu:None.R.Sionel:None.M.Toma:None.D. E- P05
.06 Cimponeriu: None. S. Nica: None. Testing the association between ACE ID and MTHFR  C667
T gene polymorphisms and arterial hypertension E- P05
.08 in the Caucasian population A novel EMD mutation in patient with dilated cardiomyopathy C. Barbarosie1, R. Nica2, O. Aparcioaie1, A. Duca1, P. Apostol3, O. Alexiu-Toma1, I. Radu1, R. Sionel1, L.Piherova1,P.Melenovska1,V.Baresova1,J.Sovova1,D. M. Toma2, D. Cimponeriu1, S. Nica4 Musalkova1, J. Sikora1, H. Hartmannova1, K. Hodanova1, T. Schimerova2, M. Kubanek2, S. Kmoch1 1Faculty of Biology, University of Bucharest, Bucharest, Romania,2CentralMilitaryUniversityEmergencyHospital 1RURD, Prague 2, Czech Republic, 2IKEM, Prague 4, "Dr. Carol Davila", Bucharest, Romania, 3Genetic Expert Czech Republic Center, Sante Clinic, Bucharest, Romania, Bucharest, Romania, 4Bucharest Emergency University Hospital, Emery-Dreifus muscular dystrophy is an inherited degen- Bucharest, Romania erative myopathy. One of the earliest manifestation of this disorders are muscle contractures causing joint deformities. Introduction: Genetic polymorphisms of various genes Almost all patients with Emery-Dreifuss muscular dystro- play a signiﬁcant role in the predisposition for arterial phy develop abnormalities in heart rhythm, such as atrial hypertension(AH).Therelationbetweenseveralgenes and ﬁbrillation, bradycardia, syncope, heart failure or an AH have been investigated in different populations but increased risk of sudden death. Among Emery-Dreifuss X- results were inconsistent and inconclusive. The aim of this linkedmyopathybelongsdegenerativemyopathycausedby study was to evaluate whether polymorphisms in two can- mutation in EMD gene. Emerin is a member of the nuclear didate genes are associated with AH in Romania’s adult lamina-associated protein family and with other proteins Caucasian population. takes part in membrane anchorage to the cytoskeleton. Materials and methods: We analysed data from 1660 Emerin is a serine-rich protein and composed of three unrelated Romanian Caucasian subjects (835 with AH and domains: nucleoplasmic domain, transmembrane domain 825 normotensive). The average age of the hypertensive and short lumenal domain. More than 100 mutations are patients and controls were 54.66±4.30 and 47.73±4.05, known in EMD gene but only one in lumenal domain. WeAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 847 present a patient diagnosed with Emery-Dreifuss muscular berelatedtoMI.Polymorphismsinthoseclockgenesmight dystrophyanddilatedcardiomyopathycausedbynewEMD beanadditionalriskfactorformyocardial infarction.Grant gene mutation at the luminal domain and its biological no. FDMZ-2019-I P8
 consequences. LM201509 NCLG, AZV 15-27682A, SVV- I. Škrlec: None. J. Milić: None. R. Steiner: None. 260367, NV19-08-00122 L. Piherova: None. P. Melenovska: None. V. Baresova: E- P05
.12 None. J. Sovova: None. D. Musalkova: None. J. Sikora: Genetic components of congenital heart defects in None. H. Hartmannova: None. K. Hodanova: None. T. children Schimerova: None. M. Kubanek: None. S. Kmoch: None. V. Galagan1,2, A. Dorokhina2,1, M. Tsyhankova1, E- P05
.10 S. Kulbalaieva1, Y. Dudierina2, V. Samilyk2 The inﬂuence of the circadian genes CLOCK and ARNTL on myocardial infarction 1National children’s specialized hospital «OKHMATDYT» of Ministry of Health of Ukraine, The Center of Medical I. Škrlec1, J. Milić2, R. Steiner3,2 Genetics, Kyiv, Ukraine, 2O.O. Bogomolets’ National Medical University, Kyiv, Ukraine 1Hystology, Genetics, Cellular and Molecular Biology Laboratory, Faculty of Dental Medicine and Health, Josip Introduction:Amongcongenitalmalformationsinchildren Juraj Strossmayer University of Osijek, Osijek, Croatia, thegreatestnumberistakenbydefectsofthecardiovascular 2Faculty of Medicine Osijek, Josip Juraj Strossmayer system. According to Ukrainian and foreign researchers, University of Osijek, Osijek, Croatia, 3Clinical Department congenital heart defects (CHD) occur at an average fre- of Cardiovascular Diseases and Intensive Care, Clinic for quency of 59-60 per 10000 newborns. The purpose of this Internal Medicine, University Hospital Osijek, Osijek, study was to determine the frequency ofCHD in newborns Croatia and genetic components of this pathology in Kyiv. Materials and methods: The following methods were Introduction: The circadian rhythm regulates various used in this work: clinical-genealogical, cytogenetic physiological mechanisms, and its disruption can promote including cytomolecular (FISH), biochemical (TMS) and manydisorders.Manycardiovasculareventsshowmorning conventional clinical and instrumental methods. circadian preferences, such as myocardial infarction (MI), Results:ThefrequencyofisolatedCHDinnewbornswas dissection of aortic aneurysms, and stroke. Disturbance of determined based on medical-genetic counseling (MGC) endogenous circadian rhythms enhances the chance of MI, practice at the Specialized Center of Medical Genetics in showing that circadian clock genes could have a crucial Kyiv.In2018thefrequencywas90per10000livebirths,in functionintheonsetofthedisease.Itwashypothesizedthat 2019- 93 per 10000. All cases were conﬁrmed by the polymorphisms of one nucleotide (SNP) in two circa- cardiologist-ultrasound-diagnostics at specialized cardiac dian rhythm genes (CLOCK and ARNTL) could be asso- centers and maternity hospitals. During the study period ciated with MI. (2018-2019) the weighted percentage of an isolated CHD Materials and methods: This case-control study was was 53% among all congenital malformations in live births performed on 1057 participants. The sample included 431 in Kyiv. Analysis of genetic components including patients (243 males, 188 females) of Croatian origin with syndromes of various forms of the CHD (2018-2019), ﬁrst non-fatal acute myocardial infarction and 626 participants discovered during MGC, showed that the causes of the inthecontrolgroupwithoutMI.ThreeSNPswereanalyzed CHD were due to chromosomal pathology- 52%, isolated in CLOCK (rs13124436, rs6811520, and rs11932595), and forms- 24%, genetic pathology- 13%, undifferentiated three in the ARNTL gene (rs12363415, rs4757144, and multiple malformations- 11%. rs3789327). Conclusions: Every child with a validated form of the Results:Statisticallysigniﬁcantdifferences,estimatedby CHD should pass the MGC and screening at a specialized the chi-square test, were found in the distribution of alleles genetic institution to eliminate syndromal forms, calculate and genotypes between MI and no-MI groups of the various genetic risks for the family and prevent them. The CLOCK (rs6811520 and rs13124436) and ARNTL mean frequency of isolated CHD in newborns is 92 per (rs3789327 and rs12363415) genes. Some of the tested 10000 in Kyiv. SNPswereassociatedwithcardiovascularriskfactorsinMI V.Galagan:None.A.Dorokhina:None.M.Tsyhankova: patients. None. S. Kulbalaieva: None. Y. Dudierina: None. V. Conclusion:Accordingtotheresultsofthepresentstudy, Samilyk: None. thepolymorphismsintheCLOCKandARNTLgenescould848 J.delPicchia E- P05
.15 Hadjidekova1,S.Mehrabian5,M.Petrova5,L.Traykov5,D. Genomicmarkersinthedeterminationoflong-termrisk Toncheva1,2 in patients with stable angina undergoing coronary bypass surgery 1Department of Medical Genetics, Medical University of Soﬁa, Soﬁa, Bulgaria, 2Gynecology and assisted reproduc- A. Ponasenko, M. Sinitsky, A. Tsepokina, M. Asanov, tion hospital “Malinov”, Soﬁa, Bulgaria, 3Department of O. Barbarash Biology, Medical genetics and Microbiology, Faculty of Medicine, Soﬁa University “St. Kliment Ohridski”, Soﬁa, Research Institute for Complex Issues of Cardiovascular Bulgaria, 4Department of Genetics, Faculty of Biology, Diseases, Kemerovo, Russian Federation Soﬁa University “St. Kliment Ohridski”, Soﬁa, Bulgaria, 5Depatment of Neurology, UH “Alexandrovska”, Medical Introduction: Cardiovascular mortality in Russian Fed- University of Soﬁa, Soﬁa, Bulgaria erationis57%.Itisknownthatgeneticpolymorphismplay the key role in cardiovascular diseases development. The Introduction: Clinical and epidemiological studies have aim of this research was to determine the most important demonstratedalinkbetweenAlzheimer’sdisease(AD)and polymorphicvariantsofgenesinvolvedinﬁvepathogenetic high levels of blood lipids such as cholesterol, a common waysofcoronaryarteryatherosclerosisamongpeople from feature of coronary heart disease (CHD), yet the biological large industrial region. mechanisms remain unknown. Materials and methods: 78 polymorphic variants of 41 Materials & Methods: Whole-exome sequencing was genesinvolvedininﬂammation,lipidmetabolism,endothe- performed on two DNA pools set up of Alzheimer patients lial function, blood coagulation and innate immune (n=70)andhealthyindividuals(n=100),respectively.After response were analyzed in 260 coronary artery disease reads quality ﬁltering, 143,493 genetic variants detected in patientswithstableanginaand300healthydonors(control) bothpoolswereannotated.Alistofvariantsassociatedwith resident in Kemerovo Region using PCR method. CHDwascompiledusingthepubliclyavailableENSEMBL Results: It was discovered that coronary artery disease database(n=1479).Wesurveyedthepooldataforpresence patients from Kemerovo Region are characterized by the of CHD associated variants and selected those present in difference in genotype frequencies compared to overall both pools. European population. Genes of inﬂammation and endothelial Results: Of the 92 CHD associated variants detected in function(NO S3
rs1799983,EDNrs5370andCRPrs3093077) our pool data, 24 variants in 22 genes were estimated to more contribute to coronary artery disease in resident of large have signiﬁcantly higher frequency in AD patients industrial region. Polymorphism in genes of innate immune compared to the healthy individuals (FDR<0.05). Func- response (TLR1 rs5743551, I L1
F9 rs17659543) and coagula- tional analysis was performed on the 22 genes using tion factor II (rs1799963) can play protective role. APOB, ToppGene platform. Results indicate lipid metabolism and TLR1 and TREM1 associated with increased mortality from lipoprotein transport associated pathways to be most cardiovasculardiseases;andSELPLG–withhighriskofacute signiﬁcantly overrepresented in AD patients compared to cerebrovascular accident development. Genes of lipid and controls. calcium metabolism have no signiﬁcant contribution in Conclusion: The analysis of CHD associated variants in coronary atherosclerosis. This study was supported by basic AD patients and healthy controls suggests shared herit- research project of Research Institute for Complex Issues of abilityingenesinvolvedinoverrepresentedlipidpathways. Cardiovascular Diseases №0546-2015-0012. Acknowledgment: KP-06-N33/5 from 13.12.2019 - National Science Fund A. Ponasenko: None. M. Sinitsky: None. A. Tsepokina: of Bulgaria. None. M. Asanov: None. O. Barbarash: None. DN 03/7 from 18.12.2016 - National Science Fund of Bulgaria. M.B. Ganev: None. D. Serbezov: None. L. Balabanski: E- P05
.16 None.R.Vazharova:None.S.Karachanak-Yankova:None. Functional gene analysis indicates shared heritability of O. Antonova: None. D. Nikolova: None. M. Mihaylova: coronary heart disease and Alzheimer’s disease None. R. Staneva: None. V. Spasova: None. V. Damya- nova: None. D. Nesheva: None. Z. Hammoudeh: None. S. M. B. Ganev1, D. Serbezov1, L. Balabanski1,2, R. Hadjidekova: None. S. Mehrabian: None. M. Petrova: Vazharova2,3, S. Karachanak-Yankova1,4, O. Antonova1, D. None. L. Traykov: None. D. Toncheva: None. Nikolova1, M. Mihaylova1, R. Staneva1, V. Spasova1, V. Damyanova1, D. Nesheva1, Z. Hammoudeh1, S.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 849 E- P05
.18 Baas7, D. Dooijes8, F. Asselbergs7, D. Barge-Schaapveld9, A DNA repair pathway polymorphism in angiographi- P.Koopman10,A.vandenWijngaard1,S.Heymans1,11,12,I. cally proven coronary artery patients of southern Iran Krapels1, H. Brunner1,5 M. Bijanzadeh, S. Seyedian, F. Ahmadi, S. Hosseini 1MaastrichtUniversityMedicalCenter,Maastricht,Nether- lands, 2Amsterdam University Medical Center, Amsterdam, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Netherlands, 3University Medical Centre Groningen, Gro- Iran, Ahvaz, Iran, Islamic Republic of ningen, Netherlands, 4Antwerp University Hospital, Antwerp, Belgium, 5Radboud University Medical Centre, Introduction:Coronaryarterydisease(CAD)isamongthe Nijmegen, Netherlands, 6Erasmus MC University Medical most common causes of death and is based on the interac- Centre, Rotterdam, Netherlands, 7University Medical Cen- tion between environmental risk factors and predisposing ter Utrecht, Utrecht, Netherlands, 8University Medical genes. X-ray repair cross-complementing group 1 Center Utrecht, Maastricht, Netherlands, 9Leiden Univer- (XRC C1
), a DNA repair protein involved in single-strand sity Medical Center, Leiden, Netherlands, 10Heart Center breaks (SSBs) and base excision repair (BER) pathways, Hasselt, Hasselt, Belgium, 11KU Leuven, Leuven, Belgium, was reported to be responsible for the efﬁcient repair of 12The Netherlands Heart Institute, Nl-HI, Utrecht, Nether- single strand breaks and damaged bases in DNA. lands Arg399Gln (rs25487) is one of the common XRC C1
 poly- morphisms that might be associated with increased risk Filamin C (FLNC) variants are associated with cardiac and for CAD. muscular phenotypes. Originally, FLNC variants were Materials and methods: A case-control study was described in myoﬁbrillar myopathy (MFM) patients. Later, performed to investigate the relation between this poly- high-throughput screening in cardiomyopathy cohorts morphismandtheCADdevelopment.290patientsand216 determined a prominent role for FLNC in isolated hyper- controls were screened for the mentioned SNP by Restric- trophic and dilated cardiomyopathies (HCM and DCM). tion Fragment Length Polymorphisms (RFLP) method. FLNCvariantsarenowamongthemoreprevalentcausesof Results: The frequency of the GA genotype of XRC C1
 genetic DCM. FLNC-associated DCM is associated with a Arg399GlnwassigniﬁcantlyhigherinCADpatientsthanin malignant clinical course and a high risk of sudden cardiac controls(p=0.002,OR:1.21,95%CI(1.06-1.37))andalso death. The clinical spectrum of FLNC suggests different dominant mode (AA + GA) genotype of XRC C1
 pathomechanismsrelatedtovarianttypesandtheirlocation Arg399Gln had a 1.851-fold increased risk for CAD in the gene. Proper functioning of FLNC is crucial for (p=0.005). structural integrity and cell signaling of the sarcomere. The Conclusion: Our ﬁndings demonstrated that Arg399Gln secondary protein structure of FLNC is critical to ensure polymorphism of XRC C1
 has a signiﬁcant relationship and this function. Truncating variants with subsequent hap- a probable predisposing role in CAD. Our results support loinsufﬁciency are associated with DCM and cardiac the role of DNA damages and the malfunctions of DNA arrhythmias. Interference with the dimerization and folding repairsysteminCADpatients.Introducingofthiscandidate of the protein leads to aggregate formation detrimental for gene along with other related genetic variants can help the muscle function, as found in HCM and MFM. Variants development of early diagnosis and effective interventional associated with HCM are predominantly missense variants strategies that are safe, necessary and individualized for which cluster in the ROD2 domain. This domain is CAD patients. This study (project no. CVRC-9714) was important for binding to the sarcomere and ensure proper grantedbyresearchaffairsofAhvazJundishapurUniversity cell signaling. We here review FLNC genotype-phenotype of medical sciences. correlations based on available evidence. M. Bijanzadeh: None. S. Seyedian: None. F. Ahmadi: E. Vanhoutte: None. J. Verdonschot: None. G. Claes: None. S. Hosseini: None. None.A.Helderman-vandenEnden:None.J.Hoeijmakers: None. D. Hellebrekers: None. A. de Haan: None. I. E- P05
.20 The FLNC gene in myopathies and Christiaans: None. R. Lekanne-Deprez: None. E. van cardiomyopathies Craenenbroeck: None. H. Boen: None. B. Loeys: None. Y. Hoedemakers: None. C. Marcelis: None. M. Kempers: E. Vanhoutte1, J. Verdonschot1, G. Claes1, A. Helderman- None. E. Brusse: None. J. van Waning: None. A. Baas: van den Enden1, J. Hoeijmakers1, D. Hellebrekers1, A. de None. D. Dooijes: None. F. Asselbergs: None. D. Barge- Haan1, I. Christiaans2,3, R. Lekanne-Deprez2, E. van Schaapveld: None. P. Koopman: None. A. van den Craenenbroeck4, H. Boen4, B. Loeys4, Y. Hoedemakers3,5, Wijngaard: None. S. Heymans: None. I. Krapels: None. C. Marcelis5, M. Kempers5, E. Brusse6, J. van Waning6, A. H. Brunner: None.850 J.delPicchia E- P05
.21 E- P05
.23 From genomics data to multiscale simulation - portable A newly detected variant in the MYBP C3
 gene in a pipeline for extracting cardiomyophaty speciﬁc patient with hypertrophic cardiomyopathy parameters S. Josifovska1, R. Vazharova2,3, L. Balabanski2, N. Ilic Raicevic, L. Lenhardt Ackovic, V. Kovacevic, M. Malinov2, S. Panov1, M. Ganev4, D. Toncheva4 S. Stojanovic, J. Randjelovic, M. Mattioni, A. S. Yavuz, M. Lazarevic, T. Borovski 1Faculty of Natural Sciences and Mathematics, SS Cyril andMethodiusUniversity,Skopje,Macedonia,TheFormer Seven Bridges Inc, Boston, MA, United States Yugoslav Republic of, 2Genome Centre, GARH Malinov, Soﬁa, Bulgaria, 3Department of Biology, Medical Genetics Introduction: Hypertrophic and dilated cardiomyopathy andMicrobiology,FacultyofMedicine,SoﬁaUniversitySt. are the most common inherited cardiovascular diseases Kliment Ohridski, Soﬁa, Bulgaria, 4Department of Medical which lead to increased mortality and morbidity if not Genetics, Medical University of Soﬁa, Soﬁa, Bulgaria diagnosed in early stages. Design and development of new drugs and therapies which would prevent initiation and Introduction: Hypertrophic cardiomyopathy (HCM) is a progression of familial cardiomyopathies is achievable kind of cardiomyopathy, a cardiac dysfunction due to dis- today due to improved simulation methods and genomic easesofthemyocardium(WHO,1995).HMCcausespartial data availability. The goal of this study was to establish a enlargement of the myocardium. portable pipeline for annotating variants associated with Materials and methods: We report on middle aged familial cardiomyopathy and to determine induced changes patient with familial history and developed HCM. Exome atproteinlevel.Theoutputscombinedwiththeclinicaldata sequencing was performed onthe patient’s extracted DNA, could then be used for simulation of structure and function followed by a targeted analysis of genes from the “Cardio” of the heart. gene panel. Results were validated by Sanger sequencing. Materials and methods: Analyzing steps encompass Results: The analysis resulted in detection of a hetero- variant calling, variant annotation with best ﬁtting tool zygous, probably pathogenic variant in the MYBP C3
 gene using apposite databases, and ﬁnal reﬁnement of the (NM_000256.3: c.2965delG; NP_000247.2:p.Glu989- variants. The workﬂow consists of BWA-GATK best Serfs*3). This variant has not been previously reported in practices, Ensembl Variant Effect Predictor and bix2mus individuals with HCM. The MYBP C3
 encodes for the (custom-made tool). In this study, 100 samples of Cardiac myosin-binding protein C. The MYBP C3
 has a individuals with diagnosed cardiomyopathy are processed structural role as it is located in striated muscle sarcomere giving a statistically powerful dataset. The workﬂow was A-bands and binds myosin heavy chain in thick ﬁlaments written in the CWL. and titin in elastic ﬁlaments causing muscle contraction. Results: The composed workﬂow produced a subset of Pathogenic variants in the MYBP C3
 gene account for annotated variants that are cardiomyopathy speciﬁc. approximately15%ofcasesoffamilialHCM.Thedeletion Selected annotated variants were further enriched with that we detected leads toa frameshift resulting in an amino custom parameters which can be used as inputs for the acid substitution of glutamic acid to serine at codon 989. MUSICO heart function simulation. Furthermore, due to the new reading frame, a stop codon Conclusions:Thedevelopedworkﬂowfordiscoveryand can be detected 3 codons downstream, likely affecting the annotation of variants associated with analyzed forms of protein function because of a possible truncated protein inherited cardiomyopathy is operating system-independent, form. The inheritance is autosomal dominant. No other runnable on cloud or locally, ensuring portability, reprodu- known pathological or probably pathological variants cibility and reliability. This workﬂow provides an innova- associated to HCM were found. tive way to infer simulation parameters starting from Conclusions: The genetic causes underlining HMC are genomics data. complex and identifying novel variants may contribute to This research was funded by the EU project better distinction of this dysfunction and assessment of the SILICOFCM. risk of familial predisposition. N. Ilic Raicevic: None. L. Lenhardt Ackovic: None. V. S.Josifovska:None.R.Vazharova:None.L.Balabanski: Kovacevic: None. S. Stojanovic: None. J. Randjelovic: None. M. Malinov: None. S. Panov: None. M. Ganev: None.M.Mattioni:None.A.S.Yavuz:None.M.Lazarevic: None. D. Toncheva: None. None. T. Borovski: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 851 E- P05
.25 L. Nuñez1, R. Pan-Lizcano1, P. Piñon2, X. Flores2, Genetic structure of hypertrophic cardiomyopathy G. Aldama2, R. Calviño2, N. Vázquez-González3, in Russia J. M. Vazquez-Rodriguez3, M. Hermida-Prieto1 E. V. Filatova1, N. S. Krylova2, I. N. Vlasov1, 1Cardiology Research Group. Instituto de Investigación M. S. Maslova2, N. Poteshkina2, P. A. Slominsky1, Biomédica de A Coruña (INIBIC)-CHUAC-UDC, A M. I. Shadrina1 Coruna, Spain, 2Department of Cardiology, Complexo Hospitalario Universitario A Coruna (CHUAC)-INIBIC, A 1Institute of Molecular Genetics RAS, Moscow, Russian Coruna, Spain, 3Department of Cardiology, Complexo Federation, 2Pirogov Russian National Research Medical Hospitalario Universitario de A Coruña (CHUAC)- University, Moscow, Russian Federation CIBERCV, Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidad de A Coruña (UDC), A Introduction: Hypertrophic cardiomyopathy (HCM) is the Coruna, Spain most common heritable cardiovascular disease, classically deﬁned as the presence of idiopathic left ventricular Background:Sudden death (SD) due to ventricular hypertrophy. HCM is predominantly a single gene disorder ﬁbrillation(VF)duringacutemyocardialinfarction(AMI) with an autosomal dominant pattern of inheritance. How- is one of the leading causes of death in Western societies. ever,pathogenicallelesarenotidentiﬁedinatleast25%of IthasbeensuggestedthattheriskofSDduetoVFinAMI patientswithHCM.Moreover,thewholespectrumofgenes is the result of the interaction between genetic factors and and mutations that contribute to the development of this environmental factors. Moreover, it has been proposed disorderinRussianpopulationhasnotbeenfullydescribed. that variants in genes related to cardiac excitability, Therefore, the aim of our study was to identify genetic mainly SCN5A, could play an important role in VF variants associated with the HCM in patients from Russia. during AMI. Materials and methods: The study cohort included 99 Methods:Genetic variants in 36 genes encoded proteins unrelated patients with HCM. We performed targeted related to pathways involved in atherothrombosis were exome sequencing and a subsequent bioinformatic analysis analyzedby next generation sequencingin12 patients with using the various algorithms for prediction of the potential FV during AMI. Mutations found were conﬁrmed by pathogenicity of variants, as well as the ClinVar database. Sangersequencing.Visualizationofthemutationusingpdb Results: The frequency of pathogenic and potentially and in silico prediction of the effects produced by the pathogenetically signiﬁcant variants in the main HCM- mutation(MutationTester,SNA P2
,SIFT2,Polyphen,PhD- relatedgeneswas18%inourpatientswiththisdisorder.We SNP) were performed. also identiﬁed 22 potentially pathogenetically signiﬁcant Results:In one patient, p.Trp83Ser was identiﬁed in variants, including novel ones,inother HCM genes and52 KCNJ11 gene that encodes a forming KATP channel potentially pathogenetic variants in other 35 genes with subunit, whereas in another patient p.Thr738Pro in known associations to 17 different inherited cardiac SCN10A, encoding the forming subunit of the sodium conditions. channel, were identiﬁed. In both variants, more than four Conclusion: Thereby the prevalence of individual in silico tools suggested deleterious function of the pathogenic variants in HCM-related genes in Russian protein. population is very low. Therefore, it is necessary to Conclusion:Mutationsingeneencodedformingchannels continue the search for new genes and genetic variants subunits,asKCNJ11andSCN10A,couldhavearoleinthe associated with the development of HCM. This work was developmentofFVduringAMI.Thus,itisessentialtouse supported by the Russian Foundation for Basic Research anambitiousstrategy, including allgenes related tocardiac (grants no. 19-015-00343, 18-015-00322) and the Russian excitability, to clarify the pathophysiological basis of Science Foundation (grants no. 20-15-00293). ventricular ﬁbrillation in acute myocardial infarction. E.V. Filatova: None. N.S. Krylova: None. I.N. Vlasov: Funding Acknowledgements:This work was supported None. M.S. Maslova: None. N. Poteshkina: None. P.A. by a grant from Instituto de Salud Carlos III(PI18/01737) Slominsky: None. M.I. Shadrina: None. and a non-conditional-grant from Abbott Vascular. L. Nuñez: None. R. Pan-Lizcano: None. P. Piñon: None. E- P05
.27 X. Flores: None. G. Aldama: None. R. Calviño: None. N. Variants in KCNJ11 and SCN10A associated to ven- Vázquez-González: None. J.M. Vazquez-Rodriguez: None. tricular ﬁbrillation during acute myocardial infarction. M. Hermida-Prieto: None.852 J.delPicchia E- P05
.28 4National Medical Research Center for Children’s Health, A new case of Fish-eye disease in Spain. Moscow, Russian Federation, 5National Medical Research Center of Cardiology, Moscow, Russian Federation J. Sanguino, C. Rodríguez Jiménez, E. Sevilla, A. Carazo, V. Gómez del Pozo, N. Gallego-Onís, F. Arrieta, Introduction: Left venticular noncompaction cardiomyo- S. Rodríguez-Nóvoa pathy (LVNC) is a genetically determined cardiomyopathy, characterized by the presence of increased trabecularity and INGEMM, Madrid, Spain pronounced intertrabecular spaces extending into the left ventricle chamber. This study was aimed at ﬁnding new key Introduction: Fish-eye disease (FED; MIM#136120) is a links in LVNC development. rare disease with inheritance pattern autosomal recessive Materials and methods: The study included 26 families caused by Lecithin:Cholesterol Acyltransferase Deﬁciency ofLVNCpatients.Forallindividualswasperformedexome 1. This disorder is characterized by raised levels of total sequencing on Illumina Nextseq 550. cholesterol, triglycerides and decreased levels of HDL-c, Results: Clinical and instrumental examination of 102 apoA, and apoB in serum. We report a new case of suspi- people was done: 41 (40.2%) were healthy, in 61 (59.8%) cion of Fish-eye disease send to our laboratory to conﬁrm patients the diagnosis of LVNC was conﬁrmed, 15 (14%) the diagnosis genetic. were children. According to the examination results, the Patient and method: A 42-years-old male, with corneal followingclinicalphenotypesofLVNCcanbedistinguished: opacity, very level low of HDL-c in serum, splenomegaly, LVNC dilatation phenotype,LVNC hypertrophic phenotype, without anemia or kidney disease, and raised levels of LVNC and a combination of hypertrophic with dilatational triglycerides, liver enzymes and homocysteine in serum, was phenotype, isolated LVNC, a combination of LVNC with remitted to our laboratory. The patient´s DNA sample was congenitalheartdefects.Thepathogenicitywasevaluatedfor analyzed by NGS using a customized panel MTB-v2 of 411 the identiﬁed nucleotidevariants in 66 genes associatedwith genes.ThevariantfoundwasconﬁrmedbySangersequencing the developmentofLVNC andin 122 genesassociated with ResultsWefoundanhomozygousmissensevariantin LCAT, thedevelopmentofothercardiomyopathies.Pathogenic(PV) NM_000229.2: c.491G>A p.(Arg164His). In silico analysis or probably pathogenic (PPV) variants were found in 16 showed damaging and conservation for this variant. families: 11 variants in LVNC genes (5 PPV in MYH7, 2 P Conclusion: In this work, we report a new case of Fish variantsinTTN,onePVandonePPVinMYBP C3
,onePPV -eye disease. The variant found in LCAT c.491G>A p. in TPM1 and one PPV in SCN5A) and 5 variants in genes (Arg164His) had been previously reported in three siblings associated with other cardiomyopathies (2 PPV in DES, 1 with typical triad: corneal opacity, anemia and kidney PPV in RBM20, 1 PV in VCL, 1 PV in DSG2). dysfunctionandthefunctionalstudyshowedlackofactivity Conclusions: The study of LVNC development on 26 inLCAT2.However,ourpatientexhibitedamildphenotype families revealed mutations in MYH7, TTN, MYBP C3
, despite of display of same variant suggesting the existence TPM1, DES, RBM20, VCL and DSG2 genes. of others factors that decreased the clinical manifestations. A. Meshkov: None. O. Kulikova: None. R. Myasnikov: J. Sanguino: None. C. Rodríguez Jiménez: None. E. None. A. Kiseleva: None. M. Divashuk: None. A. Sevilla:None.A.Carazo:None.V.GómezdelPozo:None. Zharikova: None. O. Skirko: None. I. Eﬁmova: None. M. N. Gallego-Onís: None. F. Arrieta: None. S. Rodríguez- Pokrovskaya:None.E.Mershina:None.V.Sinitsyn:None. Nóvoa: None. E.Basargina:None.N.Sdvigova:None.S.Boytsov:None. O. Drapkina: None. E- P05
.29 Genetics of familial left venticular noncompaction E- P05
.30 cardiomyopathy in Russia Expression of miRNAs as a marker for cardiovascular risk in patients with type 2 diabetes mellitus A. Meshkov1, O. Kulikova1, R. Myasnikov1, A. Kiseleva1, M. Divashuk1,2, A. Zharikova1, O. Skirko1, I. Eﬁmova1, M. P.Gateva1,I.Mihaleva1,K.Kamenova1,S.Giragosyan2,R. Pokrovskaya1,E.Mershina3,V.Sinitsyn3,E.Basargina4,N. Dodova2, R. Kaneva2, I. Dimova3 Sdvigova4, S. Boytsov5, O. Drapkina1 1Department of Pharmacology and Toxicology, Medical 1NationalMedicalResearchCenterforPreventiveMedicine, University-Soﬁa,Soﬁa,Bulgaria,2LaboratoryofGenomic Moscow,RussianFederation,2RSAU–MAAnamedafterK. Diagnostics, Molecular Medicine Center, Medical Univer- A. Timiryazev, Moscow, Russian Federation, 3Lomonosov sity - Soﬁa, Soﬁa, Bulgaria, 3Department of Medical Moscow State University, Moscow, Russian Federation, Genetics, Medical University - Soﬁa, Soﬁa, BulgariaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 853 evidences that somatic mutations can play a role in endo- The use of circulating miRNAs as biomarkers is a potential thelial dysfunction, and atherosclerotic plaques are char- additionaloptioninthediagnosisandprognosisofdiseases, acterized by increased level of DNA adducts. The aim of complementary to established protein-based biomarkers. In this research was to study the level of genotoxic stress our study, we isolated miRNAs from plasma of diabetic markers; secretion and gene expression of proathero- patients with and without cardio-vascular disease (CVD). sclerotic cytokines IL-6 and IL-8 by endothelial cells The analysis included 6 patients with type 2 diabetes mel- exposed to alkylating mutagen mitomycin C (MMC). lituswithoutCVD(controlgroup)and9patientswithtype2 Materials and methods: Primary human coronary- diabetesmellitusandCVD(targetgroup).Followingreverse (HCAEC) and internal thoracic artery endothelial cells transcription and subsequent real-time PCR analysis of an (HITAEC) were used in this research. Cytokinesis-block equal amount of baseline miRNAs, the following miRNAs micronucleusassaywasperformedtoscoregenotoxicstress were successfully analyzed: miR-16-5p, miR-155-3p, miR- markersinexposedandcontrolcellcultures.Concentration 155-5p,miR-210-3p, miR-221-3p miR-424-5p. The com- ofIL-6andIL-8inculturemediumandmRNAlevelofthe parative analysis of expression showed a statistically sig- corresponding genes were measured immediately after niﬁcantincreaseintheexpressionofallthesemiRNAsinthe 6 hours of cell incubation with mutagen and 24 hours after target group compared to the control – see table bellow. elimination of MMC from cell cultures, using ELISA and RT-qPCR. miRNA Relativeexpression(RQ) Results: Exposed cells were characterized by increased miR-16-5p 2.5 level of all studied cytogenetic markers compared to miR-155-3p 2.2 control. After 6 hours of exposure, a signiﬁcant decrease miR-155-5p 7.5 inthesecretionandgeneexpressionofIL-8,anddecreasein miR-210-3p 5.1 the mRNA level of the IL-6 gene in the exposed cultures miR-221-3p 6.2 was discovered. At the second time point (6+24 h), on the miR-424-5p 10.5 contrary,theconcentrationandmRNAlevelofIL-8,aswell as expression of the I L6
 gene sharply increased in cultures The highest level of increase was established for miR- exposed to MMC compared to control, and the HCAEC 155-5p (its target is ICAM-1 – with role in inﬂammation were more sensitive to mutagenic effects than HITAEC. and in the regulation of vascular permeability, affected in Thisstudywassupportedbybasicresearchproject№0546- atherosclerosis) and miR-424-5p (its target is HIF1A – the 2015-0012. master transcriptional regulator of the adaptive response to M. Sinitsky: None. A. Kutikhin: None. D. Shishkova: hypoxia). In conclusion, CVD risk assessment, supported None. A. Tsepokina: None. M. Asanov: None. A. by emerging circulating biomarkers, such as miRNAs, is Ponasenko: None. important for stratifying high-risk individuals, optimizing treatment strategies, and enhancing our understanding of E- P05
.36 basic biology. Acknowledgment: This study was supported AssociationofgenepolymorphismsMTHFRinKazakh- by Grant NoD-66/2019, Medical University Soﬁa. stani patients with implanted left ventricular assist P. Gateva: None. I. Mihaleva: None. K. Kamenova: devices None. S. Giragosyan: None. R. Dodova: None. R. Kaneva: None. I. Dimova: None. M. Zhalbinova1,2, S. Rakhimova2, M. Bekbosynova3, S. Andosova3, B. Abdirova3, A. Akilzhanova2,1 E- P05
.31 InvitroinducedDNAalkylationinendotheliocytesleads 1L.N. Gumilyov Eurasian National University, Nur-Sultan, to genotoxic stress and secretion of proatherosclerotic Kazakhstan, 2National Laboratory Astana, Center for Life cytokines Sciences,Nur-Sultan,Kazakhstan,3JSC“Nationalresearch cardiac surgery center”, National medical holding, Nur- M. Sinitsky, A. Kutikhin, D. Shishkova, A. Tsepokina, Sultan, Kazakhstan M. Asanov, A. Ponasenko Introduction: Chronic heart failure (CHF) is one of the Research Institute for Complex Issues of Cardiovascular main health problems in Kazakhstan, which requires heart Diseases, Kemerovo, Russian Federation transplantation(HT)toextendthepatient’slife.Thepopular treatment of CHF is the implantation of left ventricular Introduction: Atherosclerosis is a leader in morbidity and assist device (LVAD) which extends patient’s life before mortality among all cardiovascular pathologies. There are HT. However, LVAD causes risk of thrombosis and854 J.delPicchia bleeding in cardiac patients. Patients are normally pre- years old, applied with poor weight gain, a slight speech scribed with an antithrombotic therapy to prevent risks of development delay, poor physical exercise tolerance. At an thromboembolism. The purpose of this study is to evaluate earlyage-regurgitation,lackofbodyweight.Thediagnosis patients for genetic variants responsible for risk of throm- has not been established. Examination has revealed diffuse bosis: MTHFR (*1) and MTHFR (*2). hypotension, asthenia, phenotypically signs of connective Materials and methods: Venous blood samples were tissue dysplasia, Laboratory studies: increased transami- recruited from patients (n=100) with implanted LVADs nases, increased lactate level, hepatosplenomegaly. (HW, HM2, HM3) at the National Research Center for According to clinical criteria - mitochondrial Nijmegen Cardiac Surgery. Warfarin was prescribed according to disease. Diagnostic assessment (Wolf NI, Smeitink JA. clinical protocol (min=0.9mg; max=7.2mg; Std.=1.15). Mitochondrialdisorders)inachildconﬁrmedmitochondrial Genotyping was done for MTHFR (*1) rs1801133 and pathology. As the boy grew, there was an increase of MTHFR (*2) rs1801131 by real-time polymerase chain clinical symptoms: increased weakness, fatigue, muscle reaction with TaqMan probes. hypotension, hypomimia. GC-MS in dynamics: titer 3- Results:GenotypingresultswereanalyzedonIBMSPSS metylglutaric and 3- metylglutaconic increase, MRS- con- Statistics 23 for n=98 patients (>18 years old). Results ﬁrmed mitochondrial neurocyte activity. Diagnosed with presented that most of the patients have wild type of atypical forms of 3-methylglutaconic aciduria (3-methyl- genotype which proves absence to the risk of thrombosis: glutaconic deﬁciency — CoA-hydratases) Prescription: MTHFR (*1) (G/G=47%; G/A=41%; A/A=10%, p = mitochondrial therapy during rehabilitation. It led to tem- 0.563); MTHFR (*2) (T/T =54%; T/G=38%; G/G=6%, p porary positive dynamics. Conclusions: timely diagnosis of = 0.288). Results are not statistically signiﬁcant. a rare disease based on biomarkers can improve the con- Conclusions: Research advices to study other SNPs dition of the patient due to pathogenetic therapy. which will allow us to identify the reasons of thrombosis O. Vernigor: None. O. Grechanina: None. M. and bleeding in LVAD patients and also to study more Kanyuka: None. about coagulation factors, aspirin resistance, warfarin metabolism. Study needs to add more samples to be able E- P06
.03 to compare results with other samples. X-linked ALG13-CDG resulting from c.320A>G var- M. Zhalbinova: None. S. Rakhimova: None. M. Bekbo- iant - can transferrin proﬁle change and correlate with synova: None. S. Andosova: None. B. Abdirova: None. A. the clinical phenotype? Akilzhanova: None. A. Jezela-Stanek1, A. Bogdańska2, P. Pokora3, E- P06
 Metabolic and Mitochondrial Disorders J. Paprocka4, A. Tylki-Szymańska3 1National Institute of Tuberculosis and Lung Disease, E- P06
.01 DepartmentofGeneticsandClinicalImmunology,Warsaw, The case of atypical form of 3-methylglutaconic Poland, 2The Children’s Memorial Health Institute, aciduria Department of Biochemistry, Radioimmunology and Experimental Medicine, Warsaw, Poland, 3Children’s O. Vernigor, O. Grechanina, M. Kanyuka Memorial Health Institute, Department of Pediatrics, Nutrition and Metabolic Disorders, Warsaw, Poland, Interregional Specialized Medical Genetic Center - Center 4Medical University of Silesia, Department of Pediatric of Rare (Orphan) Diseases, Kharkiv National Medical Neurology, School of Medicine in Katowice, Katowice, University, Kharkiv, Ukraine Poland Methylglutonicaciduria(MGA)isclinicallyandgenetically Introduction: Congenital Disorders of Glycosylation heterogeneous disease. Genes responsible for development (CDG) are multisystemic metabolic disorders, in general, knowndiseases:OPA3,AUH,TAZ,DNAJ C19
.Oneofthe caused by defects of N-linked, O-linked oligosaccharides diagnostic methods of MGA is an analysis of the spectrum pathways. Their clinical presentation and aetiology are of organic acids in urine by gas chromatography-mass highly heterogeneous, which may cause a diagnostic spectrometry, as there are biomarkers of the disease - 3- dilemma.Sofar,ALG13c.320A>Gvariantwasreportedin methylglutaric and 3-methylglutaconic acid increase is tenfemalesandonemale.ContrarytootherknownALG13- characteristic.Materialsandmethods:inourcenterthereare CDG, in probands harbouring this mutation normal glyco- 3 children with an atypical form of 3-methylglutaconic sylation andmass spectrometry patternwereobserved (two aciduria, a description of one clinical case. The child is 3 and one individuals, respectively). There is, however, oneAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 855 another report, giving evidence of slightly reduced glyco- Material and Method: Genomic DNAs were extracted sylation with the absence of one glycan in MS. Since these fromthepatientandhisfather,followedbyCY P27
A1gene laboratory data are not conclusive, and the number of sequencing. Furthermore, in order to demonstrate the reported patients is still very limited, we like to present deletion, multiplex ligation-dependent probe ampliﬁcatio- novel individuals, pointing out their transferrin IEF results. nof the CY P27
A1 gene was performed in the proband. Materials: Three female probands with de novo ALG13 Results:Wefoundanovelheterozygousc.508_509ins16 c.320A>G variant ( P3
, with the most severe psychomotor (p. E170
Vfs*16) mutation in CY P27
A1 gene in the pro- impairment, also heterozygous for c.3433C>T in the band’s father. Consequently, a compound heterozygous CACNA1A gene). mutation was detected in the proband. The effect of this Methods: Transferrin isoforms examined by isoelectric novelpointmutationonCY P27
A1functionwaspredictedto focusing (IEF) of iron saturated serum in agarose gel in a bedamagingbyinsilicoanalysis.Aftergeneticcounseling, pH gradient 5-7 with immunoﬁxation, demonstrated as the his grandmother who was his legal guardian, consented to percentageofeachisoformfractioninadensitometricscan. kenodeoxycholic acid (CDCA) treatment. Cholestanol Results: Transferrin isoforms showed normal proﬁles in decreased to normal levels and some symptoms improved  P1
, while in  P2
 - slight elevation of asialo, monosialo, at the end of two months treatment. disialo fraction;  P3
 - ﬁrst analysis: normal; second (in Conclusion: Genetic testing for presymptomatic family another sample): slight elevation of only disialo fraction. membersofaffectedpatientsshouldbesuggestedespecially Conclusions: Obtained IEF data delineate the character- to offer an opportunity to prevent or decrease the disease istics of ALG13-CDG caused by c.320A>G variant, manifestations with CDCA therapy. providing evidence of variability or speciﬁcity of glycosy- H.N. Cesur Baltacı: None. B. Sağlam Ada: None. N. lation defect. These may be signiﬁcant for genetic results Yürür Kutlay: None. A. Tükün: None. S. Tıraş Teber: veriﬁcation but also clinical assessment and correlation. None. T. Coşkun: None. A.Jezela-Stanek:None.A.Bogdańska:None.P.Pokora: None. J. Paprocka: None. A. Tylki-Szymańska: None. E- P06
.05 A novel CTCF variant in a patient with congenital E- P06
.04 anomalies Cerebrotendinous xanthomatosis with novel compound heterozygous mutation ofCY P27
A1gene N. Okamoto1, F. Miya2,3,4, T. Tsunoda2,3,4, K. Kosaki5 H.N.CesurBaltacı1,B.SağlamAda2,N.YürürKutlay1,A. 1Department of Medical Genetics, Osaka Women’s and Tükün2, S. Tıraş Teber3, T. Coşkun4 Children’s Hospital, Osaka, Japan, 2Department of Med- ical Science Mathematics, Medical Research Institute, 1MedicalGeneticsDepartment,AnkaraUniversity,Ankara, Tokyo Medical and Dental University, Tokyo, Japan, Turkey, 2Department of Medical Genetics, Düzen Labora- 3Laboratory for Medical Science Mathematics, tories Group, Ankara, Turkey, 3Department of Pediatric RIKENCenterforIntegrativeMedicalSciences,Yokohama, Neurology,AnkaraUniversity School ofMedicine, Ankara, Japan, 4Medical Science Mathematics, Department of Turkey, 4Departments of Pediatric Metabolism, Hacettepe Biological Sciences, Graduate School of Science, The University Faculty of Medicine, Ankara, Turkey University of Tokyo, Tokyo, Japan, 5Center for Medical Genetics, Keio University School of Medicine, Introduction: Cerebrotendinous xanthomatosis (CTX) is a Tokyo, Japan rarelipidstoragediseasecharacterizedbytheaccumulation of cholesterol and cholestanol in various tissues. It is Introduction: The DNA-binding protein CCCTC-binding inherited in an autosomal recessive manner caused by the factor(CTCF)andthecohesincomplexplayimportantroles mutations of CY P27
A1 gene localized on 2q35. This gene inchromatinarchitectureinvertebrates.Pathogenicvariants encodes sterol 27-hydroxylase. Here we present a 8-year- inCTCFwerereportedinpatientswithneurodevelopmental old male with attention deﬁcit and hyperactivity disorder. disorderswithdistinctivefacialfeatures.Wereportapatient He was born to non-consanguineous parents. He was con- with a novel variant in CTCF with intellectual disability sulted to us for CY P27
A1 gene analysis by the information (ID) and multiple anomalies. of a homozygous deletion in exon 6 of CY P27
A1 gene in Clinical Report: The 6-year-old male was the ﬁrst child his mother. Additionally, his 7-dehydrocholesterol and of healthy and non-consanguineous Japanese parents. He plasma cholestanol levelsincreased consistently withCTX. showedcongenitalcardiacanomalies,duodenalatresia,and His father had epilepsy together with limited intellectual atresia ani. His developmental milestones were also capacity. retarded. He also showed characteristic facial features.856 J.delPicchia Conventional cytogenetic studies and microarray analysis c.589G˃A(p.G197R)(p.Gly197Arg)mutationandhisfather gave normal results. is a heterozygote for c.1015G˃A (p.G339R)(p.Gly339Arg) Method: With the approval of our institutional ethics mutation. One of his asymptomatic sister is a heterozygote committee, DNA samples from the patient and her parents forc.1015G˃A(p.G339R)(p.Gly339Arg)mutation.Another were analyzed by WES. sisterwithcornealcystinosisisaheterozygoteforc.589G˃A Results: The patient was heterozygous for CTCF frame- (p.G197R)(p.Gly197Arg) mutation. Overall, we can trace shift variant (NM_006565:exon3:c.723delT:p.N241fs). The the (potential) phenotype of these patients using their variant was de novo. mutation. This study shows us the genetic heterogenity of Discussion: Cornelia de Lange syndrome, a classical cystinosisinTurkishpopulationandhelpsustounderstand cohesinopathy,mayshowmultiplemalformationsincluding the biochemical-genotype-phenotype relationship in this CHD and gastrointestinal malformations. CTCF may disease. regulateorganogenesis.MutationsinCTCFmayalsocause B. Celtikci: None. B. Kazanci: None. a multiple anomaly syndrome with ID. N. Okamoto: None. F. Miya: None. T. Tsunoda: None. E- P06
.08 K. Kosaki: None. A unique combination of two lysosomal diseases in a child revealed as a result of a screening E- P06
.07 Two forms of a disease in the same family: compound O. Buhaiova, O. Grechanina, Y. Hrechanina, L. Molodan, heterozygosity in the father and heterozygosity in his N. Pokaziy, A. Bulavina, D. Shkolnikova sister both with corneal cystinosis, and heterozygous daughter and his other sister both having risks for Interregional Specialized Medical Genetic Center - Center nephropathic cystinosis of Rare (Orphan) Diseases, Kharkiv National Medical University, Kharkiv, Ukraine B. Celtikci1, B. Kazanci2 Introduction: Lysosomal storage disorders are character- 1Hacettepe University, Ankara, Turkey, 2Ulucanlar Eye ized by comorbidity, polymorphism and genetic hetero- Hospital, Ministry of Health, Ankara, Turkey geneity, which makes their timely diagnosis difﬁcult. Materials and methods: To identify patients with Cystinosis is a rare and autosomal recessive inherited dis- atypical forms of MPS, Pompe, Gaucher, Fabry disease order resulting from the accumulation of intracellular among residents of Kharkov region in 2018. In Kharkiv cystine, due to the mutations of the CTNS gene encoding region, selective screening for accumulation diseases thecystinosinproteinthat carries thelysosomalaminoacid has begun. cystine. Its incidence is high in Turkey, because of the Results: determination of excretion of total glycosami- frequent consanguineous marriage and manifesting hetero- noglycans(GAGs)indailyurine(2733patients);determina- zygotes. The most common clinical diagnosis is kidney tion of the level of fractional blood GAGs-(683patients), involvement. Corneal form occurs later. Some cases are biochemical study of the level of enzymes and molecular diagnosed with photophobia, halo and glare style visual genetic diagnostics (712patients). This revealed: Combina- ﬁndings, depending on the density of corneal crystals. tion of Fabry disease and Pompe disease in 1 patient. In a Spindle- and fusiform-shaped corneal crystals were child with diffuse muscular hypotension, retarded physical detected in our patient and his sister. Sequencing of CTNS and statokinetic development, hepatomegaly, decreased genewasperformedonaMiSeq(Illumina).VCFﬁleswere activity of the lysosomal enzyme acid α-glucosidase, analyzed by Variant studio (Illumina) and Geneticist decreased Lyso-Gb3, the GLA gene (heterozygous variant Assistant (SoftGenetics) Software. Sequence variant clas- c.31G> C p. (Gly11Arg)) was detected. GLA - encodes a siﬁcation was done according to the ACMG Standards and homodimeric glycoprotein. A mutation in the gene affects Guidelines. Detected variants were conﬁrmed by Sanger the synthesis, processing and stability of the enzyme that sequencing. Our patient with corneal cystinosis has the causes Fabry disease, which results from the inability to compound heterozygosity of c.589G˃A (p.G197R)(p. catabolize alpha - D-galactosyl glycolipid moieties. GAA - Gly197Arg) /c.1015G˃A (p.G339R)(p.Gly339Arg) muta- The gene produces an acid alpha glycosidase enzyme. The tions, correlated with cystinosis and his daughter is a het- body uses GAA to break down the glycogen used to erozygote for c.1015G˃A (p.G339R)(p.Gly339Arg) produce energy. mutation, correlated speciﬁcally with nephropathic cysti- Conclusions: The introduction of a selective nosis. As expected, his mother is a heterozygote for screening system for diseases of accumulation made itAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 857 possible to diagnose early and to start adequate pathoge- pathogenic likelypathogenic probably variantofuncertain pathogenic signiﬁcance neticpersonalizedtherapyinatimelymannerforthisgroup of patients. For the ﬁrst time, a combination of Fabry and LDLR c.316_328delCCCAAGAC c.325T>G:p. c.2389+5G>C c.616A>C:p.( S206
R); GTGCT:p.(K107Rfs*95); ( C109
G); Pompe diseases was detected in 1 patient. LDLR c.940+1_c.940+4delGTGA; c.401G>C:p. c.663_683dupCTGCAAGGAC ( C134
S) AAATCTGACGA; O. Buhaiova: None. O. Grechanina: None. Y. Hrecha- LDLR c.1186+1G>T; c.798T>A:p.(Asp266Glu); nina: None. L. Molodan: None. N. Pokaziy: None. A. LDLR cp..1( P658643
_H16fs9*11d4e)lTGGCCCAA: c.1187-7C>G Bulavina: None. D. Shkolnikova: None. LPL c.472T>C:p.(Y158H) APOA2 c.122_123insACCGT:p. (V41=fs*2); APOA2 c.53G>A:p.(G18E) E- P06
.10 Spectrum of mutations in Russian patients with hypercholesterolemia O.N. Ivanova: None. T.D. Krylova: None. N.A. Seme- nova:None.P.A.Vasiluev:None.N.V.Milovanova:None. O. N. Ivanova, T. D. Krylova, N. A. Semenova, P. A. E.Z. E.Y. Zakharova: None. Vasiluev, N. V. Milovanova, E. Z. E.Y. Zakharova E- P06
.11 Federal State Budgetary Scientiﬁc Institution "Research Pathogenic variant p. E191
K in ALPL is common in Centre for Medical Genetics", Moscow, Russian Federa- mild forms of hypophosphatasia in Northwest Russia tion M. Fedyakov1, Y. Eismont1, T. Ivaschenko2, I. Sosnina3, Y. -Introduction: We presented a genetic spectrum of Snegova3, S. Scherbak1, Y. Barbitoff4, A. Shikov1, hypercholesterolemia in a cohort of 72 unrelated O. Glotov1 patients from Moscow region. -Materials. The patients with high level of total cholesterol (>6,7 mmol/l) and/ 1City Hospital 40, Saint-Petersburg, Russian Federation, or low-density lipoprotein cholesterol (>4,9 mmol/l) were 2D.O.Ott Research InstituteofObstetrics,Gynecology and screened on targeted NGS panel on Ion S5
 (Thermoﬁsher Reproductology, Saint-Petersburg, Russian Federation, Scientiﬁc) for the following genes: LDLR(NM_000527), 3Consultative and diagnostic center for children, Saint- APOB(NM_000384), PCSK9(NM_174936), ABCG5 Petersburg, Russian Federation, 4Bioinformatics institute, (NM_022436), ABCG8(NM_022437), APOA2 Saint-Petersburg, Russian Federation (NM_001643), LIPA(NM_000235), LPL(NM_000237). Informed consents have been obtained from all patients or Introduction: Hypophosphatasia (HPP) is a rare heritable theirlegalrepresentativestoconductthestudy.Theaverage metabolic disorder characterized by defective mineraliza- age of the patients was 12,04+/-1,27 years old. The tionofboneand/orteethinthepresenceofreducedactivity nomenclature of variants and the assessment of their of unfractionated serum alkaline phosphatase (ALP). The pathogenicity has been carried out in accordance with overallprevalenceofsevereHPPisrangefrom1/100000to HGVS, ACMG recommendations. Variant validation has 1/300 000. Mild forms of HPP are more frequent than been performed by Sanger sequencing. severe forms - expected prevalence can reach 1/6000 in -Results:Wefound44variantsamong72ofcases(61%). Westernpopulations.Russianprevalenceofmildandsevere Known pathogenic mutations have been detected in 27 HPP is still unknown. Genetic analysis provides determin- patients, 21 of them were in LDLR gene, and six in the ing of diagnosis in cases with suspected HPP. genes APOB, LIPA, ABCG8. 17 patients harbor new Materials and methods: We analyzed genomic DNA variants with varying degrees of pathogenicity (see table samplesfrom217unrelatedindividualswithsuspectedHPP below). (inclusion criteria: low and/or recurrent low levels of ALP, -Conclusions: Pathogenic LDLR variants have been lowgrowth,recurrentfracturesandothers).Primers’system detected in 47% (34/72) of unrelated patients with for Sanger sequencing was designed and validated for hypercholesterolemia, the same results were shown in the coding 2-12 exons of ALPL gene. Exome data of 353 of literature. The most common variant in this gene is the unrelated individuals(in-house controlgroup) wasusedfor known pathogenic mutation c.1775G>A(p.G592E) (6.9%) genetic variant estimation of prevalence in Northwest and the previously unpublished splicing variant c.940 Russia. +1_c.940+4delGTGA (5,5%). The study has conﬁrmed Results:Detectionratewas11%-21inheterozygousand the genetic heterogeneity of hypercholesterolemia in the 3 in compound-heterozygous. Mild HPP was founded in Russian cohort. 87,5% positive cases (21/24). 5 novel mutations (3 missense, 2 frameshift) were detected. Most frequent pathogenic variant in ALPL gene was p. E191
K in exon 6.858 J.delPicchia The prevalence of this mutation was: 2.8% in suspected closetothatinthenearestneighbors-Poland,Hungaryand HPP group (12/434), 0.28% (2/706 chromosome) in home Slovakia, but are lower than European average, and the controls, 0.25% in gnomAD. genetic heterogeneity of these diseases in Ukraine is Conclusions: Mild forms of HPP predominate in North- pronounced. west Russian patients with suspected HPP. Mutation p. Conclusions: Existence of high genetic heterogeneity of  E191
K in exon 6 is 20 times common in patients with low LSDinUkrainecreatessigniﬁcantproblemsduringmedical levels of ALP compare general population. genetic counseling for families and requires the develop- M. Fedyakov: None. Y. Eismont: None. T. Ivaschenko: ment of speciﬁc diagnostic algorithm that regulates the None. I. Sosnina: None. Y. Snegova: None. S. Scherbak: stages of diagnostic search using DNA analysis. None. Y. Barbitoff: None. A. Shikov: None. O. N. Olkhovych: None. N. Pichkur: None. N. Troﬁmova: Glotov: None. None. S. Kormoz: None. I. Gregul: None. Y. Gyvitsa: None. N. Samonenko: None. Y. Doronina: None. M. E- P06
.14 Tcygankova: None. O. Radzihovskaya: None. N. Highgeneticheterogeneityoflysosomalstoragediseases Gorovenko: None. in Ukraine E- P06
.15 N. Olkhovych1,2, N. Pichkur1,2, N. Troﬁmova1,2, A novel de novo variant in MT-AT P6
 in a patient with S. Kormoz2, I. Gregul2, Y. Gyvitsa2, N. Samonenko2,3, Mitochondrial myopathy, Lactic Acidosis and Side- Y. Doronina2, M. Tcygankova2, O. Radzihovskaya2, roblastic Anemia (MLASA) plus: expanding the clinical N. Gorovenko1,3 phenotype 1Institute of Genetic and Regenerative Medicine, Kyiv, J. Dupont1, P. Janeiro2, M. J. Palaré3, S. Quintas4, Ukraine, 2National Children Hospital Ohmatdyt, Kyiv, A. B. Sousa1 Ukraine, 3National Medical Academy of Postdiploma Education named P.L.Shupika, Kyiv, Ukraine 1Serviço de Genética Médica, Departamento de Pediatria, HospitaldeSantaMaria,CentroHospitalareUniversitário Introduction: Lysosomal storage diseases (LSD) are Lisboa Norte, Centro Académico de Medicina de Lisboa, inherited metabolic diseases that are caused by genetic Lisbon, Portugal, 2Centro de Referência de doenças alterationsinlysosomalenzymesgenes.Mostofthehuman hereditárias do metabolismo, Departamento de Pediatria, disease is characterized by marked genetic heterogeneity, HospitaldeSantaMaria,CentroHospitalareUniversitário far greater than previously appreciated. This degree of Lisboa Norte, Centro Académico de Medicina de Lisboa, allelic, locus, and phenotypic heterogeneity has important Lisbon, Portugal, 3Unidade de Hematologia Pediátrica, implications for gene discovery and has important impli- Departamento de Pediatria, Hospital de Santa Maria, cations for development of molecular treatments for indi- Centro Hospitalar e Universitário Lisboa Norte, Centro vidual patients. Académico de Medicina de Lisboa, Lisbon, Portugal, Aim: Analysis of genetic heterogeneity of the most 4Unidade de Neurologia Pediátrica, Departamento de common lysosomal storage diseases in patients from Pediatria, Hospital de Santa Maria, Centro Hospitalar e Ukraine. UniversitárioLisboaNorte,CentroAcadémicodeMedicina Materials and methods: The frequencies and spectrum de Lisboa, Lisbon, Portugal of causes mutations in patients with Gaucher (n=62), Niemann-PeakA/B(n=16),metachromaticleukodystrophy Introduction: MLASA is a mitochondrial disorder char- (MLD) (n=28), mucopolysaccharidosis type I (MPS I) acterized by myopathy, lactic acidosis, and sideroblastic (n=17), mucopolysaccharidosis type IIIA (MPS III A) anemia, associated with biallelic mutations in PU S1
 and (n=21), GM1-gangliosidosis (n=32) were analyzed. Muta- YAR S2
genes.In2014,Burrageetal.reportedanMLASA- tion analysis was performed using classical PCR analysis like phenotype (OMIM 500011) in a patient harboring a and Sanger sequencing. Comparative analysis of the novel heteroplasmic point mutation in mitochondrial ATP common mutations in different populations was performed synthase 6 (MT-AT P6
). Pathogenic variants in MT-AT P6
 according to the published data. areacauseofNARP(neurogenicmuscleweakness,ataxia, Results: Our research has shown that the frequencies of and retinitis pigmentosa) and Leigh syndrome. common mutations in patients with Niemann-Peak A/B, Casedescription:Theprobandisan8-year-oldgirlwith MLD and GM1-gangliosidosis in Ukraine is signiﬁcantly an early infantile presentation of failure to thrive, side- different from other European. Frequencies of common roblastic anemia, axial hypotonia, nystagmus and mild mutationsinpatientswithGaucher,MPSIandMPSIIIAis developmental delay. Slow-growing, sparse and brittleAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 859 striking hair was noticed since infancy. She evolved with during pregnancy was more common among GCK-MODY developmental stagnation and severe ID. Recently, clinical patients: most switched from only diet to insulin. Total deterioration occurred during acute illness. On physical insulin per day in the 1st trimester was signiﬁcantly higher examination she has tip-toe ataxic gait, dystonia, bradyki- in GCK-MODY (34.57vs. 30.5units,p<0.005) patients and nesia, rigidity, and muscle weakness with atrophy. thedifference betweenpercentageof basal insulin was also Ophthalmologicassessment showed salt-and-pepper retino- signiﬁcantlyhigher(34.99vs.20.87%,p<0.005),thelatterof pathy. Persistent hyperlacticaemia and respiratory chain which remained signiﬁcant until the end of pregnancy. complex V deﬁciency in muscle were documented. WES There were no macrosomic or low birth weight neonates. and CNV analysis were negative. Mitochondrial genome Conclusions: GCK-MODY pregnant women received a sequencing in blood identiﬁed a novel de novo homo- higher daily dose of insulin, especially in percentage of plasmic variant in MT-AT P6
 gene (NC_012920.1: basal insulin, compared to HNF1A-MODY patients. This m.9014A>G), classiﬁed as uncertain according to ACMG could be due to attempts to achieve target fasting glucose guidelines, but considered likely pathogenic applying the levels duringpregnancyestablished forgestational diabetes ClinGenSVIBayesianclassiﬁcationframework.Functional despite different speciﬁcities of GCK-MODY. The higher studies are ongoing. dose of given insulin could be responsible for the greater Conclusions: MLASA plus is a distinctive phenotype weight gain among GCK-MODY patients. associated with MT-AT P6
 uncommon variants. MT- M. Szopa: None. K. Zawadzka: None. K. Cyganek: AT P6
–related disease is best deﬁned as a mitochondrial None. P. Witek: None. M.T. Malecki: None. diseasespectrum disorder, asdemonstratedbythepresence of NARP and Leigh features in our patient. Hair E- P06
.18 abnormalities are distinctive and might lead the clinician to suspect the diagnosis before multi-organ involvement Mucopolysaccharidosis IIIA - a clinical case develops. J.Dupont:None.P.Janeiro:None.M.J. Palaré: None.S. E. S. SHELBY, M. Axente, A. I. Grigoriu, L. Pădure; Quintas: None. A.B. Sousa: None. CNC RNC Dr. Nicolae Robanescu, Bucharest, Romania. E- P06
.16 Introduction: We present the case of a 16 year old boy Management and outcomes in pregnant women with admitted in our hospital in May 2019 with no signiﬁcant GCK-MODY and HNF1A-MODY from Poland birth or family history, normal mental and motor develop- mentuntiloneyearandsixmonthsandprogressiveonsetof M. Szopa, K. Zawadzka, K. Cyganek, P. Witek, M. T. symptoms consisting in macrocrania, hepatosplenomegaly, Malecki cognitive and motor retardation, hetero-aggressive beha- viour, insomnia, incontinence, hirsutism, coarse facial JUMC, Krakow, Poland features,muscleatrophies andscoliosis.Testingforseveral storagediseaseswasnormal.MRIshowedcorticalatrophy, Introduction: Mutations in the glucokinase (GCK) and right maxillary mucocele, corpus callosum hypoplasia, hepatocyte nuclear factor1a (HNF1A) gene are the most occipitalcyst.Hehadopticatrophyandaorticinsufﬁciency. common causes of maturity-onset diabetes of the young A diagnosis of mucopolysaccharidosis was suspicioned. (MODY). The management of both MODY types during Objectives: The goal was to establish a diagnosis for pregnancy is challenging and differs from other forms of optimal medical management and for establishing the diabetes. The aim was to assess clinical management and recurrence risk in order to offer genetic counselling to the pregnancyoutcomesamongwomenwithGCK-MODYand family. HNF1A-MODY. Method: Further investigations were performed. CT Material and Methods: We included 13 GCK and 14 showed skull hyperostosis, thickening of left clavicle and HNF1A-MODY patients. vertebrae (dysostosis multiplex) andfemoral head necrosis. Results: There was no signiﬁcant difference in age of EEGwashypovoltatedwithepileptiformdischarge.Genetic pregnancy between GCK-and HNF1A-MODY women; testing (panel for mucopolysaccharidoses) was performed. those with the HNF1A gene mutation were diagnosed with Results:Patientwas homozygousforSGSH c.1297C>T, MODY earlier (28vs.30years). HNF1A-MODY patients p.(Arg433Trp) mutation, classiﬁed as pathogenic. He was preconceptionbodyweightwashigher(67.28kg)compared diagnosed with Sanﬁlippo syndrome (MPZ type IIIA). toGCK-MODY(62.71kg),butthebodyweightgainduring Conclusions: As treatment for several types of mucopo- pregnancy was signiﬁcantly higher among GCK-MODY lysaccharidoses exists, diagnosis must be made as soon as patients(18.5vs.12.78kg,p<0.005).Treatmentmodiﬁcation possible. To our knowledge, cortical atrophy and corpus860 J.delPicchia callosum hypoplasia were described in other Sanﬁlippo N. Semenova: None. M. Kurkina: None. E. Dadaly: subtypes but - except for two Israeli Arab sisters from a None. D. Guseva: None. T. Strokiva: None. N. consanguineousfamily,innoothercasesofSanﬁlippotype Taran: None. A syndrome. This is the third case with these features, indicating they might also be associated with Sanﬁlippo E- P06
.21 type A syndrome. BH4-deﬁcient hyperphenylalaninemia in Russia E.S. Shelby: None. M. Axente: None. A.I. Grigoriu: None. L. Pădure: None. P. Gundorova1, I. A. Kuznetsova1, A. A. Stepanova1, A. V. Polyakov1, Y. S. Itkis2 E- P06
.20 A novel homozygous pathogenic PEX26 gene’s variant 1Federal State Budgetary Institution "Research Centre for in patients with Zellweger syndrome from Dagestan Medical Genetics", Moscow, Russian Federation, 2Research Centre for Medical Genetics, Moscow, Russian N. Semenova1, M. Kurkina1, E. Dadaly1, D. Guseva1, Federation T. Strokiva2, N. Taran2 Introduction: Tetrahydrobiopterin-deﬁcient hyperphenyla- 1Reseach Center for Medical Genetics, Moscow, Russian laninemia(BH4-HPA)isagroupofheterogeneousdiseases, Federation, 2Federal Research Centre of Nutrition and caused by impaired synthesis or regeneration of tetra- Biotechnology, Moscow, Russian Federation hydrobiopterin (BH4), a cofactor of the phenylalanine, tyrosine and tryptophan hydroxylases. Six different genes Introduction:Peroxisomebiogenesisdisorders(PBD)area are known as responsible for BH4 metabolism. The pro- heterogeneous group of autosomal recessive disorders that portion of BH4-HPA and the mutation spectrum of affect multiple organ systems. Approximately 80% of PBD BH4 synthesis and regeneration genes is unknown in patients are classiﬁed in the Zellweger syndrome spectrum, Russia. which are caused generally by mutations in the PEX1, Materialsandmethods:Duringthe20years,morethan PEX6, PEX10, PEX12, or PEX26 genes. 3,100 patients with PKU and HPA were diagnosed in the Materials and methods: We present two unrelated DNA-diagnostic laboratory of “RCMG”. Among them, 30 families of Dagestan origin with three 1-year-old male patients with BH4-HPA were identiﬁed. Sanger members with cholestasis hepatopathy and development sequencing of PTS and QDPR genes and custom panel delay. Parents of one family were consanguineous. All NGS sequencing of all HPA genes and DNAJ C12
 were patientswerebornatterm,hadappropriatebirthweightsfor performed. gestational age. From 2 months of age they have had poor Results: In 25 patients “HPA-BH4A” diagnosis was feeding, development delay. Physical examination showed conﬁrmed, 18 different PTS variants were found on 50 jaundiced,hepatosplenomegalyandcoagulopathy.At1year alleles. The most common variant were p.Thr106Met of age, they couldn’t sit and stand on their own. Two sibs (32,0%), p.Asn72Lys (20,0%), p.Arg9His (6,0%). Seven (monozygous twins) had very low cholesterol level and novel variant were found, including the whole PTS gene normal GGT. The concentrations of  C26
 and phytanic acid deletion. In 4 patients “HPA-BH4C” diagnosis was in plasma were increased and made up respectively conﬁrmed, 5 different QDPR variants were found on 8 13.2mM/ml (normal 0.22-2.2nN/ml) and 59.42mg/ml alleles. Three of them were not previously reported. Three (normal0-3.11mg/dl); ratio of  C26
/ C22
 was 0.149 (normal patients were homozygous and one compound-heterozy- 0.009-0.018). Another patient had normal phytanic acid gous. In addition, one patient with DOPA-responsive concentrationinplasma(0.01mg/ml)buthighlevelof C26
 dystonia and homozygous variant с.524С>А (p. and  C26
/ C22
 (15.4 and 0.312 respectively). All children Ala175Asp) in SPR gene was identiﬁed. had normal bile acid concentration in urine. Conclusions: The proportion of BH4-HPA in Russia is Results: NGS was used to analyze 52 genes responsible about1%ofallHPA.PTSgenemutationsleadtotheBH4- for hereditary diseases with cholestasis. A nucleotide HPA in 86% of cases, QDPR mutations in 14%. The variant in PEX26 gene was identiﬁed: c.347T>A (p. detection of BH4-HPA patients should be performed via Leu116Gln) in homozygous state. This variant was differential diagnostic methods. Nowadays the reported conﬁrmed with Sanger sequencing. Parents are healthy cohort is involved in setting up a pterin method into a and heterozygous for mutant allele. practice. Conclusions: Our clinical cases describe the phenotype P. Gundorova: None. I.A. Kuznetsova: None. A.A. associated with the c.347T>A (p.Leu116Gln) variant in Stepanova: None. A.V. Polyakov: None. Y.S. Itkis: None. PEX26 gen of Dagestan originAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 861 E- P06
.26 E- P06
.28 Screening for genetic variants associated with cardio- Variant nonketotic hyperglycinemia due to novel vascular diseases in patients with type 2 diabetes compound heterozygous LIAS mutations: a case with a mellitus branchpoint mutation I. Mihaleva1, M. Mincheva2,3, M. Hristova-Savova3, L. Pölsler1, B. Mühlegger1, S. Gang2, P. Traunfellner1, K. Belemezova3, M. Rizov3, S. Yovinska3, R. Dimova4, A. Amberger1, K. Wimmer1, S. Rudnik1, J. Zschocke1 T. Tankova4, P. Andreeva-Gateva1, I. Dimova2,3 1Institute of Human Genetics; Medical University 1Department of Pharmacology and Toxicology, Medical Innsbruck, Innsbruck, Austria, 2Department of Pediatrics University Soﬁa, Soﬁa, Bulgaria, 2Laboratory of Genomic and Adolescent Medicine; Academic Teaching Hospital diagnostics, Molecular Medicine Center, Medical Univer- LKH Feldkirch, Feldkirch, Austria sity Soﬁa, Soﬁa, Bulgaria, 3Genetic Laboratory, SAGBAL “DrShterev”,Soﬁa,Bulgaria,4DepartmentofEndocrinol- Nonketotic hyperglycinemia (NKH) results from defects in ogy, Medical University Soﬁa, Soﬁa, Bulgaria the glycine cleavage system and is characterized by neo- natal seizures, psychomotor delay, and elevated glycine Astrongassociationbetweentype2diabetesmellitus(DM) levels. It is caused by bi-allelic mutations affecting the and cardiovascular diseases (CVD) exists. CVD are the subunits of the mitochondrial glycine cleavage system leading cause of morbidity and mortality among patients (including GLDC). The term “variant NKH” refers to the with diabetes. Our objective was to study the allelic and deﬁciencyofoneoftheglycinecleavagecofactors,suchas genotypicfrequenciesofgeneticvariantsthathaveshowna lipoate. This organosulphur compound is also part of the strong association with CVD in diabetic patients with and oxoacid dehydrogenase complexes such as PDHC and without cardiovascular complications and to assess the requires lipoyl synthase (LIAS gene) for its biosynthesis. additional contribution of genetic variation in determining NKHwassuspectedinaboywhopresentedwithneonatal the risk for such complications. We have used CVD Stri- intractable seizures from day 2 and died at 6 weeks of age. pAssay kit (Vienna Lab) based on polymerase chain reac- Blood and CSF glycine concentrations were elevated, tion (PCR) and reverse hybridization. The following lactate was normal. mutationswerestudied:FVG1691A(Leiden),FVH1299R Massive parallel sequencing showed heterozygosity for (R2), Prothrombin G20210A, Factor XIII V34L, theknownGLDCmutationc.2316-1G>Aandthenonsense β-Fibrinogen-455G-A,PAI-14G/5G,GPIIIa L33
P(HPA- mutation c.985A>T, p.(Lys329*) in LIAS. Additionally, a 1), MTHFR  C677
T, MTHFR A1298C, ACE I/D, Apo B novel intronic variant c.551-24A>T affecting a predicted R3500Q, Apo  E2
/ E3
/ E4
. 36 diabetic patients divided in 2 branch point in LIAS intron 5 was found. Analysis of groupswereanalyzed:1)20diabeticpatientswithCVDand mRNAtranscriptsinlymphocytesoftheheterozygousLIAS 2) 16 diabetic patients without CVD. Results: We found c.551-24A>T carrier father showed retention of the 82-bp higher than population frequency for the following alleles/ intron. Presumably due to nonsense-mediated mRNA genotypes - 5.5% for FV Leiden allele, 9.7% for FVR2 decay, this splice effect, leading to the premature stop allele, 38.9% for β-Fibrinogen genotype -455G/A, 58.9% codon p.(Asp184Glyfs1*), was seen only in a small for PAI-1 4G allele, 36.1% for ACE D/D genotype. Sta- proportion of the father’s transcripts. A minigene experi- tisticallyhigherfrequencywasestablishedforβ-Fibrinogen ment conﬁrmed this effect in the majority of the minigene -455 G-A in the patients with CVD compared to non-CVD transcripts. (55% vs. 18.7%). Conclusion: We detected high frequency This case report represents the 6th patient with variant of β-Fibrinogen - 455 G/A genotype in diabetic patients, NKH due to bi-allelic LIAS mutations. It illustrates the especially in these with CVD. Based on its pro-inﬂamma- difﬁculties encountered by identiﬁcation of single hetero- tory role and its connection to possible thrombotic events, zygous coding or splice donor/acceptor variants in more patients would beneﬁt from anti-inﬂammatory treatment. than one candidate gene for a recessive condition. Acknowledgment:ThisstudywassupportedbyGrantNoD- L.Pölsler:None.B.Mühlegger:None.S.Gang:None.P. 66/2019, Medical University Soﬁa. Traunfellner: None. A. Amberger: None. K. Wimmer: I. Mihaleva: None. M. Mincheva: None. M. Hristova- None. S. Rudnik: None. J. Zschocke: None. Savova: None. K. Belemezova: None. M. Rizov: None. S. Yovinska: None. R. Dimova: None. T. Tankova: None. P. E- P07
 Immunology and Hematopoietic System Andreeva-Gateva: None. I. Dimova: None.862 J.delPicchia E- P07
.1 D. F. Osorio1, M. L. Agudelo1, O. I. Beltrán1,2 Novel Indel variants in the CALR gene in mieloproli- ferative neoplasm patients 1Facultad de Medicina, Universidad Militar Nueva Gran- ada, Bogotá DC, Colombia, 2Unidad de Genética. L. Gailite1, Z. Dobele1, D. Rots1, J. Isakova1, B. Janicka Organización Colsanitas SA, Bogotá DC, Colombia Kupra2, K. Bernate3, L. Belajeva2, L. Zarina2, S. Lejniece1 Introduction: Patients with rare diseases often go undiag- 1RigaStradinsUniversity,Riga,Latvia,2RigaEastClinical nosed for years while suffering from acute and/or chronic University Hospital, Riga, Latvia, 3Pauls Stradins Uni- symptoms and signs that resulting in numerous health ser- versity Hospital, Riga, Latvia vice use, multiple specialist involvement, and poor-quality life. The case report here describes a female adult with Objectives: Mieloproliferative neoplasm (MPN) subtypes familial articular hyperlaxity due to Loeys-Dietz Syndrome are diagnosed based on clinical and genetical data. JAK2 foundonexomesequencingandprimaryimmunodeﬁciency gene variants serves as diagnostic criteria for polycythemia conﬁrmed by hypogammaglobulinemia vera (PV), essential thrombocythemia (ET) and primary Methods: a retrospective analysis of family history, myeloﬁbrosis (PMF), while CALR gene variants - for ET detailed clinical history since infancy and adulthood, andPMF.Theaimofthestudywastosummarizemolecular physical evaluation by geneticist for contrasting phenotype data and utility of CALR gene indel testing in a clinical combined with immunological tests and trio exome MPN cohort. sequencing Material and methods: In the study 354 patients with Results: a 27-year-old woman of non-consanguineous MPN were included. All patients were tested for JAK2 p. parents; mother and aunts with symptoms of chronic V617F variant by qPCR and CALR gene indels by myalgia, joint hyperlaxity, frequent sprains. Sister presented ﬂuorescent-fragment length analysis (PCR-FFLA). Sanger multiple dislocations that have required surgical interven- sequencing was performed to conﬁrm and identify pre- tions. Father shows a history of asthma, various atopies and viously detected variants. depression. Since childhood, she presents mild hypotonia, Results: JAK2 gene variant p.V617F was identiﬁed in myalgia, recurrent ankle and rotula sprains and chronic 208 (58.8%) patients. Indels in CALR gene were identiﬁed fatigue without an identiﬁed cause. During high school has in 38 (10.7%) patients: 52bp deletion c.1099_1150del52 in suffered asthma, myopia, astigmatism, multiple foods, and 20 cases and 5bp insertion c.1154_1155insTTGTC in 12 medication allergies, inﬂammatory bowel disease, gastritis, cases. The rest six patients were identiﬁed to have rare overweight,depressionanddifﬁcultiesinlearning.Facewith variants: c.1103_1148del (2 patients), c.1111_1141del and downslanting palpebral ﬁssures, cutaneous and joint hyper- novel variants - c.1107_1140del and complex indel - laxity and skin striae. Normal echocardiography. Functional c.1131_1154delinsTTGTC (2 patients), that could be test revealed low serum IgG (5.76 g/L) and IgA (0.16 g/L), identiﬁed only with Sanger sequencing not by PCR-FFLA. normal postvaccinal antibodies production, and a trio-based CALR variant identiﬁcation in two patients with previously exome sequencing reporting a probably pathogenic variant diagnosedPVresultedinre-analysisoftheclinicaldataand (c.980G>A, p. Arg327Gln) in TGFB2 gene. changeofdiagnosistoET.ForonepatientJAK2andCALR Conclusion: Usually, cases with medical complexity can variant co-occurrence was identiﬁed. be explained by an extremely rare disease. However, Conclusions: CALR testing should be performed for all another hypothesis diagnostic maybe that constellation of MPN cases. CALR testing can help to distinguish PV from symptoms is due to the co-occurrence of two or more rare other MPN forms. Validation with Sanger sequencing is disease in an individual necessary to conﬁrm and identify rare CALR variants. D.F. Osorio: None. M.L. Agudelo: None. O.I. L. Gailite: None. Z. Dobele: None. D. Rots: None. J. Beltrán: None. Isakova:None.B.JanickaKupra:None.K.Bernate:None. L. Belajeva: None. L. Zarina: None. S. Lejniece: None. E- P08
 Intellectual Disability E- P07
.3 E- P08
.02 Young adult with co-occurrence of common variable Further clinical and molecular delineation of Alazami immunodeﬁciency and Loeys-Dietz syndrome: near the syndrome associated with variants in LAR P7
 end of the diagnostic odyssey?Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 863 E.Gumuslu1,K.Karaer2,E.Gumus3,A.Ekici1,C.Kraus1, Genomic Hybridization (aCGH) allows efﬁcient genetic A. Reis1 diagnosisofpathologicalconditionsbeforetheirfullclinical manifestation. Application of novel “genotype-ﬁrst” diag- 1Institute of Human Genetics, Friedrich-Alexander-Univer- nosis is of great importance to the patient’s health and sität Erlangen-Nürnberg, Erlangen, Germany, 2Gaziantep medical outcome due to higher rates of chromosomal GenetikHastaliklarTaniMerkezi,Gaziantep,Turkey,3Sitki abnormalities detection compared to conventional kar- Kocman University School of Medicine, Medical Genetics yotyping and multiple ligation-dependent probe ampliﬁca- Department, Mugla, Turkey tion (MLPA) analysis. Materials and methods: The aCGH technique was used Autosomal recessive neurodevelopmental disorders are to determine the genetic background of developmental extremely heterogeneous and for many only few affected abnormalities in a 8-year-old female Macedonian patient. individuals have been described hampering delineation of The blood-derived DNA sample was analyzed using the thefullspectrumofclinicalpresentation.Inalargestudyof Affymetrix® CytoScanTM 750K Array (Applied Biosys- Turkish consanguineous families we identiﬁed a family tems) that includes 550 k non-polymorphic and 200 k SNP with3affectedsiblings(twomales11and8y.o.andone5 markers. The data were interpreted by using Chromosome y.o.female)allpresentingwithintellectualdisability,severe Analysis Suite (ChAS) Software (v4.0). verbal deﬁciency (2-3 words), short stature (<3p), delayed Results: The patient showed the following clinical walking, seizures and dysmorphic features including malar conditions: motor delay, deafness, lack of concentration hypoplasia,broadnose,shortphiltrum,widemouthandfull and several dysmorhological features (blepharophymosis, lips. After excluding aneuploidies exome sequencing telecanthus, narrow palpebral ﬁssures, wide nose, low set revealed a novel frameshift insertion c.475_478dup, p. ears, small mouth and arched eyebrows). Noteworthy, the (Lys160Ilefs*2) in the LAR P7
 gene. LAR P7
 is a negative girl was operated from atrial septal defect and was transcriptional regulator of polymerase II, acting by means previously diagnosed with Ohdo Sy. Karyotyping results of the 7SK RNP system. revealed a normal female 46, XX karyotype, while the Frameshifting variants in LAR P7
 have been associated MLPAanalysisformicrodeletionswasnegative.TheaCGH with Alazami Syndrome (OMIM 615071) characterized by analysisdetected apathological microduplication occurring ID, severe growth restriction and characteristic facial at the 10q26.3 cytoregion (787 kb, 26 genes included), as dysmorphisms. To date, 15 patients were reported. By well as mosaic presence of 3 copies of the Xq26.3q28 comparing this family with the previously reported cases, cytoregion (15,864 kb, 115 genes included). westrengthenthekeyfeaturesofAS:ID,growthrestriction, Conclusion: The present chromosomal abnormalities andhighlightthefacialfeaturesincludingmalarhypoplasia, detected by aCGH analysis could be responsible for the broad nose, full lips and teeth abnormalities. Interestingly, developmental delay of the patient, considering their patholo- no cases with seizures were described, so far. As we failed gicalexpressionaccordingtoClinVardatabase.Furtherstudies to identify in exome sequencing any variant in seizure are needed to conﬁrm these preliminary ﬁndings. associated genes and all three siblings are concordant we D. Nestoroska: None. V. Anastasovska: None. E. wonderedifthissymptomispartoftheclinicalspectrumof Sukarova-Angelovska: None. M. Pesevska: None. G. AS. Although we cannot exclude an undetected cause Ilieva: None. independentofLAR P7
,weproposethatseizuresareasofar undescribed symptom associated with Alazami Syndrome. E- P08
.05 E.Gumuslu:None.K.Karaer:None.E.Gumus:None.A. BRAT1-related neurodevelopmental disorders: two Ekici: None. C. Kraus: None. A. Reis: None. unrelated patients - one previously undescribed mutation E- P08
.03 Genomic and clinical characterisation of microduplica- B. Eichhorn1, S. Weidensee2, H. Reichenbach3, M. Klaus1 tions in a patient with developmental delay 1MVZ Mitteldeutscher Praxisverbund Humangenetik D. Nestoroska, V. Anastasovska, E. Sukarova-Angelovska, GmbH, Dresden, Germany, 2MVZ Mitteldeutscher Prax- M. Pesevska, G. Ilieva isverbund Humangenetik GmbH, Erfurt, Germany, 3MVZ MitteldeutscherPraxisverbundHumangenetikGmbH,Leip- Genetic Laboratory, University Pediatric Clinic, Skopje, zig, Germany Macedonia, The Former Yugoslav Republic of BRAT1 gene mutations cause lethal neonatal rigidity and Introduction: The implementation of array Comparative multifocal seizure syndrome (RMFSL) or864 J.delPicchia neurodevelopmental disorder with cerebellar atrophy with Introduction: Loss-of-function variants in BRSK2 have or without seizures (NEDCAS), inherited in an autosomal- recently been described as causative for a neurodevelop- recessive manner. RMFSL is characterized by lack of mental phenotype in 12 individuals with speech delay and developmental progress, neonatal onset hypertonia, micro- variable additional features including intellectual disability, cephaly,intractableseizuresanddeathbeforetheageoftwo motordelay,behavioralissuesandautism.Hereweprovide years, whereas NEDCAS results in milder clinical course. a detailed clinical description of two further individuals Here, we report a 2 9/ -year-old girl with severe global with variants in BRSK2. 12 developmental delay (absent speech, no sitting), short sta- Materials and methods: We performed phenotype ture, microcephaly, mild facial dysmorphism, brain ven- analysis and exome sequencing on two individuals with tricle enlargement and stereotypic hand movements. The intellectual disability and developmental delay of secondfemalepatientshowedalsoprofounddevelopmental unknown cause. disability (nohead control), lack of eyecontactwith ocular Results: We identiﬁed two previously undescribed motility disturbance, microcephaly, and mild facial dys- heterozygous variants in BRSK2: the frameshift variant morphism. Epileptic seizures occurred at the second day of c.1398del; p.(Ser467Alafs*42) and the de novo missense life. She died at 17 months. A panel diagnostic via variant c.209T>C; p.(Leu70Pro). Both individuals pre- sequencing by synthesis was conducted, including candi- sentedwithdevelopmentaldelay/mildintellectual disability date genes contributing to neurodevelopmental disorders. with pronounced speech delay. One individual had Patient 1 and 2 each carried a well-described mutations unilateral renal agenesis and inguinal hernia, which have causing either RMFSL or milder phenotype (c.638dupA/p. not been described in individuals with BRSK2 variants (Val214Glyfs*189)) and involved in a RMFSL before. (c.2125_2128delTTTG/p.(Phe709Thrfs*17)), respectively. Conclusion: Our data provide further insight into the Additional, both girls harbour the identical previously BRSK2-associated phenotype. So far, no genotype-pheno- undescribed variant c.2164_2165delinsGA/p.(Leu722Asp) type correlation can be determined. resulting in a missense mutation. Generally, amino acid H.Kemmer:None.B.Popp:None.A.Verloes:None.D. substitutions in BRAT1 gene in homozygous or compound Horn: None. M. Holtgrewe: None. C. Zweier: None. N. heterozygous state have been described to be causative for Ehmke: None. neurodevelopmental disorders. Segregation analysis in our families conﬁrmed compound heterozygosity. There is a E- P08
.08 strong evidence for the disease causing effect of the New insights into the phenotype of CO L4
A3BP-related unknownmutationintheBRAT1gene,duetotheevidence intellectual disability: an emerging Golgipathy in two unrelated cases. Although a genotype-phenotype correlation is not noticeable for this variant. J. R. Alves1, J. Dupont1, J. P. Monteiro2, A. B. Sousa1 B. Eichhorn: None. S. Weidensee: None. H. Reich- enbach: None. M. Klaus: None. 1Serviço de Genética Médica, Hospital de Santa Maria, Centro Hospitalar e Universitário Lisboa Norte, Lisboa, E- P08
.06 Portugal, 2Serviço de Pediatria, Hospital Garcia de Orta, Phenotypic presentation of two additional individuals Almada, Portugal with heterozygous variants in BRSK2 Introduction: CO L4
A3BP encodes a protein implicated in H. Kemmer1, B. Popp2,3, A. Verloes4, D. Horn1, intracellular ceramide transport to the Golgi complex. De M. Holtgrewe5, C. Zweier3, N. Ehmke1 novo missense variants in this gene have been linked to developmental disorders (DD) in a large-scale study of 1Institute of Medical Genetics and Human Genetics, patients with severe undiagnosed DD (Fitzgerald et al., Charité-Universitaetsmedizin Berlin, Berlin, Germany, 2015). Only ﬁve patients have been reported to date and 2Institute of Human Genetics, University of Leipzig clinical data remains very scarce. We report a new patient Hospitals and Clinics, Leipzig, Germany, 3Institute of with CO L4
A3BP-related intellectual disability (ID) aiming Human Genetics, Friedrich-Alexander-Universität Erlan- to contribute to the recognition of this condition. gen-Nürnberg, Erlangen, Germany, 4Department of Genet- Materialsandmethods:Clinicaldatawascollectedfrom ics, APHP-Robert DEBRE University Hospital, Denis the patient’s medical records and compared with previous Diderot School of Medicine, Paris University, Paris, reports from scientiﬁc literature and databases. France, 5Core Unit Bioinformatics - CUBI, Berlin Institute Results: A 5 year-old girl with unremarkable family of Health, Berlin, Germany history, pregnancy and delivery, presented with postnatal microcephaly, axial hypotonia, and severe globalAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 865 developmental delay. Short stature and facial dysmorphisms words spoken at 2.5 years with poor vocabulary at the were noted and, at 24 months, she developed generalized moment. Good social skills were present. Karyotype was seizures.Currently,shedoesnotwalkunaided,saysonlyone normal. aCGH analysis showed 1 pathogenic copy of the word, and has poor visual contact and marked stereotypic segment on the chromosome 10q11.22 (437 kb) including behaviorwithbruxism.Wholeexomesequencingidentiﬁeda GPRIN2(611240) gene associated with brain development, de novo pathogenic variant in CO L4
A3BP ( S260
L). according to aDGV and ClinVar databases. Conclusions:Thismissensevariantwaspreviouslyfound Conclusions: The application of microarray will expand in 4 out of 5 known patients, suggesting a mutational the spectrum in diagnosing cytogenomic abnormalities by hotspotinthisgene.Formerfunctionalevidenceindicatesit including complex structural variants. resultsinintracellularimbalancesinceramide,pivotaltothe M. Pesevska: None. V. Anastasovska: None. E. Sukar- synthesis of sphingolipids. Our case has signiﬁcant overlap ova-Angelovska: None. D. Nestoroska: None. G. with clinical data from previous patients. This report adds Ilieva: None. evidence to an emerging consistent phenotype associated with CO L4
A3BP mutations, characterized by severe ID, E- P08
.10 postnatal microcephaly, epilepsy, autistic behavior includ- Deletion 7q31.2q31.31 segregating in a family with ing striking bruxism, and unspeciﬁc dysmorphic features. speech and language deﬁciencies J.R.Alves: None.J.Dupont:None.J.P.Monteiro: None. A.B. Sousa: None. M. Rieger1, M. Krumbiegel1, M. Reuter1, A. Schützenberger2, A. Reis1, C. Zweier1 E- P08
.09 Paediatric patient with deletion on chromosome 1Institute of Human Genetics, Friedrich-Alexander-Univer- 10q11.22 diagnosed by aCGH sität Erlangen-Nürnberg FAU, Erlangen, Germany, 2Divi- sionofPhoniatricsandPediatricAudiology,Departmentof M.Pesevska,V.Anastasovska,E.Sukarova-Angelovska,D. Otorhinolaryngology, Head and Neck Surgery, Friedrich- Nestoroska, G. Ilieva Alexander-Universität Erlangen-Nürnberg FAU, Erlangen, Germany University Pediatric Clinic, Skopje, Macedonia, The Former Yugoslav Republic of Deletions of chromosome 7q31 have been described in individualswithvariableneurodevelopmentaldisordersand Introduction: The microchip-based diagnostic practices speech impairment. These deletions usually contain become widely introduced in postnatal diagnosis of indi- FOX P2
, in which loss-of-function mutations represent a viduals with developmental delay and dysmorphism. Array major cause for speciﬁc language and speech phenotypes. ComparativeGenomicHybridization(aCGH)technologyto Recently,asinglepatientwithdevelopmentaldelayaswell whole human genome screening revealed an unexpectedly as speech and language impairment carrying a 3.2 Mb large number of deletions and duplications. deletion in 7q31.2q31.31 excluding FOX P2
 was reported. Materials and methods: aCGH analysis was perform in By chromosomal microarray analysis we now identiﬁed a pediatricpatientwithdysmorphiaandmotordelayusingthe similar microdeletion in three family members presenting CytoScan_750k Array platform (Affymetrix) which com- with variable speech, language and neurodevelopmental prises 550 k non-polymorphic and 200 k SNP markers by phenotypes.Theindexpatientpresentedwithnormalmotor the Chromosome Analysis Suite (ChAS) Software (v4.0). milestones but delayed speech development, reduced com- Results: Our patient was born with small birth weight prehension and an incomplete sentence structure at age 5 with idiopathic thrombocytopenia during the neonatal years.Atage10yearsheattendedaschoolforchildrenwith period. At the age of 4 years, she has short stature and special needs and presented with microcephaly, attention following sings of dysmorphia - sparse hair, baldness in deﬁcits and slurred speech. His sister was referred at age 3 infancy, slow growing hair, wide fontanel, dry skin, no years with normal ﬁrst milestones but a delay in speech sweating,smallteeth,deepseteyes,widenasaltip,smooth development. Linguistic testing revealed impairment of all philtrum, up slanted palpebraes, protruded tongue in language and speech levels with limited vocabulary and infancy, prominent forehead and some missing teeth-upper slurred and imprecise pronunciation. The mother had incisors. Hydronephrosis on the left kidney, reﬂux vesi- attended a school focusing on speech and language deﬁ- caurinaria, atrial septal defect, dilatated pulmonary artery ciencies and now presented with slurred speech. Segrega- and CNS plexus hypertrophy were noticed by ultrasono- tion analysis in the healthy, maternal grandparents did not graphy. Also, subclinical hypothyreosis was present. She detectthemicrodeletion,thusindicatingdenovooccurrence has mild motor delay, started to walk at 20 months, ﬁrst inthemother.Thedeletioncontains17genesandislocated866 J.delPicchia in close proximity to the 3’ end of FOX P2
, but not including it. Though positional effects on FOX P2
 expres- Clinicalandgeneticsfeaturesofbothpatients sion cannot be excluded, our ﬁndings support a new locus Feature Patient1 Patient2 on 7q31.2q31.31 associated with mild neurodevelopmental Coordinate(GRCh37) 233195538- 233195538- and more prominent speech and language phenotypes. 233318065 233311912 M. Rieger: None. M. Krumbiegel: None. M. Reuter: Length 123kb 116kb None. A. Schützenberger: None. A. Reis: None. C. Overlapped ALPP,ALPP L2
, ALPP,ALPP L2
, Zweier: None. codinggenes DI S3
L2  DI
S3 L2
 Inheritance father unknown E- P08
.11 Clinical signiﬁcance of 2q37.1 duplication in patients with intellectual disability and facial dysmorphism Discussion and conclusion: Duplication of 2q37 includ- ing DI S3
L2  is assumed as benign (DECIPHER, ISCA, Z. Capkova1,2, P. Capkova1,2, J. Srovnal1,3, K. Staffova1,3, ClinVar). We described two unrelated patients with ASD, K. Adamova1,2, J. Pazderova1, M. Hajduch3, ID and facial dysmorphia who carried the duplication of M. Prochazka1,2 2q37 including DI
S3 L2
. We suggest that this CNV might cause of abnormal phenotype with variable penetrance. Of 1Department of Medical Genetics, University Hospital course,wecannotexcludeanucleotidelevelchangeswhich Olomouc, Olomouc, Czech Republic, 2Department of could explain a variable penetrance of 2q37 duplication. Medical Genetics, Faculty of Medicine and Dentistry, Acknowledgment: Supported by MH_CZ_DRO_F- Palacký University Olomouc, Olomouc, Czech Republic, NOL_00098892, IGA_LF_2020_007 3InstituteofMolecularandTranslationalMedicine,Faculty Z. Capkova: B. Research Grant (principal investigator, of Medicine and Dentistry, Palacký University Olomouc, collaborator or consultant and pending grants as well as Olomouc, Czech Republic grants already received); Modest; University Hospital Olomouc, Palacký University Olomouc. P. Capkova: B. Background: 2q37 duplications including only ALPP, Research Grant (principal investigator, collaborator or ALPP L2
, DI S3
L2  have been already described in patients consultant and pending grants as well as grants already withIDandfacialdysmorphia.However,theseduplications received); Modest; University Hospital Olomouc, Palacký were concluded as benign variations based on inheritance University Olomouc. J. Srovnal: B. Research Grant from health parents. (principal investigator, collaborator or consultant and Aim:WereporttwounrelatedpatientswithASD,IDand pendinggrantsaswell asgrantsalreadyreceived); Modest; facial dysmorphic features. University Hospital Olomouc, Palacký University Olo- Methods: Karyotyping, exclusion of CGG triplet repeats mouc. K. Staffova: B. Research Grant (principal investi- expansion in FMR1 and chromosomal microarray (CMA) gator,collaboratororconsultantandpendinggrantsaswell were performed in both patients after informed consent as grants already received); Modest; University Hospital collecting from their parents. Olomouc, Palacký University Olomouc. K. Adamova: B. Results: Chromosomal aberration and Fragile-X syn- Research Grant (principal investigator, collaborator or drome were excluded in both. 2q37 duplication including consultant and pending grants as well as grants already ALPP, ALPP
L2 , DI
S3 L2
 was revealed by CMA. In patient received); Modest; University Hospital Olomouc, Palacký 1theduplicationwasinheritedfromfather.Inheritancewas University Olomouc. J. Pazderova: None. M. Hajduch: unknown in patient 2. No other clinically relevant CNVs None. M. Prochazka: None. were observed. E- P08
.14 Early neurodevelopmental milestones acquisition in Clinicalandgeneticsfeaturesofbothpatients fragile X syndrome, a caregivers online report Feature Patient1 Patient2 Height <3thpercentile 40thpercentile C. Azevedo Soares1,2, D. Gonzaga3, I. Vaz Matos3, Headcircumference <3thpercentile 34thpercentile N. Tkachenko1, A. Fortuna1,2, G. Soares1, A. Prior3 Weight <3thpercentile 23thpercentile 1Centro de Genética Médica Jacinto Magalhães, Porto, Bodymass 15.02 15.50 index(BMI) Portugal, 2Unit for Multidisciplinary Research in Biomedi- Addclinicalfeatures microcephaly none cine, Instituto de Ciências Biomédicas Abel Salazar/ Universidade do Porto, Porto, Portugal, 3Unidade deAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 867 Neurodesenvolvimento, Serviço de Pediatria, Centro compound-heterozygous mutations in the GRID2 gene, Materno-InfantildoNorte,CentroHospitalarUniversitário encoding an ionotropic glutamate receptor. So far, seven do Porto, Porto, Portugal affectedindividualsfromthreeunrelatedfamilieshavebeen reported. The disorder is characterized by delayed psycho- Introduction: Fragile X syndrome (FXS) is a genetic dis- motor development, intellectual disability, severely order affecting neurodevelopment caused by FMR1 dys- impaired gait due to progressive cerebellar ataxia, ocular function.Theidentiﬁcationofdevelopmentaldelaypatterns movement abnormalities, and progressive cerebellar atro- could accelerate the diagnostic of FXS in a population of phy in brain imaging. By trio exome sequencing, we now children with development delay. identiﬁed a novel homozygous variant (c.568C>T; p. Methods: We designed an online survey in which FXS Gln190*)inGRID2inafouryearoldfemalepatientfroma patients’ caregivers indicated patients characteristics. We consanguineous Iraqi family. Both parents were conﬁrmed usedtheHaizea-Llevantdevelopmentscaleasareferenceof to be heterozygous carriers. The patient was born after normalcy.Timeofacquisitionwasexpressedasmonthsold uneventful pregnancy and showed early-onset severe (mo) and for each milestone timing it was calculated the delayed psychomotor development. At the age of 4 years, median (M) and  P25
 and  P75
 ( P25
- P75
). she does not sit, walk or speak and presents with severe Results:Fifteencaseswereconsideredforanalysis:three muscular hypotonia. Further clinical characteristics are a females and 12 males. The median age for postnatal distinct truncal and appendicular progressive ataxia and diagnosis was 48 mo: 36 mo for males and 72 mo for binocularverticalnystagmuswithahighfrequenthorizontal females.MaleFXSpatientsshowedadelayedacquisitionof component, central hearing loss and incomplete loss of early milestones such as cervical control (M= 6mo, 2-12 sight.Shedoesnotﬁxobjectsorinteracts withpeople.She mo) with normal median time of acquisition of the ﬁrst isdystrophicwithaweightunderthethirdpercentileofthe word (M= 13mo, 11.75-21mo), and delayed acquisition of centralEuropeanstandard.Eatinghairandgnashingofteeth autonomous walking (M= 22mo, 16.5-24 mo). Given the are striking behaviors. In addition, cerebral magnetic reso- small number of female FXS in our study, it was not nance imaging (MRI) showed cerebellar hypoplasia. Our possible to conclude if females had a characteristic pattern ﬁndings further delineate the mutational and clinical spec- of developmental delay. trum of GRID2 associated spinocerebellar ataxia type 18. Conclusions: FXS patients present a biphasic delayed K.L.M.L. Hetzelt: None. C. Kraus: None. S. Kusnik: development intheﬁrst twoyears of lifewithanimportant None.C.Thiel:None.A.B.Ekici:None.A.Reis:None.C. delayontheacquisitionofgrossmotorskills.Nevertheless, Zweier: None. the clinical presentation was highly variable to allow the discrimination these patients with FXS by their pattern of E- P08
.17 developmental delay. Notwithstanding, this work bring the A novel patient helps to deﬁne the phenotype, develop- attentiontotheearlygrossmotorskillsimpairmentinFXS, mental trajectory and clustering of de novo missense that can be improved with targeted interventions. mutations in the HECW2 syndrome C. Azevedo Soares: None. D. Gonzaga: None. I. Vaz Matos: None. N. Tkachenko: None. A. Fortuna: None. G. S. Bendova1, M. Vlckova1, M. Hancarova1, D. Prchalova1, Soares: None. A. Prior: None. V. Stranecky2, Z. Sedlacek1 E- P08
.16 1Department of Biology and Medical Genetics, Charles A case of autosomal recessive spinocerebellar ataxia University 2nd Faculty of Medicine and University Hospital type 18 with a novel mutation in GRID2 Motol, Prague, Czech Republic, Prague, Czech Republic, 2Department of Pediatrics and Adolescent Medicine, Diag- K. L. M. L. Hetzelt1, C. Kraus1, S. Kusnik2, C. Thiel1, nostic and Research Unit for Rare Diseases, Charles A. B. Ekici1, A. Reis1, C. Zweier1 University 1st Faculty of Medicine and General University Hospital,Prague,CzechRepublic,Prague,CzechRepublic 1Institute of Human Genetics, Friedrich-Alexander-Univer- sität Erlangen-Nürnberg FAU, Erlangen, Germany, De novovariants in HECW2,whichencodes theHECT,  C2
 2DepartmentofPediatrics,UniversityHospitalforChildren and WW domain containing  E3
 ubiquitin protein ligase 2, and Adolescents, Friedrich-Alexander-Universität Erlan- were initially identiﬁed in large exome sequencing (ES) gen-Nürnberg FAU, Erlangen, Germany studies.AseriesofsevenpatientsclearlyassociatedHECW2 withaneurodevelopmentaldisorderwithhypotonia,seizures Autosomal-recessivespinocerebellarataxiatype18isarare and absent language (OMIM #617268) in 2017. Since then geneticneurologic disorder. It iscaused by homozygous or onlytwonovelcasereportshavebeenpublished.Wepresent868 J.delPicchia the genotype, phenotype and developmental trajectory of a dysmorphism including upslanting palpebral ﬁssure, bul- new patient, and review all previous cases. The 8-year-old bous nose, cleft lip and palate, pectus excavatum, boy has hypotonia, microcephaly, failure to thrive, severe intellectual disability, developmental delay, hypotonia and intellectual disability, absent speech, and seizures. His facial increased alkaline phosphatase level. One out of three featuresincludeprominentupperlipandstrabismus.TrioES sisters of index patient had similar clinical features. The identiﬁeddenovovariantChr2(GRCh37):g.197106886C>T, other family members were healthy. Whole exome sequen- NM_001348768.1(HECW2):c.3572G>A, p.(Arg1191Gln). cing (WES) was performed to the index patient. Sanger Thevarianthasbeenreportedinthreepreviouspatients,and seguencing analysis was used for family segregation is considered causal for the HECW2 syndrome. The pheno- analysis. type of the patient ﬁts the previous cases; however, he also Results: A novel homozygous mutation (c.715_717del hasaventricularseptumdefect,andheneitherhasabnormal TGG;p.Trp239del)ofPGA P3
genewasdetectedwithWES brain MRI ﬁndings nor requires gastrostomy tube feeding. analysis in the index patient (NM_033419.5). Family Long-termfollow-upshowsregressionofmotorskillsaround segregationanalysiswasperformedandbioinformatictools 12 months, abnormal EEG ﬁndings since 14 months wereusedfortheevaluationofthisnovelvariant.Thesame (prompting anti-epileptic therapy), and self-injurious beha- homozygous mutation was noted by sanger seguencing viour and sleep disturbances since 45 months of age. Our analysis in her younger sister, who had similar clinical analysis(includingvariantsfromlargestudiesanddatabases) features. Both parents and the other healthy sisters were indicatesthatdeleteriousmissenseHECW2variantsclusterin heterozygous for this mutation. exons encoding the HECT domain and its adjacent region Conclusions:Wereportenovelhomozygousmutationof (exons20-29,withresiduesArg1191,Arg1330andGlu1445 PGA P3
 gene. HPMRS should be kept in mind in patients being the hotspots), and possibly also the WW2 domain with developmental delay, hypotonia, cleft palate and mild (exons 12-13). Concurrently, these regions are deserts for to moderate serum ALP elevation. missense variation in normal individuals. Supported by 17- F.Hazan:None.S.Gürsoy:None.P.Karaoğlu:None.Ü. 29423A, LM2018132 and 00064203. Yılmaz: None. S. Bendova: None. M. Vlckova: None. M. Hancarova: None. D. Prchalova: None. V. Stranecky: None. Z. E- P08
.19 Sedlacek: None. A 3-year old girl with Hypotonia, Ataxia, And Delayed- Development Syndrom (HADDS) E- P08
.18 AnovelPGA P3
mutationintwosiblingswithhyperpho- K. Khuller1, T. Haack2, C. Finetti3, F. J. Kaiser1, sphatasia with mental retardation syndrome A. Kuechler1 F. Hazan1, S. Gürsoy2, P. Karaoğlu3, Ü. Yılmaz3 1Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany, 2Institut für 1DepartmentofMedicalGenetics,Dr.BehcetUzChildren’s MedizinischeGenetikundAngewandteGenomik,Tübingen, Hospital,Izmir,Turkey,2DepartmentofPediatricGenetics, Germany, 3SPZ, Elisabeth-Krankenhaus, Essen, Ger- Dr.BehcetUzChildren’sHospital,Izmir,Turkey,3Depart- many ment of Pediatric Neurology, Dr. Behcet Uz Children’s Hospital, Izmir, Turkey Hypotonia, ataxia, and delayed development syndrome (HADDS, OMIM #617330) is a neurodevelopmental syn- Introduction: Hyperphosphatasia with mental retardation drome characterized by congenital hypotonia, delayed syndrome (HPMRS) OMIM # 239300), is an autosomal psychomotor development, variable intellectual disability recessive disorder characterized facial dysmorphism, intel- with speech delay, variable dysmorphic facial features, and lectual disability, seizures, cardiac abnormalities, develop- ataxia,oftenassociatedwithcerebellarhypoplasia.In2017, mental delay and elevated alkaline phosphatase. Six heterozygous variants in EBF3 are described for the ﬁrst subgroups of HPMRS were ideﬁned in which pathogenic time by three parallel publications in 2017 as causative for mutations affect genes involved in either synthesis (PIGV, HADDS (Chao et al., 2017, Harms et al., 2017, Sleven PIGW, PIGO, PIGY) or remodeling (PGA P2
, PGA P3
) of et al., 2017). At present, 23 patients with different types of the anchor proteins. mutations including missense, frameshift or nonsense Material and methods: A two year-old girl patient was mutations as well as variants affecting conserved splice referred to our genetic clinic for intellectual disability and elements are reported. All reported cases showed a hetero- hypotonia. There was a ﬁrst-degree consanguinity between genous phenotype. We report on a case of a 3-year old girl the parents. This patient had microcephaly, facial with a class 5-mutation in EBF3, detected by Next-Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 869 Generation-Sequencing. She presented with delayed O. Levchenko: None. N. Demina: None. A. development, microcephaly, ataxia, reﬂux, and feeding Lavrov: None. difﬁculties. She also showed a thermoregulatory dysfunc- tion, which was not observed in other affected individuals E- P08
.23 sofar.Wepresentdetailedclinicaldataofourpatientinthe Patient with the Tatton-Brown-Rahman syndrome &lt context of the current literature thus expanding the pheno- de novo constitutive DNMT3A variant typic spectrum of the HAAD syndrome. K.Khuller:None.T. Haack:None. C.Finetti:None.F.J. I. Jaszczuk1,2, I. Winkler3, A. Sobczyńska-Tomaszewska4, Kaiser: None. A. Kuechler: None. M. Lejman5, A. Pietrzyk4, M. Kacprzak4 E- P08
.20 1University Children’s Hospital, Department of Pediatric TMEM222 is a new cause of autosomal recessive Hematology, Oncology and Transplantology, Lublin, intellectual developmental disorder Poland, 2Department of Cancer Genetics with Cytogenetic Laboratory, Medical University, Lublin, Poland, 3St’Johns O. Levchenko, N. Demina, A. Lavrov Center Oncology, Lublin, Poland, 4MedGen Medical Centre, Warsaw, Poland, 5Genetic Diagnostics, Depart- Research centre for medical genetics, Moscow, Russian ment of Pediatric Hematology, Oncology and Transplan- Federation tology, Medical University, Lublin, Poland Introduction: The prevalence of autosomal recessive Introduction: Tatton-Brown-Rahman syndrome (TBRS; intellectual developmental disorder (ARIDD) in affected OMIM 615879) isanovergrowthandintellectual disability children of an outbred population is estimated about 10%. syndrome, ﬁrst described in 2014. Additional clinical fea- There are 72 types of ARIDD described in OMIM. tures includedysmorphic features, obesity,musculoskeletal TMEM222 was once described as a candidate gene for disorders (hypotonia, hypermobility, kyphoscoliosis) and ARIDD with moderate intellectual disability, speech delay, behavioural problems (autistic spectrum disorders) and mild hypotonia, aggressiveness and body shivering. afebrile seizures. The underlying cause of the syndrome is Materials and methods: Whole exome sequencing constitutivevariantsintheDNMT3gene.Wepresentan11- (WES) was performed using IlluminaTruSeq® ExomeKit old boy with recognized Tatton-Brown-Rahman syndrome and IDT xGen® Exome Research Panel on Illumina and conﬁrmed variant in the DNMT3 gene. NextSeq 500. Materials and methods: During molecular diagnostic Results: We describe the Caucasian 31-year-old men procedure analysis of FMR1 gene for FRAXA syndrome born from consanguineous parents. Birth weight was 4800 and panel of 264 genes correlated with autism and mental g,conditionsevere.Hehadinfantilespasmswhenwokeup retardation (NGS) were performed. duringﬁrst2-8months.Hewalkssince3yearswithataxia, Results: For FMR1 gene expansion of CGG repeats was speaks few words, understands speech and uses computer. not identiﬁed. NGS analysis allowed identiﬁcation of Phenotype: hypotonia, microcephaly, hypothelorism, big known heterozygotic variant p.Pro904Leu (c.2711C>T) in nose, short philtrum, big mouth, full lips, gingival the DNMT3A. This variant is reported in dbSNP database hyperplasia, small chin, broad and short distal phalanges, (rs149095705) and ClinVar Database as likely pathogenic. narrow feet with valgus deformity, broad big toe. His Molecular analysis of p.Pro904Leu was also performed for brother 11 years old has similar phenotype but with proband’s mother and sister were mutation was not prominentincisorsandseizuressincebirth.Hecannotwalk identiﬁed. Unfortunately the father’s material was not andspeak.Hisbirthweightwas4700g.Theirhealthysister available for genetic analysis. There is high probability of hadbirthweight3500g.WESrevealedhomozygoussplice de novo character of identiﬁed variant. variant c.539+2T>C NM_032125 in TMEM222. Sanger Conclusions: In the case of patients with intellectual sequencing conﬁrmed this variant as heterozygous in disability and obesity, Tatton-Brown-Rahman syndrome parents and sister, and homozygous in affected brother. should be considered in the differential diagnosis. Studies Conclusions: Given the similarity of the phenotype with using theNGStechnique facilitate thediagnosisofpatients thepreviouslydescribed,thecorrespondenceofsegregation with intellectual disabilities. to the autosomal recessive type of inheritance, we suppose I. Jaszczuk: None. I. Winkler: None. A. Sobczyńska- this variant to be causative. We describe new ARIDD with Tomaszewska:None.M.Lejman:None.A.Pietrzyk:None. developmentaldelay,hypotonia,seizures,highbirthweight M. Kacprzak: None. and dimorphisms.870 J.delPicchia E- P08
.24 S.Susgun:None.E.Yucesan:None.O.Kocaturk:None. Biallelic NALCN variant detected by homozygosity M. Calik: None. U. Ozbek: None. S. Ugur Iseri: None. mapping and whole exome sequencing in a consangui- neous family from Turkey E- P08
.27 Laryngomalacia, recurrent overgrowth of pharyngeal S. Susgun1,2,3, E. Yucesan1, O. Kocaturk4, M. Calik5, lymphoid tissue, mild developmental delay and macro- U. Ozbek2,6, S. Ugur Iseri2 cephaly in a girl with a de novo heterozygous mutation in ZBTB7A 1Department of Medical Biology, Faculty of Medicine, BezmialemVakifUniversity, Istanbul, Turkey, 2Department C.vonderLippe1,K.Tveten1,Ø.L.Holla1,Ø.L.Busk1,M. ofGenetics,AzizSancarInstituteofExperimentalMedicine, G. Haug2, W. Thorstensen3,4, A. K. Aasebøstøl3, Istanbul University, Istanbul, Turkey, 3Graduate School of T. Prescott1 Health Sciences, Istanbul University, Istanbul, Turkey, 4Department of Neurology, Faculty of Medicine, Harran 1DeptofMedicalGenetics,TelemarkHospitalTrust,Skien, University, Sanliurfa, Turkey, 5Department of Pediatric Norway, 2Dept of Medical Genetics, St. Olavs University Neurology, Faculty of Medicine, Harran University, Hospital, Trondheim, Norway, 3Dept of Otolaryngology, Sanliurfa, Turkey, 6Department of Medical Genetics, Head and Neck Surgery, St. Olavs University Hospital, School of Medicine, Mehmet Ali Aydinlar Acibadem Trondheim, Norway, 4Dept of Neuromedicine and Move- University, Istanbul, Turkey ment Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway Neurodevelopmental disorders (NDD) are a large and het- erogeneous group of diseases including intellectual dis- Case:This12-year-oldgirlhadacongenitalumbilicalhernia ability,developmentaldelayandautismspectrumdisorders. and laryngomalacia, as well as frequent upper airway infec- Several ultra rare NDD associated variants in numerous tions, obstructive sleep apnea and serious otitis media from genesspeciﬁcalmosttosinglefamilieshavebeenidentiﬁed infancy. Strikingly, recurrent pharyngeal lymphoid hyper- by unbiased next generation sequencing technologies. To plasiahasnecessitated17surgicalprocedures;startingatage determine the genetic component of NDD in a con- 15monthsold.Herthymusisdescribedaslargeforherage. sanguineousfamilyfromTurkey,wehaveperformedSNP- Generalized lymphadenopathy / hepatosplenomegaly are based homozygosity mapping in the family along with absent. She has mild motor and language delay. Current whole exome sequencing (WES) in the affected sib pair. measurements are height 25%, weight 4 kg > 97,5%, head The SNP genotyping data generated on two different array circumference97,5%.WES-triodetectedadenovononsense chips was combined with PLINK to detect homozygous variant in ZBTB7A, NM_015898.3:c.832G>T p.(Glu278*). stretchescommontotheaffectedsibpair.TheWESdatawas Thevariant isnot presentingnomAD, and the geneisLoF- ﬁltered for rare alleles with predicted pathogenic impact on intolerant(pLI=0.96;O/e=0:07)andispredictedtoresultin proteinfunctioninthehomozygousloci.Thiscollectiveeffort NMD. No other SNVs ofinterestweredetected,and a 180k has led us to identify a loss of function variant in NALCN in array CGH analysis was unremarkable. the homozygous state. Sanger sequencing has conﬁrmed Discussion: ZBTB7A (OMIM #605878) encodes the segregation of this variant with the NDD phenotype in the leukemia/lymphoma related factor, LRF ZBTB7A is a pedigree. NALCN encodes a member of sodium leak channel candidate gene for some phenotypic features reported in complexandisassociatedwitharecessiveOMIMphenotype; individualswithmicrodeletionsofchromosome 19p13.3; Hypotonia, infantile, with psychomotor retardation and notably macrocephaly, obesity, sleep apnea, umbilical characteristic facies 1 (MIM:615419) hernia, learning difﬁculties and developmental delay Our study presents the combined analysis of linkage and (1,2) - all features present in the girl we describe. Ohishi exomeanalysisasapowerfulandprecisetooltodiagnosea et al. (3) recently reported a boy with macrocephaly, clinically rare and recessively inherited condition on intellectual disability and sleep apnea who had a de novo molecular level. We are planning to analyze possible likely pathogenic heterozygous missense variant in functional effects for the variant using in vitro studies to ZBTB7A. enlighten the molecular pathogenesis. Conclusion:WebelievethatthedenovoZBTB7Avariant ThisworkhasbeensupportedbythegrantsofTUBITAK in our patient is the cause of her distinct phenotype -- (113 S331
) and TUBA GEBIP 2019 program and Bezmia- laryngomalacia, recurrent overgrowth of pharyngeal lym- lem Vakif University Scientiﬁc Research Support Unit phoid tissue, macrocephaly and delayed motor and (Project no:12.2019/9) language development.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 871 C. von der Lippe: None. K. Tveten: None. Ø.L. Holla: E- P08
.32 None. Ø.L. Busk: None. M.G. Haug: None. W. Thor- The clinical utility of targeted NGS in neurodevelop- stensen: None. A.K. Aasebøstøl: None. T. Prescott: None. mentaldisorders:acaseofagirlwithpontocerebellar hypoplasia caused by TSEN54 gene pathogenic E- P08
.31 variants Study of diagnostic yield of genetic studies in neuronal migration disorders M. Wayhelova1,2, V. Vallova1,2, E. Hladilkova2, H. Filkova2, J. Oppelt3, J. Soukalova2, P. Kuglik1,2 N. Ortiz Cabrera, M. Vilar Egea, B. Fernández Garoz, V. Cantarín Extremera, A. Duat Rodríguez, L. González 1Department of Experimental Biology, Faculty of Science, Gutierrez Solana, M. Jimémez Legido, V. Soto Insuga, MasarykUniversity,Brno,CzechRepublic,2Departmentof M. Ruiz Falcó, J. García Peñas Medical Genetics, University Hospital Brno, Brno, Czech Republic, 3CEITEC-Central European Institute of Technol- HospitalInfantilUniversitarioNiñoJesús,Madrid,Spain ogy, Masaryk University, Brno, Czech Republic Neuronal migration is the key factor in lamination of cer- Next-generation sequencing (NGS) techniques represent ebral cortex. At 12th day stage of development neuronal a widely used, powerful tool for the identiﬁcation of the progenitorsbeginmigration.Excitatoryneuronsarebornin genetic causes of neurodevelopmental disorders and the dorsal ventricular zone and migrate superﬁcially to the congenital abnormalities. We present a case of a girl cortical plate. These neurons migrate along the vertical (*2016) from the 3rd gravidity of healthy non-con- ﬁbers of the radial glia. The layers of the cortex form in an sanguineous couple (mother *1984, father *1978). She “inside-out” sequence with later born neurons migrating was diagnosed a global developmental delay, micro- past their predecessors in the cortical plate so that they are brachycephaly,severedysplasiaofbrainstemandmuscle more superﬁcial in their ﬁnal position than earlier born hypertonia. She has a normal female karyotype 46,XX neurons(1). and normal array-CGH proﬁle arr(1-22,X)x2. She was The neuronal migration disorders (NMD) include: lissen- investigated by targeted NGS by gene panel ClearSeqXT cephaly, periventricular heterotopia, polymicrogyria (PMG) Inherited Disease (Agilent Technologies) containing and cortical dysplasias(2). NMD present with: epilepsy, more than 2700 genes known to cause inherited dis- developmental delay (DD), intellectual disability (ID) and orders. We detected pathogenic variants in the TSEN54 other malformation could be associated. Although the gene in compound heterozygosity, NM_207346.2:c.[56 majority of this disorders have a genetic base, some +2T>G;160C>G];[919G>T]. The parents are healthy environmental causes such as intrauterine infections could heterozygouscarriersofthesevariants,aswasconﬁrmed causethem(3).Todaymorethan100geneshavebeenrelated by Sanger sequencing. Pathogenic variants of the to NMD (3) including genes related to tubulinopathies (2). TSEN54 are causative in extremely rare pontocerebellar WedidanobservationalstudyofNMDpatientsseenatthe hypoplasia (PCH) type 2A, 4 and 5. The combination Clinical Geneticclinic from june2018until december 2019. of splicing and missense variants has been described We analyzed the results of NGS based genetic studies. in only one case of PCH5 so far, resulting in recurrent Results: 29 patients were studied, the global diagnostic fetal lethality. Therefore, we suggest the TSEN54 yieldwas28%.Wewereabletodetectlargedeletionsusing pathogenic variants could have been the cause of pre- NGS. We found pathogenic variants in ARFGEF2, ARX, vious recurrent abortions in the presented family. This DEPD C5
, DYN C1
H1, NEDD4L, PAFAH1B and TCF20. case showed the usefulness and effectivity of our mole- Pathogenic variants in DEPD C5
 were the most frequent cular diagnostics algorithm enhanced by NGS approa- pathogenic ﬁnding 29% of positive results. ches to elucidate the molecular genetic causes in Conclusions: One third of patients with NMD will heterogeneous neurodevelopmental disorders. Supported beneﬁt from a genetic diagnosis. DEPD C5
 is a frequently by the project of Faculty of Science of Masaryk Uni- involved in this disorders. versity MUNI/A/1127/2019 and IP UH Brno 2019 N. Ortiz Cabrera: None. M. Vilar Egea: None. B. PIG 5/19. Fernández Garoz: None. V. Cantarín Extremera: None. A. M. Wayhelova: None. V. Vallova: None. E. Hladilkova: Duat Rodríguez: None. L. González Gutierrez Solana: None. H. Filkova: None. J. Oppelt: None. J. Soukalova: None. M. Jimémez Legido: None. V. Soto Insuga: None. None. P. Kuglik: None. M. Ruiz Falcó: None. J. García Peñas: None.872 J.delPicchia E- P08
.33 ears.Hehaswidelyspacedteethandelongatedgums.Since Intrafamilial variability of Refsum syndrome the age of 8 months he has fever/infection associated seizures but needs no permanent medication. S. Geuer, I. Schwaab, R. König In this report we present detailed clinical and molecular data of a new patient with SKDEAS to raise awareness of Bioscientia, Ingelheim, Germany this clinically recognizable rare intellectual disability syndrome. A consanguine Pakistani couple with two daughters affec- A. Busche: None. M. Vockel: None. A. Bohring: None. ted by intellectual disability and developmental delay has been investigated by genetic diagnostics. The younger girl E- P08
.36 hasmoreseveredevelopmentdelayandshowsincontrastto Two families with inherited protein truncating CHD3 her sister microcephaly, craniosynostosis and autistic variants suggest reduced penetrance in Snijders Blok- behaviour. Whole exome sequencing of the more severe Campeau syndrome affectedsisterrevealedahomozygouspathogenicvariantin PEX5 - a gene known to be causative for autosomal J. van der Spek1, J. den Hoed2, L. Snijders Blok1,2,3, recessive Refsum syndrome. Segregation analysis con- C.W.Ockeloen1,M.E.H.Simon4,L.E.L.M.Vissers1,3,S. ﬁrmed homozygosity of the variant in the other sister and E. Fisher2,3, T. Kleefstra1,3 heterozygosityoftheparents.Wholeexomesequencingdid notdetectanotherpotential pathogenicvariant.Thus,itcan 1Department of Human Genetics, Radboud University be concluded that the detected PEX5 variant causes a Medical Center, Nijmegen, Netherlands, 2Language and Refsum syndrome with uncharacteristic features and ahigh Genetics, Max Planck Institute for Psycholinguistics, intrafamilial variability. Nijmegen, Netherlands, 3Donders Institute for Brain, S. Geuer: A. Employment (full or part-time); Signiﬁcant; CognitionandBehaviour,Nijmegen,Netherlands,4Depart- Bioscientia. I. Schwaab: A. Employment (full or part- ment of Medical Genetics, University Medical Center time); Signiﬁcant; Bioscientia. R. König: A. Employment Utrecht, Utrecht, Netherlands (full or part-time); Signiﬁcant; Bioscientia. Chromodomain Helicase DNA-binding 3 (CHD3) is a E- P08
.35 chromatin remodeling ATPase which functions as an A further patient with Skraban-Deardorff syndrome: important subunit of the nucleosome remodeling and dea- Presentation of the clinical and molecular phenotype of cetylase (NuRD) complex. De novo mutations in CHD3 a rare intellectual disability syndrome resultinSnijdersBlok-Campeausyndrome(#MIM618205), characterized by global developmental delays and/or intel- A. Busche, M. Vockel, A. Bohring lectual disability, speech delay, macrocephaly, hypotonia and facial dysmorphism. The vast majority (~95%) of InstitutfürHumangenetik,WestfälischeWilhelms-Universi- pathogenic mutations reported so far are missense muta- tät, Münster, Germany tions. Interestingly, CHD3 is predicted to be extremely intolerantforlossoffunctionvariance.Non-penetranceand/ The Skraban-Deardorff syndrome (SKDEAS, or variable expressivity has not been reported. Here we OMIM#617616)isararegeneticconditioncharacterizedby describe two cases with seemingly pathogenic, but inher- intellectualdisability, ahistoryoffebrileand/or non-febrile ited, protein truncating variants in CHD3. seizures, and a recognizable facial appearance. SKDEASis In a 4-year-old girl with global developmental delay, caused by heterozygeous mutations in WDR26 autism spectrum disorder, severe feeding difﬁculties, and (OMIM*617424)andisinheritedinanautosomaldominant facial dysmorphisms, ﬁtting with the spectrum of Snijders pattern. To our knowledge only 15 patients have been Blok-Campeau syndrome, whole exome sequencing reported so far. revealed a nonsense variant, p.(W1217*), in the CHD3 Here we present a 3 year and 3 months old boy with helicasedomain.Thevariantwasinheritedfromherhealthy SKDEAS due to the heterozygous de novo mutation mother and grandmother. c.508G>T; p.(Gly170*) in WDR26. He has moderate In a 3-year-old boy with developmental delays, pre- intellectual disability and shows the characteristic facial dominated by speech delay, another maternally inherited gestalt comprising prominent forehead, bitemporal narrow- nonsense variant, p.( S1443
*), was found. Facially, he ing, large appearing eyes with rounded palpebral ﬁssures, resembled the gestalt previously described for Snijders depressed nasal root, rounded nasal tip, anteverted nares, Blok-Campeausyndrome. Hismother,inwhomthevariant short philtrum, tended upper lips, full checks, and low setAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 873 was de novo, had macrocephaly and was otherwise performed within the TRANSLATE-NAMSE care project. unaffected. Theresultingvariantswereprioritizedusingphenotypeand Thesetwocasesexemplifythatproteintruncatingvariants imagedata(PEDIA/PrioritizationofExomeDatabyImage in CHD3 may result in reduced penetrance and/or variable Analysis). A probably pathogenic hemizygous variant expressivity.Wearecurrentlycollectingmorefamilieswith c.410A>G;p.(Asp137Gly)intheSMSgenewasdetectedin inherited CHD3 variants to enhance our understanding of both brothers and subsequently also in the affected cousin. disease penetrance in Snijders Blok-Campeau syndrome. The mothers are heterozygous carriers of the SMS variant. Additionally, we will perform functional studies of these We emphasize the marked intrafamilial variability of CHD3 variants to increase our insight in the underlying intelligence from low normal to mild / moderate ID of this pathogenic mechanisms. rareandpossiblyrecognizableX-linkedDD/IDsyndrome. J. van der Spek: None. J. den Hoed: None. L. Snijders K.Cremer:None.S.Hoffjan:None.A.Schmidt:None.S. Blok: None. C.W. Ockeloen: None. M.E.H. Simon: Peters: None. M. Kreiß: None. E. Mangold: None. M. None. L.E.L.M. Vissers: None. S.E. Fisher: None. T. Mücke: None. H. Hundertmark: None. F. Brand: None. A. Kleefstra: None. Heimbach: None. A. Knaus: None. A. Buness: None. S. Sivalingam: None. P.M. Krawitz: None. H. Engels: None. E- P08
.37 Snyder-Robinson syndrome with notable intrafamilial E- P08
.39 clinical variability detected by WES and PEDIA X-linked TAF1 intellectual disability - decoding a new neurodevelopmental entity in the genomic era K.Cremer1,S.Hoffjan2,A.Schmidt1,S.Peters1,M.Kreiß1, E. Mangold1, M. Mücke3, H. Hundertmark1, F. Brand4, A. R. Gouveia, O. Moldovan, A. B. Sousa Heimbach1, A. Knaus4, A. Buness5, S. Sivalingam5, P. M. Krawitz4, H. Engels1 Serviço de Genética, Hospital de Santa Maria, Centro Hospitalar e Universitário Lisboa Norte, Centro Acadé- 1InstituteofHumanGenetics,UniversityofBonn,Schoolof mico de Medicina de Lisboa, Lisboa, Portugal Medicine & University Hospital Bonn, Bonn, Germany, 2Institute of Human Genetics, Ruhr-University Bochum, Introduction: TAF1 is a subunit of the transcription factor Bochum, Germany, 3Center for Rare Diseases Bonn IID complex important in embryogenesis and neuronal (ZSEB), University Hospital Bonn, Bonn, Germany, 4Insti- development. Recently, X-linked mental retardation tute for Genomic Statistics and Bioinformatics, School of 33 syndrome (MRX S33
; MIM#300966) caused by patho- Medicine & University Hospital Bonn, Bonn, Germany, genicvariantsinTAF1wasdescribed,featuringintellectual 5Core Unit for Bioinformatics Data Analysis, University of disability (ID), hypotonia, neurological abnormalities, and Bonn, School of Medicine & University Hospital Bonn, dysmorphicfeatures.Toourknowledge,36missenseanda Bonn, Germany splice site pathogenic variants have been reported so far. Case Presentation: A 10-year-old boy with develop- Pathogenic variants in the spermine synthase (SMS) gene mental delay was referred for genetic evaluation. He was cause the X-linked recessive Snyder-Robinson syndrome the only child of non-consanguineous parents with no (SRS, MIM #309583), which is characterized by develop- relevant family history. Atrial septal defect, restrictive mental delay / intellectual disability (DD / ID), speech muscle ventricle septal defect, mild Ebstein malformation, abnormalities, muscle and bone abnormalities, growth and axial hypotonia, were documented in the neonatal retardation,epilepsy,andfacialdysmorphism.Wereporton period. He evolved with moderate to severe ID, limited twobrotherswithnon-speciﬁcDDandmuscularhypotonia. speech (barely 20 words), hypertonic lower limbs, ataxic The older, nine-year-old brother showed motor develop- gait, midline stereotypies, self-injurious behavior, and mental delay, speech abnormalities, intelligence in the severe strabismus (surgically corrected). He had no lower average range (total IQ 89), asthenic build with a autonomy for daily activities. Cerebral MRI was normal. borderlinetallstature,longﬁngersandtoes,hyperextensible On physical examination, he presented slight facial joints, and mild facial dysmorphism. The younger, two- asymmetry, downslanted palpebral ﬁssures, sunken eyes, year-old brother showed motor and speech developmental bulbous nose, downturned corners of the mouth, micro- delay and a similar facial gestalt. Family history comprised gnathia, and deep plantar creases. Karyotype, array-CGH, a cousin (son of the mother’s sister) with global develop- and metabolic investigation were normal. mental delay (total IQ 50), muscular hypotonia and EEG Results: Whole exome sequencing was performed after abnormalities. An X-linked ID syndrome was suspected. extensive investigation, revealing a hemizygous TAF1 Whole exome sequencing (WES) of both brothers was874 J.delPicchia variant: c.412+4A>G, affecting splicing. Maternal testing Conclusions:According totheproposedanalysis results, conﬁrmed it was de novo. splice site variant NC_000003.12(NM_001024847.2): Conclusions: This variant, which had not been pre- c.1600-2A>G in TGFBR2 gene disrupts mRNA splicing viously reported, was classiﬁed as probably pathogenic. leading to a truncated protein and causing LD S2
. According to the literature, this is the second pathogenic The work was funded by the Research Council of splice site variant described in TAF1. Our case shares Lithuania (No. S-MIP-17-19/LSS-150000-1179). common features with previously described patients, but Keywords: TGFBR2, Loeys-Dietz syndrome 2, qPCR there is wide clinical variability making WES/WGS best G. Petraitytė;: None. E. Siavrienė: None. V. Mikštienė: suited to reach a diagnosis. None. R. Norvilas: None. B. Burnytė: None. A. Utkus: R. Gouveia: None. O. Moldovan: None. A.B. Sousa: None. E. Preikšaitienė: None. None. E- P08
.41 E- P08
.40 A novel de novo truncating TRIM8 mutation associated Analysis of the effect of a novel splice site variant in with intellectual disability and renal failure. TGFBR2 on mRNA level M. A. McClatchey1, Z. D. du Toit2, R. Vaughan1, G.Petraitytė;1,E.Siavrienė1,V.Mikštienė1,R.Norvilas2,B. S.D.Whatley3,S.Martins3,S.Hegde4,J.teWaterNaude5, Burnytė1, A. Utkus1, E. Preikšaitienė1 D. H. Thomas6, D. F. Grifﬁths6, Genomics England Research Consortium, A. J. Clarke1,3, A. E. Fry1,3 1Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius Uni- 1Division of Cancer and Genetics, Cardiff University, versity, Vilnius, Lithuania, 2Hematology, Oncology and Cardiff, United Kingdom, 2Department of General Medi- Transfusion Medicine Center, Vilnius University Hospital cine, Glangwili General Hospital, Carmarthen, United Santaros Klinikos, Vilnius, Lithuania Kingdom, 3All Wales Medical Genomics Service, Cardiff, United Kingdom, 4Children’s Kidney Centre, University Introduction: TGF-β signaling pathway is a critical mole- Hospital of Wales, Cardiff, United Kingdom, 5Paediatric cular pathway in a regulation of cell growth, development, Neurology Service, University Hospital of Wales, Cardiff, and differentiation. One of the receptors of this pathway is United Kingdom, 6Department of Cellular Pathology, encoded by TGFBR2 (MIM#190182) gene. Heterozygous University Hospital of Wales, Cardiff, United Kingdom pathogenic variants in TGFBR2 are the cause of Loeys- Dietz syndrome2(LD S2
; MIM#610168),adisorderwhich Introduction: Truncating mutations in the C-terminus of mainlyaffectstheconnectivetissue.Herewereportanovel the TRIM8 protein have been reported in patients with splicesitevariantinTGFBR2geneandpresentitseffecton severe developmental delay, intellectual disability and epi- mRNA level. lepsy. Only six previous patients have been reported (see Materials and methods: DNA of the proband was Assoum et al PMID: 30244534). Three of the previous analyzed by next generation sequencing gene panel patients were noted to have proteinuria and one (a patient technology. In order to elucidate the pathogenicity of the with epileptic encephalopathy) was diagnosed with identiﬁed splice site variant in the TGFBR2 gene, total nephrotic syndrome. blood mRNA of the proband was isolated, template cDNA Case Presentation: We describe an 8-year-old boy with was synthesized and quantitative PCR using TaqMan gene mild intellectual disability who was found to have expression assay designed for TGFBR2 gene was proteinuria at 2 years of age. Renal biopsy ﬁndings were performed. suggestive of focal segmental glomerulosclerosis. The Results: TGFBR2 gene acceptor splice site variant proteinuria persisted and the patient’s kidney function NC_000003.12(NM_001024847.2):c.1600-2A>G was declined despite treatment. He had a renal transplant at 7 detected in proband’s DNA. Using different bioinformatics yearsofage.Priortothetransplanthehadthreegeneralized tools, this variant was predicted to be pathogenic and seizureswhichwerecontrolledwithsodiumvalproate.Trio- affecting mRNA splicing. Quantitative expression analysis based whole genome sequencing as part of the 100,000 of several TGFBR2 exons revealed that c.1600-2A>G Genomes Project found a de novo heterozygous frameshift causes loss of 5’ part of exon 8 - the last exon of analyzed mutation in TRIM8 (NM_030912.2) c.1198_1220del, p. transcript, presumably leading to a frameshift and a loss of (Tyr400ArgfsTer2). part of Ser/Thr kinase domain and C-terminus of TGFBR2 Conclusion: The experience of this patient is further protein. evidence that TRIM8 truncating mutations cause both neurological and renal features. This case also suggestsAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 875 the spectrum of disease associated with TRIM8 mutations gene mutation with diverse neurologic features. Our case may be wider than previously thought - with the potential supportstheinterfamiliarvariabilityofthesamemutationin for more severe kidney problems but milder intellectual this gene. disability. We highlight the need for proteinuria screening G. Büki: None. J. Zima: None. B. Galik: None. A. in patients with TRIM8 mutations. Gyenesei: None. K. Hadzsiev: None. B. Melegh: None. J. M.A. McClatchey: None. Z.D. du Toit: None. R. Bene: None. Vaughan: None. S.D. Whatley: None. S. Martins: None. S. Hegde: None. J. te Water Naude: None. D.H. Thomas: E- P09
 Neurogenetic and Psychiatric Disorders None. D.F. Grifﬁths: None. A.J. Clarke: None. A.E. Fry: None. E- P09
.02 Probably digenic Aicardi-Goutieres syndrome caused E- P08
.42 by heterozygousADAR-andRNASEH2B-mutations- an A recurrent Z C4
H2gene mutation associated with extended case report diverse neurological symptoms in a patient with Wieacker-Wolff syndrome M. Hempel1, A. Bley1, T. Bierhals1, K. Radig1, M. Lee-Kirsch2, C. Kubisch1 G. Büki1,2, J. Zima1, B. Galik2, A. Gyenesei2, K. Hadzsiev1,2, B. Melegh1,2, J. Bene1,2 1University Medical Center Hamburg-Eppendorf, Ham- burg, Germany, 2Technical University Dresden, Dresden, 1University of Pecs, Medical School, Clinical Center, Germany Department of Medical Genetics, Pecs, Hungary, Pecs, Hungary, 2Szentagothai Research Center, University of Introduction: Aicardi-Goutières syndrome (AGS) is an Pecs, Pecs, Hungary, Pecs, Hungary inﬂammatory disease associated with a broad phenotypic spectrum although an infantile sub-acute encephalopathy Introduction: Wieacker-Wolff syndrome is an X-linked represents the classical manifestation. Mutations in seven recessive neurodevelopmental disorder presenting e.g. genes have been identiﬁed causing monogenic AGS: intellectual disability, developmental delay, characteristic TREX1, ADAR, RNASEH2A, RNASEH2B, RNASEH2C, facial features and contractures of the feet. Relatively few SAMHD1, IF1H1. The majority of patients carry biallelic cases have been reported so far with high clinical hetero- mutations, however for speciﬁc variants in ADAR, TREX1 geneity, especially amongst heterozygous females. The and IF1H1 a dominant effect has been described. diseaseiscaused bymutations inthe Z C4
H2gene, altering Casereport:Wereportonaboypresentingwithmuscular a zinc ﬁnger domain-containing protein with four cysteine hypotonia and global developmental delay at the age of and two histidine residues. 6 months, who furtherdeveloped slow regression, secondary Materialsandmethods:Whole-genomesequencingwas microcephaly and movement abnormalities. A brain MRI performed in a 5-year-old male patient to identify the revealed a leukencephalopathy with severe hypomyelination disease-causing mutation. Libraries were prepared using of cerebral white matter. Blood interferon signature showed TruSeqTM DNA PCR-Free HT Library Prep Kit (Illumina) the characteristic pattern of an interferonopathy type 1. and sequenced on NovaSeq 6000 platform (Illumina) with Genetic results: Whole exome sequencing in the index 150bp paired-end chemistry. The detected mutation was and his healthy unrelated parents identiﬁed a maternally validated by Sanger sequencing. inherited recurrent mutation in RNASEH2B (p.Ala177Thr) Results: A recurrent hemizygous missense mutation and a paternally inherited very likely pathogenic variant in (c.593 G>A) in Z C4
H2 gene was discovered in our patient ADAR (p.Arg892Cys). Neither a second coding variant in and not in his parents. This mutation leads to an arginine- these two genes nor other variants explaining the phenotype glutamineaminoacidchangeandsofaritwasfoundonlyin couldbedetected.Genome-wideCNVanalysisdidnotshow one large family. However, our patient shares common a relevant CNV, in particular not in AGS-associated genes. hallmarks of the syndrome with the previously reported RNAanalysisfromskinﬁbroblastsveriﬁedbothvariantsina cases, the unique feature is that he does not present seizure heterozygous state but could not detect a second aberration and he has a severe speech delay. affecting the RNASEH2B or ADAR transcripts. Discussion:Intra-andinterfamiliarphenotypicvariability Discussion: The patient reported here is affected by is a well-known phenomenon in several Mendelian classical AGS. Extended genetic analysis revealed com- disorders. Among patients with Wieacker-Wolff syndrome bined heterozygous mutations inRNASEH2B andADAR as only one recurrent mutation was reported in the Z C4
H2 the most probably cause of disease strongly suggesting a gene until now. Here we report another recurrent Z C4
H2 digenic inheritance of AGS in this pedigree.876 J.delPicchia M. Hempel: None. A. Bley: None. T. Bierhals: None. K. The investigation was ﬁnanced by grant of Poland’s Radig: None. M. Lee-Kirsch: None. C. Kubisch: None. National Health Program for 2016-2020 (no. 74/44/3.4.3/ 18/DEA). E- P09
.03 D. Czarnecki: None. M. Ziółkowski: None. A. Długosz: The connection of COMT and receptor DRD2 poly- None. J. Feldheim: None. N. Waszkiewicz: None. A. morphisms with alcohol craving and hunger in people Kułak-Bejda: None. M. Gorzkiewicz: None. J. Budzyński: treated due alcohol dependence None. J. Chodkiewicz: None. A. Junkiert-Czarnecka: None. D. Czarnecki1, M. Ziółkowski1, A. Długosz2, J. Feldheim2, N. Waszkiewicz3, A. Kułak-Bejda3, M. Gorzkiewicz4, E- P09
.04 J. Budzyński5, J. Chodkiewicz6, A. Junkiert-Czarnecka7 Case report: Alexander Disease in a 12-month-old male infant with epilepsy and global retardation 1Nicolaus Copernicus University, Department of Psychia- tricNursing,Torun,Poland,2UniversityofTechnologyand N. Baba, K. Burghardt, I. Schreyer, C. A. Hübner Life Sciences, Faculty of Chemical Technology and Engineering, Bydgoszcz, Poland, 3Medical University of Institute of Human Genetics, University Hospital Jena, Białystok, Department of Psychiatry, Choroszcz, Poland, Jena, Germany 4NicolausCopernicusUniversity,DepartmentofMolecular GeneticsandJustice,Torun,Poland,5NicolausCopernicus We report on a 12-month-old male infant of healthy University, Department of Vascular and Internal Diseases, unrelatedGermanparentswhowaspresentedinourgenetic Torun,Poland,6UniversityofLodz,InstituteofPsychology, counseling center in September 2019 with global retarda- DepartmentofHealthPsychology,Łódź,Poland,7Nicolaus tion. One month before, he had two focal clonic seizures Copernicus University, Department of Clinical Genetics, predominantly on the left side of the body, which led to Torun, Poland hospitalization. The family history revealed no epilepsy or other relevant neurological or genetic diseases. An MRI Introduction: In Poland about 25% patients maintains scanofthebrainrevealedaseveremyelinationdefectwith abstinence, after one year from ﬁnished of therapy. So it’s white matter abnormalities. Genetic diagnostic workup important, to identify the predictors of relapse of alcohol included:cytogeneticanalysis, array-CGHand NGS-based drinking. To the predictors belong among others alcohol panel diagnostics for familial focal epilepsies, extended craving, which in some patients is the strongly connected regarding GFAP. NGS identiﬁed a likely pathogenic with hungerbefore meal.It isconsiderthat polymorphisms mutation in GFAP (c.235C>G (p.Arg79Gly) hetero- of COMT and DRD2 genes are associated with increase of zygous).Toourknowledgethisspeciﬁcmutationhasbeen alcohol drinking. Aim of study was evaluation of connec- reported in only one patient suffering from Alexander tion, feeling of alcohol craving and hunger in patients with disease (AxD) (Gorospe et al., 2002). AxD is a very rare alcohol dependence with polymorphism of DRD2 neurodegenerative disease which belongs to the leukody- (c.2137G>A) and COMT (c. 472G>A). strophies. Patients with AxD have unspeciﬁc symptoms Material and Methods: Studied 184 patients during like progressive motor and intellectual retardation, devel- hospitalization due to alcohol dependence and 99 people opmental regression and multiple other neurological with control group. In study, used the scales: PACS, scale symptoms including seizures. In most cases gain-of-func- ofhungerbeforemealsandalsomoleculartestingofCOMT tion mutations in GFAP encoding the glial ﬁbrillary acidic and DRD2 polymorphism. protein underlie this disorder, which result in the accu- Results:PatientswithoutCOMTpolymorphism,butwith mulation of the variant protein in astrocytes, then called polymorphismofDRD2(genotypeG/A)felthighvaluesof Rosenthal ﬁbers. The exact cellular pathogenesis remains alcohol craving, which did not decrease during 4 weeks of unknown. Only about 500 cases of AxD have been therapy (7.18 vs. 7.00; p>0.05). At the same time, patients reported worldwide. Survival time depends on the age at feltstronglyhunger,whichdidnotdecreaseduring4weeks onset of AxD, a median of 14 years was found in a larger of therapy (13 vs. 11; p>0.05). The observation, suggest, cohort (Prust et al., 2011). AxD should be considered dif- that it can be extracted, based on the tested polymorphism, ferential diagnosis of global developmental retardation, group of patients who feel chronic and co-existing alcohol seizures and white matter abnormalities. craving and hunger, and this patients have got risk of N. Baba: None. K. Burghardt: None. I. Schreyer: None. relapse alcohol drinking or nutrition disorders. C.A. Hübner: None. Conclusions: The polymorphism of DRD2 can be connected with the strongly alcohol craving and hunger.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 877 E- P09
.07 B. Budisteanu: None. I. Focsa: None. F. Linca: None. Copy number variants in autism spectrum disorders D. Ioana: None. G. Gaina: None. L. Albulescu: None. patients I.Dobrescu:None.M.Budisteanu:None.A.Arghir:None. S. M. Papuc1, A. Erbescu1, C. Iliescu2,3, M. Dobre1, E- P09
.09 I. Minciu2,3, F. Rad2,3, I. Mihailescu3, L. Mateescu2,3, A. C. A new case of beta-propeller protein-associated neuro- Tutulan-Cunita1,4, R. Grozavescu2,3, E. Andrei3, degeneration (BPAN) in a 7-year old male with a novel B.Budisteanu3,I.Focsa1,2,F.Linca3,D.Ioana3,G.Gaina1, mosaic WDR45 mutation L.Albulescu1,I.Dobrescu2,3,M.Budisteanu1,3,5,A.Arghir1 H. Wang, G. Fteeh 1Victor Babes National Institute of Pathology, Bucharest, Romania, 2Carol Davila University of Medicine and LomaLindaUniversity,SchoolofMedicine,LOMALINDA, Pharmacy, Bucharest, Romania, 3Prof. Dr. Alex. Obregia CA, United States Clinical Hospital of Psychiatry, Department of Pediatric Neurology, Bucharest, Romania, 4Cytogenomic Medical Introduction: Beta-propeller protein-associated neurode- Laboratory, Bucharest, Romania, 5Titu Maiorescu Uni- generation (BPAN) is a neurodegeneration with brain iron versity, Faculty of Medicine, Bucharest, Romania accumulationdisorder.BPANisveryrare,withfewthan60 casesreportedtodateinwhichthevastmajorityofcasesare Copy-number variants (CNVs) have been shown to be female and sporadic, resulting from a de novo mutation in involved in etiology of neurodevelopmental disorders like theWDR45genelocatedatXp11.23.Herewereportanew autism spectrum disorders (ASDs), intellectual disability case of BPAN in a male. (ID), and other psychiatric disorders. Chromosomal Case Description: This a 7 years old adoptive boy with microarray analyses (CMA) has offered a high detection history of autism, developmental delay, and seizures. He rateofsmallandlargeCNVsassociatedwithASD,andled was not able to walk until age of 4 and nonverbal. He was to discovery of new autism genes. We report on the results diagnosedwithLennoxGastautsyndrome.EEG(duringthe of chromosomal CMA investigation in a group of ASDs sleep) showed frequent to abundant high to very high patients. Eighty patients were referred to our laboratory for voltage sharp, spike and slow wave discharges present in genetic testing with ASDs as part of a broad phenotype right and left hemisphere. The brain MRI indicated including ID or other clinical features. A complete clinical prominent mineralization of the globus pallidi and sub- evaluation was performed with focus on psychiatric exam- stantia nigra considering iron accumulation or mitochon- ination and psychological evaluation with speciﬁc ASDs drial disorder. tests (ADOS, ADI-R). Array-CGH completed with kar- Result: The initial workup of chromosome microarray yotyping, FISH and qPCR tests were performed. A total of was negative, the subsequent brain-iron accumulation gene 21 pathological CNVs (14 deletions and 7 duplications), panel reported as WDR45, X-linked, c.577C>T (p. with a median length of 3.7 Mb were detected in 17 Gln193*), zygosity (indeterminate, 46% allele fraction), patients.Theinvolvedgenomicregionsoverlap550OMIM pathogenic. genes.Besideswell-describedsyndromicregionsassociated Discussion/Conclusion: BPAN is phenotypically similar with ASDs (e.g. deletions of 1q21.1, 22q13.3, 22q11.2, inbothmaleandfemalewhichischaracterizedbyclustered MBD5; Xq28 duplication), other genomic regions, rarely spasm,hypsarrhythmiapatternsonEEGanddevelopmental reported in patients with ASDs were identiﬁed (deletion of delay or regress. The similarity in both genders was 8p11.2p21.2, 9q34.1, 9p13, duplication of 7p22.2p22.1, explained by somatic mosaicism in surviving males and CHRNA7); thus having the potential to reveal new ASD germline or somatic mutations in females, as well as genes. Our data illustrates the utility of array-CGH in the skewing of X chromosome inactivation. Only a few male investigation of patients with ASDs, speciﬁcally in the caseswerereportedandthisisanewmalecasewithanovel context of complex phenotypes. Acknowledgment: The mosaic mutation and presenting with characteristic clinical research leading to these results has received funding from features. theEEAGrant2014-2021,undertheprojectcontractNo6/ H. Wang: None. G. Fteeh: None. 2019, and MRI Projects PN 92.033.02.03 and PN 16.22.05.01. E- P09
.10 S.M. Papuc: None. A. Erbescu: None. C. Iliescu: None. New mendelian gene for bipolar disorder. M. Dobre: None. I. Minciu: None. F. Rad: None. I. Mihailescu: None. L. Mateescu: None. A.C. Tutulan- Cunita: None. R. Grozavescu: None. E. Andrei: None.878 J.delPicchia M. F. Rossi1,2, D. Lopergolo1,2, M. A. Trusso3, E. Benetti4, E. Dámaso1, A. Culiáñez-Casas2, I. Lara-Espejo2, C. Fallerini1, S. Furini4, A. Goracci3,5, A. Fagiolini3,5, M. Castillejo1, A. Castillejo2, M. García-Escudero2, A. Renieri1,2, F. Mari1,2 J. Soto2 1Medical Genetics, University of Siena, Siena, Italy, 1ElcheUniversityHospital-FISABIO,Elche,Spain,2Elche 2Genetica Medica, Azienda Ospedaliera Universitaria University Hospital, Elche, Spain Senese, Siena, Italy, 3Department of Molecular Medicine and Development, University of Siena, Siena, Italy, Introduction: Bipolar disorder (BD) is a complex psy- 4Department of Medical Biotechnologies, University of chiatric condition with high heritability. Extended families Siena, Siena, Italy, 5Department of Mental Health; with high prevalence of BD provide an opportunity to PsychiatryUnit,AziendaOspedalieraUniversitariaSenese, identify novel risk genes. We present ﬁndings from whole Siena, Italy exome sequencing (WES) obtained from a Spanish family with high density of BD cases and dominant autosomal Introduction: Bipolar Disorder (BP) is a mental health pattern of inheritance. condition characterized by extreme mood ﬂuctuations that Materials and -Methods: Blood DNA was obtained includeemotionalhighsandlows.Itaffectsabout1%ofthe from 8 family members: ﬁve patients diagnosed of BD, world population and its estimated heritability is around another patient with other mental disorder and two healthy 70%, similar to Schizophrenia. individuals. WES was performed using SureSelect-Human- Materialsandmethods:AlargeautosomaldominantBP AllExonV6+UTR (AgilentTechnologies) libraries and family with eleven affected subjects was included in the sequencing on Illumina-NovaSeq6000. Alignment and study. Mental health of seven family members was variant calling was performed by SureCall and variant ascertained by clinical observation and by the use of ﬁltering by a custom pipeline for cohort analyses on Alissa speciﬁc tests. Exome sequencing was performed in all Interpret softwares (AgilentTechnologies). members.Variantsprioritizationwasperformedonthebasis Results:Thetotalsizeofcapturedregionwas90Mb.An of the frequency (<5%), evidence of pathogenicity and average of 87% of the target regions had 30X coverage or association with BP. better. The within-family association of rare coding and Results:Threemembers,thefemaleproband,hermother splice-site variants with predictable loss of function and his maternal uncle, were diagnosed with BP and four present in cases and absent in controls was investigated. members (two proband’s sisters and two proband’s male We found an unreported stopgain candidate variant cousins) were categorized as healthy subjects. Exome (NM_001080521.3:c.161C>A) at RASSF10 gene, co-seg- analysis revealed one single variant that met the above regating with BD (p=0.036). RASSF10 plays an important given criteria present in all three affected members and in roleinregulatingembryonicneurogenesis.Itisexpressedin none of the healthy ones. It is a missense variant, absent in normal brain tissue and epigenetically inactivated in brain controls (Exome Sequencing Project or 1000 Genomes tumors.Theseevidencesmightsuggestanimportantroleof Project).Multiplelinesofcomputationalevidencesupporta RASSF10 in normal brain function. deleterious effect of the variant (CADD 35). The mutated Conclusions: RASSF10 could be a new candidate gene gene encodes for a protein involved in cell motility and associated to BD, although further studies are needed to be extracellular matrix remodeling. A recent study revealed validated. New associated BD genes could shed light on that this protein is downregulated in plasma samples of a understanding the molecular basis of mental disorders and large cohort of patients with mood disorder and its deﬁning possible targets for new treatments. expression was reduced in a C. elegans model of E. Dámaso: None. A. Culiáñez-Casas: None. I. Lara- Alzheimer’s disease. Espejo:None.M.Castillejo: None.A.Castillejo: None.M. Conclusions: We were able to identify a gene that likely García-Escudero: None. J. Soto: None. contributed to BP in our family. M.F. Rossi: None. D. Lopergolo: None. M.A. Trusso: E- P09
.12 None.E.Benetti:None.C.Fallerini:None.S.Furini:None. Brainmalformationsdiagnosisandclinicalmanagement A.Goracci:None.A.Fagiolini:None.A.Renieri:None.F. in pediatric patients Mari: None. A. Erbescu1, S. M. Papuc1, C. Iliescu2,3, C. Burloiu2, E- P09
.11 O. Tarta- Arsene2,3, D. Barca2,3, C. Motoescu2,3, RASSF10, a new gene associated to hereditary forms of I. Minciu2,3, N. Butoianu2,3, B. Budisteanu2, A. C. Tutulan- Bipolar Disorder?Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 879 Cunita1,4,A.Dica2,C.Anghelescu2,D.Craiu2,3,A.Arghir1, for the differential diagnosis in complex clinical M. Budisteanu1,2,5 phenotypes involving cerebellar ataxia 1Victor Babes National Institute of Pathology, Bucharest, N. Ivanova1, K. Mihova1, K. Kamenarova1, S. Bichev2, Romania, 2Prof. Dr. Alex. Obregia Clinical Hospital of T. Chamova3, S. Cherninkova3, J. Samuel3, Psychiatry,Bucharest,Romania,3CarolDavilaUniversityof V. Guergueltcheva4, D. Avdjieva-Tzavella5, H. Kathom5, MedicineandPharmacy,Bucharest,Romania,4Cytogenomic A. Savov2, I. Kremensky1, V. Bojinova6, V. Mitev1, Medical Laboratory, Bucharest, Romania, 5Titu Maiorescu I. Tournev3,7, A. Jordanova1,8, R. Kaneva1 University, Faculty of Medicine, Bucharest, Romania 1Molecular Medicine Centre, Department of Medical Brain malformations (BMs) encompass a large spectrum of Chemistry and Biochemistry, Medical University – Soﬁa, disorders with various genetic etiologies, anatomic abnorm- Soﬁa, Bulgaria, 2National Genetic Laboratory, University alities, and clinical features. We report on the results of a Hospital of Obstetrics and Gynaecology “Maichin dom”, studyfocusedondiagnosisandclinicalmanagementofBMs Soﬁa, Bulgaria, 3Neurology Clinic, University Hospital inaRomanianpediatricpopulation.Onehundredandtwenty “Aleksandrovska”, Soﬁa, Bulgaria, 4Neurology Clinic, patients with BMs and complex phenotype were selected University Hospital “Soﬁamed”, Soﬁa, Bulgaria, 5Specia- from those referred for developmental delay and/or epilepsy, lized Hospital for Active Treatment Children’s Hospital, between 2010-2019, to our departments. General clinical Prof. Dr. Ivan Mitev“, Soﬁa, Bulgaria, 6Neurological examination, neurologic, dysmorphologic, psychiatric/psy- Clinic for Children, Multiproﬁle hospital for active chologic evaluations and brain imaging studies were per- treatment in neurology and psychiatry “St. Naum”, Soﬁa, formed for all the children. Genetic investigations included Bulgaria, 7Department of Cognitive Science and Psychol- array based comparative genomic hybridization (Agilent ogy,NewBulgarianUniversity,Soﬁa,Bulgaria,8Molecular Technologies), and classical and molecular cytogenetics. Neurogenomics Group, VIB-UAntwerp Center for Molecu- Gyration anomalies, corpus callosum defects, cerebellar lar Neurology, University of Antwerp, Antwerp, Belgium malformations, and heterotopia, isolated or in different com- binations,associatedwithcomplexclinicalpresentationswere Introduction: Cerebellar ataxias are genetically hetero- detected in our patient group. Genomic imbalances, 4 dele- geneousgroupofneurodegenerativedisordersthatcouldbe tions and 3 duplications, were detected in 7 patients. Syn- present with complex and variable clinical phenotypes dromic regions (17p13.3, 1q21.1, 1q43-q44, 22q11.2) were overlapping other neurological disorders. Most of them are prevalentinourstudygroup;however,someoftheseregions extremely rare and therefore, poorly studied, difﬁcult to are known to be clinically heterogeneous, thus our patients diagnoseandsymptomaticallytreated.Introductionofnext- might contribute to further delineation of the phenotypic generation sequencing in clinical practice provides a fast spectrum. In our study group, chromosomal defects were and effective decision for precise genetic diagnosis. detectedwithahighincidenceinpatientswithBMsaspartof Materials and methods: We performed whole exome complexphenotypes.Epilepticseizuresand/ordevelopmental sequence(WES)tosearchfordisease-causingvariantsin13 delaywerethemostcommonclinicalfeatures.Brainimaging patients with complex clinical phenotypes involving and genetic studies were instrumental in the diagnostic algo- cerebellar ataxia and one or more of the following rithm, with impact on prognosis and genetic counselling of symptoms: spasticity, peripheral neuropathy, epilepsy, these cases. Acknowledgment: This work was supported by dysmorphic features, intellectual disability. grants of the Romanian National Authority for Scientiﬁc Results:WES-dataanalysisledtotheidentiﬁcationofthe Research Innovation, CCCDI-UEFISCDI, Projects number potentially disease-causing variants in 10 families. They 87/2019 and 88/2019, COFUND-ERANET E-RARE 3- include ﬁve novel and four already known pathogenic HETER-OMICS-2, within PNCDI III variants in the SACS, PNPLA6, PRNP, SCN8A, SPG7, A. Erbescu: None. S.M. Papuc: None. C. Iliescu: None. CoQ8A and KIF1A genes. After additional genetic analysis C.Burloiu:None.O.Tarta-Arsene:None.D.Barca:None. andthoroughpatients’phenotypingwewereabletoconﬁrm C. Motoescu: None. I. Minciu: None. N. Butoianu: None. genetic diagnosis in 9 families. B. Budisteanu: None.A.C. Tutulan-Cunita:None.A.Dica: Conclusions: Our study enriches genetic and clinical None. C. Anghelescu: None. D. Craiu: None. A. Arghir: databases with novel genetic variants and clinical cases of None. M. Budisteanu: None. severalraregeneticdisordersthatwillhelptodelineatetheir molecular mechanisms. It added a new spot to the E- P09
.13 geographic distribution worldwide of the spastic ataxia of Whole exome sequencing greatly increases the chances Charlevoix-Saguenay that has been previously limited to a speciﬁc geographic region. WES provides a fast and880 J.delPicchia effective tool for precise genetic diagnosis that allows to investigation. Asymptomatic parents presented the GDA P1
 destinguish among variaty of clinical phenotypes sharing mutation in the heterozygous state. common clinical feature of cerebellar ataxia. Conclusion: The homozygous c.165T>G detected in Acknowledgements:ThisstudywassupportedbyGrants GDA P1
 in our patient is likely responsible for her CMT B02/3/2014 and D01-285/17.12.2019 National Science disease. This result is important in terms of diagnosis for Fund/Ministry of Education and Science, Bulgaria. molecular biologists and geneticists. N. Ivanova: None. K. Mihova: None. K. Kamenarova: N. Benslimane: None. F. Miressi: None. C. Magdelaine: None. S. Bichev: None. T. Chamova: None. S. Chernin- None.P.Faye:None.F.Sturtz:None.F.Favreau:None.A. kova:None.J.Samuel:None.V.Guergueltcheva:None.D. Lia: None. Avdjieva-Tzavella: None. H. Kathom: None. A. Savov: None. I. Kremensky: None. V. Bojinova: None. V. Mitev: E- P09
.15 None. I. Tournev: None. A. Jordanova: None. R. Another case of Cofﬁn-Siris-Syndrome 10 identiﬁed by Kaneva: None. trio exome sequencing. E- P09
.14 L. Mulahasanovic1, H. Gabriel1, S. Biskup1, AnovelmutationofGDA P1
associatedwithsevereform C. Schell-Apacik2, C. Bus3 of Charcot-Marie-Tooth disease 1Praxis für Humangenetik, Tuebingen, Germany, 2Medi- N. BENSLIMAN E1
, F. Miressi1, C. Magdelaine1,2, cover Human Genetics Berlin-Westend MVZ, Berlin, P. Faye1, F. Sturtz1,2, F. Favreau1,2, A. Lia1,2 Germany, 3Humangenetik Tübingen, Tuebingen, Ger- many 1EA6309-Neuropathie périphérique et Maintenance Myéli- nique, Limoges, France, 2Laboratoire de Biochimie et Cofﬁn-Siris syndrome (CSS) is a rare genetic disorder Génétique Moléculaire CHU DUPUYTREN, Limoges, characterized mainly by developmental delay, intellectual France disability and characteristic facial features. Hypoplasia or absence of the ﬁfth ﬁnger and toe nails are most common Introduction: Charcot-Marie-Tooth disease (CMT) is the in affected individuals. Until now, ten responsible genes mostcommonhereditaryneuropathywithaprevalenceof1/ for CSS have been identiﬁed. Recently, de novo variants 2500; also known as sensory-motor neuropathy. There are in the gene SOX4 were identiﬁed in four patients with several forms of CMT which are differentiated by their typical features of CSS, particularly ﬁfth ﬁnger clin- modeoftransmission(recessive,dominant,autosomalorX- odactyly(Zawertonetal.,2019).ThisnewCSStype10is linked), and their electrophysiological aspect (demyelinat- characterized by intellectual disability, microcephaly and ing or axonal forms). Currently, more than 90 genes are facial abnormalities. SOX4 belongs to a family of SRY- involved in CMT. related transcription factors, which are playing a key role MaterialandMethods:A47-year-oldpatientpresenting in multiple developmental pathways. Expression studies CMT disease was sampled with peripheral blood collected showed that SOX4 is highly expressed during neurogen- inEDTAtubesaftergivingherinformedconsent.Genomic esis. All four pathogenic SOX4 variants identiﬁed before DNA was extracted by standard methods. Next Generation were located within the SOX family-speciﬁc HMG Sequencing(NGS)strategywasperformedusinga92genes domain of the protein, which is crucial for DNA-binding. custom panel designed for CMT and associated neuropa- Here we report on a mildly affected female patient car- thies diagnosis. rying the de novo variant c.278T>A; p.Leu93Gln in the Results: The patient was a 47-year-old woman, present- SOX4 gene, which is also located in the HMG domain. ing a severe demyelinating form of CMT disease. The Shecouldsitattheageof4monthsandstartedwalkingon diseaseonsetwasinearlychildhoodwithalossofwalking his own with 15 months. She had delayed speech devel- around the age of 11 and since then a wheelchair opment and learning disability, was restless and agitated, dependence. Molecular biology analysis highlighted the and was diagnosed with ADHD at the age of 8 years. At presence of a new GDA P1
 mutation, never described to theageof21,shepresentedwithmilddysmorphicfeatures date. This mutation, c.165T>G, located on exon 2, was (e.g. long face; deep-set, dysmorphic ears; low palpepral presented in the homozygous state and leads to the ﬁssures; diffuse inserted eyebrows; wide mouth; long replacementofanasparticacidinposition55byaglutamic ﬁngers;slight brachydactyly ofthe ﬁfth ﬁngers; broad big acid (p.Asp55Glu) and it is predicted pathogenic by two toes) and displayed anxiety and a lack of motivation. prediction softwares. Splicing involvement is under L. Mulahasanovic: None. H. Gabriel: None. S. Biskup: None. C. Schell-Apacik: None. C. Bus: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 881 E- P09
.18 arecausedbysustainedorintermittentmusclecontractions. Clinical features of three familial cases of Neuronal The major feature is over-activity of muscles required for Intranuclear Inclusion Disease (NIID) movement. Dystonias can clinically vary in their manifes- tation and severity affecting all age groups and leading to H. Furuya, Y. Miyamoto, T. Furushima, S. Ohtsuru, considerabledisabilityandimpairedqualityoflife.Withits Y. Morita, Y. Osaki high throughput capacity and proportionally low cost, next generation sequencing is now being extensively used in Kochi Medical School, Kochi, Japan research/diagnostic settings to determine novel genes and mutations associated with dystonias. Background: Neuronal intranuclear inclusion disease Materials and methods: Genomic DNA was isolated (NIID)(MIM 603472) is a neurodegenerative disorder from whole blood. Whole exome sequencing (WES), characterized by eosinophilic intranuclear inclusions in followed by family segregation analysis using Sanger neuronal cells. Such inclusions are also found in non-neu- sequencing, was performed on 21 probands with hetero- ronalcells.Theclinicalfeaturesandpathologicalﬁndingsin genous dystonia phenotypes. The pathogenicity of the patientswithNIIDarehighlyvaried.Here,wepresentthree variant was scored by the prediction tools DANN, GERP, familialNIIDcasesaccompaniedwithparkinsonism,which SIFT and MutationTaster. is not so common in this disorder. Results: WES revealed 10 dystonia genes with varying Objective: Cases: All cases are adult onset NIID with frequenciesand12variants,4ofwhicharenovel(Table1). Parkinsonism with dementia and severe psychosis. The diagnostic rate is 62%. Table1 Genes and variants Results: In MRI imaging, diffuse cerebral atrophy was identiﬁed in Turkish dystonia cohort observed in all cases. High intensity of the cortico- medullary junction in diffusion-weighted imaging (DWI), Genes(#of Mutations Zygosity Novel/ which is characteristic ﬁndings in NIID, was seen in all families) Reported NIID. In neurological examination, all NIID showed laterality or severely increased Pulmomental Reﬂex GCH1(n=3) c.284C>Tp.Pro95Leu het Novel c.631_632delATp. hethet Reported (PMR). Ante-mortem diagnosis was made by identiﬁcation Met211ValfsTer38 Reported of intranuclear inclusions with skin biopsy in all NIID. c.646C>Tp.Arg216Ter Neuroimaging diagnosis for usual Parkinsonism shows PTS(n=2) c.84-3C>G hom Reported normal with DAT scan and MIBG scintigraphy. TOR1A(n=1) c.907_909delGAGp. het Reported Conclusion: Intranuclear accumulation of abnormal Glu303del proteins and/or dysfunction of protein degradation SL C2
A1(n=1) c.972G>Ap.Ser324Ser het Reported might underlie in the pathogenesis of NIID. However, DDC(n=1) c.1040G>Ap.Arg347Gln hom Reported NIID is considered as a heterogeneous disease entity and KMT2B(n=1) c.6863delCp. het Novel shows various clinical features. Although dementia is Pro2289ArgfsTer36 common in NIID, Parkinsonism is also often observed in TH(n=1) c.698G>Ap.Arg233His hom Reported this disorder. Achknowledgement: We also thank to Dr. AT P13
A2(n=1) c.1551_1556delCCTCAC hom Novel Sone J and Prof. Sobue G (Department of Neurology, p.Leu518_Thr519del Nagoya University, Japan) for immune staining of biopsy AT P1
A3(n=1) c.1838C>Tp.Thr613Met het Reported specimen. KIF1C(n=1) c.2005C>Tp.Arg669Ter hom Novel H. Furuya: None. Y. Miyamoto: None. T. Furushima: None.S.Ohtsuru:None.Y.Morita:None.Y.Osaki:None. Conclusions:The10genesidentiﬁedrevealahighlocus E- P09
.20 heterogeneity. Further, AT P13
A2 and KIF1C which also The Complex Molecular Basis of Dystonias in a give rise to spasticity and ataxias, point to genetic and Turkish Cohort pathophysiological overlaps between neurological conditions. S. Tekgul1, G. Simsir1, Z. Yapici2, A. Basak1 S. Tekgul: None. G. Simsir: None. Z. Yapici: None. A. Basak: None. 1Koç University, Istanbul, Turkey, 2Istanbul University, Istanbul, Turkey E- P09
.21 Genetic study of early-onset parkinsonism in Thailand: Introduction: Dystonias are neurological conditions in targeted next-generation sequencing which abnormal movements or postures are observed, that882 J.delPicchia P. Phowthongkum performed comprehensive study of HLA gene variants discovered by NGS after lack of pathogenic mutations in Faculty of Medicine, Bangkok, Thailand patientsaffected by epilepsy with orwithout autism/mental retardation and compared with patients with other pathol- Background: Early-onset Parkinson disease (EOPD) is ogies (referred as controls). We focused on variants anno- deﬁned by PD with the onset age of less than 50 years. tated as Variants of Unknown Signiﬁcance (VUS). We Patients may present predominantly with lower limb dys- determined the frequency of such variants in DRB1 and toniaratherthantypicalrestingtremorinlate-onsetpatients DRB5, in cases and controls, as they were the most com- which is the challenge in making the diagnosis in younger monlyfoundinbothgroups.Thefrequencyvariedbetween patients. Many patients apparently are responded dramati- 11-15% in cases and 11-23% in controls. In addition, we callywithdopaminereplacementbutdevelopedearlymotor reported variants found only in cases(5 variants in DRB5 complications, in contrast, to consistently respond to the and 1 in DRB1), only in controls (7 in DRB5 and 10 in treatmentinDOPAResponsiveDystonia(DSD).Molecular DRB1)andbothincasesandcontrols(5inDRB5and6in diagnosis, therefore, helps in diagnosis EOPD, facilitates DRB1). We found 2 HLA-DMB and 2 HLA-G variants genetic counseling and treatment customization. only in cases. This is a pilot study of the involvement of Methods: A total of 51 patients with early-onset HLA class II gene variants in neurological disorders and it parkinsonism from 49 families referred to Neurogenetics will be followed by the analysis of these individual Center at King Chulalongkorn Memorial Hospital. Genetic variants’ role. test was performed with targeted next-generation sequen- F. Shakola: None. I. Dimova: None. V. Peycheva: None. cing panel containing 34 genes causing PD or dystonia. K. Mihova: None. K. Kamenarova: None. R. Kaneva: Results:ElevenpatientswithEOPD(21.5%)werefound None. tocarrylikelypathogenicorpathogenicvariantsinGBA(5/ 51),PARK2(4/51 from 2 families),PINK1 (2/51 from 2 E- P09
.27 families). Familial EOPD (2 families) harbored 3 different Identiﬁcationofthemolecularetiologyinearlyepileptic pathogenic variants in PARK2 (one family with homo- encephalopathy using whole exome sequencing zygous deletion of exon7 and the other family with one heterozygous deletion of exon 5 and one heterozygous E.Isik1,T.Atik1,S.KeskinYilmaz2,G.Aktan2,H.Onay3,S. missensevariant).Theyallhaveonsetoflessthan30years. Gokben2, F. Ozkinay1,3 Conclusions: Our ﬁndings add an understanding of the genetic architecture of EOPD in Southeast Asia. Targeted 1Subdivision of Pediatric Genetics, Department of Pedia- next-generation sequencing is an effective and affordable trics, Faculty of Medicine, Ege University, Izmir, Turkey, methodformakinggeneticdiagnosisforPD.Heterozygous 2Subdivision of Pediatric Neurology, Department of GBA deﬁnitely increases risk of EOPD in the Southeast Pediatrics, Faculty of Medicine, Ege University, Izmir, Asianpopulation.Individualseekingcarriertestingincludes Turkey, 3Department of Medical Genetics, Faculty of GBA should be informed about the risk of parents to Medicine, Ege University, Izmir, Turkey develop neurological disorders. P. Phowthongkum: None. Epilepticencephalopathies(EEs)areagroupofdevastating disorders caused by epileptic activity; resulting in dete- E- P09
.23 rioration in developmental, cognitive and motor functions. NGSsurveyinneurologicaldisorders-focusonvariants ThenumberofgenesidentiﬁedasbeingresponsibleforEEs in HLA class II genes has been increasing rapidly. However, despite a compre- hensive molecular analysis, a molecular diagnosis can only F. Shakola, I. Dimova, V. Peycheva, K. Mihova, beestablishedin50%ofcases.Theaimofthisprojectisto K. Kamenarova, R. Kaneva use whole exome sequencing to determine the molecular etiology of EEs inmolecularly undiagnosed patients witha Molecular Medicine Center, MU Soﬁa, Soﬁa, Bulgaria pedigree suggestive of an autosomal recessive single gene disease. Three EEs families, having either consanguineous Neuroinﬂammatory mechanisms may be involved in the parents of an affected individual and/or having more than genesis of epilepsies and autistic spectrum disorders. An one affected offspring were enrolled in the project. Prior to NGS study with TrueSightOne gene panel was performed this project, the families had been evaluated using a next on 30 patients with neurological disorders (including sei- generation sequencing panel which included 16 EE genes; zures as a main component). In 10 patients pathogenic/ however,nomolecular diagnosis could be established.In5 probably pathogenic mutations were discovered. We have cases from the 3 selected EEs families in our study geneticAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 883 etiology was investigated using WES, with segregation These genes have been previously reported in literature analysisthenbeingperformedusingSangersequencing.All associated to MS. patients in the study group had infantile onset epileptic Conclusions: These ﬁndings support the idea that seizures and severe developmental delay. WES revealed familial MS could present a genetic background. The biallelicdiseasecausingmutationsinDENDD5A,GRNand variants found in this research require further study and TBCD genes in Family 1, Family 2 and Family 3, respec- could lead to a better understanding of MS. tively.Ineachfamily,theidentiﬁedvariantsassociatedwith L.TorreFuentes:None.J.Matías-GuiuAntem:None.V. the disease were segregated. Reverse phenotyping sup- Pytel: None. P. Montero Escribano: None. L. Hernández ported the molecular analysis. In conclusion, this study Lorenzo: None. P. Maietta: None. S. Álvarez: None. U. providesavaluablecontributiontothegenotype-phenotype Gómez Pinedo: None. J. Matías-Guiu Guía: None. relationship by determining rare epilepsy syndromes in a previously undiagnosable patient group. WES provides a E- P09
.30 usefuldiagnosticalternative;particularlyinconsanguineous Spontaneous rescue of a FMR1 repeat expansion families. E.Isik:None.T.Atik:None.S.KeskinYilmaz:None.G. E. Erbs, M. Rasmussen, D. L. Lildballe Aktan: None. H. Onay: None. S. Gokben: None. F. Ozkinay: None. Department of Clinical Genetics, Lillebælt Hospital, Vejle, Denmark E- P09
.28 Whole-exome sequencing in familial multiple sclerosis Introduction:FragileXsyndrome(FXS)isusuallycaused by CGG-repeat expansion in the 5’ UTR region of the L. Torre Fuentes1, J. Matías-Guiu Antem2, V. Pytel1, Fragile X Mental Retardation 1 (FMR1) gene of >200 P. Montero Escribano2, L. Hernández Lorenzo1, repeats causing methylation of the region. Rare cases are P.Maietta3,S.Álvarez3,U.GómezPinedo1,J.Matías-Guiu caused by pathogenic variants within the coding region. Guía1,2 Materials and methods: Genetic testing for FXS was requested in a male infant born to a mother known to 1InstituteofNeuroscience,HealthResearchInstituteofSan harbour a FXS full mutation (>200 CGG-repeats). The Carlos Clinical Hospital, Madrid, Spain, 2Neurology maternal grandmother was a carrier of a FXS premutation. department, San Carlos Clinical Hospital, Madrid, Spain, AnalysisofCGG-repeatsoftheFMR1genewasperformed 3NIMGenetics, Madrid, Spain usingPCR,RP-PCR,andSangersequencing.STRmarkers were used in linkage analysis. Introduction: Multiple sclerosis (MS) is an inﬂammatory Results: An unexpected very short PCR fragment was autoimmune disease of the central nervous system (CNS) detected in the male infant. Subsequent Sanger sequen- which causes demyelination and axonal damage. MS is cing conﬁrmed an 88 bp deletion (c.1-156_1-69del) in considered a polygenic disease where genetic risk factors hemizygous form. The deletion included all CGG- can be more likely detected in familial MS. The aim of the repeats and ﬂanking sequences. However, the deletion studyistoanalysegeneticvariationsofsignallingpathways did not include FMR1 exons. Linkage analysis revealed and genes related to MS. that the allele, which has been expanded in the mother Materials and methods: Whole-exome sequencing andthematernalgrandmother,waspassedontothemale (WES) with Ion Proton technology was performed in 138 infant. individuals from 23 families including at least 2 MS Conclusion: Grønskov et al. previously reported a ~150 patients.WecomparedpatientswithMS,patientswithother bp deletion of all CGG-repeats and ﬂanking sequences in a autoimmune disease and healthy individuals. Signalling normal female patient, who was hemizygous for the FMR1 pathways and genes related to MS were analysed. Variant gene due to a large deletion of the other X chromosome. ﬁltering and prioritization were performed with an own Western blot showed that the FMR1 protein level was pipeline using criteria to include relevant and functional unaffected. This reported deletion comprises the deletion variants associated to MS. detectedinthemaleinfant.Basedonthisreport,weexpect Results: In our cohort, some variants matched criteria to our patient to be unaffected. be considered as a possibly pathogenic variable. The In conclusion, a male infant was rescued from FXS by a associated genes (NOD2, NLR P7
, CY P24
A1, TNFAI P3
, spontaneous deletion. TNFRSF13B, LR P2
, CIITA, ACE) were mainly involved in E. Erbs: None. M. Rasmussen: None. D.L. Lildballe: the immune system as well as in vitamin D regulation. None.884 J.delPicchia E- P09
.32 D. Nikolova: None. M. Mihaylova: None. R. Staneva: Genes with variants associated with frontotemporal None.V.Damyanova:None.M.Ganev:None.V.Spasova: dementia are enriched in extracellular matrix organiza- None. D. Nesheva: None. Z. Hammoudeh: None. S. tion pathways Hadjidekova: None. S. Mehrabian: None. M. Petrova: None. L. Traykov: None. D. Toncheva: None. S.Karachanak-Yankova1,2,L.Balabanski1,3,D.Serbezov1, R. Vazharova3,4, O. Antonova1, D. Nikolova1, M. E- P09
.33 Mihaylova1, R. Staneva1, V. Damyanova1, M. Ganev1, V. Characterization of the PRNP gene mutations and the Spasova1, D. Nesheva1, Z. Hammoudeh1, S. Hadjidekova1, genotype-phenotype correlation in Hungarian patients S. Mehrabian5, M. Petrova5, L. Traykov5, D. Toncheva1,6 with prion disease 1Department of Medical Genetics, Medical Faculty, Med- H.Zeke1,Á.Palásti1,B.A.Fekete1,V.Molnár1,A.Gál1,Z. ical University-Soﬁa, Soﬁa, Bulgaria, 2Department of Grosz1, G. G. Kovács2, M. J. Molnár1 Genetics, Faculty of Biology, Soﬁa University “St. Kliment Ohridski”, Soﬁa, Bulgaria, 3Gynecology and assisted 1Institute of Genomic Medicine and Rare Disorders, reproduction hospital “Malinov”, Soﬁa, Bulgaria, Semmelweis University, Budapest, Hungary, 2Department 4Department of Biology, Medical genetics and Microbiol- of Laboratory Medicine and Pathobiology, University of ogy, Faculty of Medicine, Soﬁa University “St. Kliment Toronto, Toronto, ON, Canada Ohridski”, Soﬁa, Bulgaria, 5Depatment of Neurology, UH “Alexandrovska”, Medical University-Soﬁa, Soﬁa, Bul- Introduction:Abnormalaccumulationofprionproteinsare garia, 6Bulgarian Academy of Sciences, Soﬁa, Bulgaria responsible for several fatal neurodegenerative diseases. PRNP is the only gene in which pathogenic variants are Introduction: Frontotemporal dementia (FTD) is a geneti- known to cause genetic prion disease. However, several cally and pathologically heterogeneous degenerative dis- pathogenicmutationsofPRNPwithheterogeneoustypeand order,secondtoAlzheimer’sdiseaseasacauseofdementia position were published with disease-causing or modifying in patients under 65 years of age. The present case-control effectonotherneurodegenerativedisorders.Inasigniﬁcant study aims to broaden the understanding of the molecular portion, genetic cause can be explained with the most pathogenesisofFTDbywholeexomesequencing(WES)of common pathogenic mutation  E200
K in the PRNP gene. pooled DNA samples. Materials and methods: Hundred-twenty-six patients Materialsandmethods:Theanalysiswasundertakenon werereferred(ageatreferral:57+13,7years)toourinstitute 140 FTD patients grouped in two DNA pools (original and with clinically suggested prion disease during 2015-2019. replicate) and a control DNA pool of 100 age-matched Sangersequencingwasappliedtoanalyzetheentirecoding healthy subjects. The WES was performed in BGI region of PRNP gene. Genomics at a mean coverage of at least 250 x per sample Results: Altogether 25 unrelated prion-positive cases and the obtained variants were ﬁltered by stringent criteria. were detected during the 4-year observational period. Results: The number of biallelic autosomal variants Heterozygous c.598G>A ( E200
K) variant was detected in foundinthecontrolDNApoolis180692.Theoriginaland 22/25 cases. Besides this most commonvariantinone case replicate patient DNA pool contain 18 003 and 21 555 the previously described c.350 C>T (A117V) variant was variantsnotfoundinthecontrolpool,respectively.Among found. In one family a rare, 168 bp octapeptid-repeat these variants 2344 are found in both patient pools, as 175 insertion was observed, which is known to be associated have less than 1% frequency in non-Finish Europeans in with a very slow disease progression. In addition, a novel GnomAD. These variants are located in 174 genes and can mutation c. 490 A>G (R164G) has been also identiﬁed be considered as FTD associated. The pathway enrichment which associated to a slow progression as well. analysis of these genes using Reactome software platform Conclusions: In our cohort 88 % of the genetically showed over-represented pathways mainly in extracellular conﬁrmed prion disorders were associated to the most matrix organization. common  E200
K PRNP mutation. The type and location of Conclusion: The detection of over-represented extracel- thealterationofthePRNPgenemayhaveanimportantrole lular matrix organization pathways in FTD contributes to in the determination of the phenotype, which makes the the understanding of the pathogenetic mechanisms under- genetic counselling challenging. lying neurodegeneration. Acknowledgment: KP-06-N33/5 Funding: This study was supported by the Hungarian from 13.12.2019 - National Science Fund of Bulgaria. Brain Research Program (KTIA_NAP_ 2017-1.2.1-NKP- S. Karachanak-Yankova: None. L. Balabanski: None. D. 2017-00002). Serbezov: None.R.Vazharova:None.O.Antonova:None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 885 H. Zeke: None. Á. Palásti: None. B.A. Fekete: None. V. None. G. Karadima: B. Research Grant (principal investi- Molnár:None.A.Gál:None.Z.Grosz:None.G.G.Kovács: gator,collaboratororconsultantandpendinggrantsaswell None. M.J. Molnár: None. as grants already received); Modest; Pﬁzer. F. Consultant/ Advisory Board; Modest; Roche. G. Koutsis: B. Research E- P09
.35 Grant (principal investigator,collaboratororconsultantand Autosomalrecessiveaxonalneuropathywithneuromyo- pending grants as well as grants already received); tonia; mutations in HINT1 are not uncommon in the Signiﬁcant; Teva Pharmaceuticals, Genesis Pharma. Other; Greek population Signiﬁcant; Novartis, Genesis Pharma, Sanoﬁ-Genzyme, Teva. Z. Kontogeorgiou1, D. Pandis2, C. Kartanou1, M. Breza1, T. Zambelis2, M. Panas1, G. Karadima1, G. Koutsis1 E- P09
.38 Trio whole-exome sequencing conﬁrms KCND2 de novo 1Neurogenetics Unit, 1st Department of Neurology, School missense mutations as a cause of autosomal dominantly ofMedicine,EginitionHospital,NationalandKapodistrian inherited severe seizures and developmental delay University of Athens, Athens, Greece, 2Clinical Neurophy- siology Unit, 1st Department of Neurology, School of U. Zechner, D. Rosenkranz, H. Bolz Medicine, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece Senckenberg Centre of Human Genetics, Frankfurt, Ger- many Autosomal recessive axonal neuropathy with neuromyoto- nia (ARAN-NM) has been recently shown to result from Trio whole-exome sequencing was carried out in a female histidine triad nucleotide-binding protein 1 (HINT1) gene proband with epileptic encephalopathy (delayed myelina- mutations. It accounts for around 10% of recessive axonal tion, hypoplastic corpus callosum, abnormal EEG) and Charcot-Marie-Tooth disease (CMT) in European popula- severe global retardation noticed from the age of 3 months tions. A single case has been reported to date in the Greek (no psychomotor milestones acquired, muscle hypotonia, population. We presently report a case-series of 3 Greek irregular eye movements and lack of ﬁxation, stereotypic patients with ARAN-NM identiﬁed during screening of hyperkinetic arm and leg movements) and her healthy par- undiagnosed recessive axonal CMT cases with a combina- ents. The patient manifested intractable epileptic seizures tion of whole-exome and Sangersequencing.Patient 1 was fromtheageof1year;therewasnosigniﬁcantpsychomotor a 19 year-old female presenting with walking difﬁculty at development. She died at the age of 21 years. A hetero- the age of 8 years. She gradually developed lower limb zygous de novo missense variant, c.1210G>C (p.(Val404- atrophies and at 15 years old was also diagnosed with Leu)),wasdetectedinKCND2,thegeneencodingKv4.2,a myoclonic epilepsy. On EMG she showed motor axonal majorpore-formingsubunitinsomatodendriticsubthreshold neuropathy with neuromyotonia. She was compound het- A-type potassium current (ISA) channels. The variant has erozygous for mutations c.110G>C (p.Arg37Pro) and not been described in the literature or in disease- and c.250T>C(p.Cys84Arg)inHINT1.Patient2wasa20year- population-speciﬁc variant databases. It leads to the oldwomanpresentingwithwalkingdifﬁcultiesattheageof exchange of an evolutionarily highly conserved residue in 14years.Shegraduallydevelopedfootdropandupperlimb the  S6
 transmembrane segment which is part of the chan- distal weakness. On EMG she showed a motor axonal nel’scentralporeforionpermeation.All11appliedinsilico neuropathy with neuromyotonia. She was homozygous for prediction algorithms categorized the variant as deleterious. the c.110G>C (p.Arg37Pro) mutation in HINT1. Patient 3 In a previous report on KCDN2 as a disease gene, a wasa 49year-oldmalepresentingwith walking difﬁculties monozygotic twin pair with epilepsy and developmental attheageof15years.Hegraduallydevelopedfootdropand delay carried a heterozygous de novo missense variant upper limb distal weakness. On EMG he showed a pre- affecting the same residue (Lee et al., PMID: 24501278). dominantly motor axonal neuropathy with neuromyotonia. This p.(Val404Met) mutation (c.1210G>A) was shown to He was homozygous for the c.110G>C (p.Arg37Pro) lead to enhanced inactivation of closed Kv4.2 channels and mutation in HINT1. We conclude that HINT1-related CMT impaired inactivation of open channels (Lin et al., PMID: may be relatively common in Greece and should be further 29581270). Thus, our ﬁnding supports dominant de novo systematically screened for in appropriately selected KCND2 missense variants as a cause of intractable, early- populations. onset epilepsy with severe global retardation. Z. Kontogeorgiou: None. D. Pandis: None. C. Kartanou: U.Zechner:None.D.Rosenkranz:None.H.Bolz:None. None. M. Breza: None. T. Zambelis: None. M. Panas:886 J.delPicchia E- P09
.39 E- P09
.42 Correlation of genetic analysis and evolution of MRI Earlyonsetofcomplexseizuresasaﬁrstsignof16p11.2 changes leading to diagnosis of Labrune syndrome deletion syndrome J. Pilch1, M. Machnikowska-Sokołowska2, M. Rydzanicz3, E. Sukarova-Angelovska, V. Anastasovska, F. Duma, A. Pollak3, J. Kosińska3, P. Gasperowicz3, L.Muaremovska,D.Nestoroska,G.Ilieva,M.Pesevska,M. K. Gruszczynska2, E. Emich-Widera1, R. Płoski3 Velkov 1DepartmentofPediatricNeurology,MedicalUniversityof PediatricClinic,Skopje,Macedonia,TheFormerYugoslav Silesia, Katowice, Poland, 2Department of Diagnostic Republic of Imaging and Interventional Radiology, Department of Radiology and Nuclear Medicine, Medical University of Background: Recent technologies enabled clariﬁcation of Silesia, Katowice, Poland, 3Department of Medical Genet- some previously undetected causes of intellectual disability ics, Medical University of Warsaw, Warsaw, Poland andautismspectrumdisorders.Therearereportsof16p11.2 deletion in the literature, describing variable clinical pre- Progressive leukoencephalopathy with calciﬁcation and sentation in patients. Most of them describe developmental cysts wasﬁrst reportedbyLabrune in1996.Thepathology delay, autism and seizures, however phenotypic pattern is underlyingthediseaseisadiffusecerebralmicroangiopathy undistinguishable and variable. There is still no sufﬁcient with development of micro-, macrocysts, tumour-like vas- clinical data of this CNV in babies. cular hyperplasia, calciﬁcation, glial proliferation, demye- Case report: We report on a patient with developmental lination, necrosis, iron deposition and haemorrhage. delay and complex seizures. This is a second child in a Mutations in the SNORD118 gene were associated with family, the pregnancy and delivery was uneventful. Labrune syndrome in 2012. Since then only individual Microcephaly, foramen ovale and generalized hypotonia cases have been presented. were noticed shortly after birth. At the age of 3 months he We report a normally developing 10-years-old girl developed infantile spasms, followed by profound devel- suffering from chronic headaches without neurological opmental delay within the next several months. He has symptoms. Initially, Aicardi-Goutieres syndrome was microcephaly, early closure of the fontanel, high forehead, suspected. We performed retrospective analysis of three bitemporal narrowing, wide nasal root, narrow palpebral annual brain MRI with MR angiography. In all MRI we features, upper lip notch, short neck, cryptorchidism. found diffuse symmetrical white matter areas of increased Karyotype was normal. aCGH analysis (using Affymetrix® signal with U-ﬁbers sparing. Deep nuclei were affected. CytoScanTM 750K Array) showed deletion of 16p11.2 Cystic areas, enlarging in consecutive examinations were (1.430kb),alsodeletiononchromosome14q11.2(433kb), observedinthalami,withmasseffectinlastMRI.Multiple both are considered as pathogenic according aDGV signals with blooming effect were spread both supra- and database. infratentorially. Partial peripheral contrast enhancement Discussion and conclusion: Deletion of the 16p11.2 is wasseeninsupratentorialchanges.AsuspicionofLabrune mostly described in older children that developed autistic syndrome has arose after progression of cysts in degener- spectrum of disorder, ADHD, etc. Wide clinical variability ated white matter and appearance of calciﬁcations. is described between patients, mostly due to the variations Complex heterozygous mutations 17:008173448-G>C onsizeandbreakpointofthedeletedregion.Therearesome and 17:008173570-G>C in the SNORD118 gene encoding inconsistencies in phenotype described in literature, how- small nuclear RNA were found in patient using whole everthiscouldbeapartofachangingphenotypewithage. exome sequencing. Both parents are carriers of identiﬁed Since the baby had two pathogenic microdeletions, it is mutations. difﬁcult to distinguish between two phenotypes. Conclusion: Follow up MRI examinations in normally E. Sukarova-Angelovska: None. V. Anastasovska: None. developing child and correlation with in-depth genetic F. Duma: None. L. Muaremovska: None. D. Nestoroska: analysis led to diagnosis of a rare genetic metabolic None. G. Ilieva: None. M. Pesevska: None. M. syndrome. Collaboration between radiologists, geneticist Velkov: None. and clinicians was crucial for establishing ﬁnal diagnosis. J.Pilch:None.M.Machnikowska-Sokołowska:None.M. E- P09
.45 Rydzanicz: None. A. Pollak: None. J. Kosińska: None. P. WholeExomeSequencingofconsanguineousfamiliesof Gasperowicz: None. K. Gruszczynska: None. E. Emich- clinicallydiagnosedwithNeurodevelopmentalDisorders Widera: None. R. Płoski: None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 887 B. Turkgenc1, K. Yararbas2,3, H. Keskin Karakoyun1,4, EXOS C3
, B4GALNT1, GBA2, WWOX, ERC C6
, CHKB, A.Yesilyurt1,A. Gezdirici5,B.Tatlı6,7,N. H.Akcakaya8,N. TBCK, GLDC,TRAPP C9
, CY P7
B1, MID1 and TTN E. Hacifazlioglu9, O. Coskun7, G. Yesil10, B. Ekici11, genes. CL P1
 and GJ C2
 genes were found mutated twice. C. Yıldırım12, H. Onal13, G. Turanlı14, Y. Alanay15,16 A total of 6 novel variants were identiﬁed. Interestingly, clinicallyrelevantTTNandMID1variantsweredetectedin 1Acibadem Genetic Diagnostic Center, Istanbul, Turkey, thesamepatient,explainingthecombinatorialeffectsofthe 2Acibadem Genetic Diagnosis Center, Istanbul, Turkey, genes may contribute to phenotype complexity and 3Department of Medical Genetics, Faculty of Medicine, variability. Acibadem University, Istanbul, Turkey, Istanbul, Turkey, Conclusions: Identiﬁcation of pathogenic/ potentially 4Department of Biochemistry and Molecular Biology, pathogenic variants and novel variants may lead to the Acibadem University, Istanbul, Turkey, 5Kanuni Sultan design of personalized therapeutic strategies and the Süleyman Training and Research Hospital, University of implementation of genetic counseling of NDD as well as Istanbul Health Sciences, Istanbul, Turkey, 6Pediatric to monitoring and early intervention, even before the onset Extreme NeuroTherapeutics Center, Istanbul, Turkey, of the disorder. 7Department of Pediatric Neurology, Faculty of Medicine, B. Turkgenc: None. K. Yararbas: None. H. Keskin Istanbul University, Istanbul, Turkey, 8Department of Karakoyun: None. A. Yesilyurt: None. A. Gezdirici: None. Genetics, Aziz Sancar Institute of Experimental Medicine, B. Tatlı: None. N.H. Akcakaya: None. N.E. Hacifazlioglu: Istanbul University, Istanbul, Turkey, 9Zeynep Kamil None.O.Coskun:None.G.Yesil:None.B.Ekici:None.C. Women’s and Children’s Disease Training and Research Yıldırım: None. H. Onal: None. G. Turanlı: None. Y. Hospital, Istanbul, Turkey, 10Department of Medical Alanay: None. Genetics, Faculty of Medicine, Bezmialem Foundation University, Istanbul, Turkey, 11Pediatric Neurology, Vital E- P09
.50 Fulya, Istanbul, Turkey, 12Department of Pediatric Neurol- Early-onset parkinsonian syndrome and PLA2G6 gene ogy, Acibadem Altunizade Hospital, Istanbul, Turkey, mutation 13Department of Pediatric Endocrine and Metabolism, Istanbul Kanuni Sultan Süleyman Training and Research C. Skrypnyk1, M. B. Falah2 Hospital, Istanbul, Turkey, 14Department of Pediatric Neurology, Faculty of Medicine, Medipol University, 1ArabianGulfUniversity,CollegeofMedicineandMedical Istanbul, Turkey, 15Department of Pediatric Genetics, Sciences, Al Jawhara Center for Molecular Medicine, AcibademMaslakHospital,Istanbul,Turkey,16Department Manama, Bahrain, 2Arabian Gulf University, University of Medical Genetics, Faculty of Medicine, Acibadem Medical Center, King Abdullah Medical City, Manama, University, Istanbul, Turkey Bahrain Introduction: Neurodevelopmental disorders (NDD) are Introduction: The parkinsonian syndromes encompass a heterogeneous conditions in which the development of the numberofentitiesgroupedbasedonsharedclinicalfeatures central nervous system is disturbed. Recent advancements but separated by different pathologies. Non-motor features in genomics have enabled scientists to identify numerous evolvingcoincidentwithprogressivemotordisabilitymake mutations underlying NDD. the diagnosis very challenging. Materials and methods:We usedwhole exome sequen- Material and methods: Clinical assessment, brain cing (WES) to identify the causative genes in 22 patients MRI, EEG, biochemical proﬁle and genetic testing were with NDD. Consanguinity was reported in all families. performed for a 25 years old male patient that Genomic DNA was extracted using the QIAamp DNA presentedwithprogressiveneurologicalsymptoms,general- Blood Mini QIAcube Kit (QIAGEN, Hilden, Germany). ized myoclonic jerks, unilateral left upper body tremor and The DNA libraries were created by the Nextera DNA rigidity, walking difﬁculties, swallowing difﬁculties, poor Exome kit (Illumina) and sequenced on NextSeq concentration and attention, behavioral changes and bouts 500 sequencer using 2x150 bp sequencing kits (Illumina). of anger. Bioinformatic analyses were performed on Seqgenomize Results: The patient is the ﬁrst child of healthy ﬁrst platform including an automated variant classiﬁcation tool. degree cousins parents and has a positive family history of Results:InseriesofpatientswithNDDstudiedbyWES, epilepsy. Behavioral changes were recorded since age 17 we found pathogenic/likely pathogenic variants in 17 years old and neurological symptoms had onset at age 22. different genes, which consist of 2 frameshift duplication, CAG repeats testing was previously reported normal and 4 frameshift deletion, 6 nonsense, 9 missense and a splice ruledoutHuntingtondisease.BrainMRIshowngeneralized site variants in WDR62, CL P1
, IGHMB P2
, ADSL, GJ C2
, cerebral and cerebellar atrophy without signs of iron888 J.delPicchia accumulation or T2 lesions in basal ganglia. EEG revealed rs1800629, IL-1β rs16944, and IL-6 rs1800795 was generalized epileptic complexes. Serum ceruroplasmin and performed using TaqMan real-time PCR assays. copper values were normal. Rare forms of Parkinson, Results: IL-1β rs16944 G allele in females has been Multiple system cerebellar atrophy and Spinocerebellar associated with faster PD progression on UPDRS motor ataxia were considered as differential diagnoses. Whole examination (Part III, p=0.014), on motor complications genomesequencingidentiﬁedaPLA2G6genehomozygous (Part IV, p=0.026), and on UPDRS total (p=0.005). IL-6 pathogenicmissensemutationandclariﬁedthediagnosisof rs1800795 GG genotype was statistically signiﬁcant Parkinson Disease type 14 (OMIM#612953, predictor of depression (p=0.047) and anxiety (p=0.004) ORPHA199351). progression on related scales. Conclusions:Wholegenomesequencingisaveryuseful Conclusion: Polymorphic variants in IL-1β, and IL-6 and fast tool in elucidating a complex and heterogeneous genesinﬂuenceParkinson’sdiseasecourseduringﬁve-year phenotype. PLA2G6 mutations should be considered in follow-up. patients with atypical early-onset parkinsonian syndrome. M. Pesic: None. N. Maksimovic: None. A. Aleksic: Genetic testing is required when consanguinity associates None. M. Gulic: None. A. Djuranovic: None. M. Grk: with complex and early neurodegenerative onset. None. M. Dusanovic Pjevic: None. I. Stankovic: None. V. C. Skrypnyk: None. M.B. Falah: None. Markovic: None. A. Marjanovic: None. I. Novakovic: None. N. Dragasevic-Miskovic: None. V.S. Kostic: None. E- P09
.52 Polymorphisms in genes for proinﬂammatory cytokines E- P09
.53 IL-6, IL-1β, andTNF-α in relation with Parkinson’s Search for molecular genetic factors in Parkinson’s disease progression disease M. Pesic1, N. Maksimovic1, A. Aleksic2, M. Gulic1, M. Shadrina1, S. Pchelina2, S. Illarioshkin3, P. Slominsky1 A. Djuranovic1, M. Grk1, M. Dusanovic Pjevic1, I. Stankovic3, V. Markovic3, A. Marjanovic3, I. Novakovic1, 1Institute of Molecular Genetics, Russian Academy of N. Dragasevic-Miskovic3, V. S. Kostic3 Sciences, Moscow, Russian Federation, 2The Petersburg Nuclear Physics Institute of the National Research Center, 1InstituteofHumanGenetics,Belgrade,Serbia,2Instituteof Kurchatov Institute, Russian Academy of Sciences, Gat- Medical Statistics and Informatics, Belgrade, Serbia, china,RussianFederation,3FederalStateScientiﬁcInstitu- 3Clinic for Neurology, ClinicalCenter ofSerbia, Belgrade, tion, Scientiﬁc Center of Neurology, Russian Academy of Serbia Sciences, Moscow, Russian Federation Introduction: Parkinson’s disease (PD) is a progressive Introduction: At present, there is no doubt about the and complex neurological disorder with heterogeneous complexityofthenatureofthepathogenesisofParkinson’s symptomatology.Chronicneuroinﬂammationcontributesto disease(PD)duetodisruptioninthefunctioningofvarious the pathogenesis of PD. Activation of microglia and metabolic systems, which leads to dopaminergic system increased levels of pro-inﬂammatory mediators such as deﬁciency. At the moment, there is no single picture of the tumor necrosis factor alpha (TNF-α), interleukine-1 beta etiopathogenesis of this disease. (IL-1β), and interleukine-6 (IL-6) have been reported after Materials and methods: Toxic models of PD in rodents post-mortem analysis of the substantia nigra from PD andvarioussamplesofpatientswithPDwerestudiedusing patients. This study aimed to estimate the association of sequencing of full exome, transcriptome, and RT-PCR. TNF-αrs1800629,IL-1βrs16944,andIL-6rs1800795with Results: An analysis of patients with a presumed thedisease progressionintheinitial motorstage,afterﬁve- autosomal dominant form of PD revealed eight new genes, year follow-up. mutations in which can lead to the development of the Material and methods: Our study included 64 con- disease, was carried out. Three different variants were secutivePDoutpatientsatHoehnandYahrdiseasestage1. detected in the SCN3A gene in three patients. Analysis of The severity of PD, depression, anxiety, and cognitive toxic models of PD revealed new ones that can play an impairment were evaluated using rating scales: Uniﬁed important role at different stages of pathogenesis (vesicular ParkinsonDiseaseRatingScale(UPDRS)Part(I-IV),Mini- transport, projection of neurons, RNA splicing and Mental State Examination (MMSE) score, Hamilton myelination processes). A detailed analysis of the mRNA Depression Rating Scale (HAM-D), and Hamilton Anxiety level of individualgenes intheperipheral blood ofpatients Rating Scale (HAM-A). Patients completed the same with PD revealed several genes, the level of which protocol at Years 1, 2, 3, and 5. Genotyping of TNF-α speciﬁcally varied in untreated patients with PD.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 889 Conclusion: Our data indicate a consistent involvement E- P09
.55 ofthetranscriptomeinthepathogenesisofPDandhighlight Further evidence of the expanding clinical spectrum of the independent role of various brain structures and PIGT-CDG: from epileptic encephalopathy to intellec- individual parts of nerve cells in the formation of a tual disability with epilepsy. response to the development of neurodegeneration. In addition, we showed the possible involvement of SCN3A I.BenAyed1,2,F.Kamoun3,A.Souissi4,A.Bouzid4,M.Ben in the process of neurodegeneration. This work was Said4, S. Ben Nsir3, W. Bouchaala5, A. Tlili6,7, C. Triki3, S. supported by the Russian Science Foundation (grants 20- Masmoudi4 15-00262). M. Shadrina: None. S. Pchelina: None. S. Illarioshkin: 1Laboratory of Molecular and Cellular Screening Pro- None. P. Slominsky: None. cesses,Center ofBiotechnologyofSfax, UniversityofSfax, Tunisia., SFAX, Tunisia, 2Medical Genetic Department, E- P09
.54 University Hedi Chaker hospital of Sfax,, Sfax, Tunisia, Polymorphism of the functional promoter microsatellite 3Child Neurology department, Universitary Hedi Chaker locus of the arginine vasopressin receptor in Yakut men hospitol of Sfax,, SFAX, Tunisia, 4Laboratory of Molecular arelinkedtoextraversion&neuroticismpersonalitytraits and Cellular Screening Processes, SFAX, Tunisia, 5Child Neurology department, Universitary Hedi Chaker hospitol S.S.Nakhodkin1,N.A.Barashkov1,2,V.G.Pshennikova1,2, of Sfax,, SFAX, Tunisia, SFAX, Tunisia, 6Department of S. A. Fedorova1 AppliedBiology,CollegeofSciences,UniversityofSharjah, Sharjah,UnitedArabEmirates,7HumanGeneticsandStem 1M.K. Ammosov North-Eastern Federal University, Cell Laboratory, Research Institute of Sciences and Yakutsk, Russian Federation, 2Laboratory of Molecular Engineering, University of Sharjah, Sharjah, United Arab Genetics, Yakut Scientiﬁc Centre of Complex Medical Emirates Problems, Yakutsk, Russian Federation Introduction: PIGT-CDG is a rare Glycosylpho- Polymorphismofthefunctionalpromotermicrosatellitelocusof sphatidylinositol disorder. The patients show a broad clin- the arginine vasopressin receptor (AVPR1A) can cause the ical spectrum from epileptic encephalopathy to severe formationofpersonalitytraitscharacterizedbyimpulsivity,poor intellectual disability and treatable epilepsy with later age control of one’s impulses, extravagance, anxiety, exaggeration at onset. of the expected danger and an acute reaction to social dis- PatientandMethods:Illumina®TruSight™Oneclinical approval.Inthispaper,weevaluatedtheeffectoftheR S1
locus exomewasperformedina4-year-oldgirlwithMiSeqnext- in the AVPR1A gene, in the formation of personal character- generation sequencing platform in order to explore a istics in 121 individuals of Yakut men, and also conducted a profound developmental delay associated with severe comparativeanalysisofthefrequencydistributionofallelesand hypotonia, seizure, and nystagmus. genotypes. The study revealed the involvement of the poly- Results: The analysis revealed a homozygous missense morphicmarkerR S1
intheformationofsuchpersonaltraitsas variant in PIGT (NM_015937.6): c.1519C>T (p. "avoidanceofdamage"and"dependenceonreward".Thedata Arg507Trp). Segregation analysis supports the recessive obtainedindicateamodulatingeffectofethnicityonidentifying pattern of inheritance. The pathogenicity of p.Arg507Trp associations of the AVPRA1 gene with personality traits. The wasestimatedasdeleteriousbyweb-basedpredictiontools. frequenciesofR S1
allelesdifferedinYakut(Asian)volunteers So far 26 patients with a GPI anchor deﬁciency due to compared to white (Finland, Ireland, Israel), and European recessive PIGT variants have been described. Our patient whitepopulationshadahigherrangeofGATAtrackdiversity. shares the most common features associated with PIGT- WeidentiﬁedsevendifferentallelesoftheR S1
marker.Atthe CDG: intellectual disability/development delay, seizures, same time, short and long alleles (R8, R14, R15, R16) were nystagmus, and brain MRI anomalies. Most of the absent in our sample in homozygous form. The Yakut popu- published PIGT deﬁcient patients had evident cortical and lationischaracterizedbyapronounceddeﬁcitofheterozygotes cerebellaratrophy.Ourpatientdemonstratedsevereatrophy and a low level of actual heterozygosity, which can be of the cerebral hemispheres with slight atrophy of the explained by the founder effect in the Yakut population. The cerebellum at the age of 4 years. If the predominant work was supported by the Ministry of science and higher presentation of patients is that of an epileptic encephalo- education of the Russian Federation (the main part of NEFU) pathy including severe drug resistance, only some cases and with the support of RFBR grant (18-05-600035_arctic). (4/26)withsevereIDandtreatableepilepsywithlaterageat S.S. Nakhodkin: None. N.A. Barashkov: None. V.G. onsetwerereported.Ourpatienthadaglobaldevelopmental Pshennikova: None. S.A. Fedorova: None.890 J.delPicchia delay with seizures; she became seizure-free with only one father carried the same heterozygous MYORG variant and antiepileptic drug. showed no brain calciﬁcation. Conclusion: Here, a report a novel pathogenic missense Conclusions: We report a homozygous MYORG change variant in PIGT gene associated with treatable epilepsy asthemostlikelycauseofPFBCpresentingasparoxysmal strengthening the hypothesis that missense variant can lead dyskinesia in our patient and thus expand the known to cause a milder phenotype with treatable seizures phenotypic spectrum of MYORG-associated PFBC. I.BenAyed:None.F.Kamoun:None.A.Souissi:None. A.Westenberger:F.Consultant/AdvisoryBoard;Modest; A. Bouzid: None. M. Ben Said: None. S. Ben Nsir: None. Centogene.G.Saranza:None.K.Grütz:None.C.Klein:F. W. Bouchaala: None. A. Tlili: None. C. Triki: None. S. Consultant/Advisory Board; Modest; Centogene. A.E. Masmoudi: None. Lang: None. E- P09
.56 E- P09
.57 Primary familial brain calciﬁcation manifesting as A Portuguese family-based exome sequencing in pri- isolatedparoxysmaldyskinesia:Casereportofapatient mary headaches with a homozygous MYORG change A. Dias1,2, M. Alves-Ferreira1,2, J. Sequeiros1,2, J. Pereira A. Westenberger1, G. Saranza2, K. Grütz1, C. Klein1, Monteiro1, A. Sousa1,2, C. Lemos1,2 A. E. Lang2,3 1i3S – Instituto de Investigação e Inovação em Saúde, 1Instituteof Neurogenetics, University of Lübeck, Lübeck, Porto, Portugal, 2ICBAS - Instituto Ciências Biomédicas Germany, 2Edmond J. Safra Program in Parkinson’s Abel Salazar, Porto, Portugal Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, ON, Introduction: Primary headaches comprises migraine with Canada, 3Division of Neurology, Department of Medicine, or without aura (MA/MO) and cluster headache (CH). University of Toronto, Toronto, ON, Canada During the last 17 years, our group has been able to clini- cally characterize more than a thousand patients, relatives Introduction: Primary familial brain calciﬁcation (PFBC) and controls and we performed several candidate-gene isahereditarydisordercharacterizedbycalciumdepositsin association studies in different pathways. Moreover, we the brain and presenting clinically with neuropsychiatric found several variants involved in the vascular component, symptoms,cognitivedysfunction,oravarietyofmovement trigeminal nociceptive plasticity, neurogenic inﬂammation disorders. Currently, changes in six genes are known to and in the release of neurotransmitters. However, these cause PFBC, with SL C20
A2, PDGFB, PDGFRB, XPR1 complex diseases are caused by several genetic factors. variants related to autosomal dominant forms and MYORG Whole-exomesequencing(WES)isapowerfulapproachto and JAM2 variants to autosomal recessive ones. explorecodingregions,particularlylow-frequencyvariants. Patients and Methods: We identiﬁed a 26-year-old OuraimwastoperformaWESinthreefamiliestounravel femalepatient,presentingwithperiodicinvoluntarypostur- genetic factors involved in migraine and CH susceptibility. ing of her limbs and symmetrical bilateral brain calciﬁca- Materials and methods: We gathered clinical informa- tions.GenetictestingwasperformedforPRRT2,SL C20
A2, tion and DNA samples from 3 families with primary PDGFB, PDGFRB, XPR1, and MYORG. Her parents also headaches and associated phenotypes. Afterwards, a WES underwent targeted MYORG sequencing. was performed. Results:Inourpatient,theparoxismalkinesigenicattacks Results:Weanalysed20patientsfromthe3familiesand ﬁrstappearedateightyearsofage,becamemorefrequentin we found common and rare variants in genes already her teenage years (up to ten attacks per day) and were associated with migraine subtypes as CACNA1A and completely absent during her pregnancies. Neurologic PRRT2 and in new genes that may open new pathways examination was normal between episodes. Neuroimaging of study. revealed symmetrical bilateral calciﬁcations involving the Conclusions:Thesepreliminaryresultsneedtobefurther cerebellum, basal ganglia, thalamus, midbrain, and the explored and interactions among these variants need to be frontal and occipital cortical and subcortical areas. In understood to deepen the pathophysiological pathways of addition, in her pregnancies, the placentae were noted to migraine. In the future, we will also correlate epigenetics have widespread calciﬁcation. Our genetic analyses identi- and brain activity data to assess the risk of chronic and ﬁed a homozygous previously reported and likely patho- episodic migraine in women. Understanding the mechan- genicmissensevariantintheMYORGgene(c.1831C>T;p. isms underlying primary headache pathophysiology could Arg611Trp) and no PRRT2 changes in our patients. Her lead to the development of more effective and better-Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 891 tolerated therapeutic approaches to avoid the overlay of E- P09
.60 painful events. Potential genetic modiﬁers of the inherited neurodegen- A. Dias: None. M. Alves-Ferreira: None. J. Sequeiros: erative disorder SCA3 None. J. Pereira Monteiro: None. A. Sousa: None. C. Lemos: None. R. M. Burger1,2,3,4, M. L. Saraiva-Pereira5, M. Franca6, C.Gordon7,L.B.Jardim5,M.Cornejo-Olivas8,O.Rieß1,2,3, E- P09
.58 T. Schmidt1,2,3 PrevalenceofPTENmutationsinTurkishchildrenwith autism spectrum disorders and macrocephaly 1University of Tübingen, Medical Genetics and Applied Genomics, Tübingen, Germany, 2University of Tübingen, H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3, Center of Rare Diseases, Tübingen, Germany, 3University B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7, of Tübingen, NGS Competence Center of Tübingen M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 (NCCT), Tübingen, Germany, 4IZKF, Graduate program oftheUniversityofTübingen,Tübingen,Germany,5Labor- 1Demiroglu Bilim University, Istanbul, Turkey, 2Istanbul atório de Identiﬁcação Genética, Hospital de Clínicas de University, Istanbul, Turkey, 3Behcet Uz Hospital, Izmir, Porto Alegre, Porto Alegre, Brazil, 6Department of Turkey, 4Ege University, Izmir, Turkey, 5Katip Celebi Neurology, University of Campinas-UNICAMP, Campinas, University, Izmir, Turkey, 6Okmeydanı Hospital, Istanbul, Brazil, 7Sackler Faculty of Medicine, Tel Aviv University,, Turkey, 7Yeditepe University, Istanbul, Turkey Tel Aviv, Israel, 8Neurogenetics Research Center, Instituto Nacional de Ciencias Neurológicas, Lima, Peru Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Background: Spinocerebellar ataxia type 3 (SCA3) is an Recently,peoplewithautismspectrumdisorders(ASD)and autosomal-dominantly inherited neurodegenerative disease macrocephalywerefoundtocarrymutationsinPTENgene. and the most common inherited ataxia worldwide. Its Mutations in this gene cause PTEN Hamartoma Tumour pathogenic mutation is an abnormal expansion of the CAG Syndrome (PHTS). However, PHTS often goes undetected repeatsover55triplet-repeatswithintheATXN3genewhich especiallyinchildrensincethemanifestationsofthedisease encodesforanexcessivelylongpolyglutamine(polyQ)tract are variable and subtle and guidelines for testing are few. in the disease protein ataxin-3. Patients show a widely Studiesshow1to17%prevalenceratesofPTENmutations spread variation in age at onset and clinical variability of inchildrenwithASDandmacrocephaly.Thevaryingresults phenotype. Until today this phenomena is not fully on prevalence suggest the need for further studies. The aim explained. In the past, it was shown that the age at onset ofourstudyistoﬁndPTENprevalenceinTurkishchildren inverselycorrelateswiththeexpandedCAGrepeats.Within withASDandmacrocephalyandincreaseawarenessofthis thewiderange ofageatonsetbetween 5-75yearsonly45- syndromeinTurkey.Tothebestofourknowledgethiswill 60% can be explained by the CAG repeat expansion. be the ﬁrst PTEN prevalence study done in Turkey and Aim:Theaimofourstudyistoidentifygeneticmodiﬁers South Eastern Europe. This is also the largest pediatric whichcanexplainthewiderangeofageatonsetaswellas cohortforPTENprevalencestudyinpatientswithASDand the clinical heterogeneity of SCA3. macrocephaly. Materials and methods: PTEN sequencing Methods: Previously several genes (ATXN3, ATXN2, were done for 128 patients with ASD and head cir- APOE, CACNA1A) were described as candidate genes in cumference size more than 97% on growth charts between literature. We are genotyping two big cohorts EUROSCA the ages of 3 to 18 recruited from ﬁve different child and (Europe)andEUSAge(Israel,Brazil,Peru)intermsofsingle- adolescentpsychiatryclinicsinTurkey.Result:Wefound2 nucleotide polymorphism (SNP) within candidate genes. known pathogenic, 1 new pathogenic and 2 variants of ResultsandConclusion:Avariationinpolymorphismcan insigniﬁcance (VUS) mutations out of 128 patients. The leadtodifferentisoformsofthegenes,functionalchangesof prevalence is 2,3% (VUS mutations are excluded). Con- the encoding proteins and different interactions with mole- clusion:WerecommendPTENtestinginpatientswithASD cules.ASNPinATXN3hasalreadybeenfoundtoinﬂuence and macrocephaly. Grant for this study is awarded by the pathophysiology of SCA3.Therefore,SNPs of candidate ‘PTEN Research’ in London, UK. genes seem to have an inﬂuence on the pathophysiology of H.Kaymakcalan:None.I.Kaya:None.N.CevherBinici: SCA3 and may be promising genetic modiﬁers to observe None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: further in order to learn more about the disease. None. E. Nikerel: None. M. Aksoy: None. D. Celik: None. R.M. Burger: None. M.L. Saraiva-Pereira: None. M. S. Kose: None. N. Majroh: None. S. Duruk: None. Franca: None. C. Gordon: None. L.B. Jardim: None. M. Cornejo-Olivas: None. O. Rieß: None. T. Schmidt: None.892 J.delPicchia E- P09
.61 O. Ozgen1, G. Akan2, A. Colak3, S. Acar4, F. Oncu5, Co-ocurrence of two rare genetic diseases in a patient H. Yanbay5, D. Yeşilbursa5, S. Turkcan5, F. Atalar6 with intellectual disability, refractory epilepsy and skeletal abnormalities 1Istanbul University Medical Faculty, Aziz Sancar Experi- mentalResearchInstitute,MolecularMedicineDepartment, M. Rodrigues, M. P. Soares, P. Dias, A. B. Sousa Istanbul, Turkey, 2MUHAS Genetics Laboratory, Biochem- istryDepartment,SchoolofMedicine,MuhimbiliUniversity Serviço de Genética Médica, Hospital de Santa Maria, of Health and Allied Sciences, Dar es Salaam, Tanzania, Centro Hospitalar Universitário de Lisboa Norte EPE, United Republic of, 3Department of Biomedical Engineer- Centro Académico de Medicina de Lisboa, Lisbon, ing, Biomedical Engineering Institute, Bogazici University, Portugal, Lisbon, Portugal Istanbul, Turkey, 4Department of Bioengineering, Yildiz TechnicalUniversity,Istanbul,Turkey,5PsychiatryClinics, Introduction: Whole-exome sequencing (WES) is a pow- TurkishMinistryofHealthBakirkoyResearchandTraining erful tool to identify the genetic causes of rare mendelian Hospital for Psychiatry, Neurology and Neurosurgery, disorders and can be particularly useful in patients with Istanbul, Turkey, 6Istanbul University Medical Faculty, complex and genetically heterogeneous phenotypes. The Medical Genetics Department, Child Health Institute, authorsdescribeapatientwithphenotypicmanifestationsof Istanbul, Turkey two rare genetic diseases: autosomal recessive cerebellar ataxia type 23 (SCAR23, OMIM #616949) and con- Background:Thyroidhormonemodulationofcrucialbrain tractures, pterygia, and variable skeletal fusions syndrome- neurotransmitter systems and the misregulation of these 1A (CPSKF1A, OMIM #178110). pathways are of particular relevance in schizophrenia Methods and results: We report a 21-year-old male (SCH). Type II deiodinase enzyme (DIO2) has a critical patientborntonon-consanguineousparents,withirrelevant potency on thyroid metabolism that converts prohormone family history. He has language delay, mild to moderate thyroxine (T4) to the active hormone triiodothyronine (T3) intellectual disability (ID), refractory epilepsy, ﬁne motor also it seemsthat canparticular relevance inschizophrenia. skill deﬁcits, short neck, narrow shoulders, mild facial The aim of this study was to investigate the genetic con- dysmorphisms, hypoplastic hypothenar eminence and tributionoftheDIO2genetoSCHbythegenotypeanalysis hypoplastic ﬂexion creases. His skeletal survey showed ofDIO2Thr92AlaandORFa-Gly3Asppolymorphismsand  C4
- C5
 fusion. Brain MRI, karyotype, array-CGH and to compare the serum levels of free triiodothyronine (FT3), FMR1 testing were normal. WES revealed two variants in free thyroxine (FT4), and thyroid-stimulating hormone TD P2
 gene: c.345_348del, p.(IIe117Profs*7) (likely patho- (TSH) concentrations in 290 unrelated Turkish SCH genic) and c.949C>T, p.(Arg317*) (variant of uncertain patients and 198 healthy controls. signiﬁcance). These variants have not been previously Method and Results: We genotyped two single nucleo- reported and are in a compound heterozygous state. WES tide polymorphisms (SNPs) Thr92Ala and ORFa-Gly3Asp also showed a heterozygous deletion encompassing at least located on DIO2 gene, and performed SNP association exons 4-7 of the MYH3 gene (likely pathogenic). analysis along with the thyroid hormonal status in SCH Discussion and conclusions: The presence of variants patients and healthy controls. The distribution of Thr92Ala c.345_348del and c.949C>T in TD P2
 gene may justify the genotypes in SCH was signiﬁcantly different compared to neurological ﬁndings in our patient, namely ID and controls (p=0.045). In men cohort, both allele and epilepsy, establishing the diagnosis of SCAR23. On the genotype frequencies were found signiﬁcantly other hand, the heterozygous deletion of exons 4-7 of the different than controls (p=0.03). However, neither allele MYH3 gene might explain the dysmorphic and skeletal and nor genotype frequencies of ORFa-Gly3Asp poly- ﬁndings of the patient, whose features are more suggestive morphism were statistically signiﬁcant in the study of CPSKF1A. This case illustrates the challenge of group. Decrease of mean FT3 (p<0.001) and TSH diagnosing two genetic disorders co-occurring in the same (p=0.004) concentrations were observed in SCH patients patient. comparedtocontrols.Thr92Alagenotypeswerefoundtobe M. Rodrigues: None. M.P. Soares: None. P. Dias: None. signiﬁcantly associated with FT3 and TSH levels (p<0.05, A.B. Sousa: None. respectively). Conclusion: Our results indicate that DIO2 Thr92Ala E- P09
.62 reduces Deiodinase-2 Activity and FT3 Levels in Turkish DIO2Thr92Ala Reduces Deiodinase 2 Activity and SCHpatients.Ourﬁndingsalsoshowthattheimportanceof Serum T3 Levels in Patients with Schizophrenia thyroid hormone metabolism in SCH.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 893 O. Ozgen: None. G. Akan: None. A. Colak: None. S. E- P09
.65 Acar: None. F. Oncu: None. H. Yanbay: None. D. SOR L1
 variant associated with familial Parkinson’s Yeşilbursa: None. S. Turkcan: None. F. Atalar: None. disease and dementia in a large Greek pedigree. E- P09
.63 T. Bourinaris1, G. Xiromerisiou2, H. Houlden1, Schizophrenia patients have signiﬁcantly less f-SatIII A. Singleton3, SYNaPS study group, J. Hardy1, and more rDNA repeats compared to healthy donors J. Vandrovcova1 V. Sergeeva1, A. Poletkina1, E. Ershova1, N. Veiko1, 1UCL Institute of Neurology, London, United Kingdom, A. Martynov1, J. Chudakova1, A. Artyushin1, 2UniversityofThessaly,Larissa,Greece,3NationalInstitute E. Malinovskaya1, A. Filev1, M. Konkova1, L. Bravve2, on Aging, Bethesda, MD, United States N.Zakharova2,G.Kostyuk2,O.Agafonova1,G.Shmarina1, S. Kostyuk1 Background: 10% of Parkinson’s disease is caused by certain monogenic forms. Several causal genes have been 1FSBI “Research Centre For Medical Genetics”, Moscow, identiﬁedtodaybuttheunderstandingofunderlyinggenetic Russian Federation, 2N. A. Alexeev Clinical Psychiatric mechanisms has proved challenging. Many of the affected Hospital №1, Moscow Healthcare Department., Moscow, families remain genetically unsolved. Russian Federation Methods: In this study we use molecular techniques to investigate a large pedigree with many affected individuals Introduction: Dysregulation of rRNA biogenesis is impli- fromanisolatedvillageincentralGreeceaffectedbyahigh cated in some human diseases. rDNAcopy number (CN) in incidenceofParkinson’sdisease. Weutilizedwholeexome thegenomeisafactoratplay.F-SatIIIisanАТ-richrepeat sequencing and linkage analysis to identify coding variants ofpericentromeric heterochromatin in the ﬁrst chromosome that are of putative signiﬁcance. We then apply association (1q12). rDNA and 1q12 interact ininterphase cells. rDNA analysis across a wider population to highlight the CN might correlate with f-SatIII. signiﬁcance of these variants in sporadic cases. Materialsandmethods:Weanalyzedleukocytesof469 Results: Linkage to chromosome 11 was found with a healthy donors (HD) and 777 patientswith schizophrenia LODscoreof2.2.Thephenotypicspectrumofourpatients (F20.00, SP). CN was determined using non-radioactive was not uniform: 3 presented with Parkinson’s disease hybridization withbiotin-labelled DNA probes. without dementia, while another2 presented with dementia Results: Genomes of SP contain increased levels of thatwaslaterclassiﬁedasAlzheimer’sdisease.Allpatients rDNACNanddecreasedlevelsoff-SatIIIcomparedtoHD: carried a novel heterozygous variant in SOR L1
 segregating 532 ± 118 copies with 18,0 ± 5,9 pg/ng of f-SatIII and with disease in the family. 413 ± 105 copies with21,6 ± 6,9 pg/ng of f-SatIII, Conclusions:Thisistheﬁrst reportofthediscovery ofa respectively, p < 10 -80. Amount of f-SatIII depends on likely pathogenic variant in SOR L1
 in a large family with rDNA CN:DNA of HD and SP containing low (200 - 350) some of the affected individuals presenting with Parkin- or high (>700) CN of rDNA contained 10 - 30pg/ng of f- son’s disease without dementia at disease onset. SatIII. 55% of SP have 500 - 600 CN of rDNA and 15-20 T.Bourinaris:None.G.Xiromerisiou:None.H.Houlden: pg/ngoff-SatIII.Only15%ofHDhavethesamenumbers. None. A. Singleton: None. J. Hardy: None. J. 16% of SP have <20 pg/ng of f-SatIII and rDNA CN > Vandrovcova: None. 500with their ratio > 40, only 1.5% of HD have this ratio. 26% of HD have rDNA CN <400, f-SatIII> 20 pg/ng and E- P09
.66 their ratio <20 and only 1, 9% of SP are in this area. Thus, Molecular Complexity of Spastic Ataxias and Heredi- there is acorrelation between rDNA CN and the size if tary Spastic Paraplegias in Turkey heterochromatin regions. Conclusions:SPhavesigniﬁcantlylessf-SatIIIandmore G. Simsir1, S. Tekgul1, H. Apaydin2, S. Ertan1, A. Basak1 rDNA repeats compared to HD. V. Sergeeva: None. A. Poletkina: None. E. Ershova: 1Koç University, Istanbul, Turkey, 2Istanbul University- None.N.Veiko:None.A.Martynov: None.J.Chudakova: Cerrahpasa, Istanbul, Turkey None. A. Artyushin: None. E. Malinovskaya: None. A. Filev: None. M. Konkova: None. L. Bravve: None. N. Introduction: Hereditary spastic paraplegias (HSPs) and Zakharova:None.G.Kostyuk:None.O.Agafonova:None. autosomal recessive cerebellar ataxias (ARCAs) are neu- G. Shmarina: None. S. Kostyuk: None. rological diseases that may overlap genetically and clini- cally. Both can be associated with other neurologic or non-894 J.delPicchia neurologic symptoms and complex phenotypes. Sig- G.Simsir: None.S.Tekgul:None.H.Apaydin:None.S. niﬁcantly,ARCAsfrequentlyshowpyramidalinvolvement, Ertan: None. A. Basak: None. which results in spasticity. Molecular analysis is challen- ging due to complex genetics and rarity of these diseases. E- P09
.67 However, recent developments in next generation sequen- A homozygous pathogenic variant in the STAMBPgene cing technologies help to understand complex genetic associated with microcephaly-capillary malformation background of these diseases. syndrome - the ﬁrst case report in a Roma patient Materials and methods: DNA isolated from peripheral bloodwasused.37probandswithspasticityandataxiawere M. Giertlova1, M. Mistrik1, J. Saligova2, E. Zavadilikova2, subjected to whole exome sequencing (WES), followed by A. Baranova2, M. Hyblova3, G. Minarik3 bioinformaticanalysis.Mostfamilieswereconsanguineous. Results: 26 mutations (15 novel) in 10 genes were 1AlphamedicalInc.,Martin,Slovakia,2PediatricUniversity identiﬁed (Table1). Table1 Genes and mutations identiﬁed Hospital and Medical faculty, University of P. J. Safarik, by WES in the Turkish cohort under study Kosice, Slovakia, 3Medirex Inc., Bratislava, Slovakia Introduction: ThegeneSTAMBP(STAM-binding protein) Genes(#of Mutations Novel/Reported families) encoding a deubiquitinating enzyme is associated with microcephaly-capillary malformation syndrome (MIC- SACS(n=7) c.8867T>Cp.Leu2956Ser NovelNovelNovel CAM) (OMIM 614261). We present a case study of the c.12923_12927delAAGAA ReportedReported patient with the MIC-CAM phenotype with a homozygous p.Lys4308SerfsTer21 ReportedNovel- c.4192T>Cp.Cys1398Arg Novel pathogenic variant in the STAMBP gene. c.11374C>Tp.Arg3792Ter Materialandmethods:Thefull-termnewbornpresented c.7205_7206delTTp. with microcephaly (-3.3SD) and small capillary malforma- Leu2402ArgfsTer6 tionsindifferentareasofthebody.Focalmyoclonicspasms c.3484G>Tp.Glu1162Ter c.7732_7734delGATp. developed from the 3rd month of age. At the 6th month, the Asp2578deland focal EEG abnormalities, brain atrophy and profound c.3767A>Gp.Tyr1256Cys developmental delay with hypotonia led to suspicion of SPG7(n=5) c.1861C>Tp.Gln621Ter NovelReported the early infantile myoclonic encephalopathy. Similar c.1715C>Tp.Ala572Val NovelNovel/ clinical ﬁndings were documented in her older sister c.2096T>Cp.Met699Thr Reported c.1861C>Tp.Gln621Ter/ deceased at the 9th month of age. Consanguinity was c.1715C>Tp.Ala572Val* recorded in the family pedigree. The molecular diagnosis CAPN1(n=4) c.759+1G>Ac.397C>Tp. ReportedReported was found by whole-exome sequencing (Illumina NextSeq Arg133Terc.907T>Gp. NovelReported platform)usingHumanCoreExomeKit(TwistBioscience) Trp303Glyc.397C>Tp. andconﬁrmedbySangersequencing.Thedetectedvariants Arg133Ter wereannotatedbyIngenuityVariantAnalysis(Qiagen)and SPG11(n=2) c.7158_7161dupACAAp. NovelReported His2388ThrfsTer6 classiﬁed according to the ACMG criteria. c.3809T>Ap.Val1270Asp Results:Homozygouslikelypathogenicmissensevariant HSD17B4(n=2) c.425A>Gp.Asp142Gly Novel in the STAMBP gene was identiﬁed (hg20: MR E11
A(n=1) c.1442C>A,p.Thr481Lys Reported chr2:73831044A>G; ENST00000394070.7; c.188A>G; p. KIF1C(n=1) c.866A>Cp.Gln289Proand Novel-Novel Y63C). This genetic ﬁnding is consistent with the MIC- c.940+1G>A CAM phenotype observed in our patient. VP S13
D(n=1) c.12629C>Tp.Ala4210Val Reported Conclusion:Lessthan20casesofMIC-CAMhavebeen PNPLA6(n=1) c.940C>Tp.Arg314Trp Novel reported so far. We present the ﬁrst case of MIC-CAM SYN E1
(n=1) c.3371A>Gp.Asp1124Gly Novel syndrome in a Roma origin patient with homozygous c.188A>G; p.Y63C variant in the STAMBP gene. The heterozygous variants occur in gnomAD Exomes exclu- All patients are true homozygotes except one compound sivelyintheEuropeanpopulationwithfrequency0.000014. heterozygote* Thehypothesizedfoundereffectofthevariantremainstobe Conclusions:25/37probandsweresolved,corresponding clariﬁed. to68%diagnosticyield.Thegenesidentiﬁedpointtoahigh M.Giertlova:None.M.Mistrik:None.J.Saligova:None. heterogeneity and complexity of the cohort investigated. E. Zavadilikova: None. A. Baranova: None. M. Hyblova: The results further reveal the well-known genetic overlap None. G. Minarik: None. among HSPs and ARCAs.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 895 E- P09
.68 Ankara, Turkey, 3Gazi University Department of Pediatric Expressivity of mutations in TUBB2B is highly variable Neurology, Ankara, Turkey J. Dekker, K. E. M. Diderich, R. Schot, D. J. Smits, Introduction: Inherited Glycosylphosphatidylinositol deﬁ- M. Wilke, M. A. van Slegtenhorst, G. M. S. Mancini ciencies (IGDs) are a subclass of Congenital Defects of glycosylation. Most common ﬁndings of IGDs are devel- Erasmus MC, Rotterdam, Netherlands opmental delay, seizures, andpersistent hyperphosphatasia. Moreover GRIN2B mutations cause another rare neurode- Microtubules play an important role during cortical devel- velopmental disorder which has overlapping ﬁndings with opment by regulating mitosis and neuronal migration. IGDs, e.g. developmental delay, intellectual disability and TUBB2B codes for one the β-isoforms of tubulin and epilepsy. Herein, it is aimed to present a case diagnosed dominant negative mutations in this gene result in mal- withtwodenovovariantsinPIGOandGRIN2Bgenes:one formations of cortical development (MCD) like poly- is causing a dominant and the other is causing a recessive microgyria,pachygyria,dysmorphicbasalganglia,epilepsy disorder. and intellectual disability. However, phenotypic hetero- MaterialMethod:Aseven-month-oldgirlwaspresented geneity has been reported in cases with isolated congenital withhydronephrosis,seizure,microbrachycephaly,bilateral ﬁbrosis of extraocular muscles (CFEOM3A) and myoclo- hypoplastic ﬁfth ﬁngernails, abnormal distal phalanx nus-dystonia.Hereweshowthreeindividualsinonefamily morphology of ﬁngers on radiography and persistent withamissensevariantinTUBB2B,whoexhibitanunusual hyperphosphatasia. There was no consanguinity of her phenotype.At21weekofgestationadvancedUSrevealeda parents. Whole-exome sequencing (WES) analysis was foetus with relative small head, enlarged lateral ventricles, performed to evaluate genetic etiology. borderline hypoplastic cerebellum and a thin corpus callo- Results: Two rare variants in PIGO (NM_032634.4) sum, which were less pronounced at MRI. Given the gene; c.1944C>G (p.Cys648Trp) and c.2708_2710delTCT uncertain prognosis, the couple decided to terminate the (p.Phe903del) were shown by WES analysis. Sanger pregnancy. Exome sequencing on foetal material identiﬁed sequencing performed to the parents, and unveiled that a heterozygous maternally inherited variant in TUBB2B those two variants was maternal and de novo respectively. (c.530A>T, p.Asp177Val), not present in GnomAD and The variants were evaluated as in trans position, by using predicted damaging. The healthy mother had only a lan- a heterozygous polymorphism (rs505297) and NGS read- guagedelayinchildhood.Theoldestsonofthecouplewas ings of WES data. Further, a rare de novo variant was also examined because of mild delay of both motor skills detected in GRIN2B (NM_000834.5) gene: c.1852G>A and speech. He follows regular education programme with (rs1428234478) (p.Val618Ile). extra support. The same variant in TUBB2B was conﬁrmed Conclusion: Some prospective and retrospective studies intheson.HisMRIrevealeddecreasedsupratentorialbrain have been shown the underestimated number of multiple volume, enlarged ventricles, mild cortical dysgyria, thin molecular diagnosis of which results in phenotypes over- corpus callosum and dysmorphic vermis and basal ganglia, lapping or separated. In our case phenotypes of two a pattern typical of tubulinopathies. Although we cannot diagnosis were overlapping. If one of multiple genetic exclude that the mother is a mosaic carrier, these results diagnoses had been overlooked, this would change the illustrate the wide phenotypic heterogeneity of tubulino- present or future management options of disorders and pathies, including reduced penetrance and very mild genetic counseling to families. expressivity. A. Sezer: None. Ö.B. Gündoğdu Öğütlü: None. Z. J. Dekker :None. K.E.M. Diderich: None. R. Schot: Türkyılmaz:None.K.Gücüyener:None.G.Kayhan:None. None. D.J. Smits: None. M. Wilke: None. M.A. van F.E. Perçin: None. Slegtenhorst: None. G.M.S. Mancini: None. E- P10
 Neuromuscular Disorders E- P09
.69 An infant with two de novo variants causing recessive E- P10
.01 and dominant disorders: Diagnostic challenge Aicardi-Goutières Syndrome: unexpected another gene mutation which related epilepsy: a case report A. Sezer1, Ö. B. Gündoğdu Öğütlü1, Z. Türkyılmaz2, K. Gücüyener3, G. Kayhan1, F. E. Perçin1 1Gazi University Department of Medical Genetics, Ankara, Turkey, 2Gazi University Department of Pediatric Surgery,896 J.delPicchia F.Duymus1,B.GokselTulgar1,D.Esin1,G.Turkoglu1,M. progressive,highlydisablingandlife-threateningdiseasein E. Sarı1, T. Cora1, A. Kartal2 shorttermifanearlytreatmentisnotestablished.Itisarare disease, with prevalence less than 1 / 100,000 habitants in 1Selcuk University Faculty of Medicine, Medical Genetics worldwide. Huelva is one of the most important endemic Department, Konya, Turkey, 2Selcuk University Faculty of foci of the disease worldwide and the second in Spain. Medicine, Pediatric Neurology Department, Konya, Tur- Inherited with anautosomaldominant pattern characterized key byareducedpenetrance,whichvariesaccordingtoageand geographic area. This poses big problems and big chal- Aicardi-Goutières syndrome (AGS) is an inherited ence- lenges to monitoring patients and their families. phalopathy that mainly affects the brain, the immune sys- Objectives:Toknowthepenetranceintheendemicfocus tem, and the skin. Several of the genes (TREX1, of Valverde del Camino, Huelva RNASEH2A, RNASEH2B, RNASEH2C, IFIH1, ADAR, Methodology: A retrospective, observational study was SAMHD1)mutationscancauseAGS.Thesyndromecanbe performed. For this work, medical records have been seen as autosomal dominant/recessive. Generally, the onset collected and statistically analyzed. Demographic details ofAGSoccurswithintheﬁrstfewdaysormonthsoflife.In (sex, age at diagnosis of the disease, age at the onset of our case, the most severe neonatal form of AG S1
 is typi- symptoms) were obtained callyduetomutationintheTREX1gene.Inadditiontoour Results: Data from 112 patients have been analyzed patient, SPTAN1 gene mutation was detected. This gene Conclusions: The prevalence obtained in our population mutationcancauseEarlyinfantileepilepticencephalopathy is quite different between mens and womens. A higher type 5 which inherited autosomal dominant. We thought proportion of men develop symptoms, most women with thatthecommonpointofthetwomutationsmightbesevere the pathogenic variant are asymptomatic. This could be epilepsyandcerebellaratrophyforourpatient.Herepileptic explained by the presence of polymorphisms in the TTR attacks started at about 4 months of age. On the physical gene that modulate disease expression as well as clinical examination microcephaly, joint stiffness, dystonia, abnor- symptoms. Thisisa very interestingﬁeld ofstudy that will mal eye movements, tetraplegic spasticity, and neuromotor allow us to better understand the disease. developmental retardation were presented. In cranial MR, cerebral atrophy, intracerebral calciﬁcations, and calciﬁca- PopulationPenetrance tions of the periventricular area were observed. Epilepsy Age Overall Mens Womens attacks started at the age of 3 months. We performed (years) penetrance% penetrances% penetrance% RNASEH2B gene sequence analysis in the patient and could not detect a mutation. We detected two mutations 30 3 4 0 with whole-exome sequencing. One of them was homo- 40 10 16 2 zygous c.13_15dupATC mutation in the TREX gene and 50 16 20 9 the other was heterozygous c.2882 C> T in the SPTAN1 60 28 33 21 gene. AGS is a very rare disease of unknown frequency. 70 34 40 25 Ouraiminpresentingthiscaseistoseetworaremutations >70 51 60 37 together and think that the disease can change its severity. F. Duymus: None. B. Goksel Tulgar: None. D. Esin: None.G.Turkoglu:None.M.E.Sarı:None.T.Cora:None. Á.GrageraMartínez:None.L.HerranzArriero:None.C. A. Kartal: None. Borrachero Garro: None. F. Muñoz Beamud: None. E- P10
.02 E- P10
.04 Penetrance of Familial Amyloid Polyneuropathy in Amyotrophic lateral sclerosis (ALS) in the Faroe Huelva. One of the most important foci in worldwide Islands, a genealogical approach Á.GrageraMartínez1,L.HerranzArriero2,C.Borrachero M. Johansen1,2, K. Svenstrup3, Ó. Mortensen4, Garro1, F. Muñoz Beamud1 G. Andorsdóttir4, M. S. Petersen1,2 1Juan Ramon Jimenez University Hospital, Huelva, Spain, 1Department of Occupational Medicine and Public Health, 2Badajoz University Hospital, Badajoz, Spain The Faroese Hospital System, Tórshavn, Faroe Islands, 2CentreofHealthSciences,UniversityoftheFaroeIslands, Introduction: Hereditary amyloidosis mediated by trans- Tórshavn, Faroe Islands, 3Neurological Department, Uni- thyretin (hATTR) is a hereditary, neurodegenerative, versity Hospital Copenhagen, Rigshospitalet andAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 897 BispebjergHospital,Copenhagen,Denmark,4FarGen,The Materialsandmethods:WehavestudiedtheDNAof43 Genetic Biobank of the Faroe Islands, Tórshavn, Faroe Russian CMT-patients (25 myelinopathy, 18 axonopathy) Islands after excluding the most common cause of CMT – PM P22
 duplications. MPS libraries were prepared with the use of ALS is a progressive neurodegenerative disease. In 5-10% Ion AmpliSeq™reagents and sequencing by Ion  S5
™Sys- of cases, a family history is identiﬁed. Although the inci- tem. Panel includes 15 CMT genes: MFN2, MPZ, EGR2, dence of ALS in the Faroes is similar to other European FGD4, LITAF, PM P22
, PRX, MOR C2
, SH3T C2
, HINT1, countries, we have observed an overrepresentation of cases HSPB1, NEFL, NDRG1, GDA P1
, GJB1, mutations in originating from the small geographically isolated island of whichwerepreviouslyidentiﬁedasthecauseofthedisease Suðuroy,whichleadtothestudyaim:estimationoffamilial for at least 2 unrelated Russian families. ALS in the Faroese population. All ALS cases have been Results: After the targeted MPS sequencing, a deﬁnite registered since 1987. In this study, 43 patients were molecular diagnosis deﬁned as a pathogenic or a likely included. First, familial ALS was recognized when occur- pathogenic variant, was reached in 16% of cases (n = 7). ringbetweenﬁrst-orsecond-degreerelatives.Secondly,the Variants of unknown signiﬁcance were found in 16% of Faroese Multi Generation Register, which contains infor- cases (n = 7). 68% (n=29) of cases were molecularly mation aboutfamilial relationships since 1650,was usedto undiagnosed. In most cases variants were found in the construct pedigrees amongst patients to identify risk SH3T C2
(5) and MFN2(3) genes. 6 patients had variants in families (≥3 cases within 3 generations). Fifteen cases ori- the following genes: MPZ, GDA P1
, HINT1, LITAF, PRX, ginated from Suðuroy where the prevalence of ALS was MOR C2
. more than 3 times higher than the nationwide prevalence. Conclusion: Diagnoses by the MPS panel were con- Six patients had familial ALS (13.9%) of which four ori- ﬁrmedfor16%ofthepatients,whiletheWESisefﬁcientin ginatedfromSuðuroy.Throughpedigrees,weidentiﬁedsix 19-45%ofcases.Thus,smallMPS-panelisausefultoolfor additional patients with possible familial ALS (28%). This highly genetically heterogeneous pathology. It helps to study is suggestive of familial clustering in excess of avoid consequent tests of frequent genes associated with expectedforALSinSuðuroyandtheproportionoffamilial CMT with the Sanger sequencing while having the ALS in the Faroe Islands was high. High levels of efﬁciency comparable to WES. inbreedingandgeneticsubstructurehavebeendemonstrated M.D. Orlova: None. O.A. Schagina: None. O.P. Ryzh- in the Faroese population. Combined with these results, kova:None.G.E.Rudenskaya:None.E.L.Dadali:None.A. there is strong support of a genetic contribution to ALS in V. Polyakov: None. the Faroe Islands and further genetic studies are warranted. Funding: Aage og Johanne Louis-Hansens Fond, Minister E- P10
.06 Erna Hamiltons Legat for videnskab og kunst, Sjúkra- Rapid exome sequencing with in silico variant prioritiz- kassagrunnurin, Betri Stuðul, Aase og Ejnar ing and the diagostic odyssey of a child with various Danielsens Fond. neurological symptoms M. Johansen: None. K. Svenstrup: None. Ó. Mortensen: None. G. Andorsdóttir: None. M.S. Petersen: None. A. Illés1, K. Árvai1, B. Kocsis-Deák1, Á. Herczegfalvi2, P. Lakatos3, J. Kósa1,3 E- P10
.05 Efﬁciency of the MPS panel of 15 genes associated with 1PentaCore Laboratories, Budapest, Hungary, 22nd genetically heterogeneous hereditary neuropathies Department of Pediatrics, Semmelweis University, Buda- pest, Hungary, 3Department of Internal Medicine and M. D. Orlova, O. A. Schagina, O. P. Ryzhkova, Oncology, Semmelweis University, Budapest, Hungary G. E. Rudenskaya, E. L. Dadali, A. V. Polyakov Introduction: The hereditary motor and sensory neuro- Research Centre for Medical Genetics, Moscow, Russian pathies are a heterogenous disease group which could be Federation caused by several gene mutations, such as deletions, duplications and single nucleotide substitutions. The com- Introduction:Charcot-Marie-Toothdiseaseisagenetically plex genetic etiology could harden the differential diag- heterogeneous pathology related to hereditary peripheral nostics and lengthen the path to identify the genetic neuropathies.Thepurposeoftheresearchistoevaluatethe background. efﬁciency of panel sequencing for a highly genetically Material and methods: In our case, a four-year-old boy heterogeneous pathology. was examined, who born with hypotonia and showed delayed motor development. At the age of three, EMG898 J.delPicchia analysis showed axonal polyneuropathy and motor nerve musclehistologyrevealedpositivesarcoglycanproteinsbut conduction could not be detected in his legs. After the reduceddysferline.Duetothemusclebiopsyresultwehave analysis of copy number variations of PM P22
 and SMN planned DYSF gene sequence analysis and a novel genes, further neuropathies associated genes were c.754A>G (p.Thr252Ala) variant was detected in homo- sequenced without any results. Finally, whole exome zygous state. This variant was classiﬁed as likely patho- sequencing was performed, and the results were analysed genic accordingto ACMG criteria andsegregation analysis by focusing on primer neuropathy associated genes. revealedtheparentsoftheprobandascarrier.Accordingto Results: A pathogenic heterozygous  S72
L mutation her physical examination and the result of the molecular (rs104894621) was identiﬁed in the PM P22
 gene, which analysis we have concluded that this novel mutation gen- was previously associated with Charcot-Marie-Tooth dis- erates a phenotype as Limb Girdle Muscular Dystrophy ease. Sanger sequencing also conﬁrmed the result. Type 2b of the dysferlinopathy spectrum. Conclusions: Based on our result the clinical diagnosis S. Kocagil: None. E. Kaplan: None. E. Susam: None. B. was conﬁrmed and the genetic counsellor could provide Durak Aras: None. S. Artan: None. E. Erzurumluoglu adequate information to the parents before the birth of the Gokalp: None. O. Cilingir: None. second child. It is important to highlight that in case of neuropathies, after screening copy number variations, E- P10
.12 performing whole exome sequencing could shorten and The retrieval of candidate genes of inverse comorbidity make easier the identiﬁcation of potential pathogenic between cancer and neurodegeneration considering mutations in the background of the symptoms. The fast apoptosis as a key process identiﬁcation of causal variants could contribute to the selection of speciﬁc therapy and family planning. D. Gomboeva1, O. Saik2, E. Bragina1, V. Ivanisenko2, A.Illés:None.K.Árvai:None.B.Kocsis-Deák:None.Á. V. Puzyrev1 Herczegfalvi: None. P. Lakatos: None. J. Kósa: None. 1TomskNationalResearchMedicalCenter,Tomsk,Russian E- P10
.10 Federation,2FederalResearchCenterInstituteofCytology A novel mutation of DYSF gene in a patient with Limb and Genetics, Novosibirsk, Russian Federation Girdle Muscular Dystrophy type 2b Introduction: Epidemiological studies have revealed the S. Kocagil1, E. Kaplan2, E. Susam1, B. Durak Aras1, reduced cancer incidence in patients with Huntington dis- S. Artan1, E. Erzurumluoglu Gokalp1, O. Cilingir1 ease (HD), indicating a presence of inverse comorbidity or dystropy of HD and cancer. The one of promising biolo- 1EskisehirOsmangaziUniversityMedicalGeneticsDepart- gical process, which unites these two groups of diseases, is ment, Eskisehir, Turkey, 2Eskisehir Osmangazi University apoptosis. Cancer is characterized by inhibited apoptosis, Pediatric Neurology Department, Eskisehir, Turkey while in HD, on contrary, apoptosis is up-regulated. Thus, identiﬁcation of pro- and anti-apoptotic genes and study of Dysferlinopathy muscular disease spectrum encompasses a their regulation is hopeful for investigation of inverse group of phenotypes; including Limb Girdle Muscular comorbidity mechanisms of HD and cancer. Dystrophy type 2b, Myoshi myopathy, scapuloperoneal Materials and methods: The genetic network was syndrome, distal myopathy with anterior tibial onset, ele- reconstructed using ANDSystem (Ivanisenko, 2015). Net- vated serum CK concentration only, and congenital mus- work included all genes and proteins associated with HD culardystrophy.BiallelicpathogenicvariantsofDYSFgene (n=140). The list of genes of apoptosis was retrieved from is known to be responsible for dysferlinopathies. The pre- KEGG (hsa04210 identiﬁer, n=136). Prioritization was valenceofthediseaseisunknownbutincidenceishigherin carriedusingToppGeneandfunctionsofANDSystem.The the populations that consanguineous marriage is observed special criteria were calculated, including: betweenness frequently.Herewereporta17years-oldfemalepatientthat centrality, stress centrality, closeness centrality, cross-talk was referred to our outpatient clinics for proximal muscle centrality and cross-talk speciﬁcity (Saik et al., 2018). The weakness.Shehaddifﬁcultyinwalkingandclimbingstairs search of miRNA was conducted using MirTarBase forthelast6months.Inherphysicalexamination;herdeep database. tendon reﬂexes of the lower extremities were diminished, Results: 10 genes were identiﬁed: APOE, BDNF, her muscle strength was normal and she could walk on the HSPA4, HTT, I L6
, INS, LEP, PSEN1, S P1
, SQSTM1. tip of her toes and stand on her heels. Her serum creatine Through the analysis at the miRNA level, we retrieved 5 kinase levels were detected over 20.000 U/L repetitively common miRNA (let-7c-5p; miR-1-3p; miR-149-5p; miR- therefore muscle biopsy was planned. Quadriceps femoris 22-3p; miR-223-3p) regulate of expression of proteinAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 899 coding genes (S P1
, HSPA4, BDNF, I L6
). All genes are D. Esin: None. F. Duymus: None. B. Goksel tulgar: important for neurodegeneration and associated with None.G.Turkoglu:None.M.E.Sari:None.T.Cora:None. cancer: play different roles in carcinogenesis, cancer A. Kartal: None. progression dependent on type of cancer. Conclusions: The approach uncovered miRNA- apopto- E- P10
.15 tic genes regulation might give new insights into the LGMD 2E: using sequence analysis to verify sarco- mechanisms of inverse comorbidity between cancer and glycanopathy neurodegeneration. This work was supported by the RFBR grant No.19-015-00391. L. Khlunovska1, I. Lastivka1, V. Antsupova2, D. Gomboeva: None. O. Saik: None. E. Bragina: None. M. Ryznychuk1, L. Hodovaniuk3 V. Ivanisenko: None. V. Puzyrev: B. Research Grant (principal investigator, collaborator or consultant and 1HSEEofUkraine,“BukovinianStateMedicalUniversity”, pendinggrantsaswell asgrantsalreadyreceived); Modest; Chernivtsi, Ukraine, 2Bohomolets National medical uni- Russian Foundation for Basic Research. versity, Kyiv, Ukraine, 3Bukovynian Center for Rehabilita- tion and Integrated Rehabilitation of Children, Chernivtsi, E- P10
.14 Ukraine A novel compound heterozygous MPV17 mutation causing axonal sensorimotor polyneuropathy Introduction: Muscular dystrophy of the lumbar girdle (LGMD)isaheterogeneousgroupofhereditaryprogressive D. ESIN1, F. DUYMU S1
, B. GOKSEL TULGAR1, neuromuscular diseases. G. TURKOGLU1, M. E. SARI1, T. CORA1, A. KARTA L2
 MaterialandMethods:AclinicalcaseofLGMD2Eina 9 year old child. Clinical, genealogical, laboratory and 1Selcuk University School Of Medicine, Medical Genetics instrumental and molecular-genetic methods were used. Department, Konya, Turkey, 2Selcuk University School Of Results: Girl K., up to 8 years old, developed in Medicine,PediatricNeurologyDepartment,Konya,Turkey accordance with age norms. At age 8, the mother began to notice motor impairment in the child; at age 9, a duck Charcot-Marie-Tooth disease type 2EE is an autosomal walkappeared.Itbecamedifﬁcultforthechildtoclimbthe recessive sensorimotor peripheral axonal neuropathy that is stairs, squat and jump; there was pain in the calf muscles. causedby mutationsin theMPV17 gene.MPV17 encodesa The girl complained of fatigue during normal physical channel-forming protein of the inner mitochondrial mem- activity. Objective data: stimulation neuromyography - a brane.Inthiscase,itisaimedtopresenttheﬁrstclinicalreport decrease in the muscles of the lower extremities (47% on of MPV17-related axonal sensorimotor neuropathy with the right and 61% on the left); a 35-fold increase in compoundheterozygousmutation.Thepatientwasa16-year- creatinekinase levels.Toclarifythediagnosis, amolecular- old male and these second child of healthy, consanguineous genetic examination was assigned: analysis and testing of parents. He had severe distal muscle atrophy, pes cavus the removal/duplication of 123 strength genes (Los deformity, foot drop, hammertoes, atrophy of the intrinsic Angeles, 2019). Two pathogenic variants c.2T>C and hand muscles and bilateral thenar and hypothenar muscles. c.341C>T (p.Ser114Phe) were identiﬁed in the SGCB Hyporeﬂexiaofupperlimbswasobserved.Theﬁrstsymptom gene. The SGCB gene is associated with an autosomal of the patient was the loss of balance and walking difﬁculty recessive LGMD type 2E. Final diagnosis: LGMD 2E starting at the age of six. c.122G> A and c.376-9T> A (sarco-glycanopathy). mutationsintheMPV17genewasdetectedbywhole-exome Conclusions:Signiﬁcantdifﬁcultiesariseinthediagnosis sequencing.TheMPV17:c.122G>Avarianthasalreadybeen of genetic variants of neuromuscular diseases only on the described as a pathogenic variant. The MPV17:c.376-9T> A basis of a clinical study. The use of sequence analysis variantdescribedasavariantofuncertainsigniﬁcance.Tothe makesitpossibletoclarifythetypeofmusculardystrophy. best of our knowledge, the coexistence of these two hetero- Giventhehereditarynatureofthedisease,itisnecessaryto zygous mutations was not found in the literature review. In recommend genetic counseling and molecular genetic this case report, we emphasize that a novel compound het- screening for the purpose of prophylaxis and/or prognosis erozygous MPV17 mutation can cause non-syndromic per- of offspring. ipheral axonal neuropathy and should be considered in the L. Khlunovska: None. I. Lastivka: None. V. Antsupova: differential diagnosis of juvenile-adult onset severe axonal None. M. Ryznychuk: None. L. Hodovaniuk: None. sensorimotor neuropathy.900 J.delPicchia E- P10
.18 M. Truglio2, M. Fabbretti2, B. Torres2, T. Mazza2, ScreeningofSMAcarrierstatusinRepublicofMoldova A. De Luca2, M. Roggini1, L. Bernardini2, A. Pizzuti1 I. Coliban1, N. Ușurelu2, V. Sacară1 1Sapienza University of Rome, Rome, Italy, 2Casa Sollievo della Sofferenza IRCCS Foundation, San Giovanni 1Laboratory of Human Molecular Genetics, Institute of Rotondo, Italy Mother and Child,, Chisinau, Moldova, Republic of, 2Laboratory Prophylaxis of Hereditary Pathologies, Insti- Introduction: Spinal muscular atrophy with congenital tute of Mother and Child,, Chisinau, Moldova, Republic bone fractures 2 (SMABF2) is a rare autosomal recessive of neuromuscular disorder characterized by arthrogryposis multiplex congenita and prenatal fractures. Reported Introduction: Spinal muscular atrophy (SMA) is an auto- patients present biallelic loss-of-function single-nucleotide somal-recessivedisease,withafrequencyofcarriersof1:35 variants in ASC C1
 gene, encoding a subunit of the tran- upto1:117intheCaucasianpopulation.Theprevalenceof scriptional coactivator ASC-1 complex. We describe the SMA in the Republic of Moldova constitutes 8.43 ﬁrst SMABF2 case with documented prenatal disease evo- ±0,15:100000 population which is signiﬁcantly higher than lution,causedbyanin-framemicrodeletionandanonsense thedatafromOrphanet(2,93)andRussia(0,31-3,91).95% nucleotide variant in a stillbirth. of SMA is caused by deletion of exon 7 of SMN1. If both Materials and methods: The stillbirth, born from non- personsinacouplearecarriers,theyhavea1-in-4chanceof consanguineous parents, presented hydrops, lower limbs having a child with SMA. hyperextension withbendingofthehips,bilateral club-foot Materials and methods: 30 persons that formed 15 and congenital fractures. Prenatal ultrasound had showed couples who addressed for family planning, without a bilateral club-foot, closed ﬁsts and fetal biometric para- family history of SMA were diagnosed for determining the meters at middle-lower limits. Microarray analysis was status of exon 7 SMN1 by qPCR method, melting curve. performed on DNA extracted from umbilical cord. Data The DNA concentration was measured by spectrophoto- wereanalyzedbyCytoGenomicssoftware.NextGeneration metry. For PCR reaction each DNA sample was used as 2 Sequencing analysis was performed using the TruSightOne replicates for SMN1 exon 7 and 1 replicate for the external sequencing panel kit. NGS data were processed and standard (ALB, exon 12). EvaGreen was used as a DNA- analyzed using an in-house implemented pipeline. binding dye. Results: A 64Kb microdeletion, involving four exons of Results:ForallDNAsamples,ampliﬁcationoccurredfor ASC C1
,wasdetectedbymicroarrayanalysis.NGSdisclosed both exon 12 ALB and exon 7 SMN1. According to the a single-nucleotide variant of the same gene (c.1027C>T; p. melting curves, for 22 persons the exon7 SMN1 was Arg343*), resulting in a premature termination codon. determined to be present and for 8 persons was determined Conclusions: This is the ﬁrst case of ASC C1
 due to an heterozygous status (5 women and 3 men). Among those exonicmicrodeletionandanucleotidevariantincompound who are heterozygous, 2 people form the same couple. heterozygosity, expanding the mutational spectrum of this Conclusions:FollowingtheHardy-Weinbergequilibrium gene. This case provides further evidence that exonic copy (0,23) for 26% of the patients, the status of carriers of the number variants are an underestimated cause of disease- deletion was established. Screening of SMA carriers is an alleles and that the integrated use of the last generation important step in assessing the risk of giving birth to an genetic analysis tools, together with careful clinical affected child. evaluations, are fundamental for the characterization of I. Coliban: None. N. Ușurelu: None. V. Sacară: None. rare diseases even in prenatal setting. G. Mastromoro: None. M. Giuffrida: None. V. Guida: E- P10
.19 None. D. Guadagnolo: None. E. Marchionni: None. F. Di A case of Spinal Muscular Atrophy with Congenital Palma: None. M. Truglio: None. M. Fabbretti: None. B. BoneFractures2expandsASC C1
prenatalpresentation Torres: None. T. Mazza: None. A. De Luca: None. M. and mutational spectrum Roggini: None. L. Bernardini: None. A. Pizzuti: None. G. Mastromoro1, M. Giuffrida2, V. Guida2, E- P10
.20 D. Guadagnolo1, E. Marchionni1, F. Di Palma1, An interesting case: 30-year-old male patient with myotonic dystrophy typeI has got normal CTG repeats sequenceintheDMPKgene,butitdoesnotcomplywith its clinical featuresAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 901 S. Tutgun Onrat1, M. Elmas1, H. Demirbaş2 structural variants. To date, deletions of this region is mostly considered as pathogenic; yet duplications are still 1Afyon Health Science University, Faculty of Medicine, controversial.Hereapatientwith16p13.11duplicationthat Department of Medical Genetics, Afyonkarahisar, Turkey, have ﬁndings concordant with previous reports and two 2Afyon Health Science University, Faculty of Medicine, additional ﬁndings is presented, aiming to further enhance Department of Neurology, Afyonkarahisar, Turkey our understanding of the nature of 16p rearrangements. Materials and methods: After the DNA was isolated Introduction:Myotonicdystrophytype1DM1isinherited from the peripheral blood sample of the patient, the data in an autosomal dominant pattern a multisystem disorder, obtained by microarray using the “afyymetrix cytoscan causedbyexpansionofaCTGtrinucleotiderepeatinthe3′- optima array kit” were analyzed for gain or loss according untranslated region of the DMPK gene, with pathogenic to the GRCh37 (hg19) reference genome using ChAS alleles ranging from around 50 to over 1000 CTG triplets 3.1.1.27 (Chromosome Analysis Suite) software. repeats(1).Somefeaturesincludeskeletalmuscleweakness Case Report: Patient is a 5 years and 2 months old and myotonia. The age at onset is extremely variable in female,admittedtopediatricneurologydepartmentwiththe DM1, and inversely correlates with the expansion size and complaintsofseizuresandspeechdelay.Shewasdiagnosed individual-speciﬁc differences in somatic instability (2-4). with epilepsy and atypic autism. A peripheral blood Materials and methods: We want to present most karyotyping was normal (46,XX). Microarray result of the interestingly our patient-male (30 years) with Myotonic patient revealed a 1833 kbp-long microduplication, invol- Dystrophy Type I disease, the exact number of repeats of ving the 16p13.11 region. (arr[hg19] 16p13.11 the CTG trinucleotide for both alleles of the DMPK1 gene (14,897,804-16,730,375)x3) was detect by PCR-Fragman analysis. Afterwards, the age Discussion: 16p13.11 duplications were previously of the disease, the clinical severity of the disease, described as rare benign variants whereas there are also radiological and laboratory ﬁndings were compared with some reports of pathogenicity; relating it to a phenotypic these patients. In addition, detailed pedigree analysis of the spectrum involving autism, intellectual disability, hypoto- patients was performed and thus anticipation and variable nia, motor and speech delay, seizures, abnormal MRI and expressivity of the disease was determined. cardiac malformations and this spectrum applies for our Results: We ﬁnd a result of the important in terms of patient as well. Additionally, upslanting palpebral ﬁssures myotonic dystrophy; he has got clinically myotonic and preauricular skin tag are important phenotypic ﬁndings discharges in EMG(electromyography) diagnosed as myo- of our patient that were not reported before. tonicdystrophy,butwhenexaminedintermsofthenumber M.S. Yildirim: None. A.B. Arslan: None. A.G. of repeats, the DMK P1
 gene was a normal number of Zamani: None. repeats in terms of 8/17 for both alleles. Conclusions: Myotonic dystrophies represent the most E- P11
.004 variable clinical phenotypes, so treatment stratiﬁcation is Phenotypic features in a patient with 1p36 deletion key for any modern therapeutic approach. We still need syndrome much more understanding of the signs and symptoms of Myotonic dystrophies patients in correlation to their F. Stipoljev1,2, A. Vicic1,3, R. Gjergja-Juraski4,2 molecular origins. S. Tutgun Onrat: None. M. Elmas: None. H. Demirbaş: 1Clinical Hospital “Sveti Duh”, Zagreb, Croatia, 2Faculty None. of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia, 3Univesity of Applied Health Sciences, E- P11
 Multiple Malformation/Anomalies Syndromes Zagreb, Croatia, 4Children’s Hospital Srebrnjak, Zagreb, Croatia E- P11
.001 16p13.11 microduplication in a patient with seizures: Monosomy1p36ischaracterizedbyvariablesizedeletions, A case report about an elusive syndrome whilethephenotypicfeaturesincludeintellectualdisability, developmentaldelay,distinctivefacialdysmorphicfeatures, M. S. Yildirim, A. B. Arslan, A. G. Zamani hypotonia, seizures, cardiac defects, hearing impairment and ophthalmologic problems. Herein we present a patient Necmettin Erbakan University, Konya, Turkey with 1p36 deletion syndrome. The girl was born with muscular VSD and the Pierre Robin sequence. She was Background: The short arm of chromosome 16, (16p) and operated due to the Pierre Robin at the early age and got especially the 16p13.11 region is involved in many tracheal canulla up to3 years of age. MRI of the neuroaxis902 J.delPicchia later revealed the syrinx of the spine. She has distinctive in the 22q11.2 DS group versus the group without deletion facialfeaturesincludingmicrobrachycephaly,deep-seteyes (p <0.05). Conotruncal cardiac defects alone were insufﬁ- with straighteyebrows;midface hypoplasiawithbroad,ﬂat cient for 22q11.2 DS prediction but sufﬁcient when nose and philtrum. Ears are low-set, rotated backwards and accompanied with other anomalies. abnormallyshaped.Comparedtootherdescribedcases,her Conclusion: A comprehensive physical examination is chin is rather small. There are no abnormalities of gastro- crucialatidentifyinganysubtle featureswhichmay leadto intestinal system, kidneys, or genitalia. She is hypotonic, testing and a deﬁnite diagnosis. Grant from Thammasat with severe intellectual disability, refractory epilepsy and University (Grant No.2/32/2558) temper tantrums; having vision, hearing and speech pro- K. Rojnueangnit: None. T. Khetkham: None. P. Onsod: blems. Array CGH analysis using SurePrint G3 Human None. T. Chareonsirisuthigul: None. CGH 8x60K microarrayrevealed 4.3Mbloss intheregion 1p36.33-p36.32. Deletion was conﬁrmed with FISH ana- E- P11
.006 lysis using subtelomeric 1p probe, and a karyotype was Diverse phenotypes in a family of six all with 22q11.2 designated as 46,XX,del(1)(p36.32)dn. Cytogenetic analy- duplication or double duplication sis of parental peripheral blood revealed normal female karyotype in mother and a 46,XY,inv(10)(p11.2q21.2) A. Zagorac1, A. Golub1, B. Zagradišnik1, A. Erjavec karyotype in father, while FISH analysis showed normal Škerget1, D. Krgović1, Š. Stangler Herodež1, A. Osterc distribution of signals characteristic for subtelomeres 1p in Koprivšek1, N. Kokalj Vokač1,2 both parents. In conclusion, our case emphasizes the sig- niﬁcance of molecular cytogenetic analysis in order of 1University Medical Centre Maribor, Maribor, Slovenia, establishing accurate diagnosis and patient management, as 2Medical Faculty Maribor, University Maribor, Maribor, well as counseling parents regarding future pregnancies. Slovenia F. Stipoljev: None. A. Vicic: None. R. Gjergja- Juraski: None. Introduction: 22q11.2 duplications may be largely unde- tected, as a result of less-distinct, unpredictable, and/or E- P11
.005 milder phenotype. Double duplications 22q11.2 are extre- Identiﬁcation of clinical features to predict 22q11.2 mely rare. We describe the family of six, all with 22q11.2 deletion syndrome, proven by multiplex ligation-depen- duplication or double duplication. The boy proband with dent probe ampliﬁcation duplication had a global developmental delay, seizures and dysmorphic features. The girl proband with double dupli- K. Rojnueangnit1, T. Khetkham1, P. Onsod2, T. cation, had sensorineural hearing loss, mild intellectual Chareonsirisuthigul2 disabilities, mild speech delay and minor dismorphic fea- tures. Other relatives were unaffected, except for very mild 1Thammasat University, Klong-Luang, Thailand, 2Mahidol possible manifestations in the mother. University, Bangkok, Thailand Materials and methods: aCGH analysis using 8x60K array, microsatellite segregation analysis and QF-PCR for Introduction: 22q11.2 deletion syndrome (22q11.2 DS) is the informative marker on peripheral blood for all family, the most common microdeletion syndrome with a wide were performed. Clinical exsom analysis by NGS of the variety of clinical features. However, there are no clinical affected boy and the girl, were done. criteriafordiagnosis;conﬁrmationissolelybygenetictests. Results: aCGH revealed 3 copies, approximately 2,8Mb, Normally, these tests are only performed if clinicians of22q11.2inbothparents,affectedboyandoneunaffected recognize signs and symptoms; therefore, we aimed to girland4copiesofthesameregioninoneaffectedgirland identify any clinical features that may help clinicians be another unaffected girl. Segregation microsatellite analysis aware of 22q11.2 DS. and QF-PCR conﬁrmed that both parents carry the Materials and methods: Participants with at least two duplication (2:1), two children inherited duplication from anomalies were enrolled from June 2015 - May 2018 at theirmother,anothertwodaughtersinheritedtwocopiesof Thammasat University Hospital. Complete patient history 22q11.2 (2:2) from each parent, it’s a double duplication. and physical examinations were done; multiplex ligation- NGS analysis didn’t identify any additional mutations that dependent probe ampliﬁcation analysis for 22q11.2 were would be clinically characterized as being pathogenic. performed with blood samples. Conclusions: The family described illustrates the pheno- Results: Out of 48 participants, we identiﬁed 11 (23%) typic variability associated with 22q11.2 duplication or with 22q11.2 DS. Palate anomalies, hypocalcemia, and ≥ 3 doubleduplication.Itprovidessupportfortheviewthatthe affectedbodysystemswerehighlysigniﬁcantpresentations 22q11.2 duplication/double duplication may not beAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 903 pathogenic on its own and require additional genetic, cases thanks to international datasharing would allow us to epigenetic or nongenetic factors, to express the phenotype. concludeontheimplicationofthisgeneinasevereformof A. Zagorac: None. A. Golub: None. B. Zagradišnik: 3C syndrome. None. A. Erjavec Škerget: None. D. Krgović: None. Š. N. Bourgon: None. M. Lefebvre: None. A. Bruel: None. Stangler Herodež: None. A. Osterc Koprivšek: None. N. J. Thevenon: None. J. Riviere: None. C. Poe: None. M. Kokalj Vokač: None. Chevarin: None. T. Jouan: None. Y. Duffour: None. L. Faivre: None. C. Thauvin: None. E- P11
.007 A homozygous WDR91 nonsense variant responsible of E- P11
.008 severe form of 3C syndrome Allan Herndon Dudley syndrome due to a novel pathogenic variant in the SL C16
A2 gene N. BOURGON1,2, M. LEFEBVR E1
,2, A. BRUE L1
,2, J. THEVENON1,2, J. RIVIER E1
,2, C. PO E1
,2, T. N. Delchev, H. M. Kathom, D. M. Avdjieva-Tzavella M. CHEVARIN1,2, T. JOUAN1,2, Y. DUFFOUR1,2, L. FAIVR E1
,2,3,4, C. THAUVIN1,2,3,4 Medical University-Soﬁa, Soﬁa, Bulgaria 1UMR 1231, GAD team, DIJON, France, 2FHU TRANS- Introduction:Allan-Herndon-Dudleysyndrome(AHDS)is LAD, Dijon, France, 3Centre de Génétique, CHU Dijon a rare, X-linked condition caused by various pathogenic Bourgogne,Dijon,France,4CentrederéférenceAnomalies variantsintheSL C16
A2gene.InhemizygousmalesAHDS du Développement, Dijon, France is characterized by dysthyroidism, hypotonia and feeding difﬁculties (in infancy), developmental delay and drug- Introduction: 3C syndrome is a rare genetic syndrome resistant seizures. Additional ﬁndings may include pyr- characterized by craniofacial anomalies, cardiac and cere- amidal and extrapyramidal signs as well as intellectual bral related to WSH C5
 (MIM # 220210) and CCD C22
 disability. Heterozygous females are rarely affected. (MIM # 300963) variants. Molecular bases of some cases Materials and methods: We present a 9 month old boy suspected of 3C syndrome remained identiﬁed. with facial dysmorphism, psychomotor delay and myoclo- Patients and methods: We report 4 fetuses with 3C nus in addition to hypomyelination ﬁndings on brain MRI. syndrome from a unique consanguineous family. Case 1 Dysthyroidism(elevatedT3,lowT4,fT4levelsandnormal had a fetal hydrops with hygroma coli, cerebellar TSH) alongside poor weight gain, irritability and axial hypoplasia, severe tetraventricular hydrocephalus with hypotonia were also found. Based on those ﬁndings a macrocephaly,facialdysmorphiaandinterventricularseptal targeted SL C16
A2 gene sequencing was performed. defect. The 3 other cases have been suspected with fetal Results: A novel hemizygous variant, c.695del (p. hydrops during the ﬁrst trimester associated with brain Asn232Metfs*35), was identiﬁed in SL C16
A2 conﬁrming abnormalities. the diagnosis - Allan-Herndon-Dudley syndrome (MedGen Results:ESperformedincase1identiﬁedahomozygous UID: 208645). This variant is neither present in population WDR91 nonsense variant (NM_014149.3:c.240C>G, p. databases (ExAC no frequency) nor reported in the Tyr80*) in a homozygous region. Family segregation literature in individuals with SL C16
A2-related conditions. conﬁrmed the homozygous status of this variant in all Thissequencechangecreatesaprematuretranslationalstop affected fetuses and in the heterozygous status in both signal and has been classiﬁed as pathogenic. parents, as well as two healthy children and absence in the Conclusions:Allan-Herndon-Dudleysyndrome,however third healthy child. International datasharing and targeted rare, should be considered in children manifesting the sequencingofacohortof3Csyndromepatientshavesofar typical clinical, phenotypic, laboratory and imaging ﬁnd- failed to identify other patients with WDR91 variants. ings. In our case we found a speciﬁc constellation of WDR91 interacts with WDR81 in the endosome-lysosome developmental delay and dysthyroidism which lead to pathway for early-to-late endosome conversion. WDR91 targeted sequencing analysis and the correct diagnosis. We appears to be essential, particularly for neuronal and brain hope that this novel pathogenic variant in SL C16
A2 will development. provide additional information about AHDS and its Conclusion: Identiﬁcation of a homozygous WDR91 genotype-phenotype correlations. nonsense variant in several fetuses with 3C syndrome in a T.N. Delchev: None. H.M. Kathom: None. D.M. consanguineousfamilysuggeststhatWDR91isanewgene Avdjieva-Tzavella: None. responsible for this syndrome. Identiﬁcation of new similar904 J.delPicchia E- P11
.009 E- P11
.010 Clinical characterization of Aicardi-Goutières Syn- The third family with TAF6-related phenotype: Ala- drome 7 in an extreme preterm infant, due to a zami-Yuan syndrome recurrent IFIH1 variant E. Tuc1, F. B. Bengur1, A. Aykut2, O. Sahin2, Y. Alanay3 E. Phillips, M. Kerr, A. Khan 1Acibadem Mehmet Ali Aydinlar University School of DepartmentsofMedicalGeneticsandPediatrics,University Medicine, Istanbul, Turkey, 2Marmara University School of Calgary Cumming School of Medicine, Alberta Chil- of Medicine, Department of Ophthalmology, Istanbul, dren’sHospitalResearchInstitute.,Calgary,AB,Canada Turkey, 3Acibadem Mehmet Ali Aydinlar University School of Medicine, Department of Pediatrics, Pediatric Genetics Introduction: Aicardi-Goutières Syndrome (AGS) is a Unit, Istanbul, Turkey genetically heterogeneous disorder of interferon 1 upregu- lation.Approximately10%ofpatientspresentatbirthwitha Introduction:HomozygousvariantsinTAF6genecausean congenital infection-like syndrome with hepatosplenome- autosomal recessive intellectual disability syndrome with galy, thrombocytopenia, neurologic abnormalities and brain Cornelia de Lange syndrome (CdLS)-like features, namely calciﬁcations.Characterizationof this disorder in premature Alazami-Yuan Syndrome (ALYUS;MIM#617126). We infantsislimited,anddiagnosisinthisgroupischallenging. report the sixth patient from a third family with additional We present a case of AGS type 7 in an extreme preterm ocular and behavioral features. infant, and highlight the role of whole exome sequencing ClinicalReport:Theprobandwasevaluatedafterfamily (WES) in providing a timely diagnosis. memberswithcongenitalnystagmuswerereferred.Heisan Materials and methods: A female infant was delivered 18-years-old male with moderate intellectual disability, at 27+2 for pre-eclampsia, IUGR, and abnormal Dopplers. mild dysmorphic features and stereotypic behaviors. His Frombirth,shehadrefractorythrombocytopenianecessitat- movements stop when verbally distracted and he responds ing almost-daily transfusions, as well as anemia, progres- with single words. Bilateral nystagmus was noticed in sive hepatosplenomegaly, cholestasis, pulmonary childhood. Flash electroretinogram recordings of cone and hypertension, respiratory insufﬁciency, poor feeding, and rod function were normal. Ophthalmological evaluation of punctate brain calciﬁcations. Screening for TORCH infec- other family members with congenital nystagmus demon- tionsandautoimmunethrombocytopeniawasnegative.She strated decreased visual acuity and impaired cone and rod wastreatedtwiceforpresumedculture-negativesepsis,with function. minimal clinical improvement. In the face of worsening Results: Whole exome sequencing (WES) in family multi-organdysfunction,palliativemeasureswereinstituted members revealed two different causative genetic condi- and she died at 54 days. tions. Homozygous missense pathogenic variant, Results: Singleton WES identiﬁed a likely pathogenic c.323T>C;p.(Ile108Thr) in TAF6 (NM_001190415.1) and variant in IFIH1: c.2159G>A, p.(Arg720Gln). This mis- heterozygous missense variant of uncertain signiﬁcance, sense variant has been reported twice in ClinVar, and c.1708G>A;p.(Val570Met) in PD E6
C (NM_006204.3) published in 6 individuals with variable AGS. Pathogenic were identiﬁed in the proband. His sister and her son were variants in IFIH1 cause autosomal dominant AG S7
, and both homozygous for the variant in PD E6
C gene. account for 3-5% of cases. Conclusion: The proband shares the same homozygous Conclusion: AG S7
 presents with a variable phenotype, missense variant, c.212T>C;p.(Ile71Thr) in TAF6, pre- including a neonatal-onset form. Phenotypic overlap with viously reported in a Saudi family by Alazami et al. Three common disorders of prematurity complicates diagnosis in siblings from the same Saudi family and a Turkish patient critically ill, extreme preterm infants. Rapid WES in such were simultaneously published by Yuan et al. Comparison cases can provide a timely diagnosis, and inform counsel- of WES data from the proband and the published Saudi ling on prognosis, recurrence, and end-of-life decision family revealed a shared haplotype of 3Mb in the region making. Grant: MITO-FIND, funding from including TAF6 gene. This ﬁnding supports pathogenicity MITOCANADA ofthishomozygousvariantandsuggestsanancientfounder E. Phillips: None. M. Kerr: None. A. Khan: B. Research effect. Grant (principal investigator,collaboratororconsultantand E. Tuc: None. F.B. Bengur: None. A. Aykut: None. O. pendinggrantsaswell asgrantsalreadyreceived); Modest; Sahin: None. Y. Alanay: None. MITO-FIND. F. Consultant/Advisory Board; Modest; MITOCANADA.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 905 E- P11
.014 Introduction: Haploinsufﬁciency of HNRNPK, which The First Case Report Coexistence of Asymmetric encodestheheterogeneousnuclearribonucleoproteinK,has Crying Face, Congenital Ptosis And Isotretinoin recently been identiﬁed as cause of Au-Kline syndrome Embryopathy (MIM #616580). Major ﬁndings include muscular hypoto- nia, developmental delay, intellectual disability, cardiac, M. Seven1, A. Kalayci Yigin1, M. T. Alay1, S. Sozer urogenital and skeletal abnormalities, and a characteristic Tokdemir2 facial gestalt. With one exception, all patients with Au- Kline syndrome published so far have loss-of-function 1Department of Medical Genetics, Cerrahpasa Medical mutations. There is only a single patient with a de novo Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, missense variant (p. L155
P) which is located in KH2, the 2Department of Genetics, Aziz Sancar Research Institute of second of three K-homology RNA-binding (KH) domains Experimental Medicine, Istanbul, Turkey of HNRNPK which ensure sequence-speciﬁc RNA and DNA binding. Due to the limited number of patients, the Introduction:IsotretinoiniscategorizedasXgroupofdrug phenotypicconsequences ofmissensevariantsinHNRNPK by Food and Drug Administration (FDA). Teratogenic remain to be deﬁned. effects are well deﬁned and mainly includes: craniofacial Methods and results: We report a second patient abnormalities,cardiovascular,centralnervesystem,thymic/ with a de novo missense variant in HNRNPK and typical parathyroid anomalies and ear abnormalities [1]. Asym- features of Au-Kline syndrome. The 10 year-old girl metric crying face (ACF) is very rare ﬁnding of 0.2-0.6% hassevereglobaldevelopmentaldelay,muscularhypotonia, and mimics the sign of peripheral facial paralyses. Gen- cleft palate, a branchial cyst, hydronephrosis, vertebral erally, associated with left-sided predominance. segmentation anomalies and facial dysmorphism. Based Clinical Findings and method: 28-day baby referred to on the clinical phenotype Au-Kline syndrome was our clinic for dysmorphological examination. Her mother suspected and conﬁrmed by Sanger sequencing was followed-up in our teratology clinic for isotretinoin which revealed a de novo missense variant c.146C>T, p. usage during the pregnancy. On baby’s physical examina-  L49
P in HNRNPK [NM_0021404]. This variant affects a tion; congenital ptosis in the right eye, ACF, nevus moderately conserved amino acid, locates to KH1, ﬂammeus in the glabella, cleft in the right earlobe, retro- the ﬁrst K-homology RNA-binding domain of HNRNPK, micrognathia, bilateral sandal gap, radial deviation in wrist is not listed in GnomAD and is predicted to be pathogenic and metatarsus adductus were detected. The right lower lip by in silico tools. Together with the typical clinical of the patient was observed to be moving down, when phenotype this strongly suggests that the variant is crying.ACFwasidentiﬁed.Inordertoexcludefacialnerve disease-causing. paralysis, electromyelography (EMG) was performed. His Conclusion: Our observation conﬁrms that HNRNPK karyotype was normal. missense variants affecting KH domains can lead to the Conclusion:Intheliterature,thereisonlyonecasereport characteristic clinical phenotype of Au-Kline syndrome. about isotretinoin embryopathy with ACF which was not C. Fauth: None. U. Albrecht: None. E. Maurer: None. J. conﬁrmed by EMG. Congenital ptosis is a common sign Zschocke: None. andmaybeassociatedwithmanyabnormalities,however,to the best of our knowledge coexistence of congenital ptosis E- P11
.016 andACFwithisotretinoinembryopathyistheﬁrstreported Clinical and molecular characterization of a rare case case in here. diagnosed with Bardet Biedl Syndrome M. Seven: None. A. Kalayci Yigin: None. M.T. Alay: None. S. Sozer Tokdemir: None. I. O. Focsa1, M. Budisteanu2,3,4, C. Burloiu2, L. C. Bohiltea1, M. Balgradean5,6 E- P11
.015 Au-Klinesyndromeduetoadenovomissensevariantin 1"C.Davila"UniversityofMedicineandPharmacy,Buchar- HNRNPK est, Bucharest, Romania, 2Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, Bucharest, Romania, 3Victor Babes C. Fauth1, U. Albrecht2, E. Maurer1, J. Zschocke1 National Institute of Pathology, Bucharest, Romania, 4Titu Maiorescu University, Bucharest, Romania, 5Marie Curie 1Institute of Human Genetics, Medical University Children’s Clinical Hospital, Bucharest, Romania, 6Carol Innsbruck, Innsbruck, Austria, 2Department of Pediatrics Davila University of Medicine and Pharmacy, Bucharest, I, Medical University Innsbruck, Innsbruck, Austria Romania906 J.delPicchia Bardet Biedl syndrome (BBS) is a rare, pleiotropic cilio- Department of Molecular Medicine, University of Pavia, pathy caused by mutations in 21 genes. BBS 12 gene Pavia, Italy mutations are responsible for 5-6% from molecular diag- nosed cases. Clinical spectrum is highly variable in- and Introduction: Basel-Vanagaite-Smirin-Yosef syndrome between families. The main features are: rod cone dystro- (BVSYS) is an extremely rare autosomal recessive genetic phy, polydactyly, obesity, cognitive impairment, renal disorder characterized by severe developmental delay and anomalies and urogenital malformations. We report on a variable congenital anomalies, caused by variants in the new case of BBS caused by BB S12
 mutation. The 7 years MED25 gene. Since 2015, 17 patients have been described old girl is the ﬁrst child, born at 42 weeks from healthy, with common clinical features and homozygous variants in unrelated, gypsy parents. Physical parameters at birth were the MED25 gene, leading to a better deﬁnition of the phe- normal. Post axial polydactyly in all four members, bra- notype associated with BVSYS. chydactyly and 2-3 ﬁngers syndactyly, were noted. Last Materials and methods: Here we report two young physical exam reveals macrocephaly (OFC >2SD), obesity sisters, of consanguineous parents, presenting typical (weight >6SD), dysmorphyc features, rod cone dystrophy, dysmorphicfeaturesandneuroimagingﬁndingsofBVSYS, genital malformations, severe intellectual disability, and plus polymicrogyria. behavior abnormalities (self aggressive behavior, hyperki- Patient 1 showed features of BVSYS at physical nesia, food intake abnormalities). Over the last year, renal examination (strabismus, large and overhanging nasal tip, dysfunction and hypertension have occurred. Clinical short philtrum, down-turned corners of the mouth, micro- diagnosiswasestablishedduetopresenceofmorethanfour gnathia, bilateral 2nd-3rd toe syndactyly Y-shaped) and a primary features included in consensus criteria. Molecular delayed psychomotor development. Brain MRI showed genetic tests conﬁrmed the diagnosis, identifying an bilateral perisilvian polymicrogyria, thin corpus callosum, homozygous nonsense mutation in BB S12
 gene temporal and parietal atrophy, cyst of the cavum septum (c.1063C>T;p.Arg355*).Themutationwasreportedﬁrstin pellucidumandcavumvergae,enlargementofthethirdand 2007intwoFrenchgypsyfamilies.Later,othertwopatients lateral ventricles. were reported. Our patient brings new evidence in the Patient2(patient1’ssister)showsimilarclinical features phenotype caused by this rare mutation. Further studies are at physical examination and brain MRI; she died at 1 year needed for a better understanding of genotype-phenotype of age and authoptic investigations were not performed. relation. Albeit there is a little experience in predicting the Results (patient 1): Karyotype and array-CGH were phenotypeseveritytaking into account themutational load, normal; WES identiﬁed an homozygous frameshift variant anearlyclinicalandmoleculardiagnosismaybehelpfulfor c.1778_1779delAG in MED25. The variant leads to a good management of these patients. stop coding formation and results in a loss of function I.O. Focsa: None. M. Budisteanu: None. C. Burloiu: protein. None. L.C. Bohiltea: None. M. Balgradean: None. Conclusions: Our cases showed among neuroimaging ﬁndings also perisilvian polymicrogyria. which has never E- P11
.017 been described before in BVSYS. We suggest including it Improving the phenotype description of Basel-Vana- among the possible cerebral anomalies of BVSYS and gaite-Smirin-Yosef syndrome, MED25-related: the rele- emphasize the importance of a detailed clinical and vance of neuroimaging ﬁndings. neuroradiological evaluation of these patients. I. Maini: None. E. Errichiello: None. S. Carafﬁ: I. Maini1, E. Errichiello2, S. Carafﬁ1, S. Rosato1, None. S. Rosato: None. V. Bizzarri: None. M. Pollazzon: V. Bizzarri1, M. Pollazzon1, G. Trimarchi1, G. Contrò1, None. G. Trimarchi: None. G. Contrò: None. C. Gelmini: C. Gelmini1, M. Napoli3, R. Pascarella3, S. Rizzi4, None. M. Napoli: None. R. Pascarella: None. S. Rizzi: C. Fusco5, O. Zuffardi6, L. Garavelli1 None. C. Fusco: None. O. Zuffardi: None. L. Garavelli: None. 1MedicalGeneticsUnit,DepartmentofMaternalandChild HealthDepartment,AUSL-IRCCSofReggioEmilia,Reggio E- P11
.018 Emilia, Italy, 2Unit of Medical Genetics, Department of Concurrent hypomethylation in both IC loci found in a Molecular Medicine, University of Pavia,, Pavia, Italy, Beckwith-Wiedemann syndrome case 3Neuroradiology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy, 45. Child Neuropsychiatry Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy, 5Child Neuropsychiatry Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy, 6Unit of Medical Genetics,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 907 V. Anastasiadou1, I. Kyprianou2, A. Miltiadous2, A.Mroczkowska5,P.Skowera5,B.Styka5,D.Winnicka5,M. P. Gerasimou2, J. Chi3,2, I. Savvidou1, P. Costeas2,3 Lejman5, J. Kowalczyk1 1DepartmentofClinicalGenetics, ArchbishopMakariosIII 1Department of Pediatric Hematology, Oncology and Medical Centre, Nicosia, Cyprus, 2Molecular Hematology- Transplantology, Children’s University Hospital, Lublin, oncology, Karaiskakio Foundation, Nicosia, Cyprus, 3The Poland, 2Department of Neonate and Infant Pathology, Center for the Study of Haematological Malignancies, Children’s University Hospital, Lublin, Poland, 3MedGen Nicosia, Cyprus MedicalCentre,,Warsaw,Poland,4DepartmentofClinical GeneticsandPatomorphology,UniversityofZielonaGora, Introduction: Beckwith-Wiedemann syndrome (BWS) is Zielona Gora, Poland, 5Laboratory of Genetic Diagnostic, a clinically heterogeneous overgrowth syndrome asso- Children’s University Hospital, Lublin, Poland ciated with an increased risk of embryonal tumour development. BWS incidence ranges from 1 in Introduction: Cantu syndrome is characterized by con- 10,000-15,000 newborns with 85% of the cases sporadic. genital hypertrichosis, characteristic craniofacial dys- Genetic or epigenetic alteration within two domains of morphicfeatures,cardiomegalyandosteochondrodysplasia. imprintedgrowthregulatorygenesonchromosome11p15, It is caused by mutations in ABC C9
 or KCNJ8 genes. We I C1
 (H19DMR) or I C2
 (KvDMR), lead to deregulation wouldliketoreporttwonewcasesofCantusyndrome:33- and BWS phenotype. Other known causes of BWS are year-old patient and her 3-month-old daughter. Mother uniparental disomy (UPD), trisomy 11p15, mutations in during adolescence was diagnosed with hypogonadotropic the CDKN1C gene, as well as small deletions and hypogonadism. She had distinctive facial features, hyper- translocations. trichosisonthefaceandpolycysticovaries.Neithersignsof Materials and methods: We describe a 2-year-old girl, cardiomegaly nor osteochondrodysplasia were observed. referred because of global developmental delay. On Her daughter had similar coarse facial features, generalized examination we noted macrosomia, midface and scalp hypertrichosis and enlarged tongue. She was born on time hemangiomas and a protruding tongue. She suffers of with normal length and weight parameters. After genetic choking episodes. Speech is limited. She is the ﬁrst child consultation Whole Exome Sequencing was performed. andaproductofspermdonation.Macrosomiawasnotedon Materials and methods: The sequencing of isolated, prenatal ultrasound. Neonatal hypoglycemia was not enriched genomic DNA was performed on NovaSeq 6000. reported. MS-MLPA analysis (MRC Holland) was per- Raw sequences in fastq format were mapped to hs37d5 formed to look for epimutations in the imprinted 11p15 reference. The following in silico prediction software regionassociatedwithBWS(I C2
lossofmethylationorI C1
 programs were used to assist with interpretation of gain of methylation). The results were conﬁrmed with a pathogenicity of detected variant: SIFT, MutationTaster, second sample from the proband. PolyPhen-2 as embedded in Alamut visual v 2.9.0. The Results:Concurrenthypomethylationonboth imprinting presence of the variant in control populations was checked loci,I C1
andI C2
,wasobservedonchromosome11p15.No in 1000Genomes, the ExomeVariantServer, and the Exome copy number chromosomal abnormalities were detected. Aggregation Consortium and gnomAD. Sanger sequencing Conclusions: We discuss the clinical and molecular was also performed. ﬁndings of this case because of the rarity of simultaneous Results: A new missense variant Arg1116Pro was found loss of methylation pattern in both I C1
 and I C2
 loci. in one allele of ABC C9
 gene. Considering the symptoms Relevant literature is currently limited. andthedetectedvariantpatientswerediagnosedwithCantu V. Anastasiadou: None. I. Kyprianou: None. A. Miltia- syndrome. dous:None.P.Gerasimou:None.J.Chi:None.I.Savvidou: Conclusion: We would like to present two patients- None. P. Costeas: None. mother and her daughter with some distinctive clinical featuresforCantusyndromeandnewpathogenicvariantin E- P11
.020 ABC C9
 gene. Our report is a valuable contribution in New heterozygous pathogenic variant in ABC C9
 gene expanding molecular and clinical spectrum of Cantu identiﬁed in two patients diagnosed with Cantu syndrome. syndrome K. Wojciechowska: None. A. Tarkowska: None. M. Kacprzak: None. D. Loska: None. A. Pietrzyk: None. M. K. Wojciechowska1, A. Tarkowska2, M. Kacprzak3, Babicz: None. M. Holweg: None. A. Mroczkowska: None. D. Loska3, A. Pietrzyk4, M. Babicz5, M. Holweg5, P.Skowera:None.B.Styka:None.D.Winnicka:None.M. Lejman: None. J. Kowalczyk: None.908 J.delPicchia E- P11
.022 T. Atik, S. Simsir, E. Isik, F. Ozkinay Further delineation of putative CDK10 loss-of-function variants: a new form of ciliopathy phenotype Ege University Faculty of Medicine, Department of Pediatrics, Izmir, Turkey G. Forzano1, R. Artuso2, E. Andreucci2, V. Palazzo2, A.Pagliazzi1,F.Vanderwert1,G.Gori1,F.DiGiovanni1,E. Developments in the genomic era and large-scale exome/ Fiorentini1, S. Giglio3 genome sequencing studies have identiﬁed mutations in several members of the CHD (Chromodomain Helicase 1Medical Genetics Unit, University of Florence, Florence, DNA-binding protein) gene family in neurodevelopmental Italy, 2Medical Genetics Unit, Meyer Children’s University disorders.EspeciallythegroupIIICHDfamilyconsistingof Hospital, Florence, Italy, 3Medical Genetics Unit, Uni- CHD6, CHD7, CHD8 and CHD9 has well-documented versity of Florence, Meyer Children’s University Hospital, rolesintranscriptionregulation,impactinginorganogenesis. Florence, Italy Thesefourenzymesaresimilarintheirconstituentdomains. While mutations in the CHD2 and CHD8 have been linked CDK10encodesaproteinkinasewhichinteractswithcyclin toautismandintellectualdisability.Additionally,CHD7has to form a heterodimeric protein kinase that plays a central beenfoundtobeassociatedwithCHARGEsyndromewhich role in the regulation of cellular growth, ciliogenesis and isawell-knowncongenitalmalformationsyndrome.Herein primary cilium elongation. Bi-allelic loss-of-function this report, we present a case having intellectual dysability, CDK10 mutations have been recently reported associated autism and several congenital anomalies and a de-novo with a distinct disorder, named Al-Kaissi syndrome, nonsensemutationinCHD8geneasapossiblecauseofthe describedsofarinonly10patientsfrom6distinctfamilies. clinical phenotype. A 5,5 year-old boy with macrocephaly, We report the case of a 5-year-old boy with a complex autism, intellectual disability and congenital anomalies phenotype: growth retardation, global developmental delay including severe hypospadias, ventricular septal defect, with absent speech, thin corpus callosum and paucity of inguinal hernia, cryptorchidism, anal atresia and hemi- white matter visible at the brain MRI, vertebral anomalies vertebrae(T12) was referred to our department. He has also and a typical facial appearance (triangular face, bilateral been treating for hypothyroidism. Trio whole exome epicanthic folds, hypertelorism, depressed nasal bridge, sequencing(WES) was performed, and a de-novo hetero- low-set and posteriorly rotated ears, small chin); besides zygousnonsensec.727C>T(p.Arg243*)mutationintheﬁrst these features, our patient was born with ostium secundum exon of CHD8 was detected and it was found to be likely atrial septal defect and pulmonary valve stenosis. Array- pathogenic according to ACMG 2015 criteria. We consider CGH and CHD7 molecular analysis were normal. Trio that the mutation found in the patient could be responsible whole exome sequencing (WES) disclosed a homozygous for a congenital malformation syndrome similar to splice site variant in the CDK10 gene. Our patient’s phe- CHARGE syndrome, causing a disruption in CHD7-CHD8 notype resembles the clinical features described in patients complex. Further functional analysis is planned. As a con- affected by Al Kaissi syndrome, except for the congenital clusion, mutations in CHD8 gene, especially disrupting heart defect (CHD): none of the patients with the same CHD7-CHD8 complex, could be responsible for a con- mutation as our case were reported to have any heart genital malformation syndrome similar to CHARGE. anomalies; to date, only one patient with Al-Kaissi syn- T. Atik: None. S. Simsir: None. E. Isik: None. F. drome showed patent ductus arteriosus. The WES analysis Ozkinay: None. excluded further variants of the genes described in asso- ciation with heart malformations and therefore our case is E- P11
.025 likely to allow us to expand the clinical phenotype of a Chromoanasynthesis with involvement of chromosome syndrome which is not yet fully characterised. 21: rare cause for dysmorphic features and develop- G.Forzano:None.R.Artuso:None.E.Andreucci:None. mental disorder V. Palazzo: None. A. Pagliazzi: None. F. Vanderwert: None. G. Gori: None. F. Di Giovanni: None. E. Fiorentini: J. Lisfeld1, M. Pettersson2, S. Rudolph3, S. Fuchs1, None. S. Giglio: None. J. Eisfeldt2, M. Hempel1, A. Lindstrand2 E- P11
.024 1Institute of Human Genetics, University Medical Center AnonsensemutationintheﬁrstexonofCHD8causesa Hamburg-Eppendorf, Hamburg, Germany, 2Department of multi-organ disease phenotype: Is it a novel syndrome Molecular Medicine and Surgery, Karolinska Institutet and or a detection of an additional gene resulting in Department of Clinical Genetics, Karolinska University CHARGE syndromeAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 909 Hospital, Stockholm, Sweden, 3Gemeinschaftspraxis für Chromosome 15 spans more than 102 million DNA base HumangenetikundGenetischeLabore,Hamburg,Germany pairsandrepresentsmorethan3percentofthetotalDNAin cells.Chromosome15likelycontains600to700genesthat Background: Although various complex chromosomal provide instructions for making proteins. These proteins rearrangements have been described, the underlying performavarietyofdifferentroles inthebody.Changesin pathomechanisms are still not fully understood. One of the the number or structure of chromosome 15 can cause models discussed is chromoanasynthesis, a replication- intellectual disability, delayed growth and development, based process that forms complex rearrangements during hypotonia, and characteristic facial features. These changes numerous cycles of fork stalling and template switching include an extra copy of part of chromosome 15 in each (FoSTeS) and microhomology-mediated break-induced cell,amissingsegmentofthechromosomeineachcell,and replication (MMBIR). A commonly acknowledged a circular structure called ring chromosome 15. Sixteen mechanism for catalyzing these events is DNA polymerase patients who have a CNV on 15th chromosome as a result slippage, which could lead to both inter- and intrachromo- of the arrayCGH analysis made using 180K CGH + SNP somal rearrangements. oligoarrayaftertheyhadbeendirectedtoTrakyaUniversity Case report: We report on a 22-year-old man with Hospital,GeneticDiseasesDiagnosisCenterbetween2016- moderate global developmental delay, short stature, micro- 2019, were included in our study. The indications of the cephaly, severe hearing impairment and dysmorphic patients were intellectual disability, hypotonia, micro- features resembling patients with Down syndrome. Brain cephaly, developmental delay, increased nuchal translu- MRI and echocardiography results were normal. cency,intrauterinegrowthretardationetc.Ninepatientshad Methods and results: Chromosome analysis revealed a 15q partial deletion and 7 patients had 15q partial dupli- derivative chromosome 21. CGH array analysis could cation. As a result of the segregation analysis, 3 patients delineate one duplication on 21p and ﬁve duplications on werediagnosedwithAngelmanSyndrome,onepatientwas 21q.Follow-upanalysisusingshort-readpaired-endwhole- diagnosed with Ring15. It was determined that 4 patients genome sequencing (WGS) revealed a complex rearrange- (del. in 2 patients, dup. in 2 patients) with CNV on chro- ment consisting of a total of seven duplications on mosome 15q had inherited the CNV from a parent. As a chromosome 21. Four out of the total seven breakpoint result of segregation analysis, the diagnoses of the 8 junctions could be delineated on the nucleotide level and patients, 4 having a deletion and the other 4 having a provided evidence of DNA polymerase slippage and errors duplication, will be conﬁrmed. during DNA replication as the underlying mechanism of H.Gurkan: None. E. Atlı:None. S. Yalcıntepe: None. E. formation. Chromosome analyses and WGS data for both &. Atlı: None. S. Demir: None. Y. Özen: None. H. parents were unremarkable, thereby indicating a de novo Tozkır: None. rearrangement. Discussion: The patient described here is affected by a E- P11
.027 complexchromosomalrearrangementconsistingofmultiple Distal 18q deletion syndrome in girl partial duplications within chromosome 21. Duplications were mostly rearranged and one was inverted. O.Gumeniuk,Y. Chernenkov, S.Sanaeva, P.Golobokova, J.Lisfeld:None.M.Pettersson:None.S.Rudolph:None. T. Ilysova S. Fuchs: None. J. Eisfeldt: None. M. Hempel: None. A. Lindstrand: None. Saratov State Medical University, Saratov, Russian Fed- eration E- P11
.026 Clinical results of chromosome 15 copy number Distal18qdeletionsyndromeisararehereditarywithpiece variations distal section of the long (q) arm of chromosome 18 is missing. Syndrome can lead to a wide variety of signs and H.Gurkan1,E.Atlı1,S.Yalcıntepe1,E.&.Atlı1,S.Demir1, symptoms. Purpose. To study the features distal 18q dele- Y. Özen1, H. Tozkır2 tionsyndromeingirl.Patientandmethods.14-year-oldgirl with physical and sexual delayed development, language 1Trakya University, Medical Faculty, Department of delay, learning difﬁculties, muscle weakness, deformation MedicalGenetics,Edirne,Turkey,2Tekirdag,NamıkKemal ofthefoot,frequentnon-diabeticketoacidosis.Physicaland University, Medical Faculty, Department of Medical instrumental examination, conventional chromosomal ana- Genetics, Tekirdag, Turkey lysis was carried out. Results. Girl was born full term with normal birth weight, following a pathological pregnancy.910 J.delPicchia Tetralogy of Fallot was diagnosed in neonatal period. region:threecopiesof400Kbp(withoutgenes),fourcopies FamilyHistory:congenitalcataractinthemotherandinthe of 406Kbp (involving CDH4 gene), three copies of grandfather on the mother’s side. She attends a special 543Kbp (containing three genes: CDH4, MIR125, TAF4) needs school and has poor school performance, with difﬁ- and four copies of 2.304Mbp, comprising TAF4 and 86 culty in attention, concentration, comprehension and obey- more genes. ing orders. She had delayed physical and sexual Discussion: In the present case conventional and development, microcephaly, poor subcutaneous fat, asym- molecular cytogenetics detected a marker chromosome metric wide chest, long arms, short shoulders, gait dis- derived from chromosome 20. The array clariﬁed the turbance,deformityofthefootontheright(Friedreichfoot) amount and the segment involved. The extra chromosome and speciﬁc facial dysmorphies: wide nose bridge, hyper- comprisedacomplexduplication/triplicationinthe20q13.3 telorism, epicantum, thin upper lip, "carp mouth". Her IQ region. The girl has some dysmorphic features and global (intelligence quotient) was 53, and he showed mild mental developmental delay consistent with 20q duplication retardation. Laboratory examination: increased level of syndrome. Nevertheless, to our knowledge this is the ﬁrst TSH,adecreaseinT4(primarycongenitalhypothyroidism, case involving only this region. Every new case of a rare late form). Abdominal ultrasound: echo-signs gallbladder chromosomal alteration should be reported in order to agenesischaracteristic.Conventionalchromosomalanalysis obtain a more precise genotype/ phenotype correlation, on 30 metaphases from peripheral blood lymphocyte cul- improving risk evaluation and genetic counselling. tures showed two cell lines: 46, XX, del(18)(q21q21). M.Souto:None.P.Botelho:None.M.Martins:None.O. Conclusions.Theclinicalfeaturesofthecasewerefrequent Moutinho: None. R. Pinto Leite: None. non-diabeticketoacidosis,gallbladderagenesis,severeheart disease and late genetic diagnosis. E- P11
.030 O. Gumeniuk: None. Y. Chernenkov: None. S. Sanaeva: A Rare Case Report: Cloves Syndrome None. P. Golobokova: None. T. Ilysova: None. M. T. Alay1, A. Kalayci Yigin1, B. Uyanik2, M. Seven1 E- P11
.028 A complex duplication/triplication of 20q 1Department of Medical Genetics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, M. Souto1, P. Botelho1, M. Martins2, O. Moutinho3, 2Department of Medical Genetics, University of Health R. Pinto Leite1 Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey 1Laboratório de Genética, Centro Hospitalar Trás-os- Montes e Alto Douro, Vila Real, Portugal, 2Consulta de Introduction: Clove(s) syndrome (CS) is one of the rare Genética,CentroHospitalar Trás-os-MonteseAltoDouro, syndromes characterized with congenital adipose tissue Vila Real,Portugal,3ServiçodeGinecologia eObstetrícia, excessivesize,vascularmalformation,epidermalnevusand CentroHospitalarTrás-os-MonteseAltoDouro,VilaReal, scoliosis/spinalmalformation.Althoughtheetiologyofthe Portugal disease is not fully understood, it usually occurs as a result ofpost-zygoticmutationsthatfunctioninthePIK3CAgene. Introdution: Partial duplication of the long arm (q) of CSsyndromecanaffectsofttissue,bloodvessels,bone,and chromosome 20 occur very rarely. The phenotype usually internalorgans.Itssymptomsvarywidelybetweenmildand consists of brachycephaly, epicanthus, anteverted nostrils, severe anomalies. shortneck,verticalchindimple,andcongenitalheartdefect Clinical Findings: A 3-year-old girl was referred to our or murmur. Some cases have development growth, speech, outpatient clinic with a preliminary diagnosis of vascular motor, and social interactions delay. The authors present a malformation. In her physical examination, there was case of partial trisomy 20q. progressivegrowthintheabdomen,pigmentedskinlesions ClinicalReport:8-year-oldgirlwithshortstature,minor in the left half of the body from birth, and capillary dysmorphic features and global developmental delay. malformation(nevusﬂammeus)intherightlowerlimband Blood culture and cytogenetic analysis were performed perivulvar region. Scoliosis, left hemihypertrophy, sandal according standards protocols. Cytogenetics analysis gap and macrodactyly were detected in the toes. revealedachromosomemarkerinallmetaphasesanalyzed. Results: In the Clinical Exom DNA sequence analysis Parents karyotype were normal. Fluorescence in situ from the blood sample taken from the patient, a Hetero- hybridization(FISH)techniqueidentiﬁedtheextramaterial zygous c.436G˃A p.(Val146Ile) mutation was detected and as chromosome 20. Array Comparative Genomic Hybridi- conﬁrmedbySangersequence.ThePIK3CAgeneisnamed zation (aCGH) technique revealed a gain in the 20q13.33Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 911 as an oncogene encoding 23 exons, located on the PI3K/ severe arthrogryposis and intrauterine growth restriction. AKT signal pathway. Thehomozygousstateinourpatientcanbethecauseofthe Conclusion: As a result of changes in the PIK3CA gene, severe phenotype that was not described before. congenitallipamatosishasbeenreportedtocauseanomalies M. Marques: None. P.M. Almeida: None. S.M. Ribeiro: and syndromes such as overgrowth, vascular malforma- None. F. Ramos: None. L. Ramos: None. tions, epidermal nevus. Applying the diagnostic criteria of Keppler-Noreuiletal.,ourcasewasfoundtobecompatible E- P11
.032 withthediagnosisofCS.CSistheﬁrstcasereportedinour TwoTwinSisterWithCohenSyndromeAndHirsutism: country supported by molecular analysis. A Case Report Keywords: Cloves Syndrome, PIK3CA gene, Clinical Exome. F. Ozdemir1, A. Kalayci Yigin1, Z. Ocak2, M. Seven1 M.T. Alay: None. A. Kalayci Yigin: None. B. Uyanik: None. M. Seven: None. 1Department of Medical Genetics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey, E- P11
.031 2Department of Medical Genetics, Medical Faculty, Uni- CockayneSyndrome:apreviousdescribedheterozygous versity of Istinye, Istanbul, Turkey variant in homozygosity Introduction: Cohen syndrome is a genetic disease char- M.Marques1,P.M.Almeida1,2,S.M.Ribeiro1,F.Ramos1, acterizedbyarareneurodevelopmentaldelay,microcephaly L. Ramos1,2 and hypotonia. While phenotypic ﬁndings may differ among patients, it may appear normal in the neonatal per- 1Hospital Pediátrico, Centro Hospitalar e Universitário de iod,asfacialfeaturesarenotevident.Theﬁrstclinicalsigns Coimbra, Coimbra, Portugal, 2Faculty of Health Sciences, include nutritional difﬁculties, hypotonia, microcephaly, University of Beira Interior, Covilhã, Portugal neuromotor developmental retardation and joint hypermo- bility. Due to neutropenia, upper respiratory infections and Cockayne syndrome (CS), is a rare autosomal recessive oral aphthae could be observed. The disease has an auto- multisystem disorder, mainly characterised by postnatal somal recessive inheritance pattern and is caused by growth failure, progressive neurological dysfunction, mutations in the VP S13
B gene. microcephaly, impaired vision and hearing, skeletal ClinicalFindingsandMethod:Inthisstudy,wepresent abnormalities and premature ageing. CS is caused by two twin sister cases with hirsutism ﬁndings and neuro- mutations in ERC C6
 and in ERC C8
 gene. Studies per- motor developmental retardation, microcephaly, mega formed thus far have failed to delineate clear genotype- sisterna magna in cranial MR and prominent antihelix, phenotype relationships. low hairline, camptodactyly and dysmorphic ﬁndings such We present a one-year-old girl, from consanguineous as narrow forehead. DNA were isolated from peripheral parents, referred due to congenital cataracts, microcephaly, blood samples taken from two siblings. The mutation was shortstatureandarthrogryposis.Shehadahistoryofreduced detectedasaresultofclinicalexomanalysisandconﬁrmed fetalmovements,intrauterinegrowthrestrictionandhydram- by Sanger sequence. The results were evaluated with nios. At 6 months of life she had microcephaly (-3,0SD), American College of Medical Genetics (ACMG) criterias growth failure and severe developmental delay. Brain MRI and compared with genetic databases. showeddiffusehypomyelinationofthecerebralwhitematter, Result: As a result of the analysis, c.412+1G> T hypoplasticcorpuscallosumandsmalllens.Weperformeda pathogenic variant was detected homozygous in the broad gene panel analysis that identiﬁed a probably VP S13
B gene in both sisters. Conclusion: This mutation pathogenic missense variant [c.611C>T (p.Thr204Lys)] in supports Cohen’s syndrome with clinical ﬁndings. homozygous form, on ERC C8
 gene. Parental study con- Keywords: Cohen Syndrome, Hirsutism, Clinical Exome ﬁrmed that they are heterozygous for this variant. Sequencing. CS belongs to the family of NER (nucleotide excision F. Ozdemir: None. A. Kalayci Yigin: None. Z. Ocak: repair)-related disorders existing a large variation in None. M. Seven: None. severity. Our patient has CS type 2, which is a neonatal severe form, typically lethal in the ﬁrst decade of life. Our E- P11
.036 patient has a homozygous probably pathogenic missense A large homozygous deletion in two sibs suffering from variant in the ERC C8
 gene that was already described in a multiple congenital disorders compound heterozygous state (c.611C>A; c.1122+1delG) whohasCStypeI,withoutcongenitalcataracts,smalllens,912 J.delPicchia S. Seyedhassani1, M. Ebrahimi1, M. Tavakoli1, L. Najaﬁ2, Universitaire de Rennes, ERN-ITHACA, Rennes, France, M. Neshan1,3 2Rennes University, Institute of Genetics and Development of Rennes (IGDR) UMR6290 CNRS, Rennes, France, 1Dr. Seyedhassani medical genetic center, Yazd, Iran, 3Service de Génétique Moléculaire et Génomique, Centre IslamicRepublicof,2Islamicazaduniversity,Tehran,Iran, Hospitalier Universitaire de Rennes, Rennes, France, Islamic Republic of, 3National institute for genetic engi- 4APHP, GH Pitié Salpêtrière, Department of Genetics, neering and biotechnology, Tehran, Iran, Islamic Republic Unit of Development Genomics, Paris, France, Paris, of France,5UnitéFonctionnelledegénétiqueclinique,Hôpital ArmandTrousseau,Assistancepublique-HôpitauxdeParis, One family was referred to genetic counseling center Centre de Référence Maladies Rares des anomalies du because of multiple disabilities. They had three involved développement et syndromes malformatifs, Paris, France, children resulting from consanguineous marriage with 6Department of Clinical Genetics, Amsterdam UMC - inbreedingcoefﬁcientabout6.25%.A10monthsboyanda Locatie VUMC, Amsterdam, Netherlands 8 years old girl suffering from delayed development, high crying, irritability, decreased head circumference, visual Holoprosencephaly (HPE; MIM# 236100) is the most and hearing impairment and ﬁnally quadriplegic mental frequent congenital brain malformation (1 in 10,000 live retardation. Another girl was dead in 11 years old with births, 1 in 250 conceptuses). It results from incomplete similar manifestations. This family had three normal chil- midline division of the prosencephalon between 18th and dren and was pregnant too. 28th day of gestation, affecting both the forebrain and the Chromosomal study and CGH array were normal. Whole face. The clinical spectrum is very wide, ranging from Exome Sequencing were used to enrich all exons of protein- severe HPE with a single cerebral ventricle and cyclopia codinggenesaswellassomeimportantothergenomicregions. to clinically unaffected carriers in familial HPE. The full Next generation sequencing was performed to sequence close spectrum of HPE includes also microforms characterized to 100 million reads on Illumina Sequencer. In this test, point by midline defects, with cleft lip/palate, hypotelorism, mutations and micro-insertion/deletions and duplication coloboma and/or single maxillary median incisor (<20bp)can be simultaneouslydetected.Alarge homozygous (SMMI). HPE is phenotypically and genetically hetero- deletionaroundfollowingregionwaspredicted:chr11:653904- genous and was previously considered as a dominant 710516,about56600bp,includinggenes:TMEM80,EP S8
L2 , disease with variable expression and incomplete pene- DEAF1. DEAF1 gene acts as a regulator of transcription. trance. From the use of High Throughput Sequencing Activity of this protein is important in the regulation of Technologies, it emerges that the penetrance and the embryonic development. Mutations in this gene have been phenotypic variability have digenic or oligogenic origin. found in individuals with cognitive disability. EP
S8 L2
 is a To date, at least 18 genes are implicated in HPE and are ProteinCodinggene.DiseasesassociatedwithEP S8
L2 include all associated with key pathways of forebrain develop- Deafness. TMEM80 is target gene of DEAF1 and decreased ment including sonic hedgehog (SHH) pathway. Inter- mRNAlevelswereobservedforTmem80throughoutthebrain estingly, among these genes, DIS
P1  appears to have a ofDEAF1knockoutmice.Clinicalmanifestationswereseenin speciﬁc mode of inheritance. DIS
P1  is a positive factor involved sibs appeared as a result of dysfunction of deleted necessary for efﬁcient secretion of the SHH morphogen genes individually and interaction with other related genes. and thus the establishment of its concentration gradient Prenatal diagnosis was done and fetus born in normal along the midline of the neural tube. We describe the condition. clinical characteristics of three families with severe HPE S.Seyedhassani:None.M.Ebrahimi:None.M.Tavakoli: or microform associated to compound heterozygous var- None. L. Najaﬁ: None. M. Neshan: None. iants in DIS
P1 . We will review the literature and discuss the genotype-phenotype correlations. E-
P11 .037 A. Lavillaureix: None. C. Dubourg: None. C. Quelin: Recessive inheritance of DIS
P1  variants in holoprosen- None. B. Keren: None. S. Whalen: None. Y. Hendriks: cephaly spectrum patients None. J. Bos: None. V. David: None. V. Dupe: None. S. Odent: None. A. Lavillaureix1,2, C. Dubourg3,2, C. Quelin1, B. Keren4, S.Whalen5,Y.Hendriks6,J.Bos6,V.David3,2,V.Dupe2,S. E-
P11 .038 Odent1,2 Detection of the pathogenic CNVs in the Macedonian patient with profound developmental delay 1Service de génétique clinique, Centre de Référence Maladies Rares, CLAD-Ouest, Centre HospitalierAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 913 V. Anastasovska1, E. Sukarova-Angelovska1, D. Nestoroska1, N. Zdraveska2, G. Ilieva1, M. Pesevska1 EBF3-relateddisorderswereﬁrstdescribedin2017(Sleven etal,Harmsetal,Chaoetal,Tanakaetal,Blackburnetal). 1Genetic Laboratory, Skopje, Macedonia, The Former Commonly reported features include global delays, mild- YugoslavRepublicof,2DepartmentofNeonatology,Skopje, severe intellectual disability, ataxia, hypotonia, and mild Macedonia, The Former Yugoslav Republic of facialdysmorphisms.Additional ﬁndings include high pain tolerance, febrile seizures, brain malformations, strabismus, Introduction: The array Comparative Genomic Hybridi- feedingdifﬁculties,scoliosis,genitourinaryanomalies,short zation (aCGH) is now recognised as a ﬁrst tier diagnostic stature, perseverative social behaviours and motor testforpatientswithwiderangingphenotypesandhasledto stereotypies. greater sensitivity in the detection of sub-microscopic Herein, we report on a 19-year old female patient with a genomic changes and pathogenic copy number variants de novo likely pathogenic heterozygous variant in EBF3, (CNVs). c.487C>T, p.(Arg163Trp). Our patient shows many symp- Materials and methods: aCGH was performed in the toms of EBF3-related disorders, including cognitive delay, Macedonian patient with clinical signs of dysmorphia and mental health concerns, hypotonia, strabismus, autonomic developmental delay using the Affymetrix® CytoScanTM dysfunction, poor feeding, complex renal anomaly, neuro- 750K Array (Applied Biosystems), that comprises 550 k genicbladder,febrileseizures,unstablegait,andanunusual non-polymorphic and 200 k SNP markers. The data was coronal pattern of sulcation in the cerebellar tonsils. analysed using Chromosome Analysis Suite (ChAS) Soft- Additionally, she had two unexplained episodes of ware (v4.0). signiﬁcant elevation in AST and ALT (4000-6000 U/L), Results:Wedescribea2.5-year-oldgirlwithdysmorphia not previously reported. and developmental delay. She has midfacial hypoplasia, Our report provides further expansion of the phenotypic facial asymmetry, prominent cheeks, deep set eyes, narrow spectrum of EBF3- related disorders. Long term outcomes rima oculi, short bulbous nose, simple and lop ears, round arenotwelldescribed;ourpatientrepresentsthethirdoldest face and brachydactyly. Congenital hypothyroidism was individualintheliterature.Theelevatedlivertransaminases detected at newborn screening, therefore she was on remain unexplained and could be related to her EBF3- continuous l-thyroxine therapy. At the age of 2 weeks the related disorder, but the possible underlying mechanism is baby developed hemolytic crises, followed by apnoic unknown. EBF3 encodes a member of the early B-cell episodes. Developmental delay was noticed at 6 months factor transcription factor family. Haploinsufﬁciency has of age, both for global and ﬁne motor skills. She started to been proposed as a mechanism of EBF3-related disease walk at 2 years of age, and no speech development so far. (Lopes et al. 2017). This report contributes to the under- Her height and weight are below 3 percentile. Karyotype standing of the long-term outcomes and health surveillance was 46,XX, del18p- (11.1-pter). aCGH analysis was for affected individuals, and further supports the ﬁnding of showed pathogenic 3 copies of the chromosomes multiple pleiotropic effects seen in EBF3-related disorders. 6q13q14.1 (4.081 kb) and 19p13.3 (650 kb) and one copy C.A. Chang: None. W. Al-Hertani: None. M. of chromosome 18p11.32p11.21 (14.919 kb), according to Innes: None. aDGV and ClinVar databases. Conclusions: The array CGH analysis has become a E-
P11 .040 widely accepted tool that supplements conventional kar- Expansion of phenotypic spectrum of E
P300  mutations yotyping in patients with an unexplained phenotype. V. Anastasovska: None. E. Sukarova-Angelovska: None. R. Kosaki1, K. Kosaki2 D.Nestoroska:None.N.Zdraveska:None.G.Ilieva:None. M. Pesevska: None. 1Division of Medical Genetics, National Center for Child HealthandDevelopmentHospital,Setagaya,Tokyo,Japan, E-
P11 .039 2Center for Medical Genetics, Keio University School of EBF3-related neurodevelopmental disorder - case Medicine, Tokyo, Japan report of female with phenotypic expansion and review of the literature Rubinstein-Taybi syndrome (RSTS) is a congenital mal- formation syndrome characterized by typical facial C. A. Chang1, W. Al-Hertani2, M. Innes1 appearance, broad thumbs and halluces, and intellectual disability.HeterozygousmutationsinCREBBP(50-60%)or 1Alberta Children’s Hospital, Calgary, AB, Canada, 2Bos- E
P300  (8-10%) have been detected. Recently, a hetero- ton Children’s Hospital, Boston, MA, United States geneous group of patients with CREBBP or E
P300914  J.delPicchia mutations who have clinical features atypical for RSTS duodenal stenosis was treated surgically. Ultrasound have been reported though exome analysis. We here report revealed an agenesis of the left kidney, and a pancreas four unrelated patients with E
P300  mutations to expand anulare. At the age of 9 months, he presented with phenotypicspectrum.[Methods]Informedconsentfromthe microbrachycephaly, triangular facies, iris coloboma on parents and approval from the local institutional review botheyes,low-setears,andpartialcutaneoussyndactylyof board were obtained. Medical exome analysis was per- the 4th and 5the toes on the left foot, consistent with formed. [Results] All the four patients had heterozygous previous reports of patients with F
S1 . mutationofE
P300 .Patient1)5-month-oldmalewithsome Methods: Conventional chromosomal analysis (CA), ofRSTSincludingintellectualdisability(ID),broadthumbs, array-CGH, quantitative PCR (qPCR) and Whole Trio andventricularseptaldefect.Nonsensemutationp.Gln965* Exome Sequencing (Trio-WES) were performed. was detected. Patient 2) 2-year-old female with atypical Results: GTG karyotyping showed a normal male result. features of RSTS including ID and normal thumbs. Mis- Array CGH detected a 4.9 Mb microdeletion of chromo- sense mutation p.Val1656Ala was detected. Patient 3) 11- some region 2p24.3 to 2p24.1, resulting in haploinsufﬁ- month-old female with double outlet right ventricle, mye- ciency of MYCN. qPCR segregation analyses of the index lomenigocele, hydrocephalus, imperforate anus, coloboma, patientandhisparentsdemonstratedadenovodeletion.No and hearing impairment. Dual mutations were detected: pathogenic variants beside the 2p24 microdeletion were E
P300  frameshift mutation p.Gln2048Thrfs*24 and SO
S1  revealed by Trio-WES of the patient and his parents. Thr778Pro mutation. Patient 4) 6-year-old female with Conclusion: Our results conﬁrm that F
S1  can be caused PDA, PS, coloboma, and hearing impairment.: E
P300  fra- by microdeletions of the chromosomal region 2q24 as meshift mutation p.Gln2048Thrfs*24 was detected.[Dis- single abnormality. cussion]Wedemonstratedtheclinicalvariabilityofpatients C. Schell-Apacik: None. S. Rauschke: None. A. Weber: with E
P300  mutations. The combination of coloboma and None.M.Blankenburg:None.L.Mulahasanovic:None.H. imperforate anus has been reported in a patient with a fra- Gabriel: None. S. Biskup: None. M. Stumm: None. meshiftmutation(p.H815Tfs*128)inE
P300 (Masudaetal. 2015).Recurrenceofsuchaspeciﬁccombinationofdefects E-
P11 .044 suggestscausalrelationship.PhenotypicspectrumofE
P300  Ocular phenotype inpatients withGNB5variantsandim- mutations may be much broader than has been previously pact of variants onGbeta5 expressionand function appreciated. R. Kosaki: None. K. Kosaki: None. Z. Shao1,2, A. Tumber3, J. Maynes4, E. Tavares3, S. Hewson2, A. Schulze2, P. Kannu2, A. Vincent3 E-
P11 .042 Deletion 2p24 and Feingold Syndrome Type 1 1Post-Graduate Medical Education, University of Toronto, Toronto, ON, Canada, 2Division of Clinical and Metabolic C. Schell-Apacik1, S. Rauschke2, A. Weber2, Genetics,HospitalforSickChildren,Toronto,ON,Canada, M. Blankenburg2, L. Mulahasanovic3, H. Gabriel3, 3Department of Ophthalmology and Vision Sciences, S. Biskup3, M. Stumm2 Hospital for Sick Children, Toronto, ON, Canada, 4Divi- sionofMolecularMedicine,TheHospitalforSickChildren 1Medicover Human Genetics Berlin-Westend MVZ, Berlin, Faculty of Medicine, University of Toronto, Toronto, ON, Germany, 2Medicover Genetics GmbH, Berlin, Germany, Canada 3Praxis für Humangenetik Tuebingen, Tuebingen, Ger- many BiallelicmutationsinGproteinsubunitbeta5(GNB5)gene were ﬁrst reported to cause a multi-system disorder with Introduction: Feingold Syndrome Type 1 (F
S1  - OMIM cardinal characteristics that include global developmental #164280) is a very rare syndromic microcephaly entity for delay, seizures, generalized hypotonia, early-onset sinus which MYCN is the major disease-causing gene. The inci- node dysfunction and eye disease. We have previously dence of F
S1  is currently unknown. About 10% of F
S1  reported the unique electroretinal signal of a 3-year-old patients have deletions encompassing all or part of the femalewithahomozygousnullvariantinGNB5(GNB5-L; MYCN gene. We report an additional F
S1  case, carrying a NM_016194.3:c.1032C>A/p.Y344* and GNB5-S; 4.9 Mb de novo microdeletion of the chromosomal NM_006578.3:c.906C>A/ p.Y302*) representing dual ret- region 2p24. inalsignallingdefectsthatconstitutesfeaturesofbradyopsia Clinical data: The boy is the only child of unrelated and rod ON-bipolar dysfunction. Subsequently, another parents. He was born in the 32th (31+5) gestational week female patient was identiﬁed with a homozygous missense by Caesarean after preeclampsia. At the age of two days, a variant in GNB5 (NM_016194.3:c.920T>G/p.
L370 R)Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 915 throughwholeexomesequencing(WES).Furthermore,this identiﬁed in introns: deletions c.76+36delAC in intron 1 patientalsohasahomozygousmissensevariantinMCC
C1  SAL
L1  gene, c.120+42G>T in intron 1 of TC
L1  and (c.1394C>Tp.T465I)thatrepresents3-methylcrotonyl-CoA c.298_34C>T in intron 2 of TC
L1  gene and substitution of carboxylase deﬁciency. The 3-MCC deﬁciency was con- c.393+36T>A in intron 3 of TC
L1 B gene. ﬁrmedenzymatically.AnotherheterozygousHemoglobinE Conclusions: Molecular evaluation is of extreme impor- variant of codon 26 (GAG>AAG) [HBB c.79G>A] that tance for families with a history of GHS. Diagnosis, early represents HbE trait was also identiﬁed, consistent with detection of the syndrome and good management make patient’s clinical presentation of splenomegaly. We there- possible of normal life of the patient. fore conducted a deep phenotypic analysis to segregate the B.A. Marszalek-Kruk: None. contribution of each genetic variant with a focus on her ocular phenotype whichinvolveshigh myopia. Wealso set E-
P11 .046 out to study the impact of the GNB5 variants on gene 45,X/46,XY gonosomal mosaicism as an unexpected expression,translationandprotein-proteininteractionusing ﬁnding in a patient with lymphoproliferative disease primary ﬁbroblast culture from the patient. With increased useofWESingeneticdiagnosis,morepatientsarefoundto J. Stellmachova1, V. Curtisova1, P. Rohon2, R. Vrtel1, have multiple molecular variants in syndromes with over- P. Vrtel1, K. Adamova1, D. Vrbicka1, M. Prochazka1, lappingphenotypes.Thisstudyhighlightstheimportanceof M. Palova3 detailed phenotyping and need of functional assays to aid variant classiﬁcation. This work is supported by the Rare 1Department of Medical Genetics University Hospital and Disease Foundation and the BC Children’s Hospital Foun- Palacky University, Olomouc, Czech Republic, 2Palacky dation Microgrant. University, Olomouc, Czech Republic, 3Department of Z. Shao: None. A. Tumber: None. J. Maynes: None. E. Hematooncology University Hospital and Palacky Univer- Tavares: None. S. Hewson: None. A. Schulze: None. P. sity, Olomouc, Czech Republic Kannu: None. A. Vincent: None. Introduction: We present a case of delayed diagnosis of a E-
P11 .045 mixed gonadal dysgenesis in a 53 old woman. Mutations in SAL
L1 , TC
L1  and TC
L1 B genes in Case presentation: The patient had short stature patients with Goldenhar syndrome (150cm), obesity, coarse facial features, mild male pattern hair loss, primary amenorrhea and borderline intellect. Her B. A. Marszalek-Kruk short stature and primary amenorrhea were never investi- gated. She was ascertained following a diagnosis of Department of Genetics, Wroclaw University of Environ- follicular lymphoma during a preventive mammography. mental and Life Sciences, Wroclaw, Poland Cytogenetic examination of the bone marrow detected complex changes including 46,XY clones prompting a Introduction: Goldenhar syndrome (GHS) is a rare inher- request for genetic examination with following results: ited syndrome. The incidence of this disease is between Karyotype from peripheral blood:45,X [12]/46,XY[38] 1:5600 to 1:25000. Syndrome is a multiple congenital dis- (24% monosomy X), FISH native peripheral blood: ish order characterized by malformed ears, micrognathia, oral (DXZ1x1)[40]/(DXZ1x DYZ3x1)[160] (20% monosomy cavity malformations and dermal cysts. Due to malforma- X), FISH buccal smear: ish (DXZ1x1)[68]/(DXZ1x tion patients usually have problem with airway. DYZ3x1)[132] (34% monosomy X). Her gonads were Materials and methods: DNA was isolated from removed,andpresenceofboth45,Xand46,XYcloneswas peripheral blood leukocytes from the patients. Exons of detected by FISH. Patients with "45,X/46,XY mixed genes SAL
L1  TC
L1  and TC
L1 B were ampliﬁed by gonadal dysgenesis" syndrome can present with small polymerasechain reaction(PCR)under optimal conditions, stature have an increased risk of gonadoblastoma and usingspeciﬁcprimers.ThePCRproductsweresubjectedto congenital abnormalities of heart and kidneys (similar like RFLP analysis and were puriﬁed on the DNA Gel Out Turner syndrome). columns followed by direct sequencing method. Conclusion: Early diagnosis of gonosomal mosaicism Results: During examination were detected 3 substitu- 45,X/46,XY enables multidisciplinary cooperation and tions. The c.3720G>A mutation in exon 3 of the gene treatment. Although the Czech Republic has a very good SAL
L1  which is a silent mutation (A1240A). Another of and longstanding tradition of primary care which enables the described mutation is c.166G>A in exon 2 of TC
L1  the diagnosis in most cases to be reached by puberty there causingtheconversionofV56Iandc.277G>Ainexon2of are still some adult patients who remain undiagnosed. This TC
L1 BcausingG93R.Additionally4polymorphismswere case highlights the usefulness of karyotype examination in916 J.delPicchia women with unexplained primary amenorrhea and/or short E-
P11 .049 stature. New case of Bardet Bield Syndrome caused by novel Supported by MH CZ - DRO (FNOl, 00098892) biallelic mutations in IFT172 gene J. Stellmachova: None. V. Curtisova: None. P. Rohon: None. R. Vrtel: None. P. Vrtel: None. K. Adamova: None. M. Sánchez Soler1, M. Ballesta-Martínez2, A. Serrano- D. Vrbicka: None. M. Prochazka: None. M. Palova: None. Antón1, V. López-González2, L. Rodríguez-Peña1, E. Guillén-Navarro2 E-
P11 .048 HDA
C2  as a potential ‘second hit’ to KIAA0586. Novel 1Medical Genetic Sección, H. Clinic Universitary V. ‘two hit hypothesis’ vs Digenic inheritance (DI) ? Arrixaca, IMIB-Arrixaca, El Palmar, Spain, 2Medical Genetic Sección, H. Clinic Universitary V. Arrixaca, S. Kupchik1, S. Lau1, O. Beckett1, K. McWalter2, IMIB-Arrixaca. CIBERER, El Palmar, Spain E. Normand3, Y. Kogelman1, P. Campeau4 Introduction: IFT172 is part of the intraﬂagellar transport 1MaimonidesMedicalCenter,Brooklyn,NY,UnitedStates, (IFT), a bidirectional mechanism allowing the protein 2Gene Dx, Gaithersburg, MD, United States, 3Gene Dx, motility within the cilia and biallelic mutations inthis gene Gaithesburg, MD, United States, 4University of Montreal, have been described in patients with isolated retinosis pig- Montreal, QC, Canada mentosa, short-rib thoracic displasia 10 with or without polydactyly, joubert syndrome, recently with oro-fagio- An11yearoldfemalewithshortstature,repairedopenneural digital syndrome and only in three cases of Bardet Bield tubedefect(NTD)andpostaxialpolydactyly(PAP)wasfound syndrome (BBS). on trio exome sequencing to have two frameshift variants, a Material and methods: Description of a new case of paternally inherited pathogenic AR variant in KIAA0586: BBS caused by two novel mutations in IFT172 gene. c.428delG:p.Arg143LysfsX4 and a de novo variant of Results5 years-old boy, ﬁrst child of healthy non con- unknown signiﬁcance in HDA
C2 : c.1359_1362delAACA: p. sanguineous parents. He had retinosis pigmentosa, myopia, Thr454ArgfsX51.KIAA0586encodesaconservedcentrosomal languagedelay,obesity(weightp>99+4.8SD),OFCp>99 proteinessentialforciliogenesis. Bi-allelicpathogenic variants (2.7SD), generalized brachydactyly, abnormal palmar inKIAA0586resultinaspectrumofautosomalrecessive(AR) creases, round face, short palpebral ﬁssures, small teeth ciliopathy disorders ranging from short rib thoracic dysplasia andonecafeaulaitspot.Cardiacandrenalanomalieswere with polydactyly-14 to Joubert syndrome. HDA
C2 , not cur- ruled out and the hearing was normal. ArrayCGH and rentlyknowncausativeofdisease,isamammalianzincﬁnger molecular study of Prader-Willi were normal. Firstly, transcriptionfactorhistonedeacetylase2proteinthatactsboth commom mutations associated with BBS were studied as positive and negative regulator of transcription. HDA
C2  without positive result. NGS of genes associated with found expressed in mouse brain may play a role in normal retinosis pigmentosa detected two variants probably dama- proliferationanddifferentiationofneuralprecursorcells.There ging in IFT172 gene: c.2635G>A and c.4540-6C>G. The are reports of a de novo HDA
C2  missense variant in an indi- ﬁrstwaspresentinthemother andthesecond inthefather, vidual with a Cornelia de Langue syndrome like phenotype, supporting their pathogenity. NTDandPAPwhoalsoexhibiteda15q11.2-q11.3duplication Conclusions: We report on a new case of BBS due to and in an individual with intellectual disability (ID). We biallelic mutations in IFT172 gene supporting its implica- hypothesize our patient’s phenotypic manifestations could be tion in this syndrome. We describe two new mutations in explainedbyeitherdigenicinheritance(DI)orbyanovel‘two thisgene.AchievingmoleculardiagnosiswithNGSpermits hithypothesis’inwhichasingleARpathogenicallelereaches adequate genetic counseling in families. thresholdofclinicalexpressionduetopresenceofanadditional M.SánchezSoler:None.M.Ballesta-Martínez:None.A. de novo variant in a signiﬁcant regulatory transcript namely Serrano-Antón: None. V. López-González: None. L. HDA
C2 . If conﬁrmed, it could have signiﬁcant genetic coun- Rodríguez-Peña: None. E. Guillén-Navarro: None. seling and genetic mechanisms of disease causation implica- tions.Acollaborationisunderwaytocharacterizephenotypic E-
P11 .050 and biochemical consequences of HDA
C2  mutations. Father-daughterincest:30-year-oldwomanwithSeckel- S. Kupchik: None. S. Lau: None. O. Beckett: None. K. like microcephaly and homozygous STIL pathogenic McWalter: A. Employment (full or part-time); Signiﬁcant; variant Gene Dx. E. Normand: A. Employment (full or part-time); Signiﬁcant;GeneDx.Y.Kogelman:None.P.Campeau:None.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 917 C. Ding1, J. Spranger2, S. Diederich1, D. Galetzka1, Diagnosis and veriﬁcation of multiple congenital dys- S. Schweiger1, O. Bartsch1 morphism (MCD) syndromes is often difﬁcult due to the varietyofclinicalforms andinter-andintrafamilialclinical 1Institut Institute of Human Genetics, University Medical polymorphism. It is known that in sporadic cases, the Centre of the Johannes Gutenberg University, Mainz, diagnosis will be most reliable with the full range of phe- Germany, 2Children’s Hospital, University Medical Centre notypic sings. Differential diagnosis of MCD syndromes of the Johannes Gutenberg, Mainz, Germany can also be difﬁcult due to the similarity of phenotypic features in different syndromic forms. In such cases, the Among children resulting from incestuous matings, mental problem of clarifying the diagnosis and resolving the issue retardation and congenital malformations are known to be of the possibility of conducting a prenatal diagnosis of the very common (PMID: 6779972, 5127404), but molecular disease in the fetus in the family during subsequent preg- studies to identify the underlying defects in these children nancy can be solved by the use of high-throughput DNA are still scarce or lacking (PMID: 26320005, 20509080). sequencingmethods.Proband,aboybornin2013,wasﬁrst Wereporthereawomanresultingfromaforcedincestuous consultedwiththeaimofdiagnosisattheageof2yearsold conception (father-daughter incest). For many years, her regarding complaints of short stature, congenital ptosis, diagnosis had been Seckel syndrome due to extreme pri- nystagmus,severehypotrichosis,renalhypoplasia,violation mary microcephaly (-10 SD), pre- and postnatal growth of pronation-supination (radio-lunar synostosis?), lobar retardation (-5 SD), prominent nose, and severe develop- holoprosencephaly, delayed development. Cartilage-hair mental retardation. Upon re-examination at age 30 years, hypoplasiaandNoonansyndromewereexcludedclinically. she also displayed profound intellectual disability, absent CMA was negative. The NGS revealed a small deletion in speech, most severe behavioral abnormalities resulting in KIAA0556 gene (c.2373delC) in a homo- or hemizygous blindness (due to head banging and eye scratching) as well state. Thus,thediagnosis ofJoubertsyndrome(JS) type 26 as tetraplegia. Microarray analysis revealed a highly was established. JS is a heterogeneous disease - 36 genetic increased loss of heterozygosity (LOH 25.3%), consistent forms are presented in the OMIM, all with AR type of with incest. Of note, LOH >50% was detected for eight inheritance which have far from classical phenotypic man- chromosomes. Whole exome sequencing revealed a ifestations of this syndrome. A stricter approach to the homozygous variant c.3377A>G p.Tyr1126Cys in the description of phenotypes will probably solve the problem STIL gene. of such a high genetic heterogeneity. Supported by RFBR Pathogenic STIL variants result in non-syndromic auto- grant 18-015-00090. somal recessive primary microvephaly type 7 (MCPH7, V.A. Galkina: None. A.V. Marakhonov: None. R.A. OMIM #612703). The degree of intellectual disability Zinchenko: None. amongreportedpatientsisveryvariable,rangingfrommild to severe, and seems not to be genotype speciﬁc. Several E-
P11 .055 features observed in the proband (including stereotypic Co-occurrence of mutations in KIF7 and KIAA0556 in behavior, tetraplegia, and profound global retardation) are Joubert syndrome with ocular coloboma, pituitary not typical ﬁndings in MCPH7, suggesting that additional malformation and growth hormone deﬁciency unrecognized recessive variants could possibly have con- tributed to the more complex phenotype in the patient, M. Niceta1, M. L. Dentici1, A. Ciolﬁ1, R. Marini2, adding to the classic form of MCPH7. S. Barresi1, F. R. Lepri1, A. Novelli1, E. S. Bertini1, C.Ding:None.J.Spranger:None.S.Diederich:None.D. M.Cappa2,M.C.Digilio1,B.Dallapiccola1,M.Tartaglia1 Galetzka: None. S. Schweiger: None. O. Bartsch: None. 1Genetics and Rare Diseases Research Division, Ospedale E-
P11 .054 Pediatrico Bambino Gesù, Rome, Italy, 2Unit of Endocri- The problem of identifying syndromes with a high nology, Academic Department of Pediatrics, Ospedale degree of genetic heterogeneity and clinical Pediatrico Bambino Gesù, Rome, Italy polymorphism Introduction: Joubert syndrome is a recessive neurodeve- V. A. Galkina, A. V. Marakhonov, R. A. Zinchenko lopmental disorder characterized by clinical and genetic heterogeneity.Clinicalhallmarksincludehypotonia,ataxia, Research Center for Medical Genetics, Moscow, Russian facial dysmorphism, abnormal eye movement, irregular Federation breathingpatterncognitiveimpairmentand,themolartooth sign is the pathognomonic midbrain-hindbrain918 J.delPicchia malformationonmagneticresonanceimaging.Thedisorder patients with KS distinct face, neurodevelopmental deﬁcit, ispredominantlycausedbybiallelicmutationsinmorethan congenital heart disease, and skeletal/dental malformations. 30 genes encoding proteins with a pivotal role in mor- Our patients have respectively partial atrio-ventricular phology and function of the primary cilium. Oligogenic septal defect, double outlet right ventricle, left ventricular inheritance or occurrence of genetic modiﬁers has been hypertrophy and atrio-ventricular septal defect with atrial suggested to contribute to the variability of the clinical isomerism. Neurodevelopmental deﬁcits were constant but phenotype. We report on a family with peculiar clinical variablewithrespectivelydevelopmentaldelay,behavioural spectrum Joubert syndrome molecularly and clinically dis- troubles with autistic traits, perceptive sensory deafness, secting a complex phenotype, in which hypogonadism, mentalretardationanddelayedspeechwithabnormalvoice; pituitary malformation and growth hormone deﬁciency learning disabilities and behavioural troubles; developmen- occur as major features. tal delay, psycho-motor retardation, delayed speech, and Case Description and Methods: A 7 year-old male was mental retardation; and ﬁnally learning disabilities and enrolledinadedicated“UndiagnosedPatientsProgram”for hypernasal speech. apeculiarformofJoubertsyndromecomplicatedbyirisand Conclusion: KS is a clinically recognizable syndrome retinochoroidal coloboma, hypogonadism pituitary malfor- andmostpatientshaveapathogenicvariantintheKMT2D mation, and growth hormone deﬁciency. The molecular or KDM6A genes. The ﬁve cardinal manifestations of KB basis of the complex phenotype was investigated by whole deﬁned in 1988 have been revisited recently (2018). The exome sequencing. new consensus diagnostic criteria propose that a deﬁnitive Results: The concomitant occurrence of homozygosity diagnosis can be made in an individual of any age with a formutationsinKIF7andKIAA0556wasidentiﬁed,andthe history of infantile hypotonia, developmental delay and/or assessment of major clinical features associated with intellectualdisability,andoneorbothofothermajorcriteria mutations in these two genes provided evidence that these like pathogenic molecular variant. In fact, either with or two independent events represent the cause underlying the without molecular genetic conﬁrmation, it seems to be complexity of the present clinical phenotype. possible to go on toward a correct clinical diagnosis. The Conclusion: Beside the clinical variability of Joubert phenotypicvariabilityislinkedtothenatureoftheinvolved syndrome, co-occurrence of mutations in ciliopathy-asso- protein in the epigenetic machinery (readers, writers, ciated genes may contribute to increase the clinical erasers, or chromatin remodelers). complexity of the trait. N.B. Abdelmoula: B. Research Grant (principal inves- M.Niceta:None.M.L.Dentici:None.A.Ciolﬁ:None.R. tigator, collaborator or consultant and pending grants as Marini: None. S. Barresi: None. F.R. Lepri: None. A. well as grants already received); Modest; Research Unit Novelli: None. E.S. Bertini: None. M. Cappa: None. M.C. UR17E
S36 . B. Abdelmoula: B. Research Grant (principal Digilio: None. B. Dallapiccola: None. M. Tartaglia: None. investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit E-
P11 .056 UR17E
S36 . R. Louati: B. Research Grant (principal Neurodevelopmental disorders and chromatin remodel- investigator, collaborator or consultant and pending grants ing dysregulation: the lessons from Kabuki syndrome as well as grants already received); Modest; Research Unit spectrum and clinical presentation of Tunisian cases UR17E
S36 . F. Abid: B. Research Grant (principal investigator, collaborator or consultant and pending grants N.B.ABDELMOULA,B.Abdelmoula,R.Louati,F.Abid, as well as grants already received); Modest; Research Unit T. Sammouda, W. Smaoui, N. Abdellaoui, K. Trigui, O. UR17E
S36 . T. Sammouda: B. Research Grant (principal Kaabi, W. Ltaif, S. Aloulou, S. Mallek, S. Kammoun, investigator, collaborator or consultant and pending grants UR17E
S36  members as well as grants already received); Modest; Research Unit UR17E
S36 . W. Smaoui: B. Research Grant (principal Medical University, Sfax, Tunisia investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit Objective: Kabuki syndrome (KS) [MIM: 147920] is UR17E
S36 . N. Abdellaoui: B. Research Grant (principal linked to dysregulated lysine degradation and chromatin investigator, collaborator or consultant and pending grants organization pathways. Here, we report four Tunisian as well as grants already received); Modest; Research Unit patients, who fulﬁlled clinical criteria of KS, including UR17E
S36 . K. Trigui: B. Research Grant (principal neurodevelopmental deﬁcits. investigator, collaborator or consultant and pending grants Clinical Presentation: During our genetic couselling at as well as grants already received); Modest; Research Unit the medical university of Sfax (Tunisia), we recorded four UR17E
S36 . O. Kaabi: B. Research Grant (principalAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 919 investigator, collaborator or consultant and pending grants Discussion:Thisistheﬁrstgeneticallyconﬁrmedcaseof as well as grants already received); Modest; Research Unit LADD syndrome in Georgia, presenting with epilepsy as a UR17E
S36 . W. Ltaif: B. Research Grant (principal new feature. Genetic testing lead to more accurate genetic investigator, collaborator or consultant and pending grants and recurrence risk counseling. Our case expands the as well as grants already received); Modest; Research Unit phenotypic and mutational spectrum of FGFR2 and UR17E
S36 . S. Aloulou: B. Research Grant (principal conﬁrms application of WES as a ﬁrst-line diagnostic test investigator, collaborator or consultant and pending grants in individuals with multiple congenital anomalies. More as well as grants already received); Modest; Research Unit studies are needed to deﬁne whether genotype-phenotype UR17E
S36 . S. Mallek: B. Research Grant (principal correlations exist. investigator, collaborator or consultant and pending grants T. Tkemaladze: None. E. Abzianidze: None. E. Kvar- as well as grants already received); Modest; Research Unit atskhelia: None. M. Ghughunishvili: None. V. Skrahina: UR17E
S36 . S. Kammoun: B. Research Grant (principal None. A. Rolfs: None. investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit E-
P11 .060 UR17E
S36 . TGM1 mutation spectrum in patients with lamellar ichthyosis E-
P11 .059 Lacrimo-auriculo-dento-digital LADD syndrome: ﬁrst F. Ozkinay1, H. Onay1, G. OZTURK1, E. ISIK1, case report of a Georgian patient D. AYYILDIZ EMECEN1, E. ARSLAN1, F. HAZAN2, T. Atik1 T. Tkemaladze1,2, E. Abzianidze1, E. Kvaratskhelia1, M. Ghughunishvili2,1, V. Skrahina3, A. Rolfs3 1EgeUniversityFacultyofMedicine,Izmir,Turkey,2S.B.U. DR.BEHCET UZ CHILDREN’S EDUCATION AND 1Tbilisi State Medical University, Tbilisi, Georgia, 2Givi RESEARCH HOSPITAL, Izmir, Turkey Zhvania Pediatric Academic Clinic, Tbilisi, Georgia, 3CENTOGENE AG, Rostock, Germany Aim: Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of keratinization disorders, caused Background: Lacrimo-auriculo-dento-digital (LADD) by mutations in at least 13 different genes. Lamellar syndromeisextremelyraregeneticdisorderwithonlyabout icthyosis (LI) which is one of the phenotypic features of 100casesreportedworldwide.LADDsyndromeoccursdue ARCI presents with dark brown, plate-like scale with no to pathogenic changes FGFR2, FGFR3 or FGF10 genes. erythroderma. TGM1 mutations is the most common cause Clinical signs and severity may vary, but almost uniformly of the classic LI phenotype. In this study, we investigated there is involvement of the lacrimal systems, cup-shaped the clinical and molecular ﬁndings of eleven LI patients ears, dental and digital abnormalities. who had mutations in TGM1 gene. Case Report: Here we report of a 9 years old girl with Method: Ten patients clinically diagnosed asLI and two LADDsyndromefromGeorgia.Atbirthshepresentedwith consangineouscarrierparents (theirchildwithLIhaddied) malformed left hand, ventricular-septal defect, congenital havingmutationsinTGM1genewereincludedinthestudy. inguinal hernia and kidney aplasia. Dysmorphic features All patients (including death child) were examined by an include lacrimal duct obstruction, low-set and cup-shaped experienced dermatologist and clinical geneticist. Patient ears, dental aplasia and salivary gland malformation. Her histories; including demographic, clinical and laboratory hearing loss started from 2,5 years and is slowly ﬁndings, were obtained from hospital records. TGM1 gene progressive. Interestingly she developed generalized sei- analysiswasperformed usinganext generationsequencing zures from 2,5 years which is not a common feature of platform (Illumina MiSeq). LADD syndrome. Patient was on anti-epileptic treatment Results: Six patients were female, ﬁve male. Plate-like for3yearsandisnowseizure-freeanddrug-freeforalready scale with no eritroderma, the typical features of LI, was 4 years. deﬁned in all patients. Eleven different mutations were Methods: Whole exome sequencing (WES) was per- identiﬁed; eight were missense, two frameshift and one formed and c.1547C>T p.(Ala516Val) variant was identi- nonsense. While ten patients carried the same mutations in ﬁed in FGFR2 gene. In silico tools predict the change both alleles, one was compound heterozygous (c.160C>T; disrupts normal function of the FGFR2 protein. Addition- c.1469A>G). Three of the eleven mutations (c.1148T>G, ally, parental testing conﬁrmed de novo status of the c.889G>A. C.2189delG) in the TGM1 gene had not variant. previously been reported in the literature.920 J.delPicchia Conclusion: By deﬁning three novel mutations, this with LIG4 syndrome diagnosis. Parental testing conﬁrmed study enriched the molecular spectrum of ichthyosis, and compound heterozygosity. also provided a further insight for genetic counselling. J. Chi: None. P. Gerasimou: None. A. Miltiadous: None. F. Ozkinay: None. H. Onay: None. G. Ozturk: None. E. I.Kyprianou:None.L.Koumas:None.L.Loizou:None.E. Isik:None.D.Ayyildizemecen:None.E.Arslan:None.F. Papachristodoulou: None. E. Karaoli: None. A. Loizou: Hazan: None. T. Atik: None. None. P. Costeas: None. E-
P11 .061 E-
P11 .062 The Rare LIG4 Syndrome: A case report A case ofantenatal Bartter’s Syndrome with a novel MAGED2 variant manifesting with severe polyhydram- J. Chi1, P. Gerasimou1, A. Miltiadous1, I. Kyprianou1, L. nios and intrauterine fetal death Koumas1, L. Loizou2, E. Papachristodoulou2, E. Karaoli2, A. Loizou2, P. Costeas1 M.Nagasaka1,2,S.Nakago1,C.Nagano2,N.Morisada2,K. Nozu2, K. Iijima2 1Molecular Hematology-oncology, Karaiskakio Founda- tion, Nicosia, Cyprus, 2Pediatric Oncology-Hematology, 1Takatsuki General Hospital, Takatsuki, Japan, 2Kobe Archbishop Makarios III Hospital, Nicosia, Cyprus University Graduate School of Medicine, Kobe, Japan Introduction: The LIG4 syndrome is a rare hereditary Introduction:Polyhydramniosiscausedbyvariousfactors. disorderassociatedwithimpairedDNAdouble-strandbreak Recently,theMAGED2genelocatedontheXchromosome repair mechanisms. Patients show unusual facial features, has been reported to be responsible for antenatal Bartter microcephaly, growth and/or developmental delay, various syndrome with most severe polyhydramnios. skin abnormalities and pancytopenia, which is associated Case: The patient wasagirl diedinutero at31weeksof with combined immunodeﬁciency. gestation.Themotherwasa29-year-oldwoman(gravida3, Case Description: 12-year old patient with obvious para2).Theﬁrstchilddiedinuteroat37weeksofgestation syndromic features with severe microcephaly, very short without polyhydramnios. The second child was normally stature and a very low body weight. Bird-like facial features, delivered at 36 weeks of gestation. She presented with resemblingSeckel’ssyndromeorFanconianemiapatients.He severe polyhydramnios during the third pregnancy. Fetal hadnosignsofacuteillnessnormalignancy.Thepatientisof development was good and no cardiac or morphological Syriandescentandisthesecondchildofasix-memberfamily. abnormalities werenotedbyfetal ultrasound.Onfetal MRI Parents are ﬁrst-degree relatives, both reported healthy. at 27 weeks of gestation, no brain malformation or Methodology: A custom HaloPlexHS (Agilent) NGS gastrointestinal obstruction was noted, but the bladder was panelwasusedtoinvestigatemutationsingenesinvolvedin large.Shehadbeentreatedwithamnioreductionsixtimesin Bone Marrow Failure/Severe Combined Neutropenia, total, but the fetus died suddenly in utero at 31 weeks of Anemias and Chromosome Breakage Syndrome. Sanger gestation. The child was a girl weighing 1980 g, and she sequencing performed parental carrier status. had no apparent morphological abnormalities. Interpretation: Two variants in the LIG4 gene were Genetic testing: Sequencing of DNA from the frozen identiﬁed, c.2440C>T p.(Arg814Ter) and umbilical cord of the third child revealed a de novo c.1273_1278delAGAGAA p.(Arg425_Glu426del). LIG4 nonsenseMAGED2variantwithheterozygosity.SkewedX- c.2440C>T is a nonsense heterozygous variant which chromosome inactivation was observed via prematurely terminates the protein and is classiﬁed as HUMARA assay. pathogenic and LIG4 c.1273_1278del is an in-frame Conclusion: We believe that our case showed a severe deletionclassiﬁedaslikelypathogenicaccordingtoACMG phenotypeofantenatalBartter’ssyndromeduetoMAGED2 recommendations. Compound heterozygous mutations in truncating variant and skewed X-chromosome inactivation. the LIG4 gene have been associated to LIG4 syndrome, an M.Nagasaka:None.S.Nakago:None.C.Nagano:None. autosomal recessive disorder caused by homozygous or N. Morisada: None. K. Nozu: None. K. Iijima: None. compound heterozygous mutations. Parental testing revealed that LIG4 c.2440C>T variant was maternally E-
P11 .066 inherited and the LIG4 c.1273_1278delAGAGAA variant Intra-uterinefetaldeathinMeier-GorlinSyndromedue was paternally inherited. to compound heterozygous variants of OR
C6  gene with Conclusion: The patient is compound heterozygous for a novel mutation: a case report the pathogenic (c.2440C>T) and likely pathogenic (c.1273_1278del) variants in the LIG4 gene, consistentAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 921 H. Thorn1, S. Drunat2, C. Fleury3, E. Alanio4, J. Bory5, Fenzy: None. M. Blocquaux: None. C. Jacquin: None. C. S.Bonneau5,M.Doco-Fenzy6,M.Blocquaux7,C.Jacquin6, Poirsier: None. M. Mozelle-Nivoix: None. C. Poirsier8, M. Mozelle-Nivoix1 E-
P11 .068 1Medical Genetic Service, CH Simone VEIL, Troyes, A novel GTPB
P2  splicing mutation in two siblings France, 2LaboratoryofMoleculargenetics,HôpitalRobert affected with microcephaly, generalized muscular atro- Debré,PARIS,France,3AnatomicalPathologyLaboratory, phy, and hypotrichosis CHU de Reims, Reims, France, 4Anatomical Pathology laboratory,CHUdeReims,Reims,France,5Obstetricsand E. Akbariazar, I. Abdi Rad, A. Vahabi GynaecologyDepartments, CHUdeReims,Reims,France, 6Medical Genetic Service, CHU de Reims, Reims, France, UrmiaUniversityofMedicalSciences,Urmia,Iran,Islamic 7Cytogenetics Laboratory and Laboratory of Molecular Republic of Genetics,CHUdeReims,Reims,France,8MedicalGenetic Service, CHU de Reims, Troyes, France Background: One of the challenging pitfalls in the genetic counseling of patients with syndromic microcephaly is a The Meier-Gorlin Syndrome (MGS) is a rare autosomal deﬁnite clinical diagnosis to determine its etiology. Any recessive disorder with characterized malformatives fea- unknownsyndromicmicrocephalynecessitates piling upof tures. Among mutations of the pre-replication complex clinicalandmoleculargeneticsdatainthehopeofgettinga (OR
C1 , OR
C4 , OR
C6 , CDT1, CD
C6 ), OR
C1  and OR
C4  genotype-phenotype correlation. mutations appear to be responsible of the most severe Materials and methods: In this study, we identiﬁed a phenotypes.However,OR
C6 mutationscanleadtoasevere novel splice site mutation in the GTPB
P2  gene by Whole abnormal embryological development. Exome Sequencing in two siblings with microcephaly and We present the case of an intrauterine fetal death at progressive generalized muscular atrophy associated with 32 weeks during dichorionic diamniotic twin pregnancy. hypotrichosis. The fetus had a compound heterozygous OR
C6  mutation, Results:ThissplicesitemutationintheGTPB
P2 geneis inherited from both parent. predictedtodisruptthehighlyconservedacceptorsplicesite At 16 weeks, a severe inadequate intra-uterine growth of exon 4 in the GTPB
P2  gene. associated with a genu recurvatum and oligohydramnios Conclusion: We describe syndromic microcephaly wereobservedforoneofthetwins(ultrasoundidentiﬁcation related to GTPB
P2  gene in two siblings with an autosomal of the fetal sex: female). There was no family background recessive pattern of inheritance, and to the best of our aside the mother which presented neuroﬁbromatosis type I. knowledge, is the ﬁrst report of the GTPB
P2  related The parents were unrelated. hypotrichosis microcephaly with generalized muscular Fetal karyotype by amniocentesis on the pathological dystrophy. fetuswas46,XY.Thegeneticexplorationwascompletedby Grant references: This research received no speciﬁc MLPA. No quantitative chromosomal abnormalities were grantfromanyfundingagencyinthepublic,commercial,or detected. not-for-proﬁt sectors. After caesarean delivery at 37 weeks, the fetal anatomo- E. Akbariazar: None. I. Abdi Rad: None. A. pathological examination observed a male fetus with major Vahabi: None. inadequate intra-uterine growth, bilateral microtia, external genital hypoplasia and probable hypospadias, associated E-
P11 .071 withabnormaljointmorphologyandskeletalmalformations Genotypes and phenotypes in 6p25 deletion syndrome evoking a MGS. His twin brother was healthy. A panel of genes responsible for primary microcephaly I. Bader1, I. Reindl2, G. Sander1, G. Kronberger1, wasperformedandhighlighted2OR
C6 heterozygousVUS: A.Pleyers1,H.Mayr2,J.Koch2,J.Atzwanger2,C.Frenzel2, c.449+5G>A variant, previously described in patients with E. Haschke-Becher3, D. Kotzot1, W. Sperl2 Meier-Gorlin syndrome, and a new c.360-1G>T variant, never described before and that could also be responsible 1Unit for Clinical Genetics, Paracelsus Medical University forMeier-Gorlinsyndromeaccordingtosplicingprediction Salzburg, Salzburg, Austria, 2Department of Pediatrics; software. Study of alternative splicing conﬁrmed the ParacelsusMedicalUniversity,Salzburg,Austria,3Depart- pathogenicity of the two variants. ment of Medical and Chemical Laboratory Diagnostics, H. Thorn: None. S. Drunat: None. C. Fleury: None. E. Paracelsus Medical University Salzburg, Salzburg, Aus- Alanio:None.J.Bory:None.S.Bonneau:None.M.Doco- tria922 J.delPicchia Wereportthephenotypeandgenotypeoftwochildrenwith gene. We encountered a 3-year-old female patient with a microdeletion in 6p25: distinctive facial appearance (narrow bifrontal diameter, frontal bossing, telecanthus, epicanthal folds, prominent 1. A 4 years and 11 months old boy with a cMRI antihelices, prominent ears, uplifted earlobes, prominent showing large bifronto-temporal arachnoidal cysts nasal bridge), intellectual disability, delayed motor devel- and multifocal white-matter-lesions involving the opment, hypotonia and short stature. She was clinically periventricular, deep, and subcortical cerebral white diagnosed with MOWS. However, since direct sequencing matter. The phenotype of the boy included mild for ZEB2coding exons displayed nopathogenic variantsin developmental delay, strabism, slightly dysmorphic the patient, we performed whole exome analysis for trio in features and mild hearing impairment. the family. No pathogenic SNVs in ZEB2 but biallelic fra- Molecular karyotyping detected a ~ 3,9 Mb meshift variants (p.Thr282fs from mother and p.Ala503fs heterozygous microdeletion in 6p25.3 - 6p25.2 from father) in CNKSR1 were identiﬁed in the patient. deleting34genes,18ofwhichwereOMIMannotated There are two reports that a recognizable autosomal reces- including the transcription factor FOX
C1 . sive intellectual disability was caused by disruption of 2. A13yearoldgirlwithAxenfeld-Riegeranomalywho CNKSR1.Thep.Thr282fswasrecurrentandthep.Ala503fs developed glaucoma at the age of 12 years and had was novel. However, clinical manifestations of the patient surgery for ASD II in the ﬁrst year of life. The didnotmatchthephenotypesofCNKSR1mutations,which phenotype of the girl included typical dysmorphic were previously reported. In addition, a homozygous var- features. She performs extremely well at high school iantofp.Pro284HisfsTer74inCNKSR1wasregistered224/ (Gymnasium) and in sports. Molecular karyotyping 273,674 in the gnomAD. Thus, copy number analysis was detected a ~ 2,35 Mb heterozygous Deletion in performed using whole exome data. We found an 6p25.3-6p25.2 deleting 17 genes, 8 of which are approximately 360kb deletion around intron 7 of ZEB2 in annotated in OMIM, including FOX
C1 . thepatient,whichwasdenovo.Thedeletionwasconﬁrmed by the brakepoint analysis using PCR and direct Sanger- From our cases and from review of the literature we sequencing.Basedontheseﬁndings,weconcludedthatthe concludethatamicrodeletionin6p25shouldbeconsidered patient was clinically and genetically diagnosed with as the cause in patients with unclear multifocal cerebral MOWS caused by the novel deletion in ZEB2.<!--End- white matter abnormalities or Axenfeld-Rieger syndrome Fragment--> when additional dysmorphic features and congenital T.Kaname:None.K.Yanagi:None.M.Takeshita:None. anomalies are present, even when intellectual abilities are M. Omata: None. N. Kobayashi: None. Y. Abe: None. K. within the normal range (Vernon et al. 2013). Naritomi: None. Y. Matsubara: None. I. Bader: None. I. Reindl: None. G. Sander: None. G. Kronberger: None. A. Pleyers: None. H. Mayr: None. J. E-
P11 .075 Koch: None. J. Atzwanger: None. C. Frenzel: None. E. 7q11.23 duplication in a Mayer-Rokitansky-Kuster- Haschke-Becher: None. D. Kotzot: None. W. Sperl: None. Hauser syndrome patient E-
P11 .074 G. C. R. Cunha1, M. V. Zuben1, A. Lofrano-Porto1, A novel deletion in ZEB2 and biallelic frameshift M.Soares2,P.Moretti1,R.S.Bonadio1,S.F.DeOliveira1, variants in CNKSR1 identiﬁed in a patient dysmorpho- J. Mazzeu1, A. Pic-Taylor1 logically diagnosed with Mowat-Wilson syndrome 1University of Brasilia, Brasilia, Brazil, 2Hospital Uni- T. Kaname1, K. Yanagi1, M. Takeshita1, M. Omata1, versitario de Brasilia, Brasilia, Brazil N. Kobayashi1, Y. Abe1, K. Naritomi2, Y. Matsubara1 Mayer-Rokitansky-Küster-Hauser syndrome (MRKH) is a 1National Center for Child Health and Development, rare congenital disorderaffecting approximately 1:4000- Tokyo,Japan,2OkinawaNanbuRehabilitationandMedical 5000 women. This condition is the second most common Center, Naha, Japan cause of primary amenorrhea and is characterized by absence or hypoplasic uterus, absence of the upper part of Mowat-Wilson syndrome (MOWS) is an autosomal domi- vagina and normal or hypoplasic fallopian tubes. A sex- nantdisordercharacterizedbydistinctivefacialappearance, limited (female) dominant autosomal inheritance with intellectual disability, delayed motor development, micro- incompletepenetranceandvariableexpressivenesshasbeen cephaly and short stature. It is known that most patients suggested. A range of gene and genomic alterations have with MOWS have heterozygous mutations in the ZEB2 been described and contributed to the identiﬁcation ofAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 923 possible causative genes. For example, mutations in WNT4 unknown clinical signiﬁcance (VUS, class 3 variant) in the and LHX1 and CNV regions, especially 1q21.1, 16p11.2, PUF60 gene (Poly-U-Binding Splicing Factor, OMIM 17q12, 22q11.21 and Xp22, were described in affected #604819)onchromosome8q24.3.Thevariantisamissense patients. Here we described a patient with MRKH pre- substitution and has never been described in literature senting a single CNV known to cause the 7q11.23 micro- before. Pathogenic variants in the PUF60 gene are docu- duplication syndrome. The 29 year old patient, born from mentedtocause theautosomal dominant Verheijsyndrome unrelated parents, present primary amenorrhea, absence of (OMIM #615583), disorder with a complex but highly uterus and a short vagina, characteristics of the MRKH variablesymptomatologywithonsetatbirthwhichincludes syndrome,butalsogradeIIhepaticsteatosis,dorsalconvex growth retardation, global developmental delay, eye sinus scoliosis, anterolateral marginal osteophytes, ocular abnormalities, renal agenesis. Considering the patient`s problems (myopia, astigmatism and strabismus), obesity phenotype and the clinical symptomatology of the syn- and facial dysmorphisms, features that ﬁt to 7q11.23 drome produced by pathogenic mutations in the PUF60 microduplicationsyndrome.TheCMA(CytoScanTM750k gene, the identiﬁed c.1640A>G variant may be reclassiﬁed platform, Thermo Fisher Scientiﬁc, Affymetrix) revealed a as a class 4 (Likely Pathogenic) mutation. Parental testing 1,404 Kb duplication of 7q11.23 including 24 genes, the fortheidentiﬁedmutationhasbeenrecommended,butalso same recurrent duplication described in the 7q11.23 dupli- genetic testing of the brother with polydactyly might pos- cationsyndrome.AsthepatienthasMRKHandsomeofthe sibly be adviced. features of 7q11.23 duplication syndrome, we propose that V. Radoi: None. L. Pop: None. L. Bohiltea: None. N. duplication of genes in this region might also be involved Suciu: None. R. Ursu: None. the etiology of MRKH in our patient G.C.R. Cunha: None. M.V. Zuben: None. A. Lofrano- E-
P11 .080 Porto: None. M. Soares: None. P. Moretti: None. R.S. A novel splice-variant in NONO in a boy with non- Bonadio: None. S.F. De Oliveira: None. J. Mazzeu: None. compaction cardiomyopathy and corpus callosum A. Pic-Taylor: None. aplasia E-
P11 .079 V. Strehlow1, T. Bartolomaeus1, F. Cavallo2, Variant of unknown clinical signiﬁcance in the Verheij M. Karnstedt1, S. Schubert1, M. Weidenbach2 syndrome gene (PUF60) in a 5 months old boy with multiple neonatal anomalies 1InstituteofHumanGenetics,UniversityofLeipzigMedical Center, Leipzig, Germany, 2Department of Pediatric V. Radoi1,2,3, L. Pop3, L. Bohiltea1, N. Suciu3, R. Ursu1,2,3 Cardiology, Heart Centre Leipzig, University of Leipzig, Leipzig, Germany 1”Carol Davila” University of Medicine and Pharmacy, Department of Medical Genetics, Bucharest, Romania, We describe a 6 month old boy with non-compaction car- 2Synevo Romania, Central Reference Laboratory, Depart- diomyopathy (NCC), multiple VSDs, Ebstein’s anomaly ment of Medical Genetics, Bucharest, Romania, 3National and aplasia of the corpus callosum. Prenatal examination Institute for Mother and Child Health "Alessandrescu- revealed a VSD and corpus callosum aplasia. The boy was Rusescu”, Bucharest, Romania born at 38 weeks of gestation with low birth weight (-1.64 SD) and normal length and head circumference. The new- Reclassifying variants of unknown signiﬁcance (VUS) born needed respiratory support postnatally but could be coming from NGS sequencing is in many cases extremely dischargedhomeattheageof2weeks.Hewasadmittedto challenging, needing a series of supporting criteria. We HeartCentreLeipzigattheageof2.5monthsduetofailure present the case of a 5 months old boy with a complex to thrive and congestive heart failure. Echocardiography neonatal symptomatology including generalized hypotonia, showed NCC of both ventricles, multiple ventricular septal global developmental delay, growth delay, hearing impair- defects and mild Ebstein’s anomaly resulting in severe tri- ment, eye abnormalities, renal agenesis, a.o. The family cuspid regurgitation. Pulmonary artery banding was per- history of the patient revealed a brother with polydactyly. formed at the age of 4 months. Postsurgical course was The clinical suspicion at referral was CHARGE syndrome, prolonged but ﬁnally the child could be transferred to a with recommendations for genetic testing. Whole Exome specializedrehabilitationhospitalattheageof5months.In Sequencing was performed on an Illumina platform. The thecourseoftimethechildshowedadevelopmentaldelay, results of the genetic analysis invalidated the CHARGE reduced spontaneous body movements and central hearing syndrome clinical suspicion, but revealed the presence of impairment. Exome sequencing revealed the hemizygous the heterozygous c.1604G>C / p.Arg535Pro variant of splice-variant c.651-1G>C, p.? in the NONO-gene. In the924 J.delPicchia segregation analysis, a carriership for the NONO-variant of management and to deﬁne follow-up examinations based theasymptomaticmothercouldbeproven.RNAanalysisof on the clinical spectrum of the HPS subtype. the NONO-gene revealed a splice effect on exon 7 and M.M. Golas: None. S. von Hardenberg: None. T. proved the pathogenic effect of the splice-variant. In sum- Ripperger:None.J.Lentes:None.B.Schlegelberger:None. mary, we report a case with a novel NONO variant (16 D. Steinemann: None. S. Morlot: None. B. Auber: None. variants reported so far) and extend the phenotypic spec- trum by NCC of both ventricles and corpus callosum E-
P11 .084 aplasia. Unusual clinical ﬁndings in a case with PAC
S2 -related V. Strehlow: None. T. Bartolomaeus: None. F. Cavallo: syndrome None. M. Karnstedt: None. S. Schubert: None. M. Weidenbach: None. D. Avdjieva-Tzavella1, S. Atemin2,3, T. Todorov4, H.Kathom1,X.Cao5,S.Wadhwa6,Y.Lei5,V.Mitev3,R.H. E-
P11 .081 Finnell6,7, A. Todorova4,3 Expanding the clinical and genetic spectrum of the Hermansky Pudlak syndrome type 9 1Department of Clinical Genetics, University Pediatric Hospital, Medical University, Soﬁa, Bulgaria, 2Genetic M. M. Golas, S. von Hardenberg, T. Ripperger, J. Lentes, Medico-Diagnostic Laboratory “Genica", Soﬁa, Bulgaria, B. Schlegelberger, D. Steinemann, S. Morlot, B. Auber 3Department of Medical Chemistry and Biochemistry, Medical University, Soﬁa, Bulgaria, 4Genetic Medico- DepartmentofHumanGenetics,HannoverMedicalSchool, Diagnostic Laboratory “Genica”, Soﬁa, Bulgaria, 5Center Hannover, Germany for Precision Environmental Health, Department of Mole- cular and Cellular Biology, Baylor College of Medicine, Introduction:TheHermanskyPudlaksyndrome(HPS)isa Houston, TX, 77030,, TX, United States, 6Center for multisystemautosomal-recessivediseasethatresultsfroma Precision Environmental Health, Department of Molecular dysfunction of lysosome-related organelles. HPS manifests and Cellular Biology, Baylor College of Medicine, asoculocutaneousalbinism,bleedingdiathesisandvariable Houston, TX, 77030, TX, United States, 7Departments of additionalsymptoms.Basedonthecausativegene,tenHPS Molecular and Human Genetics and Medicine, Baylor subtypes have been described. HPS type 9 (HP
S9 ) being College of Medicine, Houston, TX, United States caused by loss-of-function variants in BLO
C1 S6
 is an exceedingly rare HPS subtype, and up to now, only three Introduction: Developmental and epileptic encephalo- patients have been reported to be affected by HP S9
. pathies (DEE) are a heterogeneous clinical and genetic Materials and methods: A DNA sample of the index group of neurodevelopmental diseases. Recently, PAC S2
 patientwasanalyzedbywholeexomesequencingandarray gene mutations have been implicated in DEE with cere- comparative genomic hybridization (array-CGH). bellar dysgenesis and facial dysmorphism. Almost all Results: The 19-year-old female patient presented with described patients presented with a recurrent de novo mis- oculocutaneous albinism, a bleeding disorder, and suscept- sensemutation,c.625G>A(p.Glu209Lys).Theirphenotype ibility to infections; however, the patient was neither was characterized by early-onset epilepsy, cerebellar dys- affected by gastrointestinal nor pulmonary symptoms. On genesis, dysmorphic facial features, moderate to severe clinical examination, the patient presented with pale skin, developmental delay, and autism. We report the ﬁrst Bul- blond hair as well as fair eyebrows and eyelashes. garian case of this rare syndrome. Nystagmus and photophobia were noted. Genetic analyses CaseReport:Thepatient,a17-month-oldboy,wasreferred usingwholeexomesequencingidentiﬁedanovelsplice-site to geneticevaluationbecause ofthe developmentaldelayand variantofBLO C1
S6 ,c.83-2A>Gp.?(ENST00000220531), neonatal convulsions started during the ﬁrst week of life. He in combination with a deletion of the second BLO
C1 S6
 was born at term after complicated pregnancy. Birth weight allele, which was conﬁrmed as novel interstitial microdele- was 3920 g and length was 51 cm. Physical examination tion using array-CGH (arr[GRCh37] 15q21.1 showed facial dysmorphism including hypertelorism, down- (45821145_46319127)x1). Based on the genetic analyses, slanted palpebral ﬁssures, broad nasal root, broad ﬂat nasal the patient was diagnosed with HP S9
 (MIM#614171). bridge, broad nasal tip, posteriorly rotated ears, downturned Conclusions: Our case suggests that immune deﬁciency cornersofthemouthandthinlips.Additionalfeaturesinclude maybeassociatedwithHP S9
andthusexpandstheclinical micropenis,invertedwidelyspacednipples,onehypopigmen- spectrum of HP S9
. Rigorous genetic testing, including ted skin spot, one café au lait spot, nevus ﬂammeus on the analyses for copy number alterations, is recommended for neck and coloboma of the iris. patients suspected for HPS to guide the clinicalAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 925 Results: The molecular genetic analysis was performed defects, because through adequate iodine supplementation, by whole exome sequencing (WES) of trio. The data the development of goiter can be prevented or regress. interpretation revealed a pathogenic variant c.625G>A;p. P.M.Pachniak:None.M.Malarska:None.H.Moczulska: Glu209Lys in the PAC S2
 gene. The variant was conﬁrmed None.A.Lewandowska-Polak:None.J.Makowska:None. by Sanger sequencing. M. Borowiec: None. Conclusions:Ourstudy expandstheclinicalspectrumof PAC S2
 mutations. The coloboma of the iris is an unusual E- P11
.087 feature and it is difﬁcult to determine whether it is Familial pericentric inversion of chromosome 3 predis- etiologically related to this newly recognized syndrome or posing to de novo interstitial microdeletion 3p14.3- represents a coincidental ﬁnding. p21.31 D. Avdjieva-Tzavella: None. S. Atemin: None. T. Todorov: None. H. Kathom: None. X. Cao: None. S. R.V.Vazharova1,I.Bradinova2,S.Andonova2,S.Bichev2, Wadhwa: None. Y. Lei: None. V. Mitev: None. R.H. A. Savov2 Finnell: None. A. Todorova: None. 1SoﬁaUniversitySt.KlimentOhridski,FacultyofMedicine, E- P11
.086 DepartmentofBiology,MedicalgeneticsandMicrobiology, Pendredsyndromeina32-year-old woman- casereport Soﬁa, Bulgaria, 2Medical University Soﬁa, UHOG “Mai- chin dom”, National genetic laboratory, Soﬁa, Bulgaria P. M. Pachniak, M. Malarska, H. Moczulska, A. Lewandowska- Polak, J. Makowska, M. Borowiec Introduction: Pericentric chromosome inversions are rare (except the polymorphic inv(9)(p11;q12)) and are a known Medical University of Lodz, Lodz, Poland cause of reproductive failure or birth of individuals with chromosome imbalance. Here we report clinical and mole- Background: Pendred syndrome is an autosomal recessive cularﬁndingsofindividualsfromafamilywithapericentric inherited disease characterized by by congenital sensor- inversion of chromosome 3. ineural hearing loss, hypothyroidism and Hashimoto’s dis- Materialsandmethods:Thefamilywasrevealedaspart ease. There are signiﬁcant problems with maintaining of a study of CNVs in a cohort of patients with intellectual balance due to disturbances in the vestibular system of the disability and/or multiple congenital anomalies. According internal ear. to the study protocol genetic tests included karyotyping, Case: The patient is a32-year-old woman with rheuma- MLPAandarrayCGH.ArrayCGHanalysiswasperformed toid arthritis, rheumatoid factor, ANA and anti CCP using custom designed whole-genome oligonucleotide antibodiespresentinhightiters,HLA-B27negative.Patient arrays (OGT, UK) with a median probe spacing of about has Hashimoto’s disease, hyperinsulinemia with insulin 2.5 kb and median resolution of about 10 kb. CytoSure resistance, problems with balance and permanent ear Interpret(OGT,UK)softwarewasusedforCNVdetection. implants due to congenital hearing loss of unexplained Results: In the reported family several relatives in four cause. The 35delG heterozygote status was detected at the generations were found to carry an apparently balanced age of 18. Diagnostics was expanded adding exclusion of pericentric inversion of chromosome 3 - inv(3)(p21;q21). other deletions and insertions in the 12-72bp region of the Four inversion carriers presented complex clinical features 2nd exon of the GJB2 gene, with a particular indication of including mild/moderate intellectual disability, epilepsy, theexclusionofthe167Tdeletion,the314deletionandthe occult spina biﬁda and facial dismorphism. By arrayCGH 333 deletion. The 1555A> G mitochondrial mutation was the affected family members were found to carry a not found. The patient at the time was in good condition, heterozygous 4.35 Mb interstitial microdeletion with full verbal contact, actively working professionally. (arr3p21.31p14.3(50,963,804-55,318,121)x1) encompass- Due to presence of goiter, Hashimoto’s disease, hyperinsu- ing a total of 79 genes and disrupting the DOCK3 gene. linemia and vestibular dysfunction, periodic dizziness Conclusions: Unusual ﬁndings in this family are that no Pendred’s syndrome was clinically suspected. Genetic carrier reported reproductive problems like infertility or testing to conﬁrm the syndrome is ongoing. miscarriages, all affected family members share the same Conclusions:Thepedrinaproteinmutationsoccursinthe interstitial microdeletion which occurred as de novo event thyroid follicles, internal ear, kidneys, brain, liver, as well in progenies of four different inversion carriers. This work as in semen. The disease picture can be very diverse. One was supported by funding from the Bulgarian Ministry of should always remember to think about Pendred syndrome Education and Science / FNI, Grant: DTK02-51/2009. afterexcludingthemostcommongeneticcausesofhearing R.V. Vazharova: None. I. Bradinova: None. S. Ando- nova: None. S. Bichev: None. A. Savov: None.926 J.delPicchia E- P11
.088 G. Van Winckel1, A. El Mouatani2, T. Attie-Bitach2, A Japanese girl with a novel variant of PIK3R1 showed K. Zaafrane-Khachnaoui3, A. Superti-Furga1, H. Fodstad1, deterioration of insulin resistance to biguanide F. Giuliano1 treatment 1Division of Genetic Medicine, Lausanne University Hospi- K.Yanagi1,S.Toguchi2,K.Satou1,M.Inoue2,K.Nritomi3, tal (CHUV), Lausanne, Switzerland, 2Division of Genetics, Y. Matsubara4, T. Kaname1 Necker Hospital for Sick Children, Assistance Publique- Hôpitaux de Paris (AP-HP), Paris, France, 3Medical 1Genome Medicine, National Center for Child Health and Genetics Unit 2, L’Archet Hospital, Nice, France Development, Tokyo, Japan, 2Department of Pediatrics, Naha City Hospital, Okinawa, Japan, 3Okinawa Nanbu Heterozygous variants in GLI3 are involved in a clinical Habilitation and Medical Center, Okinawa, Japan, spectrum of polydactyly. Greig cephalopolysyndactyly and 4National Center for Child Health and Development, Pallister-Hallsyndromesarethetwomainsyndromicforms. Setagaya, Japan Several isolated forms of postaxial or preaxial polydactyly are also recognized. SHORT syndrome (MIM#269880) is deﬁned by its acro- We report three unrelated individuals, all from consan- nym; short stature, hyperextensibility of joints or inguinal guineous parents. An Afghan 10-year-old girl, presented hernia or both, ocular depression, Rieger anomaly, and bilateral postaxial polydactyly of the hands associated with teethingdelay.SincethenamewasgivenbyGorlin(1975), developmental delay and multiple malformations. NGS fewer than 50 cases have been reported in the literature. disclosedahomozygousvariant,c.668G>A(p.Ser223Asn), About 10 heterozygous pathogenic variants of the PIK3R1 in GLI3. A newborn boy of Tunisian origin presented with geneinpatientswithSHORTsyndromehavebeenreported an apparently isolated bilateral hand and feet postaxial to date. Here we report a Japanese girl with clinically and polysyndactyly. He was found to have a homozygous genetically diagnosed as SHORT syndrome. A patient is variantc.1673C>T(p.Ser558Leu)inGLI3.Finally,anadult 17-year-old girl born to non-consanguineous parents at malewasdiagnosedwithbilateralmesoaxialpolydactylyof 40weeksand6dayswithbirthweightof1,484g,heightof thehandsassociatedwithintellectualdisabilityandmultiple 37.5 cm and head circumstance of 34 cm. She had most of malformations. NGS disclosed an homozygous variant in the clinically typical features of SHORT syndrome. GLI3, c.565_567delinsTCT (p.Pro189Ser). Extensibility of joints were mild. Her face was triangular To the best of our knowledge, only GLI3 monoallelic with telecanthus, deep-set eyes, wide nasal bridge, down- variants have been implicated in “GLI3 morphopathies” so turned corners of the mouth and large ears. Speech delay far.Given(1)thesimilarityofthepolydactylyphenotypesin and hearing loss were also observed. Her bone age was ourpatientstothoseofclassicGLI3morphopathies,(2)the equivalent to her age. Partial lipodystrophy of the face and rarity of the variants observed, and (3) the absence of other upper limbs were recognizable. She had insulin-resistant pathogenic variants, we suggest that these homozygous diabetes whose blood glucose was difﬁcult to control by variants in GLI3 could be causative. Of note is that the biguanidetreatment.Anovelheterozygousmissensevariant parents of these children, who are heterozygous for these in the PIK3R1 gene (NM_181523) was identiﬁed in the GLI3 variants, are clinically unremarkable. This would patient by whole exome analysis. It was de novo. The indicate when monoallelic, these variants do not reach a variant was located in PI3K regulatory subunit  P85
 inter- pathogenic threshold necessary for clinical expression. SH2 domain. A recent report shows that biguanide worsen G. Van Winckel: None. A. El Mouatani: None. T. Attie- insulin resistance in SHORT syndrome with a PIK3R1 Bitach: None. K. Zaafrane-Khachnaoui: None. A. Superti- mutation. Her blood glucose became well controlled after Furga: None. H. Fodstad: None. F. Giuliano: None. changing medication of biguanide to mecarmin. K.Yanagi: None.S. Toguchi:None.K.Satou:None.M. E- P11
.091 Inoue: None. K. Nritomi: None. Y. Matsubara: None. T. Prader-Willi syndrome caused by novel 3-7 exons Kaname: None. deletion of SNRPN gene E- P11
.090 R. Traberg, I. Nasvytiene, M. Sukys, V. Asmoniene New polydactyly phenotypes apparently associated with homozygous GLI3 variants Lithuanian University of Health Sciences, Medical Acad- emy, Department of Genetics and Molecular Medicine, Kaunas, LithuaniaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 927 We report a 6 month old boy who was referred to clinical genome may be due to uniparental disomy or identity-by- genetics consultation because of global development delay descent and may be clinically relevant. The aim of this and failure to thrive. He was 4th child of non-consanguine studywastoreportthefrequencyofROH≥10Mbor>1%in Lithuanian couple. Older brother died due to sudden infant the autosomal genome of individuals with intellectual dis- death syndrome at 12 months of age. The pregnancy was ability (ID) and (or) multiple congenital anomalies (MCA), non complicated, full term and ﬁnished with caesarean and compare these data with a control group from the section duetoplacental abruption.Muscular hypotoniaand Brazilian population, including individuals from the feeding difﬁculties noticed soon after birth. Basic bio- BIPMed repository (www.bipmed.org). chemical blood tests, abdomen ultrasound scan, brain Materials and methods: Calls of homozygosity from ultrasound scan were normal. Neurologic examination 265patientsand289controlstestedwithCytoScan™750K, showednormaltendonreﬂexesbutmuscularhypotonia.On CytoScan™ HD or SNP 6.0™ arrays (Thermo Fisher physical examination (6 months old): height 67 cm (25‰), Scientiﬁc Inc., Life Technologies, Carlsbad, CA, USA) weight 6400 g (<3‰), head circumference 42 cm (10‰). were analyzed using the Chromosome Analysis Suite - The patient was dysmorphic: almond-shaped eyes, narrow ChAS (version 4.0.0.385 (r28959) - Affymetrix®) (hg19) bifrontal diameter, narrow nasal bridge and thin vermilion with ﬁlters set as a minimum of 500 markers and size of of the upper lip, small hands and feet, unilateral cryp- 1,500kb. For complementary investigation, to date, whole torchidism. We performed methylation speciﬁc multiplex exome sequencing (WES) was performed for 4 individuals ligation-dependent probe ampliﬁcation (MS-MLPA) with increased ROH in the genome. (SALSA MLPA Probemix M E028
 Prader Willi/Angelman Results:SinglelargeROH≥10Mbweredetectedin1.9% kit, MRC Holland) of 15q11-q13 region. The analysis of patients compared to 0.3% in the control group. ROH showed 3-7 exons deletion of SNRPN gene with maternal >1% in the autosomal genome was detected in 7.2% of methylation proﬁle. Based on symptoms, clinical exam- patients compared to 1.4% in the control group. WES ination and molecular testing results the diagnosis of Pra- revealed three pathogenic homozygous variants (ASPM, der-Willi syndrome was conﬁrmed. The patient died at CTNS and DHCR7) in one patient with 5.56% of ROH. 8monthsofageduetoinfectioncomplicationsandthereis Conclusion: We found a higher proportion of ROHs in no further data about clinical course of that case. There are individuals with ID and (or) MCA. These results highlight onlyfewreportsaboutintragenicSNRPNgenevariantsthat the importance of investigating ROHs in this group of cause Prader-Willi syndrome. We present 3-7 exons dele- patientswhichwithcomplementarytests,suchasWES,can tion of SNRPN gene as novel, not reported in scientiﬁc improve diagnostic yield. Financial support: CNPq, literature, possible cause of Prader-Willi syndrome. FAPESP(#2018/08890-9), CAPES, FAEPEX-Unicamp. R.Traberg:None.I.Nasvytiene:None.M.Sukys:None. G.R. Correia-Costa: None. S. Spineli-Silva: None. I.C. V. Asmoniene: None. Sgardioli: None. A.P. dos-Santos: None. J.R. Marques- Prota: None. R. Secolin: None. N. Leijsten: None. M.H.A. E- P11
.092 Ruiterkamp-Versteeg: None.N.deLeeuw: None.I.Lopes- Report and investigation of regions of homozygosity in Cendes: None. V.L. Gil-da-Silva-Lopes: None. T.P. the autosomal genome of Brazilian individuals with Vieira: None. intellectual disability and (or) multiple congenital anomalies previously investigated by chromosomal E- P11
.093 microarray analysis A case with novel missense c.425T>C mutation in RIPK4 Gene: Bartsocas Papas Syndrome G. R. Correia-Costa1, S. Spineli-Silva1, I. C. Sgardioli1, A. P. dos-Santos1, J. R. Marques-Prota1, R. Secolin1, A. Yılmaz1, F. I. Karan2, U. Abur3, H. C. Aygün2 N.Leijsten2,M.H.A.Ruiterkamp-Versteeg2,N.deLeeuw2, I. Lopes-Cendes1, 1OndokuzMayısUniversityMedicalFaculty,Departmentof V. L. Gil-da-Silva-Lopes1, T. P. Vieira1 Pediatric Genetics, Samsun, Turkey, 2Ondokuz Mayıs University Medical Faculty, Department of Neonatology, 1Department of Medical Genetics and Genomic Medicine, Samsun, Turkey, 3Ondokuz Mayıs University Medical School of Medical Sciences, State University of Campinas, Faculty, Department of Medical Genetics, Samsun, Tur- Campinas, Brazil, 2Department of Human Genetics, key Radboud University Medical Center, Nijmegen, Nether- lands Backgound:BartsocasPapasSyndrome(BPS)isaformof lethal popliteal pterygium syndrome, caused by homo- Introduction: Regions of homozygosity (ROH) in the zygous mutation in the RIPK4 gene. Although BPS is928 J.delPicchia described lethal, review of the literature reveals individuals presence of a novel likely pathogenic variant, c.1784A>G, who survive into childhood with this condition. p.Tyr595Cys in exon 19. This variant is located in the Case presentation: The patient was born after induction catalyticandribosomaldomainoftheproteinwithahighly due to preeclampsia at 36 weeks gastation. The patient had conserved amino acid. The physico-chemical difference cleftlimb,smallnose,cloudycornea,poplitealandinguinal between Tyrosine and cysteine are very signiﬁcant. The pterygia, complet syndactyly of all ﬁngers and toes, absent variant was identiﬁed in all affected males and carrier of nails, pes equinovarus and ambigious genitale. Abdom- females all displaying clinical features of variable severity, inalandtransfontanelleultrasonographywasnormalandno consistent with CLS. It is noteworthy that most of the congenital heart malformation was detected on echocardio- affected or carrier individuals in the family developed dia- graphic examination. Percutaneous gastrostomy tube was betes type 2; further studies are required for a better deli- placed due to feding difﬁculty and tracheostomy was neation of the disorder and in order to investigate the performed for apropriate follow up. BPS was considered correlation between type 2 diabetes and CLS. with clinical ﬁndings. Next generation sequencing of T. Yammine: None. RIBK4 revealed a novel homozygous missense mutation in exon 2 (c.425T>C; p.Leu142Pro). E- P11
.095 Conclusions: BPS is rare and lethal form of popliteal A novel PIK3R1 mutation in a Chinese female with pterygium sendrome, characterized by cutaneous webbing SHORT syndrome and literature review acrossoneormoremajorjoints,cleftlip/palate,syndactyly, genital hypoplasia, ankyloblepharon, and ectodermal Q. Zhang1, X. Wang1, L. Sun2, Q.Li1, Y. Tang1, Y. Wang1, defects, absent eyelashes and eyebrows, and brittle nails. X. Li1, N. Li3, J. Wang3 Our patient had a novel missense c.425T>C mutation in RIBK4 gene. This mutation is predicted as pathological by 1Department of Endocrinology and Metabolism, Shanghai insilico programs. Missense and nonsense mutationscause Children’s Medical Center, Shanghai Jiaotong University both the lethal and nonlethal recessive forms of multiple School of Medicine, Shanghai, China, 2Department of pterygiumsyndrome,characterizedbysevereorgananoma- Pediatric and Adolescent Gynecology, The Children’s lies of ectodermal origin. Although supportive treatments Hospital of Zhejiang University School of Medicine, can be done life span is short so detection of mutation in Hangzhou, China, Hangzhou, China, 3Department of lethal genetic diseases is very important for prenatal Medical Genetics and Molecular Diagnostic Laboratory, diagnosis and patient management in subsequent Shanghai Children’s Medical Center, Shanghai Jiao Tong pregnancies. University School of Medicine, Shanghai, China A.Yılmaz:None.F.I.Karan:None.U.Abur:None.H.C. Aygün: None. Introduction: SHORT syndrome is a rare genetic disease named with the acronyms of short stature, hyper-extensi- E- P11
.094 bility of joints, ocular depression, Rieger anomaly and Novel missense mutation c.1784A>G, p.Tyr595Cys in teething delay. It is inherited in an autosomal dominant RP S6
KA3 gene responsible for Cofﬁn Lowry Syndrome manner conﬁrmed by the identiﬁcation of heterozygous in a family with variable features and diabetes 2. mutations in PIK3R1. Only 43 cases have been conﬁrmed with gene sequencing in the worldwide. T. YAMMIN E1
,2 Materials and methods: Whole exome sequencing was performed on the patient and sanger sequencing conﬁrmed 1Medical Genetics Unit, Beirut, Lebanon, 2Saint Joseph the variant comparing to her parents. We made a literature University, Beirut, Lebanon review of all reported SHORT syndrome cases online before February 2020, trying to illustrate the genotype- CofﬁnLowrysyndrome(CLS)isanX-linkedraredisorder, phenotype correlations. characterized by cognitive impairment, craniofacial dys- Results: The patient was a 15-year-old female with morphism, digit abnormalities, skeletal malformations, intrauterine growth restriction, short stature, teething delay, paroxysmal movement disorders and cardiac abnormalities. characteristic facial gestalts, hirsutism and thyroid disease. The gene altered in this disease is RP S6
KA3 (ribosomal Sequencing result indicated c.1960C>T, a novel de novo protein  S6
 kinase), located on Xp22.12. Previously identi- nonsense mutation, leading to the termination of protein ﬁedmutationsaredistributedthroughoutthe22exonsofthe translation (p. Gln654*). We also thoroughly reviewed and gene. A large Lebanese family with several affected mem- presented the clinical manifestations of SHORT syndrome bers, was referred to our Medical Genetics Unit for genetic in43patientsaccordingtothemutationsindifferentexons/ evaluation. Analysis of RP S6
KA3gene revealed the introns and in different domains of PIK3R1.Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 929 Conclusions: We reported the ﬁrst patient with SHORT genetic counseling and the risk of recurrence, also for syndrome in China, who was also the ﬁrst patient with establishing the optimal prenatal diagnosis methods thyroid disease. Features described in the acronym of depending on the mechanism of disease. SHORTsyndromearenotuniversallyseen.Thyroiddisease L.Caba:None.R.Popescu:None.N.Gorduza:None.M. may be a new clinical symptom of patient with SHORT Gramescu: None. M. Panzaru: None. M. Vicol: None. C. syndrome although it need more evidence to support. Rusu: None. E. Gorduza: None. Q. Zhang: None. X. Wang: None. L. Sun: None. Q. Li: None.Y.Tang:None.Y.Wang:None.X.Li:None.N.Li: E- P11
.100 None. J. Wang: None. RBM10 (likely) pathogenic variants are associated with a broad phenotypic spectrum, beyond the classic TARP E- P11
.096 syndrome features. The importance of moleculardiagnosisinSilverRussell syndrome for the management of an adult patient C. Kumps1, E. D’Haenens1, S. Vergult1, B. Menten1, J. Leus2, R. Van Coster3, A. Jansen4, K. Devriendt5, L. Caba1, R. Popescu1, N. Gorduza2, M. Gramescu1, A. Oostra6, O. Vanakker1 M. Panzaru1, M. Vicol3, C. Rusu1, E. Gorduza1 1Center for Medical Genetics, Ghent University Hospital, 1UniversityofMedicineandPharmacy“GrigoreT.Popa”, 9000 Ghent, Belgium, 2Medisch Centrum Maria Midde- Medical Genetics Department, Iasi, Romania, 2“St. Spir- lares, 9050 Gentbrugge, Belgium, 3Department of Pedia- idon”Hospital,EndocrinologyDepartment,Iasi,Romania, trics, Division of Pediatric Neurology and Metabolism, 3University of Medicine and Pharmacy "Grigore T. Popa", GhentUniversity,9000Ghent,Belgium,4PediatricNeurol- Bioethics Department, Iasi, Romania ogy Unit, Department of Pediatrics, UZ Brussel, 1090 Brussels, Belgium, 5Center for Medical Genetics, Katho- Introduction: Silver–Russell syndrome (SRS) is a rare lieke Universiteit Leuven, 3000 Leuven, Belgium, 6Depart- disease associated with prenatal and postnatal growth ment of Pediatrics, Division of Pediatric Neurology and retardation, characteristic craniofacial dysmorphic features Metabolism, University Hospital Ghent, 9000 Ghent, (relative macrocephaly, prominent forehead), body asym- Belgium metry and feeding difﬁculties (Netchine-Harbison Clinical Scoring System). SRS is characterized by genetic hetero- Introduction: TARP syndrome (Talipes equinovarus, geneitybecauseitcouldbedeterminedby:hypomethylation Atrial septal defect, Robin sequence and Persistent left of the imprinted control region 1 (ICR1) at 11p15.5, superior vena cava) is a rare X-linked disorder caused by maternal uniparental disomy of chromosome 7 (mUPD7), mutationsintheRBM10gene.Sofar,22patientshavebeen duplications, deletions or translocations involving the reported. We present two novel patients with likely patho- imprintedregionofchromosome7.Wepresentacase with genic RBM10 variants. molecularly conﬁrmed diagnosis of SRS at the age of Case reports: The ﬁrst male proband was born preterm 23 years. with average low birth parameters. Postnatally, a VSD, Materials and methods: The patient was clinically aspeciﬁc brain abnormalities and optical nerve hypoplasia diagnosed at 3 years of age with SRS based on delayed was noted. He displayed facial dysmorphism with tele- prenatal and postnatal growth, relative macrocephaly, canthus, upslanting palpebral ﬁssures, a large mouth with triangular face, prominent forehead, dental malposition, downturned mouth corners and retrognathia. There was a facial and limb asymmetry, bilateral ﬁnger V clinodactyly. growth and development delay. An RBM10 frameshift Thekaryotypewasnormal46,XX.Intime,bonechangesof variant (c.413_416del, p.Ser138Trpfs*60) was identiﬁed, osteoarthritis of the elbow joint, osteopenia, and hypothyr- which was inherited from a mosaic (13%) mother. The oidism were added. At age of 23 years, the patient was second male proband was born preterm with average birth molecularly tested by MLPA technique. We used SALSA measurements. After birth, limb contractures, a pectus MLPA kit M E030
 BWS/RSS (MRC Holland, Amsterdam, carinatum, scoliosis and arachnodactyly were noted. Facial The Netherlands). The MLPA result conﬁrmed the features included frontal bossing, crumpled ears and hypomethylation of H19/IGF2 IG-DMR at 11p15.5. In this microretrognathia. A diagnosis of congenital contractural situation, the recurrence risks in sibs of the proband and in arachnodactyly (CCA) was made based on a FBN2 offspring of the proband are low. missense mutation. Upon follow-up, he displayed severe Conclusions: Although the Netchine-Harbison Clinical growth and developmental delay and brain abnormalities, Scoring System is a sensitive diagnostic scoring system, atypical for CCA. Further investigations revealed a molecular testing is especially important in adulthood for930 J.delPicchia maternallyinheritedc.1888+4A>Csplicesitevariantinthe exome sequencing revealed a de novo heterozygous RBM10 gene, that caused exon 15 skipping. missense variant c.734A>G; p.Tyr245Cys in Conclusion: Initially RBM10 mutations were described TB L1
XR1 gene. inpatientswhofeaturedthefourcardinalfeaturesofTARP Conclusions: We report on a new case characterized by syndrome. However, recurrent clinical characteristics clinical phenotype of PS and de novo missense variant appear to include severe developmental delay, growth c.734A>G in TB L1
XR1 gene. This variant has been prior deﬁciency, heart defects, central nervous system, vision, reported in patient given with developmental delay, short skeletal and facial abnormalities. These 2 additional cases ﬁngers and toes but who does not share distinctive facial illustratethehighlypleiotropicnatureofRBM10mutations, featuresofPS.Hitherto,onlytenpatientswithPShavebeen beyond the classic TARP syndrome features. published. So, our report provided additional clinical and C.Kumps:None.E.D’Haenens:None.S.Vergult:None. molecular data. B. Menten: None. J. Leus: None. R. Van Coster: None. A. A. Serrano Antón: None. M. Sánchez Soler: None. M. Jansen: None. K. Devriendt: None. A. Oostra: None. O. Ballesta Martínez: None. V. López González: None. L. Vanakker: None. RodríguezPeña:None.L.Rausell:None.M.GarcíaHoyos: None. E. Guillén Navarro: None. E- P11
.101 TB L1
XR1gene(#608628)¿Differentphenotypesrelated E- P11
.103 to same variant? Multi-country teamwork to investigate an infant with 45,X/46,X der(Y)t(Y;14), whirl-pooledtype pigmentary A. Serrano Antón1,2, M. Sánchez Soler1,2, M. Ballesta mosaicism, and ambiguous genitalia Martínez1,2, V. López González1,2, L. Rodríguez Peña1,2, L. Rausell3, M. García Hoyos3, E. Guillén Navarro1,2 V.I.RomeroAguilar1,J.Pozo1,A.Llanos2,C.Hubner3,K. Hosomichi4, A. Tajima4 1Sección Genética Médica. Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain, 1Universidad San Francisco de Quito, Cumbaya, Ecuador, 2Grupo Clínico Vinculado al Centro de Investigación 2Department of Genetics, Hospital General de las Fuerzas Biomédica en Red de Enfermedades Raras (CIBERER), Armadas, Quito, Ecuador, 3Institut für humangenetik, Instituto de Salud Carlos III (ISCIII), Madrid, Spain, Universitätsklinikum Jena, Jena, Germany, 4Department 3Departamento de Genética Médica. Instituto de Medicina of Bioinformatics and Genomics, Kanazawa University, Genómica (IMEGEN), Valencia, Spain Kanazawa, Japan Introduction: Pierpont syndrome (PS) is a syndromic Introduction:AnewbornbabywasborninEcuadorfroma intellectual disability that comprises developmental delay, young non-consanguineous couple, with pigmentary shortstature,dysmorphicfeaturesanddistallimbanomalies mosaicism in whirl-pooled hyperpigmentation along the with deep palmar and plantar creases. Recurrent de novo body, ambiguous genitalia with no visible testicles and a missense variant (p.Tyr446Cys) in TB L1
XR1 gene was positive screening for suprarenal hyperplasia. A karyotype identiﬁed as disease-causing. Recently, two patients with showedatrisomy14withanadditionalsectionontheextra Pierpont-like syndrome and different de novo missense chromosome. Trisomy 14 is one of the aneuploidies com- variants in TB L1
XR1 have been reported. patible with live in a mosaic state and many cases of rear- Materials and methods: We describe the case of a 14- rangementswithchromosome14hadbeendescribedinthe year-old girl, born to healthy non-consanguineous parents. literature. The predominant phenotype of trisomy 14 Pregnancy and neonatal period were uneventful. Postnatal mosaicism includes prenatal and postnatal growth failure, growthwithheightateighthcentileandnormalweight.She ear abnormalities, congenital heart disease, developmental presented mild truncal hypotonia with psychomotor and delay and genitourinary abnormalities. Our patient only expressive language delay. She attends to special school shared some of phenotypic characteristics making addi- with major support and speech therapy. Clinical phenotype tional genetic tests compulsory. with narrow palpebral ﬁssures, depressed nasal bridge, Materials and methods: We performed a multi-country broadnose,longupperlipwithﬂatphiltrum,evertedlower teamwork investigation including karyotype in Ecuador, lipandprominentchin.Shortandbroadhandsandfeetwith FISH in Germany and WES in Japan deep-set grooves in his palms and soles. Results:KaryotypeandFISHresultsconcluded45,X/46, Results:BrainMRI,ophthalmologicalexamination,renal X der(Y)t(Y;14). WES identiﬁed no pathogenic nor likely ultrasound, metabolic analysis, Array-CGH, Fragile-X and pathogenic variants in the genes associated to suprarenal targeted exome sequencing yielded normal results. Whole hyperplasiaAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 931 Conclusions:Ourcaseistheﬁrstreportofaninfantwith E- P11
.107 a45,X/46,Xder(Y)t(Y;14). Thepigmentarymosaicism isa Possible effect of the imprinting on the Turner´s common feature on trisomy 14. The ambiguous genitalia phenotype were the result of the mosaicism which included Turner syndrome and an abnormal male cell-line. Finally, even P. Vrtel1, R. Vrtel1, K. Adamova1, D. Vrbicka1, though there was a positive test for suprarenal hyperplasia, M. Prochazka1, J. Stellmachova1, E. Klaskova2, WESanalysisreportedtherewerenodamagingvariantsand J. Zapletalova2, J. Pavlicek3, V. Hana4, V. Stara5, steroids were suspended. O. Soucek5, J. Lebl5 V.I. Romero Aguilar: None. J. Pozo: None. A. Llanos: None. C. Hubner: None. K. Hosomichi: None. A. 1Department of Medical Genetics, University Hospital and Tajima: None. Palacky University, Olomouc, Czech Republic, 2Clinic of Paediatrics, University Hospital and Palacky University, E- P11
.104 Olomouc, Czech Republic, 3Clinic of Paediatrics, Univer- Partial trisomy 1q42.11-q44 clinical and molecular sityHospital,Ostrava,CzechRepublic,43rdDepartmentof cytogenetic characterization. Case presentation Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and E. Braha1, F. Nedelea2, I. Nedelcu1, O. Popa1 General University Hospital, Prague, Czech Republic, 5Department of Pediatrics 2nd Faculty of Medicine, 1National Institute of Endocrinology "CI Parhon", Bucur- Charles UniversityandUniversity HospitalMotol,Prague, esti, Romania, 2Clinical Hospital Filantropia, Bucuresti, Czech Republic Romania Monosomy of chromosome X - Turner syndrome (TS) is Partial 1q trisomy syndrome is an extremely rare chromo- the only monosomy postnatally compatible with life. The somalabnormality,withonlyafewcasesreported.Frequent incidence of this chromosomal abnormality is 1:2500 live features were short stature, multiple minor anomalies, female births. Their phenotype can be very variable. congenital heart defects especially for terminal duplication, Common is low stature, congenital heart defects, renal learning difﬁculty, speech and developmental delay. Our abnormalities etc. Some of these defects correlate with goal is to contribute to clinical observation of 1q terminal karyotype - karyotype 45,X is the most severe. duplication. We report a male infant (4 months old) with Other hypothesis is focused on parental origin of negative family history. Clinical features include intrauter- chromosomeX.Speciﬁcdefectscancorrelatewithpaternal ine growth retardation with short stature at the time of ormaternaloriginofgonosome.Weusedmoleculargenetic clinical evaluation (-2.04 SD), mild facial dysmorphia analysis for detection microsatellite DNA markers on (microretrognathia, thick eyebrows, hypertelorism, short chromosome X to reveal the origin of these gonosome in nose, long smooth philtrum, thin upper lip vermillion, ten- TS patients. tedupper lip,dysplasticearswithsmalltriangularearlobe), We selected cohort of 50 TS patients (plus their parents) atrial septal defect ostium secundum, patent ductus arter- with 45,X karyotype conﬁrmed by karyotype and native iosus, partial 2-3 toe cutaneous syndactyly, little develop- FISH. We also tested patients with 46,XX karyotype (but mental progress (without head control at 4 months). G- Turner phenotype), for hypothesis of maternal X chromo- banded karyotype did not reveal any chromosomal some homology. abnormalities. The breakpoints were characterised by array DNA was isolated from peripheral blood of the patients CGH using the oligoarray platform CytoScan 750K Array, and the cells of the buccal mucosa of the parents. We used Gene Scan 3000 (Affymetrix). Our patient has a partial the Argus X-12QS forensic kit for the X-chromosome duplication of chromosome 1 between 1q42.11-q44 of analysis, which was optimized for our genetic testing. The 24.72 Mb in lenght (nucleotides 224,499,474 - method is based on detection of 12 STR markers from 249,224,684) according to NCBI 37/hg19. The parents chromosome X. karyotype was normal and FISH tests (for breakpoint) is to Results suggest that 70 % of X chromosomes are of beperformed.Inconclusionwereporta4months-oldmale maternal origin and 30 % cases of paternal origin. The with the distinctive clinical features and probably de novo origin of X chromosome in 46,XX cohort was biparental. 1q42.11q44 duplication without parental chromosomal The next part of our project will be a correlation speciﬁc abnormalities. The case requiers long-term medical follow- heart defects and renal abnormalities with the origin of up for other clinical particulaties highlighted with aging. gonosome. Supported by MH CZ - DRO (FNOl, E. Braha: None. F. Nedelea: None. I. Nedelcu: None. O. 00098892) and grant nr. 17-29111A Popa: None.932 J.delPicchia P. Vrtel: None. R. Vrtel: None. K. Adamova: None. D. presence of a residual mosaic trisomy 16 was excluded by Vrbicka: None. M. Prochazka: None. J. Stellmachova: karyotype analysis and FISH. None.E.Klaskova:None.J.Zapletalova:None.J.Pavlicek: Conclusions:Thisisanadditionalcaseofthephenotypic None.V.Hana:None.V.Stara:None.O.Soucek:None.J. characterization of UPD(16)mat. To date, it isthe ﬁrst time Lebl: None. that an unroofed coronary sinus is described within cardiac malformations associated with UPD(16)mat. Moreover, E- P11
.110 according to literature data, it conﬁrms the need to extend Uniparental disomy of chromosome 16: a case report follow-up. with a new cardiac malformation F. Di Palma: None. M. Goldoni: None. E. Marchionni: None. B. Caravale: None. M. Mondovì: None. G. F. Di Palma1, M. Goldoni2, E. Marchionni1, B. Caravale3, Mastromoro: None. D. Guadagnolo: None. P. Versacci: M. Mondovì3, G. Mastromoro1, D. Guadagnolo1, None. V. D’Ambrosio: None. A. Giancotti: None. L. P.Versacci4,V.D’Ambrosio5,A.Giancotti5,L.Bernardini6, Bernardini: None. A. Pizzuti: None. A. Pizzuti1 E- P11
.111 1Department of Experimental Medicine, Sapienza Univer- ClinicalanalysisVACTERL/VACTERcasesatchildren sity, Rome, Italy, 2Medical Genetics Unit, Casa Sollievo hospital in Bogotá, Colombia della Sofferenza IRCCS Foundation, San Giovanni Rotondo, Italy, 3Department of Developmental and Social J. S. Rincon Redondo1, I. Rueda1, Y. Ladino2,3, Psychology,SapienzaUniversity,Rome,Italy,4Department M. C. Cuellar1, L. A. Gonzalez1, C. M. Restrepo4, of Pediatrics, Sapienza University, Rome, Italy, 5Depart- O. I. Beltran1,2 ment of Maternal and Child Health and Urologic Science, Sapienza University, Rome, Italy, 6Medical Genetics Unit, 1Facultad de Medicina, Universidad Militar Nueva Gran- Casa Sollievo della Sofferenza IRCCS Foundation, San ada, Bogotá DC, Colombia, 2Grupo GenHOMI, Hospital Giovanni Rotondo, San Giovanni Rotondo, Italy Pediátrico de la Misericordia, Bogotá DC, Colombia, 3Maestría en Genética Humana, Universidad Nacional de Introduction:Maternaluniparentaldisomyofchromosome Colombia, Bogotá DC, Colombia, 4Unidad de Genética y 16[UPD(16)mat]isthemostoftenreportedUPDotherthan Genómica,CIGGUR,EscueladeMedicinayCienciasdela UPD(15). In literature there is not a speciﬁc phenotype Salud, Universidad del Rosario, Bogotá DC, Colombia associated with upd(16)mat and few follow-up data are reported. Introduction: The VACTER-L/VATER association has Materials and methods: We present the case of a 1-y.o. been divided on three subtypes to improve clinical classi- male of a healthy non-consanguineous parents. In prenatal ﬁcation and epidemiologic analysis. It is an acronym that diagnosis IUGR, polydramnios and single umbilical artery corresponds to a group of diverse and complex malforma- was reported. He born late preterm, small for gestational tions that was initially described as the non-random age, and showed facial dysmorphisms and congenital occurrence of ﬁve anomalies together. malformations (esophageal atresia, cardiac defects, mild Methods: Descriptive study of case series of children bone alterations, hypospadias). Transesophageal echocar- with VACTER-L/VACTER diagnosis (using the criteria diography detected persistency of left superior vena cava and classiﬁcation of the EUROCAT) at Hospital Pediátrico draining into the left atrium through an unroofed coronary de la Misericordia (April 2009-December 2016) approved sinus. Brain ultrasound showed dilated and asymmetric by institutional ethical committee. Statistical analysis done lateral ventricles. At present, cognitive and language SPSS program. abilities are adequate for age but he has mild gross motor Results: Preliminary selection of 13 patients, one was delay. Genomic DNA was extracted from peripheral blood excluded. The male: female ratio was 1,4, age range and analyzed by SNP-array (Cytoscan HD; Thermo Fisher (3 months - 9 years old), 1 case had family history of ﬁrst- Scientiﬁc). degreeconsanguinity,1casehadseconddegreeconsangui- Results: SNP-array analysis showed a 147 Kb homo- nity,andotherhadboth.FourpatientshadVACTER-LIKE, zygous 16p13.3 microdeletion and a 114 kb 16q24.3 three patients presented VACTER-STRICT, and ﬁve microtriplication, both segregated from the mother. Region showed VACTER-PLUS diagnosis. Phenotypes were: VC, of Homozigosity (ROH) analysis showed two ROH of 7 ATE, VR, VAT, VTL, ACR, VCR, VAC, VACR (X2), and 13 Mb on chromosome 16 compatible with the VCTRL, and VACRL. Additional anomalies in patients presence of UPD(16) of maternal origin. The possible withVACTER-PLUSincluded:microtia,hemifacialmicro- somia, myelomeningocele, structural SNC malformation,Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 933 these four had more than one anomaly. Eight patients had of the proband (Lennox et al., bioRxiv, 2018). F2: two cytogenetic analysis (all normal) and only one case had siblings were suspected to have Ochoa Syndrome (AR), normal sequencing exome. characterized by congenital urinary bladder dysfunction. In Conclusions: VACTERL/VACTER association has a both sibs, the analysis revealed the novel homozygous typical wide clinical variability, which was evident in our splicing variant c.1478-2A>G in the LRIG2 gene (OMIM series. Consanguinity was a relevant factor, as forth part of #608869), associated with Ochoa Syndrome. This variant the patients had it. VACTERL/VACTER has been probablyaltersthepropersplicingmechanism,leadingtoan extensively characterized by the 6 deﬁned anomalies; aberrant mRNA maturation and unfunctional protein nevertheless, diagnosis is not simple in VACTER-PLUS (ongoing experiments). Our report expands the genotypic phenotype,asthesecasesmightpresentwithco-occurrence spectrumofthepathogeneticvariantsofDDX3XandLRIG2 of multiple pathologies, atypical presentation of relatively disease-genes. In these cases, WES approach allowed us to common diseases or misdiagnosis. get closer to the end of these diagnostic odysseys. J.S. Rincon Redondo: None. I. Rueda: None. Y. Ladino: G. Moresco: None. O. Rondinone: None. A. Mauri: None. M.C. Cuellar: None. L.A. Gonzalez: None. C.M. None.C. Santaniello:None.J.Costanza:None.B.Rinaldi: Restrepo: None. O.I. Beltran: None. None. E. Rosina: None. P. Colapietro: None. S. Tabano: None. L. Fontana: None. D. Milani: None. M. E- P11
.113 Miozzo: None. Whole Exome Sequencing in unsolved pediatric cases E- P11
.115 G.Moresco1,O.Rondinone1,A.Mauri1,C.Santaniello1,J. A novel de novo frameshift mutation in SM C1
A gene Costanza1, B. Rinaldi2, E. Rosina2, P. Colapietro3, responsible for Cornelia de Lange syndrome 2 S. Tabano3,4, L. Fontana1, D. Milani2, M. Miozzo1,3 R. Szalai1,2, J. Bene1,2, L. Magyari1,2, A. Maasz1,2, 1Coordination Research Laboratories Unit, Fondazione A. Düh1,2, A. Till1,2, K. Hadzsiev1,2, B. Melegh1,2 IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milano, Italy, 2Highly Intensive Pediatric Care Unit, 1University of Pecs, Clinical Center, Department of Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Medical Genetics, Pecs, Hungary, 2Szentagothai Research Policlinico, Milano, Italy, 3Department of Pathophysiology Center, University of Pecs, Pecs, Hungary and Transplantation, Università degli Studi di Milano, Milano, Italy, 4Laboratory of Medical Genetics, Fonda- Introduction: Cornelia de Lange syndrome (CdLS) is a zione IRCCS Ca Granda Ospedale Maggiore Policlinico, clinically heterogeneous developmental disorder character- Milano, Italy ized by malformations affecting multiple systems. CdLS have been reported in children with mutations of NIPBL, Children suffering from undiagnosed diseases with a pos- SM C1
A, SM C3
A, RAD21, and HDA C8
 genes. Although, sible genetic origin underwent Whole-Exome Sequencing the appearance of classic CdLS is well-characterised, the (WES) to disclose the causative variant. We evaluated phenotypic traits of individuals with various SM C1
A twenty-two cases resulted negative to aCGH and kar- mutations have some similarities, but have other features yotyping and found the causative lesion in four of them. that make them different from classic CdLS (e.g., small Herein, we describe two paradigmatic solved cases: one hands but no limb reductions or oligodactyly, prominent withoutanydeﬁniteclinicalsuspicion(F1),andtheotherin intellectual disability and seizures despite milder structural which the diagnosis was suggested (F2). Libraries were malformations, and a high rate of isolated cleft palate). prepared using the SureSelectQXTClinical Research Exome Materials and methods: We present a patient with V2 kit (Agilent) on blood samples collected from patients CdL S2
features,includingprogressivemicrocephaly,severe and family members, and were run on NextSeq550 instru- psychomotor retardation, feeding difﬁculties, therapy resis- ment (Illumina). F1: the female proband presents delayed tant epilepsy, lack of expressive speech, nearsightedness, psychomotor development, polymicrogyria, gastro- high arched palate and abnormal palmar creases. Whole esophageal reﬂux and facial dysmorphisms. The analysis Exome Sequencing (WES) analysis was performed using identiﬁed the novel de novo missense variant c. C625
G:p. Agilent SureSelectXT library kit and Illumina sequencing H209D in the DDX3X gene, an ATP-dependent RNA technology. Sanger sequencing conﬁrmed the presence of helicase involved in neurogenesis. Mutations in DDX3X the pathogenic variant. were described as causative of X-Linked Dominant Mental Results: WES analysis identiﬁed a c.3237_3238insT (p. Retardation (OMIM #300958) and variants mapping in the Asn1080*) pathogenic variant in SM C1
A gene in a samedomainareassociatedtothespeciﬁcphenotypictraits heterozygous state. This alteration is a frameshift variant934 J.delPicchia with a resulting stop codon leading to nonsense-mediated (exones 18, 19, 20, 21) and PIK3CA (A3140T, A3140G, mRNAdecayandlossoffunction,hasneverbeenreported.  C3139
T)SensiScreen®aswellasSNaPshotmultiplexassay Conclusions: The features of Cornelia de Lange for activating FGFR3 mutations and MLPA for CDKN2A syndrome vary widely, there are 5 distinct subgroups CNVs were performed. (CdL S1
-5) according to the phenotype and affected genes. Resultsanddiscussion:FortheEGFRandPIK3CAonly HerewereportapathogenicframeshiftSM C1
Amutationin wild type of the tested genetic variants were detected. a Hungarian patient with ﬁtting but unique phenotype Mutations in FGFR3 were found in 50 % from the tested characteristics of Cornelia de Lange syndrome 2, still tumors: 65% -  S249
C, 30% Y375C and 5% G372C. representing a novel phenotypic variant, as well. Mutations in CDKN2A were detected in 37,5 % from the R. Szalai: None. J. Bene: None. L. Magyari: None. A. tested tumors: 53,3% - homozygous deletions, 40% Maasz: None. A. Düh: None. A. Till: None. K. Hadzsiev: heterozygous deletions and 6,7% duplications. None. B. Melegh: None. Conclusion: The overexpression of the EGFR and PIK3CA was not found to be related to tested mutations E- P12
 Cancer Genetics and so far these two molecules are not convenient for bladder cancer targeted therapy. On the other hand the E- P12
.07 overexpression of FGFR3 and CDKN2A could be due to Genotyping of urinary bladder carcinomas for up- detected mutations. regulated EGFR, PIK3CA, FGFR3 and CDKN2A to Acknowledgements:BGNSFGrantsNoKP-06-OPR01/ determine the potential for targeted therapy 3-2018, MANU-BAN. O.S. Antonova: None. S. Rangelov: None. B. Mladenov: O. S. Antonova1, S. Rangelov2, B. Mladenov3, None. Z. Hammoudeh: None. D. Nesheva: None. O. Z. Hammoudeh1, D. Nesheva1, O. Ivanovski4, S. Saidi4, Ivanovski: None. S. Saidi: None. G. Petrusevska: None. G. Petrusevska5, C. Slavov6, A. Dimovski7, Z. Yordanova8, C.Slavov:None.A.Dimovski:None.Z.Yordanova:None. D. Plaseska-Karanﬁlska7, Z. Popov4, A. Galabov9, D. Plaseska-Karanﬁlska: None. Z. Popov: None. A. D. Toncheva1 Galabov: None. D. Toncheva: None. 1Department of Medical Genetics, Medical University of E- P12
.08 Soﬁa, Soﬁa, Bulgaria, 2Department of Urology, University Germline variants in cancer-associated genes in pedia- Hospital ISUL-Tsaritsa Yoanna, Soﬁa, Bulgaria, 3Depart- tric and young adult patients with brain tumors ment of Urology, UMBALSM “N. I. Pirogov”, Soﬁa, Bulgaria, 4University Clinic of Urology University of St. T. S. Lisitsa1,2, V. V. Semenova1, A. A. Mitrofanov3, Cyrilius and Methodius, Skopje, Macedonia, The Former E. V. Zhukovskaya1, A. F. Karelin1, V. N. Kasatkin1, Yugoslav Republic of, 5Institute of pathology, Medical T. V. Nasedkina1,2 faculty,Skopje,Macedonia,TheFormerYugoslavRepublic of, 6Department of Urology, University Hospital ISUL- 1Dmitry Rogachev National Medical Research Center Of Tsaritsa Yoannaf Soﬁa, Soﬁa, Bulgaria, 7Research Center Pediatric Hematology-Oncology and Immunology, Mos- for Genetic Engineering and Biotechnology “Georgi D. cow, Russian Federation, 2Engelhardt Institute of Molecu- Efremov”, Macedonian Academy of Sciences and Arts, lar Biology, Russian Academy of Sciences, Moscow, Skopje, Macedonia, The Former Yugoslav Republic of, Russian Federation, 3N.N. Blokhin National Medical 8University of National and World Economy, Soﬁa, Research Center of Oncology, Moscow, Russian Federa- Bulgaria, 9The Stephan Angeloff Institute of Microbiology, tion Bulgarian Academy of Sciences, Soﬁa, Bulgaria Introduction: Pediatric and young adult brain tumors are Background:The aim of our study was to identify muta- oftenassociatedwithcancerpredispositionsyndromes.The tional status of the uroepithelial bladder cancer samples for knowledgeofspeciﬁcmutationsincancer-associatedgenes previously detected by us overexpression of EGFR, may alter the management of the cancer, offer novel tar- PIK3CA,FGFR3andCDKN2Agenesinordertodetermine geted therapies and enable early detection of other the potential for targeted therapy. malignancies. Materials & Methods: Tumour samples from 66 Patients and Мethods: Twenty-four patients with brain patients, staged pTa - T4 were collected. The epidemiolo- tumorsaged5-22yearswereenrolledinthestudy,15boys gicaldatarelatedtoage,gender,recurrence,smokinghabits and9girls.Astrocytomawasthemostcommonhistological and occupational exposure were taken from patients’ type (n=10), followed by medulloblastoma (n=6), low- questionarie. RT-PCR for mutation detection in EGFR grade glioma (n=3), ependymoma (n=2),Abstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 935 craniopharyngioma (n=1), ganglioglioma (n=1), pine- gene mutations. The most common pathogenic mutations oblastoma (n=1). Genomic DNA was isolated from were c.5266dupC, c.3624dupA and c.5444G>A in BRCA1 peripheralbloodleukocytesandnext-generationsequencing and c.67+1G>A in BRCA2. Sixty-one variants with on the NextSeq500 Illumina platform was performed. A unknown signiﬁcance(VUS),mostlymissensevariants,were multigene panel included coding sequences of 132 cancer- identiﬁed and the vast majority of them were in BRCA2 associated genes. The library was prepared using enrich- gene. In MLPA analyses seven gross deletions in BRCA1 mentbyhybridizationwithNimbleGenprobes(Roche).For were detected. The most common gross deletion in BRCA1 theanalysis ofNF1 large rearrangements MLPA assay was gene was exon 18-19 deletion. No gross deletion was performed. detected in BRCA2 gene. Four novel mutations in BRCA1 Results: In total, six patients carried NF1 mutations: andﬁvenovelmutationsinBRCA2 genewereidentiﬁed.In frameshift deletions (n=3), nonsynonymous missence two of 5 patients with both breast and ovarian cancer, (n=2) or nonsense (n=1) mutations. Patients with NF1 BRCA1 pathogenic mutation was detected and this was the mutations had optic pathway glioma (n=3), pylocytic highest mutation rate group. Among ten postmenopausal astrocytoma (n=2) and brain stem tumor (n=1). sporadic breast cancer patients, one had BRCA1 pathogenic Three patients also had clinical features of neuroﬁbroma- mutation. This rate was higher than premenopausal breast tosis type 1, but no NF1 variants were revealed. Other cancer patients’ rate with family history. This study deter- ﬁndings included likely pathogenic variants in APC and minesthevariantsofBRCAgenes,theirfrequenciesandtheir CHEK2 genes. The results were validated by Sanger clinicalsigniﬁcanceinTurkishpopulation.Also,theseresults sequencing. showed that screening indications for BRCA should be Conclusion: Germline variants associated with cancer reviewed. were found in one-third of our patients, one-fourth had the E.A.Ateş:None.C.Alavanda: None.H.Polat: None.A. mutations in NF1 gene. Thus, molecular analysis is Turkyilmaz: None. M.A. Soylemez: None. B.B. Geckinli: important to reveal NF1-associated brain tumors for None. A.I. Guney: None. accuratediagnosisofthediseaseandpersonalizedapproach to treatment including targeted therapies. E- P12
.11 T.S. Lisitsa: None. V.V. Semenova: None. A.A. Mitro- The potential of Dendrosomal curcumin (DNC) as a fanov:None.E.V.Zhukovskaya:None.A.F.Karelin:None. therapeutic agent for modulating the expression of p53 V.N. Kasatkin: None. T.V. Nasedkina: None. in both wild type and mutant type cancer cells E- P12
.09 m. montazeri1, Y. Pilehvar Soltanahmadi2, N. Zarghami3, Characterization of BRCA Genes’ Variants in Turkish M. Sadeghizadeh4 HereditaryBreastandOvarianCancer(HBOC)Patients 1Department of Medical Biotechnology, Faculty of E.A.Ateş1,C.Alavanda2,H.Polat2,A.Turkyilmaz3,M.A. Advanced Science and Technology, Tehran Medical Soylemez2, B. B. Geckinli2, A. I. Guney2 Sciences, Islamic Azad University, Tehran, Iran, Tehran, Iran, Islamic Republic of, 2Cellular and Molecular 1Marmara University Pendik and Research Hospital, Research Center, Research Institute for Cellular and MedicalGenetics Department, Istanbul, Turkey, 2Marmara MolecularMedicine,UrmiaUniversityofMedicalSciences, University School of Medicine, Medical Genetics Depart- Urmia,Iran,Urmia,Iran,IslamicRepublicof,3Department ment, Istanbul, Turkey, 3Erzurum Region Training and of Medical Biotechnology, Faculty of Advanced Medical Research Hospital, Medical Genetics Department, Sciences, Tabriz University of Medical Sciences, Tabriz, Erzurum, Turkey Iran, Tabriz, Iran, Islamic Republic of, 4Department of Genetics, School of Biological Sciences, Tarbiat Modares Breast cancer is the most common cancer among women. University, Tehran, Iran, Tehran, Iran, Islamic Republic BRCA genes are associated with %10-15 of all breast can- of cers.Sixhundred-fourpatientswhich169ofthemhadfamily history and 435 had breast and/or ovarian cancer, applied to The effect of Dendrosomal curcumin (DNC) on the our clinic. After anamnesis, pedigree analyses and physical expression of p53 in both p53 mutant cell lines SKBR3 examinations, BRCA genes were sequenced via Next-Gen- andp53wild-typeMCF7inboth RNAandproteinlevels, eration Sequencing(NGS) for all patients. Except from 67 and also cell cycle distribution and apoptosis. Curcumin patients with pathogenic mutations in BRCA genes, MLPA derived from rhizome of Curcumin longa modulates key analysiswasplannedforallpatients.Amongpatientsthathad signaling pathways in cellular processes, therefore, it is pathogenic mutation, 36 had BRCA1 and 31 had BRCA2 recentlyconsideredincancerrelatedresearchesforitscell936 J.delPicchia growth inhibition properties against human tumors. It is percentofaffectedindividualswereER/PR[1]positive,and evidenced that p53 is the most common tumor-suppressor theother30%ER/PRnegative. Quantitativeanalysisofthe gene involved in human cancers. Its mutation not only EAF1 & EAF2 gene expression in two sample groups inhibits tumor suppressor activity but also promotes (tumor&normal)wasperformedbyReal-time-PCR(cyber- oncogenic activity. Toxicity of DNC was studied using green method). The expression of the EAF1 & the EAF2 MTT assay and cell cycle distribution, apoptosis study. genes was in tumor tissue compared to normal samples Real-time PCR and Western blot analysis were used to signiﬁcantly decreased (fold change= -5.7 for the EAF1 analyze the expression of p53, and other apoptosis related gene [p=0.000] & -4.4 for the EAF2 gene [0.034]). Lower proteins. DNC treatment during the time increased the expression of the both mentioned genes is apparently cells in the SubG1 and gradually decreases them in the associated with negative prognosis of breast cancer. G1, S and G2/M phases, the percentages of early [1] ER: estrogen receptor & PR: progesterone receptor apoptosis also indicated the inhibition of cell growth S. Heydaran: None. M. Moghanibashi Mansurieh: None. in early phase. Real-Time PCR showed an increased S. Naeemi: None. mRNA expression of BAX, Noxa and p21 during the time with decreased expression of Bcl-2. The expression E- P12
.15 of p53 mutant decreased in SKBR3, and the expression Age depending prevalence of RUNX3, BRCA1 genes of p53 wild-type increased in MCF7 cells. Consequently, comethylation among female breast cancer case DNC can drive the tumor cell lines toward the apoptosis by modulating the expression of genes involved in N. Medvedieva1, O. Lobanova2, Z. Rossokha1, apoptosis and proliferation, furthermore, this study sug- V. Vershyhora1, V. Cheshuk2, R. Vereshchako2, gest p53 plays an important role in mediating the survival N. Gorovenko3 by DNC. M.montazeri:None.Y.PilehvarSoltanahmadi:None.N. 1SI Reference Centere For Molecular Diagnostic of Public Zarghami: None. M. Sadeghizadeh: None. Health Ministry of Ukraine, Kyiv, Ukraine, 2Bogomolets National Medical University, Kyiv, Ukraine, 3P.L. Shupyk E- P12
.13 National Academy of Postgraduate Education, Kyiv, The expression level of the EAF1 & the EAF2 genes is Ukraine signiﬁcantlydecreasedinIranianbreastcancerpatients Introduction: Genes comethylation is important pathways S. Heydaran, M. Moghanibashi Mansurieh, S. Naeemi of epigenetic mechanisms in the risk of breast cancer development. Hypermethylation of RUNX3 and BRCA1 department of Genetics, Islamic Azad university, Kazerun, genes is involved in disrupted oncosuppression process Iran, Islamic Republic of among breast cancer cases. But no so much known about their co-inﬂuences on breast cancer (BC) risk in different Breast cancer death rate is increasing annually in Iran, and age. Aim of the study was to evaluate RUNX3, BRCA1 early diagnosis is important to reduce the mortality rate. genes age depending comethylation status. Besidegeneticpredisposition,environmentalfactorsarethe Materials and methods: Tumor tissue of 52 BC female most known risk factors. The EAF1 & the EAF2 tumor patients was obtained during surgery. Patients (mean age suppressor genes belong to the ELL family, locating on 53.05±1.86)subdivideddependingofage:Group1(25-44 chromosome3inthehumangenome,whichantagonizethe years), Group 2 (45-60 years), Group 3 (61-85 years). Wnt/β-catenin signaling pathway in different cell lines by Obtained tumor was tested for BRCA1 and RUNX3 gene suppressing the tumorigenic activity. The change of the methylation status.Tumor samples saved using DNA/RNA expressionleveloftheEAF1&theEAF2genesisreported Shield.DNAextractedwithQuick-DNAMiniprepPlusKit. inothercancertypessuchasintestinalandblood.Here,we Bisulﬁde conversion was done by dint of EZ DNA investigated the fold change of these mentioned genes in Methylation-Gold Kit. Converted DNA with methyl- breast cancer (invasive ductal carcinoma: IDC) in Iranian speciﬁc primers was used for PCR analysis. patients. Forty Tumor and marginal normal tissues from Results: No signiﬁcant differences were found for breastcancerpatients(gradeI16%,gradeII58%,andgrade RUNX3 gene methylation. Patients of Group 1 had III 25%) were collected during surgery with immediately signiﬁcantly higher methylation status (41.2%) in BRCA1 treatment of RNA later. All selected patients were HER2 gene compared to patients of Group 2 (25%) and Group 3 positive, with an average age of 56 years old. Seventy (26.6%), respectively. Comethylation of hypermethylatedAbstractsfromthe53rdEuropeanSocietyofHumanGenetics(ESHG)Conference:e-Posters 937 BRCA1/RUNX3 was signiﬁcantly prevalence also among and CCa among women from Republic of North Group 1 compared to others (Table). Macedonia. Conclusions: Higher hypermethylated BRCA1/RUNX3 Methods: Using amultiplexPCR SNaPShotanalysiswe genes status was found among young patients (aged 25-44 genotyped rs1042522 and rs2279744 in 131 women with years). Further careful studies are needed to understand CIN or CCa and 110 cytologicaly negative women. cometylation effect of investigated genes on early breast Results: No signiﬁcant difference in either genotype or cancer development. allelic frequencies for rs1042522 and rs2279744 between cases and control was found. Stratiﬁcation of the cases based on grade of the lesion, revealed lower frequency of Methylationstatus RUNX3hypermethylation RUNX3unmethylation CCgenotypeandCalleleofrs1042522inCIN2+andCCa Group1(25-44years)17patients compared to CIN1 [GG vs CC; p=0.001, OR=0.4; CG vs BRCA1 41.2% 5.9% CC; p=0.04, OR=0.03 and CG+ GG vs CC; p=0.004, hypermethylation OR=0.2]. Furthermore, GG genotype and G allele of BRCA1 41.2% 11.7% rs2279744showedsigniﬁcantlylowerfrequencyinCIN2+ unmethylation and CCa cases then in CIN1 [G vs T p=0.02, OR=0.52; Group2(45-60years)20patients GG vs TT; p=0.04, OR=0.29; ТТ vs ТG+GG; p=0.007, BRCA1 25% 0 OR=0.34]. hypermethylation Conclusion: The Arg variant of rs1042522 and T allele/ BRCA1 60% 15% TT genotype of rs2279744 are associated with progression unmethylation of CIN1 to CIN2+ or CCa and may be used as prediction Group3(61-85years)15patients markers in CCa management. Still, clinical importance of BRCA1 26.6% 6.7% hypermethylation these variants warrants further validation in more compre- BRCA1 60% 6.7% hensive studies. unmethylation S. Duvlis: None. D. Dabeski: None. D. Plaseska- Karanﬁlska: None. N.Medvedieva:None.O.Lobanova:None.Z.Rossokha: E- P12
.21 None. V. Vershyhora: None. V. Cheshuk: None. R. Monitoring circulating tumor DNA in a breast cancer Vereshchako: None. N. Gorovenko: None. patient to provide real-time cancer progression information E- P12
.19 Impact of T P53
 (rs1042522) and MDM2 (rs2279744) L. C. Liu1, C. C. Hung2, T. K. Lin2,3, C. W. Yeh4, polymorphisms on cervical intraepithelial lesions and C. W. Huang4, Y. N. Su2,5 cervical cancer in North Macedonian women 1DepartmentofMedicine,CollegeofMedicine,ChinaMedical S. Duvlis1, D. Dabeski2, D. Plaseska-Karanﬁlska3 University, Taichung, Taiwan, 2Soﬁva Genomics Co., Ltd., Taipei, Taiwan, 3Graduate Institute of Clinical Medicine, 1Institute of public health of Republic of North Macedonia, College of Medicine, National Taiwan University, Taipei, Skopje, Macedonia, The Former Yugoslav Republic of, Taiwan, 4National Center for High Performance Computing, 2Clinic for gynecology and obstetrics, Clinical center National Applied Research Laboratories, Hsinchu, Taiwan, "Majka Tereza", Skopje,Macedonia,TheFormerYugoslav 5Dianthus Maternal Fetal Medicine Clinic, Taipei, Taiwan Republicof,3ResearchCenterforGeneticEngineeringand Biotechnology "Georgi D. Efremov", Skopje, Macedonia, Background:Liquidbiopsyisamini-invasivetestandeasyto The Former Yugoslav Republic of get specimen for cancer progression information based on circulating tumor DNA (ctDNA). In this study, we analyzed Introduction: Variant in cell cycle regulation genes may ctDNA dynamics and aim to push liquid biopsy toward clin- inﬂuenced cervical intraepithelial lesions (CIN) and malig- ical practice. nantprogressiontocervicalcancer(CCa).Singlenucleotide Method: We used next-generation sequencing (NGS)- polymorphisms (SNPs) rs1042522 within the codon 72 of based panel assay and molecular barcoding technology to T P53
 and rs2279744 within MDM2 promoter genes are analyzevariantsin197genes.Weexaminedabreastcancer plausible factors that could have impact on cervical carci- patient after surgery and frequently monitoring of ctDNA. nogenesisconferringincreasedattenuationofp53pathway. Results:InApril2017,ERBB2c.2264T>C(2.00%)was WeinvestigatedtheassociationoftheseSNPswiththeCIN detectedinctDNAaswellasERBB2c.2664T>C(70.56%)938 J.delPicchia andPIK3CAc.1634A>C (22.93%)weredetected intissue and poorly differentiated tumor cells more frequently than of the patient. After seven months, ERBB2 c.2264 T>C patientswith Pro/Ala genotype(p=0.01). Ouranalysisalso (9.00%)andPIK3CAc.1634A>C(0.76%)weredetectedin revealed that colon cancer was more frequent than rectal in ctDNA, and it seems the therapy did not work. The patient carriers of UC P2
 +3474 ins allele (p=0.02). Also, carriers was suggested to change other chemotherapy and targeted of ins allele had distant metastases more frequently than therapy. Three months later, ERBB2 c.2264 T>C (0.59%), patients with del/del genotype (p=0.024). PIK3CA c.1625 A>C (0.04%) and PIK3CA c.1634 A>C Conclusion: Our ﬁndings indicate that there is an (0.07%) were detected in February 2018. Then we follow association between PPARG gene Pro/Ala polymorphism the cancer genetic status every 1-2 months for the patient and tumor cells differentiation and UC P2
 gene +3474 ins/ with given the same treatment. For ERBB2 c.2264T>C in del polymorphism with tumor location and the presence of particular, the mutation rates were shown 0.56%, 0.68%, distant metastases in CRC patients. 1.96% and 3.48%, respectively. Key words: Colorectal cancer, PPARɣ, UC P2
 Conclusion: Using liquid biopsy to monitor ctDNA E.M.N.D. Ajaj: None. dynamicsaftersurgerymaybehelpfulforpatienttoestimate prognosis. The liquid biopsy can be used to monitor E- P12
.31 treatment effect in patient who receive cancer therapies. MGMT methylation status in glioblastomas multiforme L.C.Liu:None.C.C.Hung:A.Employment(fullorpart- time); Signiﬁcant; Soﬁva Genomics, Co., Ltd. T.K. Lin: A. A. V. Antonets, Y. G. Yakovlenko, S. V. Mordanov, Employment (full or part-time); Signiﬁcant; Soﬁva Geno- A. A. Tushev, V. A. Moldovanov, V. Y. Deribas, micsCo.,Ltd..C.W.Yeh:None.C.W.Huang: None.Y.N. S. S. Todorov Su: A. Employment (full or part-time); Signiﬁcant; Soﬁva Genomics Co., Ltd.. Rostov Medical State University, Rostov-on-Don, Russian Federation E- P12
.24 Analysis of PPARG and UC P2
